1	The	DT	O	the	det	3	SENT_1	[p1l1030t81r1080b105],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_1	[p1l1094t81r1364b112],
3	Journal	NNP	O	Journal	dep	6	SENT_1	[p1l1376t81r1474b105],
4	(	JJ	O	(	dep	3	SENT_1	[p1l1489t81r1572b109],
5	2013	CD	DATE	2013	dep	6	SENT_1	[p1l1489t81r1572b109],
6	)	CD	NUMBER	)	dep	9	SENT_1	[p1l1489t81r1572b109],
7	13	CD	NUMBER	13	dep	6	SENT_1	[p1l1588t82r1624b109],
8	,	,	O	,	_	0	SENT_1	[p1l1588t82r1624b109],
9	403-409	CD	NUMBER	403-409	_	0	SENT_1	[p1l1636t82r1759b105],
10	@	SYM	O	@	dep	12	SENT_1	[p1l2091t83r2154b143],
11	©	CD	NUMBER	©	num	12	SENT_1	[p1l1031t125r1053b147],
12	2013	CD	DATE	2013	dep	18	SENT_1	[p1l1064t124r1122b147],
13	Macmillan	NNP	ORGANIZATION	Macmillan	nn	15	SENT_1	[p1l1136t122r1260b147],
14	Publishers	NNPS	ORGANIZATION	Publishers	nn	15	SENT_1	[p1l1274t122r1398b147],
15	Limited	NNP	ORGANIZATION	Limited	dep	12	SENT_1	[p1l1411t122r1501b147],
16	All	DT	ORGANIZATION	all	det	17	SENT_1	[p1l1534t122r1563b146],
17	rights	NNS	O	rights	nsubj	18	SENT_1	[p1l1577t122r1645b153],
18	reserved	VBD	O	reserve	dep	9	SENT_1	[p1l1658t122r1761b147],
19	1470-269X	NN	O	1470-269x	dobj	18	SENT_1	[p1l1776t123r1944b148],
20	/	:	O	/	punct	21	SENT_1	[p1l1776t123r1944b148],
21	13	CD	NUMBER	13	dep	18	SENT_1	[p1l1776t123r1944b148],
22	www.nature.coml	JJ	O	www.nature.coml	amod	24	SENT_1	[p1l1030t185r1331b216],
23	tpj	NN	O	tpj	nn	24	SENT_1	[p1l1030t185r1331b216],
24	omamm	NN	O	omamm	dep	21	SENT_1	[p1l6t291r228b326],
25	.	.	O	.	_	0	SENT_1	[p1l6t291r228b326],

1	ARTICLE	NN	O	article	_	0	SENT_2	[p1l247t291r434b326],

1	A	DT	O	a	det	3	SENT_3	[p1l6t361r63b417],
2	prospective	JJ	O	prospective	amod	3	SENT_3	[p1l90t360r458b434],
3	Validation	NN	O	validation	nsubj	5	SENT_3	[p1l487t360r806b418],
4	pharmacogenomic	JJ	O	pharmacogenomic	amod	5	SENT_3	[p1l833t360r1424b434],
5	study	NN	O	study	_	0	SENT_3	[p1l1457t360r1627b434],
6	in	IN	O	in	_	0	SENT_3	[p1l1657t360r1717b417],
7	the	DT	O	the	det	9	SENT_3	[p1l1744t360r1840b418],
8	adjuvant	JJ	O	adjuvant	amod	9	SENT_3	[p1l1871t360r2146b434],
9	setting	NN	O	setting	prep_in	5	SENT_3	[p1l9t456r217b530],
10	of	IN	O	of	_	0	SENT_3	[p1l243t456r316b514],
11	colorectal	JJ	O	colorectal	amod	13	SENT_3	[p1l331t456r642b514],
12	cancer	NN	O	cancer	nn	13	SENT_3	[p1l667t475r874b514],
13	patients	NNS	O	patient	prep_of	9	SENT_3	[p1l893t456r1140b530],
14	treated	VBN	O	treat	partmod	13	SENT_3	[p1l1165t456r1381b514],
15	with	IN	O	with	_	0	SENT_3	[p1l1403t456r1544b514],
16	the	DT	O	the	det	17	SENT_3	[p1l1567t456r1662b514],
17	5-ﬂuorouraci1	NN	O	5-ﬂuorouraci1	prep_with	14	SENT_3	[p1l1689t456r2148b514],
18	/	:	O	/	punct	19	SENT_3	[p1l1689t456r2148b514],
19	leucovorin/oxaliplatin	NN	O	leucovorin/oxaliplatin	dep	5	SENT_3	[p1l8t553r712b627],
20	(	CD	NUMBER	(	num	23	SENT_3	[p1l743t553r1142b627],
21	FOLFOX4	NN	O	folfox4	nn	23	SENT_3	[p1l743t553r1142b627],
22	)	NN	O	)	nn	23	SENT_3	[p1l743t553r1142b627],
23	regimen	NNS	O	regimen	dep	19	SENT_3	[p1l1172t553r1434b627],

1	E	NN	O	e	nn	2	SENT_4	[p1l6t671r21b697],
2	Cecchin1	NN	O	cecchin1	dep	16	SENT_4	[p1l35t663r183b701],
3	,	,	O	,	_	0	SENT_4	[p1l35t663r183b701],
4	M	NN	O	m	nn	5	SENT_4	[p1l198t671r225b697],
5	D’Andrea2	NN	O	d’andrea2	appos	2	SENT_4	[p1l242t663r411b701],
6	,	,	O	,	_	0	SENT_4	[p1l242t663r411b701],
7	S	NN	O	s	nn	8	SENT_4	[p1l426t671r442b697],
8	Lonardi3	NN	O	lonardi3	appos	2	SENT_4	[p1l458t663r599b701],
9	,	,	O	,	_	0	SENT_4	[p1l458t663r599b701],
10	C	NN	O	c	appos	2	SENT_4	[p1l614t671r634b697],
11	Zanusso	NNP	PERSON	Zanusso	poss	10	SENT_4	[p1l649t663r802b701],
12	'	POS	O	'	_	0	SENT_4	[p1l649t663r802b701],
13	,	,	O	,	_	0	SENT_4	[p1l649t663r802b701],
14	N	NNP	O	N	nn	15	SENT_4	[p1l818t671r839b697],
15	Pe	NNP	O	Pe	appos	10	SENT_4	[p1l856t663r950b701],
16	|	VBD	O	|	_	0	SENT_4	[p1l856t663r950b701],
17	|	CD	NUMBER	|	num	18	SENT_4	[p1l856t663r950b701],
18	a4	NN	O	a4	dobj	16	SENT_4	[p1l856t663r950b701],
19	,	,	O	,	_	0	SENT_4	[p1l856t663r950b701],
20	D	NN	O	d	nn	21	SENT_4	[p1l966t671r988b697],
21	Errantes	NNS	O	errante	conj_and	18	SENT_4	[p1l1004t663r1137b701],
22	,	,	O	,	_	0	SENT_4	[p1l1004t663r1137b701],
23	E	NN	O	e	nn	25	SENT_4	[p1l1153t671r1169b697],
24	De	NNP	O	De	nn	25	SENT_4	[p1l1185t671r1226b697],
25	Mattia1	NNP	O	Mattia1	conj_and	18	SENT_4	[p1l1241t663r1387b701],
26	,	,	O	,	_	0	SENT_4	[p1l1241t663r1387b701],
27	J	NNP	O	J	nn	28	SENT_4	[p1l1241t663r1387b701],
28	Poleselé	NNP	O	Poleselé	conj_and	18	SENT_4	[p1l1404t663r1535b701],
29	,	,	O	,	_	0	SENT_4	[p1l1404t663r1535b701],
30	F	NN	O	f	nn	32	SENT_4	[p1l1551t671r1565b697],
31	|	CD	NUMBER	|	num	32	SENT_4	[p1l1582t663r1745b697],
32	nnocenti7	NN	O	nnocenti7	conj_and	18	SENT_4	[p1l1582t663r1745b697],
33	and	CC	O	and	_	0	SENT_4	[p1l1759t670r1817b697],
34	G	NN	O	g	nn	35	SENT_4	[p1l1833t671r1855b697],
35	Toffo	NN	O	toffo	conj_and	18	SENT_4	[p1l1869t663r1978b697],
36	|	CD	NUMBER	|	num	37	SENT_4	[p1l1869t663r1978b697],
37	i1	NN	O	i1	nsubj	16	SENT_4	[p1l1869t663r1978b697],

1	The	DT	O	the	det	2	SENT_5	[p1l13t776r70b803],
2	discovery	NN	O	discovery	nsubj	14	SENT_5	[p1l84t776r230b811],
3	of	IN	O	of	_	0	SENT_5	[p1l244t776r276b803],
4	pharmacogenomic	JJ	O	pharmacogenomic	amod	5	SENT_5	[p1l289t776r580b811],
5	markers	NNS	O	marker	prep_of	2	SENT_5	[p1l596t776r716b803],
6	in	IN	O	in	_	0	SENT_5	[p1l732t777r757b803],
7	colorectal	JJ	O	colorectal	amod	8	SENT_5	[p1l773t776r921b804],
8	cancer	NN	O	cancer	prep_in	5	SENT_5	[p1l937t784r1038b803],
9	(	CD	NUMBER	(	num	11	SENT_5	[p1l1053t777r1132b808],
10	CRC	NN	ORGANIZATION	crc	nn	11	SENT_5	[p1l1053t777r1132b808],
11	)	NN	O	)	dep	8	SENT_5	[p1l1053t777r1132b808],
12	could	MD	O	could	aux	14	SENT_5	[p1l1148t776r1231b804],
13	be	VB	O	be	cop	14	SENT_5	[p1l1248t776r1285b803],
14	setting-speciﬁc	JJ	O	setting-speciﬁc	_	0	SENT_5	[p1l1300t776r1539b811],
15	.	.	O	.	_	0	SENT_5	[p1l1300t776r1539b811],

1	FOLFOX4	NN	O	folfox4	nsubjpass	3	SENT_6	[p1l1555t777r1697b804],
2	is	VBZ	O	be	auxpass	3	SENT_6	[p1l1712t777r1732b803],
3	employed	VBN	O	employ	_	0	SENT_6	[p1l1747t776r1900b811],
4	in	IN	O	in	_	0	SENT_6	[p1l1917t777r1942b803],
5	the	DT	O	the	det	9	SENT_6	[p1l1957t776r2007b803],
6	adjuvant	JJ	O	adjuvant	amod	9	SENT_6	[p1l14t821r149b856],
7	and	CC	O	and	_	0	SENT_6	[p1l162t821r218b848],
8	metastatic	JJ	O	metastatic	amod	9	SENT_6	[p1l234t822r393b848],
9	setting	NN	O	setting	prep_in	3	SENT_6	[p1l406t822r510b856],
10	in	IN	O	in	_	0	SENT_6	[p1l526t822r550b848],
11	CRC	NN	O	crc	prep_in	9	SENT_6	[p1l565t822r633b848],
12	.	.	O	.	_	0	SENT_6	[p1l565t822r633b848],

1	This	DT	O	this	det	3	SENT_7	[p1l645t821r706b848],
2	prospective	JJ	O	prospective	amod	3	SENT_7	[p1l721t822r899b855],
3	study	NN	O	study	nsubjpass	5	SENT_7	[p1l913t821r997b856],
4	is	VBZ	O	be	auxpass	5	SENT_7	[p1l1011t822r1031b848],
5	aimed	VBN	O	aim	_	0	SENT_7	[p1l1044t821r1138b848],
6	to	TO	O	to	aux	7	SENT_7	[p1l1152t825r1183b848],
7	validate	VB	O	validate	ccomp	5	SENT_7	[p1l1196t821r1317b848],
8	in	IN	O	in	_	0	SENT_7	[p1l1331t822r1356b848],
9	the	DT	O	the	det	10	SENT_7	[p1l1370t821r1420b848],
10	adjuvant	JJ	O	adjuvant	prep_in	7	SENT_7	[p1l1433t821r1568b856],
11	setting	VBG	O	set	partmod	10	SENT_7	[p1l1581t822r1685b856],
12	the	DT	O	the	det	14	SENT_7	[p1l1699t821r1749b848],
13	pharmacogenomic	JJ	O	pharmacogenomic	amod	14	SENT_7	[p1l1764t821r2054b856],
14	markers	NNS	O	marker	dobj	11	SENT_7	[p1l16t866r136b893],
15	of	IN	O	of	_	0	SENT_7	[p1l151t865r183b893],
16	toxicity	NN	O	toxicity	prep_of	14	SENT_7	[p1l194t867r306b901],
17	reported	VBN	O	report	partmod	16	SENT_7	[p1l321t866r452b900],
18	in	IN	O	in	_	0	SENT_7	[p1l469t867r494b893],
19	the	DT	O	the	det	21	SENT_7	[p1l509t866r559b893],
20	metastatic	JJ	O	metastatic	amod	21	SENT_7	[p1l575t867r733b893],
21	setting	NN	O	setting	prep_in	17	SENT_7	[p1l748t867r852b901],
22	(	NN	O	(	dobj	17	SENT_7	[p1l869t866r939b898],
23	that	WDT	O	that	nsubj	26	SENT_7	[p1l869t866r939b898],
24	is	VBZ	O	be	cop	26	SENT_7	[p1l954t867r982b898],
25	,	,	O	,	_	0	SENT_7	[p1l954t867r982b898],
26	GSTP1-rs947894	NN	O	gstp1-rs947894	rcmod	22	SENT_7	[p1l996t867r1254b898],
27	,	,	O	,	_	0	SENT_7	[p1l996t867r1254b898],
28	and	CC	O	and	_	0	SENT_7	[p1l1268t866r1324b893],
29	-	:	O	-	_	0	SENT_7	[p1l1340t867r1517b897],
30	rs1138272	NN	O	rs1138272	dep	22	SENT_7	[p1l1340t867r1517b897],
31	;	:	O	;	_	0	SENT_7	[p1l1340t867r1517b897],
32	GSTM1-null	NN	O	gstm1-null	nn	33	SENT_7	[p1l1532t866r1707b893],
33	genotype	NN	O	genotype	dep	30	SENT_7	[p1l1723t870r1878b901],
34	;	:	O	;	_	0	SENT_7	[p1l1723t870r1878b901],
35	AGXTrs4426527	NN	O	agxtrs4426527	conj_and	22	SENT_7	[p1l1892t867r1988b893, p1l16t913r180b943],
36	,	,	O	,	_	0	SENT_7	[p1l1892t867r1988b893, p1l16t913r180b943],
37	-	:	O	-	_	0	SENT_7	[p1l193t913r382b939],
38	rs34116584	NN	O	rs34116584	dep	16	SENT_7	[p1l193t913r382b939],
39	and	CC	O	and	_	0	SENT_7	[p1l394t911r450b939],
40	del-74	NN	O	del-74	nn	42	SENT_7	[p1l465t911r560b938],
41	bp	NN	O	bp	nn	42	SENT_7	[p1l570t911r626b946],
42	)	NN	O	)	conj_and	38	SENT_7	[p1l570t911r626b946],
43	,	,	O	,	_	0	SENT_7	[p1l570t911r626b946],
44	and	CC	O	and	_	0	SENT_7	[p1l639t911r695b939],
45	to	TO	O	to	aux	46	SENT_7	[p1l708t915r739b938],
46	discover	VB	O	discover	ccomp	5	SENT_7	[p1l753t911r881b938],
47	additional	JJ	O	additional	amod	48	SENT_7	[p1l893t911r1046b938],
48	markers	NNS	O	marker	dobj	46	SENT_7	[p1l1061t911r1190b938],
49	.	.	O	.	_	0	SENT_7	[p1l1061t911r1190b938],

1	CRC	NN	ORGANIZATION	crc	nn	2	SENT_8	[p1l1202t912r1263b938],
2	patients	NNS	O	patient	nsubjpass	13	SENT_8	[p1l1277t913r1399b946],
3	(	CD	NUMBER	(	num	4	SENT_8	[p1l1413t912r1440b943],
4	n	NN	O	n	nsubj	5	SENT_8	[p1l1413t912r1440b943],
5	=	JJ	O	=	rcmod	2	SENT_8	[p1l1450t924r1475b933],
6	144	CD	NUMBER	144	num	7	SENT_8	[p1l1486t912r1548b943],
7	)	NN	O	)	dobj	5	SENT_8	[p1l1486t912r1548b943],
8	treated	VBN	O	treat	partmod	7	SENT_8	[p1l1561t911r1671b939],
9	with	IN	O	with	_	0	SENT_8	[p1l1685t911r1751b938],
10	adjuvant	JJ	O	adjuvant	amod	11	SENT_8	[p1l1765t911r1900b946],
11	FOLFOX4	NN	O	folfox4	prep_with	8	SENT_8	[p1l1913t912r2055b939],
12	were	VBD	O	be	auxpass	13	SENT_8	[p1l14t964r89b984],
13	genotyped	VBN	O	genotype	_	0	SENT_8	[p1l102t956r269b992],
14	for	IN	O	for	_	0	SENT_8	[p1l283t956r326b984],
15	57	CD	NUMBER	57	num	16	SENT_8	[p1l338t958r374b984],
16	polymorphisms	NNS	O	polymorphism	prep_for	13	SENT_8	[p1l388t956r626b992],
17	in	IN	O	in	_	0	SENT_8	[p1l641t958r666b984],
18	29	CD	NUMBER	29	num	19	SENT_8	[p1l681t958r716b984],
19	genes	NNS	O	gene	prep_in	16	SENT_8	[p1l730t964r828b991],
20	.	.	O	.	_	0	SENT_8	[p1l730t964r828b991],

1	Grade	NNP	O	Grade	_	0	SENT_9	[p1l841t956r933b984],
2	22	CD	NUMBER	22	num	3	SENT_9	[p1l952t958r999b988],
3	neurotoxicity	NN	O	neurotoxicity	nsubjpass	5	SENT_9	[p1l1014t958r1216b992],
4	was	VBD	O	be	auxpass	5	SENT_9	[p1l1229t964r1287b984],
5	associated	VBN	O	associate	rcmod	1	SENT_9	[p1l1300t956r1459b984],
6	(	RB	O	(	advmod	7	SENT_9	[p1l1475t956r1553b988],
7	false	JJ	O	false	amod	9	SENT_9	[p1l1475t956r1553b988],
8	discovery	NN	O	discovery	nn	9	SENT_9	[p1l1567t956r1712b992],
9	rate	NN	O	rate	dobj	5	SENT_9	[p1l1726t956r1928b992],
10	—	RB	O	—	advmod	5	SENT_9	[p1l1726t956r1928b992],
11	adjusted	VBN	O	adjust	dep	5	SENT_9	[p1l1726t956r1928b992],
12	q	JJ	O	q	amod	14	SENT_9	[p1l1943t956r2054b991],
13	—	NN	O	—	nn	14	SENT_9	[p1l1943t956r2054b991],
14	value	NN	O	value	dobj	5	SENT_9	[p1l1943t956r2054b991],
15	<	JJR	O	<	dep	1	SENT_9	[p1l20t1002r104b1033],
16	0.1	CD	NUMBER	0.1	num	17	SENT_9	[p1l20t1002r104b1033],
17	)	NN	O	)	dep	15	SENT_9	[p1l20t1002r104b1033],
18	with	IN	O	with	_	0	SENT_9	[p1l117t1001r183b1028],
19	single-nucleotide	JJ	O	single-nucleotide	amod	20	SENT_9	[p1l197t1001r463b1036],
20	polymorphisms	NNS	O	polymorphism	prep_with	17	SENT_9	[p1l477t1001r715b1036],
21	in	IN	O	in	_	0	SENT_9	[p1l729t1002r754b1028],
22	ABCC1	NN	O	abcc1	nn	24	SENT_9	[p1l766t1002r863b1028],
23	(	CD	NUMBER	(	num	24	SENT_9	[p1l879t1002r1054b1033],
24	rs2074087	NN	O	rs2074087	prep_in	20	SENT_9	[p1l879t1002r1054b1033],
25	:	:	O	:	_	0	SENT_9	[p1l879t1002r1054b1033],
26	odds	NNS	O	odds	nn	27	SENT_9	[p1l1067t1001r1142b1028],
27	ratio	NN	O	ratio	dep	1	SENT_9	[p1l1156t1002r1224b1028],
28	=	JJ	O	=	advmod	32	SENT_9	[p1l1233t1014r1258b1023],
29	0.43	CD	NUMBER	0.43	num	30	SENT_9	[p1l1267t1002r1516b1033],
30	(	CD	NUMBER	(	dep	28	SENT_9	[p1l1267t1002r1516b1033],
31	0.22	CD	NUMBER	0.22	num	32	SENT_9	[p1l1267t1002r1516b1033],
32	—	NN	O	—	rcmod	27	SENT_9	[p1l1267t1002r1516b1033],
33	0.86	CD	NUMBER	0.86	num	35	SENT_9	[p1l1267t1002r1516b1033],
34	)	CD	NUMBER	)	num	35	SENT_9	[p1l1267t1002r1516b1033],
35	)	NN	O	)	dep	32	SENT_9	[p1l1267t1002r1516b1033],
36	,	,	O	,	_	0	SENT_9	[p1l1267t1002r1516b1033],
37	and	CC	O	and	_	0	SENT_9	[p1l1529t1001r1585b1028],
38	ABCC2	NN	O	abcc2	nn	40	SENT_9	[p1l1597t1002r1697b1028],
39	(	CD	NUMBER	(	num	40	SENT_9	[p1l1711t1002r1886b1033],
40	rs3740066	NN	O	rs3740066	dep	1	SENT_9	[p1l1711t1002r1886b1033],
41	:	:	O	:	_	0	SENT_9	[p1l1711t1002r1886b1033],
42	2.99	CD	NUMBER	2.99	num	43	SENT_9	[p1l1899t1002r2054b1033],
43	(	NN	O	(	dep	1	SENT_9	[p1l1899t1002r2054b1033],
44	1.16	CD	NUMBER	1.16	number	45	SENT_9	[p1l1899t1002r2054b1033],
45	—	CD	NUMBER	—	dep	43	SENT_9	[p1l1899t1002r2054b1033],
46	7.70	CD	NUMBER	7.70	num	47	SENT_9	[p1l15t1047r95b1078],
47	)	NN	O	)	dep	45	SENT_9	[p1l15t1047r95b1078],
48	;	:	O	;	_	0	SENT_9	[p1l15t1047r95b1078],
49	rs1885301	NN	O	rs1885301	dep	1	SENT_9	[p1l107t1048r272b1074],
50	:	:	O	:	_	0	SENT_9	[p1l107t1048r272b1074],
51	3.06	CD	NUMBER	3.06	num	52	SENT_9	[p1l283t1047r522b1078],
52	(	NN	O	(	dep	49	SENT_9	[p1l283t1047r522b1078],
53	1.35	CD	NUMBER	1.35	number	54	SENT_9	[p1l283t1047r522b1078],
54	—	CD	NUMBER	—	dep	52	SENT_9	[p1l283t1047r522b1078],
55	6.92	CD	NUMBER	6.92	num	56	SENT_9	[p1l283t1047r522b1078],
56	)	NN	O	)	dep	54	SENT_9	[p1l283t1047r522b1078],
57	;	:	O	;	_	0	SENT_9	[p1l283t1047r522b1078],
58	rs4148396	NN	O	rs4148396	dep	1	SENT_9	[p1l534t1048r699b1074],
59	:	:	O	:	_	0	SENT_9	[p1l534t1048r699b1074],
60	4.69	CD	NUMBER	4.69	number	61	SENT_9	[p1l709t1047r968b1078],
61	(	CD	NUMBER	(	dep	58	SENT_9	[p1l709t1047r968b1078],
62	1.60	CD	NUMBER	1.60	num	63	SENT_9	[p1l709t1047r968b1078],
63	—	NN	O	—	dep	61	SENT_9	[p1l709t1047r968b1078],
64	13.74	CD	NUMBER	13.74	num	65	SENT_9	[p1l709t1047r968b1078],
65	)	NN	O	)	dep	61	SENT_9	[p1l709t1047r968b1078],
66	;	:	O	;	_	0	SENT_9	[p1l709t1047r968b1078],
67	rs717620	NN	O	rs717620	dep	1	SENT_9	[p1l980t1048r1125b1074],
68	:	:	O	:	_	0	SENT_9	[p1l980t1048r1125b1074],
69	14.39	CD	NUMBER	14.39	number	70	SENT_9	[p1l1139t1047r1443b1078],
70	(	CD	NUMBER	(	dep	67	SENT_9	[p1l1139t1047r1443b1078],
71	1.63	CD	NUMBER	1.63	num	72	SENT_9	[p1l1139t1047r1443b1078],
72	—	NN	O	—	dep	70	SENT_9	[p1l1139t1047r1443b1078],
73	127.02	CD	NUMBER	127.02	number	74	SENT_9	[p1l1139t1047r1443b1078],
74	)	CD	NUMBER	)	num	75	SENT_9	[p1l1139t1047r1443b1078],
75	)	NN	O	)	dep	70	SENT_9	[p1l1139t1047r1443b1078],
76	.	.	O	.	_	0	SENT_9	[p1l1139t1047r1443b1078],

1	hMSH6	NN	O	hmsh6	nsubjpass	5	SENT_10	[p1l1456t1046r1736b1074],
2	—	CD	NUMBER	—	num	3	SENT_10	[p1l1456t1046r1736b1074],
3	rs3136228	NN	O	rs3136228	dep	1	SENT_10	[p1l1456t1046r1736b1074],
4	was	VBD	O	be	auxpass	5	SENT_10	[p1l1747t1054r1805b1074],
5	associated	VBN	O	associate	_	0	SENT_10	[p1l1816t1046r1975b1074],
6	with	IN	O	with	_	0	SENT_10	[p1l1988t1046r2053b1074],
7	grade	NN	O	grade	nn	9	SENT_10	[p1l15t1092r102b1127],
8	3-4	CD	NUMBER	3-4	num	9	SENT_10	[p1l117t1094r172b1120],
9	neutropenia	NN	O	neutropenia	prep_with	5	SENT_10	[p1l188t1093r374b1127],
10	(	CD	NUMBER	(	number	11	SENT_10	[p1l390t1092r638b1124],
11	3.23	CD	NUMBER	3.23	num	12	SENT_10	[p1l390t1092r638b1124],
12	(	NN	O	(	dep	9	SENT_10	[p1l390t1092r638b1124],
13	1.38	CD	NUMBER	1.38	number	14	SENT_10	[p1l390t1092r638b1124],
14	—	CD	NUMBER	—	dep	9	SENT_10	[p1l390t1092r638b1124],
15	7.57	CD	NUMBER	7.57	num	16	SENT_10	[p1l390t1092r638b1124],
16	)	NN	O	)	dep	14	SENT_10	[p1l390t1092r638b1124],
17	,	,	O	,	_	0	SENT_10	[p1l390t1092r638b1124],
18	q-va	JJ	O	q-va	amod	20	SENT_10	[p1l653t1092r927b1127],
19	|	NN	O	|	nn	20	SENT_10	[p1l653t1092r927b1127],
20	ue	NN	O	ue	appos	9	SENT_10	[p1l653t1092r927b1127],
21	=	JJ	O	=	amod	23	SENT_10	[p1l653t1092r927b1127],
22	0.0937	CD	NUMBER	0.0937	tmod	21	SENT_10	[p1l653t1092r927b1127],
23	)	NN	O	)	dep	20	SENT_10	[p1l653t1092r927b1127],
24	.	.	O	.	_	0	SENT_10	[p1l653t1092r927b1127],

1	XRCC3-rs1799794	NN	O	xrcc3-rs1799794	nsubjpass	3	SENT_11	[p1l939t1093r1210b1120],
2	was	VBD	O	be	auxpass	3	SENT_11	[p1l1224t1100r1281b1120],
3	associated	VBN	O	associate	_	0	SENT_11	[p1l1296t1092r1456b1120],
4	with	IN	O	with	_	0	SENT_11	[p1l1471t1092r1536b1119],
5	grade	NN	O	grade	prep_with	3	SENT_11	[p1l1553t1092r1640b1127],
6	3-4	CD	NUMBER	3-4	num	5	SENT_11	[p1l1656t1094r1710b1120],
7	non-hematological	JJ	O	non-hematological	amod	19	SENT_11	[p1l1726t1092r2015b1127],
8	toxicity	NN	O	toxicity	nn	19	SENT_11	[p1l14t1138r126b1172],
9	(	CD	NUMBER	(	num	19	SENT_11	[p1l141t1137r408b1169],
10	8.90	CD	NUMBER	8.90	num	19	SENT_11	[p1l141t1137r408b1169],
11	(	NN	O	(	nn	19	SENT_11	[p1l141t1137r408b1169],
12	2.48	CD	NUMBER	2.48	num	19	SENT_11	[p1l141t1137r408b1169],
13	—	CD	NUMBER	—	num	19	SENT_11	[p1l141t1137r408b1169],
14	31.97	CD	NUMBER	31.97	num	19	SENT_11	[p1l141t1137r408b1169],
15	)	NN	O	)	nn	19	SENT_11	[p1l141t1137r408b1169],
16	,	,	O	,	_	0	SENT_11	[p1l141t1137r408b1169],
17	q-value	JJ	O	q-value	amod	19	SENT_11	[p1l422t1137r696b1171],
18	:0.0150	CD	NUMBER	:0.0150	num	19	SENT_11	[p1l422t1137r696b1171],
19	)	NN	O	)	xcomp	3	SENT_11	[p1l422t1137r696b1171],
20	.	.	O	.	_	0	SENT_11	[p1l422t1137r696b1171],

1	The	DT	O	the	det	2	SENT_12	[p1l709t1137r766b1164],
2	markers	NNS	O	marker	nsubjpass	10	SENT_12	[p1l782t1137r902b1164],
3	previously	RB	DATE	previously	advmod	4	SENT_12	[p1l919t1137r1076b1172],
4	identiﬁed	VBN	O	identiﬁed	partmod	2	SENT_12	[p1l1090t1136r1235b1164],
5	in	IN	O	in	_	0	SENT_12	[p1l1251t1138r1276b1164],
6	metastatic	JJ	O	metastatic	amod	7	SENT_12	[p1l1293t1138r1452b1164],
7	CRC	NN	ORGANIZATION	crc	prep_in	4	SENT_12	[p1l1466t1138r1527b1164],
8	were	VBD	O	be	auxpass	10	SENT_12	[p1l1541t1145r1616b1164],
9	not	RB	O	not	neg	10	SENT_12	[p1l1632t1141r1682b1164],
10	validated	VBN	O	validate	_	0	SENT_12	[p1l1695t1137r1845b1164],
11	.	.	O	.	_	0	SENT_12	[p1l1695t1137r1845b1164],

1	We	PRP	O	we	nsubj	3	SENT_13	[p1l1859t1138r1907b1164],
2	have	VBP	O	have	aux	3	SENT_13	[p1l1923t1137r1995b1164],
3	identiﬁed	VBN	O	identiﬁed	_	0	SENT_13	[p1l15t1182r160b1210],
4	new	JJ	O	new	amod	5	SENT_13	[p1l177t1190r240b1209],
5	markers	NNS	O	marker	dobj	3	SENT_13	[p1l256t1182r376b1209],
6	of	IN	O	of	_	0	SENT_13	[p1l391t1182r422b1209],
7	toxicity	NN	O	toxicity	prep_of	5	SENT_13	[p1l434t1184r546b1217],
8	in	IN	O	in	_	0	SENT_13	[p1l561t1184r586b1209],
9	genes	NNS	O	gene	prep_in	3	SENT_13	[p1l602t1190r692b1217],
10	of	IN	O	of	_	0	SENT_13	[p1l707t1182r739b1209],
11	transport	NN	O	transport	nn	14	SENT_13	[p1l750t1186r892b1217],
12	and	CC	O	and	_	0	SENT_13	[p1l906t1182r962b1209],
13	DNA	NN	O	dna	conj_and	11	SENT_13	[p1l979t1183r1048b1209],
14	repair	NN	O	repair	prep_of	9	SENT_13	[p1l1063t1184r1158b1217],
15	.	.	O	.	_	0	SENT_13	[p1l1063t1184r1158b1217],

1	If	IN	O	if	mark	2	SENT_14	[p1l1174t1182r1192b1209],
2	validated	VBN	O	validate	advcl	9	SENT_14	[p1l1203t1182r1344b1210],
3	in	IN	O	in	_	0	SENT_14	[p1l1361t1184r1386b1209],
4	other	JJ	O	other	amod	5	SENT_14	[p1l1402t1182r1484b1210],
5	studies	NNS	O	study	prep_in	2	SENT_14	[p1l1498t1182r1613b1214],
6	,	,	O	,	_	0	SENT_14	[p1l1498t1182r1613b1214],
7	they	PRP	O	they	nsubj	9	SENT_14	[p1l1627t1182r1695b1217],
8	could	MD	O	could	aux	9	SENT_14	[p1l1709t1182r1792b1210],
9	help	VB	O	help	_	0	SENT_14	[p1l1810t1182r1875b1217],
10	to	TO	O	to	aux	11	SENT_14	[p1l1889t1186r1920b1209],
11	identify	VB	O	identify	xcomp	9	SENT_14	[p1l1935t1182r2051b1217],
12	patients	NNS	O	patient	dobj	11	SENT_14	[p1l16t1229r138b1262],
13	at	IN	O	at	_	0	SENT_14	[p1l152t1232r181b1255],
14	risk	NN	O	risk	prep_at	11	SENT_14	[p1l196t1227r247b1255],
15	of	IN	O	of	_	0	SENT_14	[p1l260t1227r292b1255],
16	toxicity	NN	O	toxicity	prep_of	14	SENT_14	[p1l303t1229r422b1263],
17	.	.	O	.	_	0	SENT_14	[p1l303t1229r422b1263],

1	The	DT	O	the	det	3	SENT_15	[p1l16t1319r67b1347],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_15	[p1l81t1319r376b1354],
3	Journal	NNP	O	Journal	_	0	SENT_15	[p1l388t1319r501b1347],
4	(	JJ	O	(	amod	3	SENT_15	[p1l515t1320r608b1351],
5	2013	CD	DATE	2013	tmod	4	SENT_15	[p1l515t1320r608b1351],
6	)	CD	NUMBER	)	number	7	SENT_15	[p1l515t1320r608b1351],
7	13	CD	NUMBER	13	num	3	SENT_15	[p1l626t1321r672b1351],
8	,	,	O	,	_	0	SENT_15	[p1l626t1321r672b1351],
9	403-409	CD	NUMBER	403-409	appos	3	SENT_15	[p1l686t1321r825b1351],
10	;	:	O	;	_	0	SENT_15	[p1l686t1321r825b1351],
11	doi	FW	O	doi	dep	3	SENT_15	[p1l840t1319r1208b1354],
12	:10.1038	CD	NUMBER	:10.1038	dep	11	SENT_15	[p1l840t1319r1208b1354],
13	/	:	O	/	punct	14	SENT_15	[p1l840t1319r1208b1354],
14	tpj	NN	O	tpj	dep	12	SENT_15	[p1l840t1319r1208b1354],
15	.2012.31	CD	NUMBER	.2012.31	num	14	SENT_15	[p1l840t1319r1208b1354],
16	;	:	O	;	_	0	SENT_15	[p1l840t1319r1208b1354],
17	published	VBN	O	publish	partmod	3	SENT_15	[p1l1223t1319r1373b1354],
18	online	NN	O	online	prep	17	SENT_15	[p1l1389t1319r1484b1347],
19	7	CD	DATE	7	dep	18	SENT_15	[p1l1499t1321r1515b1346],
20	August	NNP	DATE	August	tmod	17	SENT_15	[p1l1530t1320r1639b1354],
21	2012	CD	DATE	2012	num	20	SENT_15	[p1l1653t1321r1727b1347],

1	Keywords	NNPS	O	Keywords	_	0	SENT_16	[p1l16t1390r185b1425],
2	:	:	O	:	_	0	SENT_16	[p1l16t1390r185b1425],
3	pharmacogenomics	NNS	O	pharmacogenomic	dep	1	SENT_16	[p1l207t1390r520b1425],
4	;	:	O	;	_	0	SENT_16	[p1l207t1390r520b1425],
5	FOLFOX4	NN	O	folfox4	dep	3	SENT_16	[p1l536t1391r685b1422],
6	;	:	O	;	_	0	SENT_16	[p1l536t1391r685b1422],
7	colorectal	JJ	O	colorectal	amod	8	SENT_16	[p1l699t1390r847b1417],
8	cancer	NN	O	cancer	dep	3	SENT_16	[p1l863t1398r971b1422],
9	;	:	O	;	_	0	SENT_16	[p1l863t1398r971b1422],
10	neurotoxicity	NN	O	neurotoxicity	dep	8	SENT_16	[p1l987t1391r1189b1425],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_17	[p1l12t1582r543b1636],

1	Validated	VBN	O	validate	dep	6	SENT_18	[p1l7t1682r305b1739],
2	markers	NNS	O	marker	nsubjpass	6	SENT_18	[p1l356t1682r605b1739],
3	have	VBP	O	have	aux	6	SENT_18	[p1l654t1682r802b1739],
4	been	VBN	O	be	auxpass	6	SENT_18	[p1l850t1682r1004b1739],
5	recently	RB	DATE	recently	advmod	6	SENT_18	[p1l1054t1682r1307b1755],
6	identiﬁed	VBN	O	identiﬁed	_	0	SENT_18	[p1l1354t1681r1652b1739],
7	for	IN	O	for	_	0	SENT_18	[p1l1699t1681r1786b1739],
8	treatment	NN	O	treatment	nn	9	SENT_18	[p1l1829t1691r2148b1739],
9	personalization	NN	O	personalization	prep_for	6	SENT_18	[p1l12t1767r494b1838],
10	in	IN	O	in	_	0	SENT_18	[p1l528t1770r579b1823],
11	oncology	NN	O	oncology	prep_in	6	SENT_18	[p1l611t1767r922b1840],
12	,	,	O	,	_	0	SENT_18	[p1l611t1767r922b1840],
13	with	IN	O	with	_	0	SENT_18	[p1l950t1767r1085b1823],
14	drug	NN	O	drug	nn	15	SENT_18	[p1l1117t1767r1263b1839],
15	toxicity	NN	O	toxicity	prep_with	6	SENT_18	[p1l1293t1770r1525b1840],
16	as	IN	O	as	_	0	SENT_18	[p1l1553t1784r1614b1824],
17	the	DT	O	the	det	18	SENT_18	[p1l1643t1767r1746b1823],
18	outcome	NN	O	outcome	prep_as	15	SENT_18	[p1l1775t1776r2059b1824],
19	of	IN	O	of	_	0	SENT_18	[p1l2089t1767r2153b1824],
20	interest	NN	O	interest	prep_of	18	SENT_18	[p1l12t1840r334b1910],
21	.	.	O	.	_	0	SENT_18	[p1l12t1840r334b1910],

1	”	NN	O	”	nsubj	3	SENT_19	[p1l12t1840r334b1910],
2	This	DT	O	this	dep	1	SENT_19	[p1l361t1853r487b1910],
3	appears	VBZ	O	appear	_	0	SENT_19	[p1l517t1870r767b1924],
4	to	TO	O	to	aux	8	SENT_19	[p1l796t1862r860b1910],
5	be	VB	O	be	cop	8	SENT_19	[p1l892t1853r966b1910],
6	a	DT	O	a	det	8	SENT_19	[p1l996t1870r1026b1910],
7	promising	JJ	O	promising	amod	8	SENT_19	[p1l1060t1856r1377b1925],
8	ﬁeld	NN	O	ﬁeld	xcomp	3	SENT_19	[p1l1407t1852r1542b1910],
9	for	IN	O	for	_	0	SENT_19	[p1l1572t1852r1660b1910],
10	improving	VBG	O	improve	prepc_for	8	SENT_19	[p1l1690t1856r2014b1925],
11	the	DT	O	the	det	12	SENT_19	[p1l2045t1853r2147b1910],
12	management	NN	O	management	dobj	10	SENT_19	[p1l12t1948r440b2011],
13	of	IN	O	of	_	0	SENT_19	[p1l462t1938r527b1996],
14	colorectal	JJ	O	colorectal	amod	15	SENT_19	[p1l546t1939r852b1996],
15	cancer	NN	O	cancer	prep_of	12	SENT_19	[p1l879t1956r1088b1996],
16	(	CD	NUMBER	(	num	19	SENT_19	[p1l1113t1940r1277b2004],
17	CRC	NN	O	crc	nn	19	SENT_19	[p1l1113t1940r1277b2004],
18	)	NN	O	)	nn	19	SENT_19	[p1l1113t1940r1277b2004],
19	therapy	NN	O	therapy	dep	15	SENT_19	[p1l1301t1939r1561b2012],
20	.	.	O	.	_	0	SENT_19	[p1l1301t1939r1561b2012],

1	However	RB	O	however	advmod	9	SENT_20	[p1l1588t1942r1884b2005],
2	,	,	O	,	_	0	SENT_20	[p1l1588t1942r1884b2005],
3	most	JJS	O	most	nsubjpass	9	SENT_20	[p1l1909t1948r2065b1996],
4	of	IN	O	of	_	0	SENT_20	[p1l2089t1938r2153b1996],
5	the	DT	O	the	det	6	SENT_20	[p1l8t2025r111b2081],
6	data	NNS	O	datum	prep_of	3	SENT_20	[p1l135t2025r271b2081],
7	have	VBP	O	have	aux	9	SENT_20	[p1l300t2025r448b2081],
8	been	VBN	O	be	auxpass	9	SENT_20	[p1l475t2025r629b2081],
9	generated	VBN	O	generate	_	0	SENT_20	[p1l656t2025r981b2096],
10	in	IN	O	in	_	0	SENT_20	[p1l1010t2027r1061b2081],
11	the	DT	O	the	det	13	SENT_20	[p1l1086t2025r1189b2081],
12	metastatic	JJ	O	metastatic	amod	13	SENT_20	[p1l1216t2027r1544b2081],
13	setting3	NN	O	setting3	prep_in	9	SENT_20	[p1l1569t2012r1875b2096],
14	'	''	O	'	_	0	SENT_20	[p1l1569t2012r1875b2096],
15	6	CD	NUMBER	6	tmod	9	SENT_20	[p1l1569t2012r1875b2096],
16	and	CC	O	and	_	0	SENT_20	[p1l1899t2025r2015b2081],
17	it	PRP	O	it	nsubj	20	SENT_20	[p1l2044t2027r2081b2081],
18	is	VBZ	O	be	cop	20	SENT_20	[p1l2106t2027r2147b2081],
19	not	RB	O	not	neg	20	SENT_20	[p1l12t2119r115b2167],
20	clear	JJ	O	clear	conj_and	9	SENT_20	[p1l156t2111r307b2167],
21	whether	IN	O	whether	complm	26	SENT_20	[p1l346t2111r613b2167],
22	these	DT	O	these	det	23	SENT_20	[p1l652t2111r824b2167],
23	markers	NNS	O	marker	nsubjpass	26	SENT_20	[p1l870t2111r1119b2167],
24	could	MD	O	could	aux	26	SENT_20	[p1l1162t2111r1333b2167],
25	be	VB	O	be	auxpass	26	SENT_20	[p1l1381t2111r1456b2167],
26	applied	VBN	O	apply	ccomp	20	SENT_20	[p1l1499t2111r1733b2182],
27	in	IN	O	in	_	0	SENT_20	[p1l1780t2113r1831b2166],
28	different	JJ	O	different	amod	30	SENT_20	[p1l1876t2110r2148b2167],
29	clinical	JJ	O	clinical	amod	30	SENT_20	[p1l10t2196r222b2253],
30	settings	NNS	O	setting	prep_in	26	SENT_20	[p1l256t2199r503b2268],
31	in	IN	O	in	_	0	SENT_20	[p1l537t2199r588b2252],
32	CRC	NN	O	crc	prep_in	30	SENT_20	[p1l621t2198r761b2253],
33	.	.	O	.	_	0	SENT_20	[p1l621t2198r761b2253],

1	Oxaliplatin	NN	O	oxaliplatin	nsubjpass	12	SENT_21	[p1l87t2282r424b2354],
2	in	IN	O	in	_	0	SENT_21	[p1l477t2285r528b2338],
3	combination	NN	O	combination	prep_in	1	SENT_21	[p1l579t2282r981b2339],
4	with	IN	O	with	_	0	SENT_21	[p1l1031t2282r1166b2339],
5	ﬂuoropyrimidines	NNS	O	ﬂuoropyrimidines	prep_with	3	SENT_21	[p1l1216t2282r1781b2355],
6	(	CD	NUMBER	(	num	8	SENT_21	[p1l1833t2284r2148b2348],
7	FOLFOX4	NN	O	folfox4	nn	8	SENT_21	[p1l1833t2284r2148b2348],
8	schedule	NN	O	schedule	dep	5	SENT_21	[p1l10t2369r313b2434],
9	)	CD	NUMBER	)	dep	8	SENT_21	[p1l10t2369r313b2434],
10	is	VBZ	O	be	auxpass	12	SENT_21	[p1l359t2371r400b2425],
11	largely	RB	O	largely	advmod	12	SENT_21	[p1l446t2369r655b2441],
12	used	VBN	O	use	_	0	SENT_21	[p1l698t2369r843b2425],
13	in	IN	O	in	_	0	SENT_21	[p1l890t2371r941b2424],
14	the	DT	O	the	det	15	SENT_21	[p1l984t2369r1087b2425],
15	treatment	NN	O	treatment	prep_in	12	SENT_21	[p1l1128t2377r1447b2425],
16	of	IN	O	of	_	0	SENT_21	[p1l1489t2368r1554b2425],
17	CRC	NN	ORGANIZATION	crc	prep_of	15	SENT_21	[p1l1591t2371r1716b2425],
18	in	IN	O	in	_	0	SENT_21	[p1l1760t2371r1811b2424],
19	both	CC	O	both	preconj	21	SENT_21	[p1l1858t2369r2001b2425],
20	the	DT	O	the	det	21	SENT_21	[p1l2045t2369r2147b2425],
21	metastatic	JJ	O	metastatic	prep_in	12	SENT_21	[p1l12t2458r340b2511],
22	and	CC	O	and	_	0	SENT_21	[p1l373t2455r489b2511],
23	the	DT	O	the	det	25	SENT_21	[p1l524t2455r627b2511],
24	adjuvant	JJ	O	adjuvant	amod	25	SENT_21	[p1l660t2455r940b2527],
25	settings	NNS	O	setting	prep_in	12	SENT_21	[p1l973t2458r1236b2527],
26	.	.	O	.	_	0	SENT_21	[p1l973t2458r1236b2527],

1	However	RB	O	however	advmod	6	SENT_22	[p1l1273t2458r1568b2520],
2	,	,	O	,	_	0	SENT_22	[p1l1273t2458r1568b2520],
3	oxaliplatin-based	JJ	O	oxaliplatin-based	amod	4	SENT_22	[p1l1601t2455r2145b2526],
4	chemotherapy	NN	O	chemotherapy	nsubjpass	6	SENT_22	[p1l10t2540r478b2613],
5	is	VBZ	O	be	auxpass	6	SENT_22	[p1l502t2543r543b2597],
6	limited	VBN	O	limit	_	0	SENT_22	[p1l571t2540r786b2597],
7	by	IN	O	by	_	0	SENT_22	[p1l816t2540r890b2613],
8	the	DT	O	the	det	9	SENT_22	[p1l912t2540r1015b2597],
9	occurrence	NN	O	occurrence	agent	6	SENT_22	[p1l1039t2557r1392b2597],
10	of	IN	O	of	_	0	SENT_22	[p1l1417t2540r1482b2597],
11	severe	JJ	O	severe	amod	12	SENT_22	[p1l1502t2557r1706b2597],
12	toxicities	NNS	O	toxicity	prep_of	9	SENT_22	[p1l1729t2543r2010b2597],
13	in	IN	O	in	_	0	SENT_22	[p1l2037t2543r2088b2596],
14	a	DT	O	a	det	16	SENT_22	[p1l2115t2557r2146b2597],
15	considerable	JJ	O	considerable	amod	16	SENT_22	[p1l10t2626r417b2682],
16	number	NN	O	number	prep_in	6	SENT_22	[p1l463t2626r713b2682],
17	of	IN	O	of	_	0	SENT_22	[p1l755t2625r820b2682],
18	patients	NNS	O	patient	prep_of	16	SENT_22	[p1l860t2613r1218b2697],
19	.7	CD	NUMBER	.7	nsubj	30	SENT_22	[p1l860t2613r1218b2697],
20	‘	CD	NUMBER	‘	number	21	SENT_22	[p1l860t2613r1218b2697],
21	9	CD	NUMBER	9	num	19	SENT_22	[p1l860t2613r1218b2697],
22	Among	IN	O	among	_	0	SENT_22	[p1l1260t2629r1492b2698],
23	those	DT	O	those	det	25	SENT_22	[p1l1536t2626r1712b2682],
24	side	JJ	O	side	amod	25	SENT_22	[p1l1756t2626r1881b2682],
25	effects	NNS	O	effect	prep_among	19	SENT_22	[p1l1924t2625r2148b2691],
26	,	,	O	,	_	0	SENT_22	[p1l1924t2625r2148b2691],
27	peripheral	JJ	O	peripheral	amod	28	SENT_22	[p1l12t2712r332b2783],
28	neurotoxicity	NN	O	neurotoxicity	appos	25	SENT_22	[p1l401t2714r819b2784],
29	is	VBZ	O	be	cop	30	SENT_22	[p1l883t2714r924b2768],
30	one	CD	NUMBER	one	rcmod	18	SENT_22	[p1l988t2728r1106b2768],
31	of	IN	O	of	_	0	SENT_22	[p1l1170t2711r1236b2768],
32	the	DT	O	the	det	34	SENT_22	[p1l1292t2712r1395b2768],
33	most	RBS	O	most	advmod	34	SENT_22	[p1l1461t2720r1617b2768],
34	common	JJ	O	common	prep_of	30	SENT_22	[p1l1680t2728r1962b2768],
35	and	CC	O	and	_	0	SENT_22	[p1l2029t2712r2145b2768],
36	disabling	VBG	O	disable	conj_and	34	SENT_22	[p1l10t2797r314b2869],
37	.	.	O	.	_	0	SENT_22	[p1l10t2797r314b2869],

1	Increasing	VBG	O	increase	amod	3	SENT_23	[p1l362t2800r681b2869],
2	cumulative	JJ	O	cumulative	amod	3	SENT_23	[p1l729t2797r1080b2854],
3	doses	NNS	O	dose	_	0	SENT_23	[p1l1126t2797r1306b2854],
4	of	IN	O	of	_	0	SENT_23	[p1l1352t2797r1416b2854],
5	oxaliplatin	NN	O	oxaliplatin	nn	6	SENT_23	[p1l1456t2797r1783b2869],
6	lead	NN	O	lead	prep_of	3	SENT_23	[p1l1833t2797r1960b2854],
7	to	TO	O	to	_	0	SENT_23	[p1l2007t2806r2070b2854],
8	a	DT	O	a	det	12	SENT_23	[p1l2115t2814r2146b2854],
9	persistent	JJ	O	persistent	amod	12	SENT_23	[p1l12t2886r323b2955],
10	sensory	JJ	O	sensory	amod	12	SENT_23	[p1l407t2900r649b2956],
11	peripheral	JJ	O	peripheral	amod	12	SENT_23	[p1l734t2884r1053b2955],
12	neuropathy	NN	O	neuropathy	prep_to	3	SENT_23	[p1l1142t2884r1512b2956],
13	associated	VBN	O	associate	partmod	12	SENT_23	[p1l1594t2884r1924b2940],
14	with	IN	O	with	_	0	SENT_23	[p1l2009t2884r2145b2940],
15	functional	JJ	O	functional	amod	16	SENT_23	[p1l8t2968r326b3025],
16	disability	NN	O	disability	prep_with	13	SENT_23	[p1l371t2969r654b3041],
17	in	IN	O	in	_	0	SENT_23	[p1l696t2972r747b3025],
18	some	DT	O	some	det	19	SENT_23	[p1l792t2986r962b3025],
19	patients	NNS	O	patient	prep_in	16	SENT_23	[p1l1006t2956r1396b3040],
20	.1	CD	NUMBER	.1	num	21	SENT_23	[p1l1006t2956r1396b3040],
21	°	NN	O	°	dobj	13	SENT_23	[p1l1006t2956r1396b3040],
22	'	''	O	'	_	0	SENT_23	[p1l1006t2956r1396b3040],
23	“	CD	NUMBER	“	num	25	SENT_23	[p1l1006t2956r1396b3040],
24	Recent	JJ	O	recent	amod	25	SENT_23	[p1l1450t2971r1664b3025],
25	investigations	NNS	O	investigation	nsubj	26	SENT_23	[p1l1707t2972r2147b3041],
26	establish	VBP	O	establish	rcmod	21	SENT_23	[p1l10t3055r286b3111],
27	the	DT	O	the	det	28	SENT_23	[p1l327t3055r430b3111],
28	persistence	NN	O	persistence	dobj	26	SENT_23	[p1l473t3058r832b3126],
29	of	IN	O	of	_	0	SENT_23	[p1l873t3054r938b3111],
30	subjective	JJ	O	subjective	amod	33	SENT_23	[p1l973t3055r1294b3127],
31	and	CC	O	and	_	0	SENT_23	[p1l1335t3055r1451b3111],
32	objective	JJ	O	objective	amod	33	SENT_23	[p1l1494t3055r1785b3127],
33	deﬁcits	NNS	O	deﬁcits	prep_of	28	SENT_23	[p1l1826t3054r2051b3111],
34	in	IN	O	in	_	0	SENT_23	[p1l2094t3058r2145b3111],
35	oxaliplatin-treated	JJ	O	oxaliplatin-treated	amod	36	SENT_23	[p1l10t3140r592b3212],
36	patients	NNS	O	patient	prep_in	28	SENT_23	[p1l642t3143r895b3212],
37	after	IN	O	after	_	0	SENT_23	[p1l939t3140r1084b3197],
38	the	DT	O	the	det	39	SENT_23	[p1l1125t3140r1228b3197],
39	interruption	NN	O	interruption	prep_after	26	SENT_23	[p1l1275t3143r1652b3212],
40	of	IN	O	of	_	0	SENT_23	[p1l1700t3140r1764b3197],
41	oxaliplatin	NN	O	oxaliplatin	prep_of	39	SENT_23	[p1l1803t3140r2148b3212],
42	,	,	O	,	_	0	SENT_23	[p1l1803t3140r2148b3212],
43	suggesting	VBG	O	suggest	partmod	21	SENT_23	[p1l10t3229r358b3299],
44	that	IN	O	that	complm	53	SENT_23	[p1l385t3227r512b3283],
45	sensory	JJ	O	sensory	amod	46	SENT_23	[p1l537t3243r779b3299],
46	neuropathy	NN	O	neuropathy	nsubj	53	SENT_23	[p1l806t3227r1175b3299],
47	could	MD	O	could	aux	53	SENT_23	[p1l1200t3227r1372b3283],
48	be	VB	O	be	cop	53	SENT_23	[p1l1402t3227r1477b3283],
49	a	DT	O	a	det	53	SENT_23	[p1l1503t3243r1533b3283],
50	long	JJ	O	long	amod	53	SENT_23	[p1l1564t3227r1875b3299],
51	—	NN	O	—	nn	53	SENT_23	[p1l1564t3227r1875b3299],
52	term	NN	O	term	nn	53	SENT_23	[p1l1564t3227r1875b3299],
53	sequela	NN	O	sequelum	ccomp	43	SENT_23	[p1l1904t3227r2145b3298],
54	in	IN	O	in	_	0	SENT_23	[p1l12t3315r62b3367],
55	more	RBR	O	more	advmod	56	SENT_23	[p1l104t3328r267b3368],
56	sensitive	JJ	O	sensitive	amod	57	SENT_23	[p1l305t3315r578b3368],
57	patients	NNS	O	patient	prep_in	53	SENT_23	[p1l618t3315r870b3383],
58	thereby	RB	O	thereby	advmod	59	SENT_23	[p1l906t3312r1155b3384],
59	challenging	VBG	O	challenge	dep	3	SENT_23	[p1l1190t3312r1560b3384],
60	the	DT	O	the	det	61	SENT_23	[p1l1598t3312r1701b3368],
61	notion	NN	O	notion	dobj	59	SENT_23	[p1l1741t3315r1943b3368],
62	of	IN	O	of	_	0	SENT_23	[p1l1983t3311r2047b3368],
63	its	PRP$	O	its	poss	64	SENT_23	[p1l2081t3315r2147b3368],
64	reversibility	NN	O	reversibility	prep_of	61	SENT_23	[p1l12t3384r450b3471],
65	.	.	O	.	_	0	SENT_23	[p1l12t3384r450b3471],

1	”	NN	O	”	ccomp	9	SENT_24	[p1l12t3384r450b3471],
2	Moreover	RB	O	moreover	advmod	1	SENT_24	[p1l491t3401r811b3463],
3	,	,	O	,	_	0	SENT_24	[p1l491t3401r811b3463],
4	clinical	JJ	O	clinical	amod	5	SENT_24	[p1l850t3398r1062b3455],
5	studies	NNS	O	study	nsubj	9	SENT_24	[p1l1104t3398r1326b3455],
6	investigating	VBG	O	investigate	partmod	5	SENT_24	[p1l1368t3401r1777b3470],
7	oxaliplatin	NN	O	oxaliplatin	nn	8	SENT_24	[p1l1818t3398r2145b3469],
8	neurotoxicity	NN	O	neurotoxicity	dobj	6	SENT_24	[p1l12t3486r430b3556],
9	seem	VBP	O	seem	_	0	SENT_24	[p1l456t3500r620b3540],
10	to	TO	O	to	aux	11	SENT_24	[p1l648t3492r712b3540],
11	indicate	VB	O	indicate	xcomp	9	SENT_24	[p1l741t3484r990b3540],
12	a	DT	O	a	det	15	SENT_24	[p1l1017t3500r1047b3540],
13	synergistic	JJ	O	synergistic	amod	15	SENT_24	[p1l1076t3486r1413b3556],
14	neurotoxic	JJ	O	neurotoxic	amod	15	SENT_24	[p1l1442t3486r1780b3540],
15	effect	NN	O	effect	dobj	11	SENT_24	[p1l1807t3483r1985b3540],
16	with	IN	O	with	_	0	SENT_24	[p1l2009t3484r2145b3540],
17	ﬂuoropyrimidines	NNS	O	ﬂuoropyrimidines	prep_with	11	SENT_24	[p1l8t3557r648b3642],
18	.	.	O	.	_	0	SENT_24	[p1l8t3557r648b3642],

1	”	NN	O	”	_	0	SENT_25	[p1l8t3557r648b3642],

1	In	FW	O	in	nn	2	SENT_26	[p2l87t36r140b89],
2	vitro	FW	O	vitro	dep	6	SENT_26	[p2l172t36r307b90],
3	and	CC	O	and	_	0	SENT_26	[p2l337t33r453b90],
4	in	FW	O	in	conj_and	2	SENT_26	[p2l486t36r538b89],
5	vivo	FW	O	vivo	pobj	4	SENT_26	[p2l571t36r692b90],
6	studies	NNS	O	study	nsubj	11	SENT_26	[p2l723t33r945b90],
7	on	IN	O	on	_	0	SENT_26	[p2l976t50r1053b90],
8	neuronal	JJ	O	neuronal	amod	10	SENT_26	[p2l1089t33r1366b90],
9	damage	NN	O	damage	nn	10	SENT_26	[p2l1400t33r1658b105],
10	mechanisms	NNS	O	mechanism	prep_on	6	SENT_26	[p2l1692t20r2149b90],
11	”	VBP	O	”	_	0	SENT_26	[p2l1692t20r2149b90],
12	indicate	VBP	O	indicate	ccomp	11	SENT_26	[p2l12t119r261b176],
13	that	IN	O	that	complm	15	SENT_26	[p2l291t119r418b176],
14	oxaliplatin	NN	O	oxaliplatin	nsubj	15	SENT_26	[p2l448t119r773b190],
15	exerts	VBZ	O	exert	ccomp	12	SENT_26	[p2l807t128r995b176],
16	a	DT	O	a	det	19	SENT_26	[p2l1026t136r1056b176],
17	direct	JJ	O	direct	amod	19	SENT_26	[p2l1088t119r1269b176],
18	pharmacological	JJ	O	pharmacological	amod	19	SENT_26	[p2l1301t119r1827b191],
19	effect	NN	O	effect	dobj	15	SENT_26	[p2l1860t118r2038b176],
20	on	IN	O	on	_	0	SENT_26	[p2l2068t136r2145b176],
21	the	DT	O	the	det	22	SENT_26	[p2l7t205r110b261],
22	excitability	NN	O	excitability	prep_on	19	SENT_26	[p2l138t205r481b277],
23	of	IN	O	of	_	0	SENT_26	[p2l507t204r572b261],
24	sensory	JJ	O	sensory	amod	25	SENT_26	[p2l595t221r837b277],
25	neurons	NNS	O	neuron	prep_of	22	SENT_26	[p2l866t221r1122b261],
26	and	CC	O	and	_	0	SENT_26	[p2l1150t205r1266b261],
27	muscle	NN	O	muscle	nn	28	SENT_26	[p2l1299t205r1519b261],
28	cells	NNS	O	cell	conj_and	25	SENT_26	[p2l1547t205r1681b261],
29	by	IN	O	by	_	0	SENT_26	[p2l1712t205r1786b277],
30	interfering	VBG	O	interfere	prepc_by	15	SENT_26	[p2l1814t204r2144b276],
31	with	IN	O	with	_	0	SENT_26	[p2l7t291r143b347],
32	vo	NN	O	vo	prep_with	30	SENT_26	[p2l232t291r677b363],
33	|	CD	NUMBER	|	num	32	SENT_26	[p2l232t291r677b363],
34	tage	NN	O	tage	dobj	30	SENT_26	[p2l232t291r677b363],
35	—	CD	NUMBER	—	num	34	SENT_26	[p2l232t291r677b363],
36	gated	VBN	O	gate	partmod	34	SENT_26	[p2l232t291r677b363],
37	Na	NN	O	na	dobj	36	SENT_26	[p2l771t294r922b353],
38	+	CC	O	+	_	0	SENT_26	[p2l771t294r922b353],
39	channels	NNS	O	channel	conj_+	37	SENT_26	[p2l1025t278r1381b348],
40	.	.	O	.	_	0	SENT_26	[p2l1025t278r1381b348],

1	”	NN	O	”	nsubj	7	SENT_27	[p2l1025t278r1381b348],
2	Another	DT	O	another	nsubj	3	SENT_27	[p2l1469t291r1729b348],
3	suggested	VBD	O	suggest	rcmod	1	SENT_27	[p2l1817t291r2144b363],
4	mechanism	NN	O	mechanism	dobj	3	SENT_27	[p2l11t378r374b435],
5	is	VBZ	O	be	cop	7	SENT_27	[p2l424t381r464b435],
6	the	DT	O	the	det	7	SENT_27	[p2l509t378r612b435],
7	deposition	NN	O	deposition	_	0	SENT_27	[p2l657t378r993b449],
8	of	IN	O	of	_	0	SENT_27	[p2l1041t377r1106b435],
9	DNA	NN	MISC	dna	nn	14	SENT_27	[p2l1148t378r1600b449],
10	—	NN	O	—	nn	14	SENT_27	[p2l1148t378r1600b449],
11	p	NN	O	p	nn	14	SENT_27	[p2l1148t378r1600b449],
12	|	NN	O	|	nn	14	SENT_27	[p2l1148t378r1600b449],
13	atinum	NN	O	atinum	nn	14	SENT_27	[p2l1148t378r1600b449],
14	adducts	NNS	O	adduct	prep_of	7	SENT_27	[p2l1647t378r1898b435],
15	in	IN	O	in	_	0	SENT_27	[p2l1946t381r1997b434],
16	the	DT	O	the	det	19	SENT_27	[p2l2043t378r2146b435],
17	dorsal	NN	O	dorsal	nn	19	SENT_27	[p2l8t464r196b520],
18	root	NN	O	root	nn	19	SENT_27	[p2l226t473r353b520],
19	ganglions	NNS	O	ganglion	prep_in	7	SENT_27	[p2l377t464r704b536],
20	,	,	O	,	_	0	SENT_27	[p2l377t464r704b536],
21	inducing	VBG	O	induce	partmod	7	SENT_27	[p2l730t464r1004b536],
22	neuronal	JJ	O	neuronal	amod	23	SENT_27	[p2l1033t464r1311b520],
23	damage	NN	O	damage	dobj	21	SENT_27	[p2l1339t464r1597b536],
24	and	CC	O	and	_	0	SENT_27	[p2l1621t464r1737b520],
25	apoptosis	NN	O	apoptosis	conj_and	23	SENT_27	[p2l1764t451r2147b535],
26	,16	CD	NUMBER	,16	num	25	SENT_27	[p2l1764t451r2147b535],
27	with	IN	O	with	_	0	SENT_27	[p2l7t551r143b607],
28	the	DT	O	the	det	29	SENT_27	[p2l191t551r294b607],
29	involvement	NN	O	involvement	prep_with	21	SENT_27	[p2l344t551r742b607],
30	of	IN	O	of	_	0	SENT_27	[p2l788t550r853b607],
31	the	DT	O	the	det	34	SENT_27	[p2l893t551r996b607],
32	glutathione-related	JJ	O	glutathione-related	amod	34	SENT_27	[p2l1044t551r1659b623],
33	detoxiﬁcation	NN	O	detoxiﬁcation	nn	34	SENT_27	[p2l1709t550r2143b607],
34	system	NN	O	system	prep_of	29	SENT_27	[p2l9t646r226b710],
35	and	CC	O	and	_	0	SENT_27	[p2l260t637r376b694],
36	the	DT	O	the	det	40	SENT_27	[p2l407t637r510b694],
37	DNA	NN	MISC	dna	nn	40	SENT_27	[p2l544t640r685b693],
38	repair	NN	O	repair	nn	40	SENT_27	[p2l718t640r900b708],
39	protein	NN	O	protein	nn	40	SENT_27	[p2l931t640r1156b708],
40	complex	NN	O	complex	prep_of	29	SENT_27	[p2l1189t624r1535b708],
41	.	.	O	.	_	0	SENT_27	[p2l1189t624r1535b708],

1	”	NN	O	”	_	0	SENT_28	[p2l1189t624r1535b708],

1	Germline	NN	O	germline	nn	2	SENT_29	[p2l86t723r375b779],
2	variants	NNS	O	variant	nsubj	17	SENT_29	[p2l426t725r674b779],
3	in	IN	O	in	_	0	SENT_29	[p2l728t725r779b778],
4	genes	NNS	O	gene	prep_in	2	SENT_29	[p2l832t739r1020b795],
5	encoding	VBG	O	encode	partmod	4	SENT_29	[p2l1072t723r1370b794],
6	DNA	NN	O	dna	nn	8	SENT_29	[p2l1426t725r1568b779],
7	repair	NN	O	repair	nn	8	SENT_29	[p2l1620t725r1802b794],
8	enzymes	NNS	O	enzyme	dobj	5	SENT_29	[p2l1851t739r2147b795],
9	,	,	O	,	_	0	SENT_29	[p2l1851t739r2147b795],
10	detoxiﬁcation	NN	O	detoxiﬁcation	nn	11	SENT_29	[p2l8t809r442b866],
11	pathways	NNS	O	pathway	conj_and	8	SENT_29	[p2l476t810r777b882],
12	and	CC	O	and	_	0	SENT_29	[p2l807t810r923b866],
13	ions	NNS	O	ion	nn	14	SENT_29	[p2l956t813r1082b866],
14	channels	NNS	O	channel	dobj	5	SENT_29	[p2l1112t810r1393b866],
15	may	MD	O	may	aux	17	SENT_29	[p2l1425t827r1558b882],
16	be	VB	O	be	cop	17	SENT_29	[p2l1588t810r1663b866],
17	responsible	JJ	O	responsible	_	0	SENT_29	[p2l1694t810r2057b881],
18	of	IN	O	of	_	0	SENT_29	[p2l2087t809r2152b866],
19	the	DT	O	the	det	21	SENT_29	[p2l7t896r110b953],
20	inter	NN	O	inter	nn	21	SENT_29	[p2l134t896r534b968],
21	—	NN	O	—	npadvmod	22	SENT_29	[p2l134t896r534b968],
22	subject	JJ	O	subject	amod	23	SENT_29	[p2l134t896r534b968],
23	variability	NN	O	variability	prep_of	17	SENT_29	[p2l555t896r866b969],
24	in	IN	O	in	_	0	SENT_29	[p2l889t899r940b952],
25	the	DT	O	the	det	26	SENT_29	[p2l964t896r1067b953],
26	occurrence	NN	O	occurrence	prep_in	23	SENT_29	[p2l1091t913r1443b953],
27	of	IN	O	of	_	0	SENT_29	[p2l1467t895r1532b953],
28	oxaliplatin	NN	O	oxaliplatin	nn	29	SENT_29	[p2l1550t896r1876b967],
29	toxicity	NN	O	toxicity	prep_of	26	SENT_29	[p2l1900t899r2146b969],
30	.	.	O	.	_	0	SENT_29	[p2l1900t899r2146b969],

1	Some	DT	O	some	det	2	SENT_30	[p2l9t985r186b1040],
2	markers	NNS	O	marker	nsubjpass	8	SENT_30	[p2l242t983r491b1040],
3	of	IN	O	of	_	0	SENT_30	[p2l545t983r610b1040],
4	toxicity	NN	O	toxicity	prep_of	2	SENT_30	[p2l656t986r888b1056],
5	have	VBP	O	have	aux	8	SENT_30	[p2l943t983r1090b1040],
6	been	VBN	O	be	auxpass	8	SENT_30	[p2l1146t983r1300b1040],
7	previously	RB	DATE	previously	advmod	8	SENT_30	[p2l1358t983r1683b1056],
8	identiﬁed	VBN	O	identiﬁed	_	0	SENT_30	[p2l1736t983r2035b1040],
9	in	IN	O	in	_	0	SENT_30	[p2l2093t986r2144b1039],
10	metastatic	JJ	O	metastatic	amod	12	SENT_30	[p2l11t1073r339b1127],
11	CRC	NN	ORGANIZATION	crc	nn	12	SENT_30	[p2l365t1072r490b1127],
12	patients	NNS	O	patient	prep_in	8	SENT_30	[p2l519t1057r918b1141],
13	,18	CD	NUMBER	,18	number	14	SENT_30	[p2l519t1057r918b1141],
14	'19	CD	NUMBER	'19	dep	12	SENT_30	[p2l519t1057r918b1141],
15	but	CC	O	but	_	0	SENT_30	[p2l947t1070r1051b1127],
16	they	PRP	O	they	nsubj	18	SENT_30	[p2l1076t1070r1217b1143],
17	are	VBP	O	be	cop	18	SENT_30	[p2l1241t1087r1336b1127],
18	likely	JJ	O	likely	conj_but	8	SENT_30	[p2l1366t1070r1525b1143],
19	to	TO	O	to	aux	20	SENT_30	[p2l1548t1079r1612b1127],
20	have	VB	O	have	xcomp	18	SENT_30	[p2l1641t1070r1789b1127],
21	a	DT	O	a	det	23	SENT_30	[p2l1816t1087r1846b1127],
22	different	JJ	O	different	amod	23	SENT_30	[p2l1874t1069r2147b1127],
23	impact	NN	O	impact	dobj	20	SENT_30	[p2l10t1159r227b1228],
24	when	WRB	O	when	advmod	25	SENT_30	[p2l290t1156r464b1213],
25	dealing	VBG	O	deal	advcl	20	SENT_30	[p2l533t1156r766b1228],
26	with	IN	O	with	_	0	SENT_30	[p2l833t1156r968b1213],
27	adjuvant	JJ	O	adjuvant	amod	28	SENT_30	[p2l1036t1156r1316b1228],
28	patients	NNS	O	patient	prep_with	25	SENT_30	[p2l1383t1159r1651b1228],
29	,	,	O	,	_	0	SENT_30	[p2l1383t1159r1651b1228],
30	especially	RB	O	especially	advmod	25	SENT_30	[p2l1717t1156r2027b1229],
31	in	IN	O	in	_	0	SENT_30	[p2l2093t1159r2144b1212],
32	relation	NN	O	relation	prep_in	25	SENT_30	[p2l11t1244r247b1301],
33	to	TO	O	to	_	0	SENT_30	[p2l293t1253r356b1301],
34	the	DT	O	the	det	36	SENT_30	[p2l400t1244r502b1301],
35	neurological	JJ	O	neurological	amod	36	SENT_30	[p2l550t1244r940b1316],
36	toxicity	NN	O	toxicity	prep_to	25	SENT_30	[p2l987t1247r1233b1317],
37	.	.	O	.	_	0	SENT_30	[p2l987t1247r1233b1317],

1	First	RB	ORDINAL	first	advmod	8	SENT_31	[p2l1280t1247r1423b1309],
2	,	,	O	,	_	0	SENT_31	[p2l1280t1247r1423b1309],
3	a	DT	O	a	det	5	SENT_31	[p2l1468t1261r1498b1301],
4	metastatic	JJ	O	metastatic	amod	5	SENT_31	[p2l1548t1247r1876b1301],
5	patient	NN	O	patient	nsubj	8	SENT_31	[p2l1924t1247r2148b1315],
6	could	MD	O	could	aux	8	SENT_31	[p2l8t1331r180b1387],
7	have	VB	O	have	aux	8	SENT_31	[p2l241t1331r389b1387],
8	undergone	VBN	O	undergo	_	0	SENT_31	[p2l447t1331r797b1403],
9	previous	JJ	O	previous	amod	10	SENT_31	[p2l855t1333r1124b1402],
10	treatments	NNS	O	treatment	dobj	8	SENT_31	[p2l1178t1339r1527b1387],
11	with	IN	O	with	_	0	SENT_31	[p2l1582t1331r1717b1387],
12	drugs	NNS	O	drug	prep_with	8	SENT_31	[p2l1775t1331r1953b1403],
13	with	IN	O	with	_	0	SENT_31	[p2l2008t1331r2143b1387],
14	neurotoxic	JJ	O	neurotoxic	amod	15	SENT_31	[p2l11t1420r348b1474],
15	potential	NN	O	potential	prep_with	12	SENT_31	[p2l409t1417r707b1488],
16	.	.	O	.	_	0	SENT_31	[p2l409t1417r707b1488],

1	In	IN	O	in	_	0	SENT_32	[p2l767t1420r817b1473],
2	addition	NN	O	addition	prep_in	11	SENT_32	[p2l878t1417r1158b1483],
3	,	,	O	,	_	0	SENT_32	[p2l878t1417r1158b1483],
4	tumor	NN	O	tumor	nn	5	SENT_32	[p2l1214t1426r1411b1474],
5	progression	NN	O	progression	nsubjpass	11	SENT_32	[p2l1470t1420r1840b1489],
6	and	CC	O	and	_	0	SENT_32	[p2l1901t1417r2017b1474],
7	its	PRP$	O	its	poss	8	SENT_32	[p2l2079t1420r2145b1474],
8	dissemination	NN	O	dissemination	conj_and	5	SENT_32	[p2l8t1504r452b1561],
9	have	VBP	O	have	aux	11	SENT_32	[p2l506t1504r654b1561],
10	been	VBN	O	be	auxpass	11	SENT_32	[p2l706t1504r859b1561],
11	related	VBN	O	relate	_	0	SENT_32	[p2l914t1504r1130b1561],
12	to	TO	O	to	_	0	SENT_32	[p2l1180t1513r1243b1561],
13	changes	NNS	O	change	prep_to	11	SENT_32	[p2l1292t1504r1556b1576],
14	in	IN	O	in	_	0	SENT_32	[p2l1609t1507r1659b1560],
15	the	DT	O	the	det	16	SENT_32	[p2l1709t1504r1812b1561],
16	levels	NNS	O	level	prep_in	11	SENT_32	[p2l1865t1504r2037b1561],
17	of	IN	O	of	_	0	SENT_32	[p2l2087t1503r2152b1561],
18	inﬂammatory	JJ	O	inﬂammatory	amod	19	SENT_32	[p2l10t1591r437b1664],
19	mediators	NNS	O	mediator	prep_of	16	SENT_32	[p2l500t1592r833b1657],
20	,	,	O	,	_	0	SENT_32	[p2l500t1592r833b1657],
21	with	IN	O	with	_	0	SENT_32	[p2l894t1592r1029b1648],
22	associated	VBN	O	associate	prepc_with	11	SENT_32	[p2l1095t1592r1424b1648],
23	increased	VBN	O	increase	dep	22	SENT_32	[p2l1492t1592r1791b1648],
24	oxidative	JJ	O	oxidative	amod	26	SENT_32	[p2l1857t1592r2146b1648],
25	stress	NN	O	stress	nn	26	SENT_32	[p2l9t1664r321b1734],
26	.2	NN	NUMBER	.2	iobj	23	SENT_32	[p2l9t1664r321b1734],
27	°	CD	NUMBER	°	number	28	SENT_32	[p2l9t1664r321b1734],
28	'21	CD	NUMBER	'21	dobj	23	SENT_32	[p2l9t1664r321b1734],
29	This	DT	O	this	nsubj	31	SENT_32	[p2l384t1678r511b1734],
30	could	MD	O	could	aux	31	SENT_32	[p2l569t1678r741b1734],
31	make	VB	O	make	rcmod	28	SENT_32	[p2l804t1678r973b1734],
32	a	DT	O	a	det	34	SENT_32	[p2l1031t1695r1061b1734],
33	metastatic	JJ	O	metastatic	amod	34	SENT_32	[p2l1123t1680r1451b1734],
34	patient	NN	O	patient	dobj	31	SENT_32	[p2l1512t1680r1735b1749],
35	particularly	RB	O	particularly	advmod	36	SENT_32	[p2l1794t1678r2148b1750],
36	sensitive	JJ	O	sensitive	dep	23	SENT_32	[p2l9t1768r282b1821],
37	to	TO	O	to	_	0	SENT_32	[p2l348t1774r412b1822],
38	environmental	JJ	O	environmental	amod	40	SENT_32	[p2l480t1765r943b1822],
39	stress	NN	O	stress	nn	40	SENT_32	[p2l1014t1774r1189b1821],
40	factors	NNS	O	factor	prep_to	36	SENT_32	[p2l1255t1764r1468b1822],
41	like	IN	O	like	_	0	SENT_32	[p2l1539t1765r1642b1821],
42	hypoxia	NN	O	hypoxium	prep_like	22	SENT_32	[p2l1713t1765r1958b1838],
43	and	CC	O	and	_	0	SENT_32	[p2l2027t1765r2144b1822],
44	oxidative	JJ	O	oxidative	amod	45	SENT_32	[p2l8t1851r297b1908],
45	stress	NN	O	stress	prep_like	22	SENT_32	[p2l332t1860r523b1917],
46	,	,	O	,	_	0	SENT_32	[p2l332t1860r523b1917],
47	resulting	VBG	O	result	xcomp	22	SENT_32	[p2l559t1851r831b1923],
48	into	IN	O	into	_	0	SENT_32	[p2l870t1854r990b1908],
49	DNA	NN	O	dna	nn	50	SENT_32	[p2l1027t1854r1168b1908],
50	damage	NN	O	damage	prep_into	47	SENT_32	[p2l1201t1851r1460b1923],
51	upon	IN	O	upon	_	0	SENT_32	[p2l1497t1868r1657b1923],
52	exposure	NN	O	exposure	prep_upon	47	SENT_32	[p2l1693t1868r1984b1923],
53	to	TO	O	to	_	0	SENT_32	[p2l2017t1860r2081b1908],
54	a	DT	O	a	det	56	SENT_32	[p2l2114t1868r2144b1908],
55	cytotoxic	JJ	O	cytotoxic	amod	56	SENT_32	[p2l8t1941r296b2011],
56	agent	NN	O	agent	prep_to	47	SENT_32	[p2l326t1925r583b2010],
57	.	.	O	.	_	0	SENT_32	[p2l326t1925r583b2010],

1	”	NN	O	”	_	0	SENT_33	[p2l326t1925r583b2010],

1	To	TO	O	to	_	0	SENT_34	[p2l83t2027r161b2081],
2	our	PRP$	O	we	poss	3	SENT_34	[p2l189t2041r293b2081],
3	knowledge	NN	O	knowledge	prep_to	8	SENT_34	[p2l325t2024r685b2096],
4	,	,	O	,	_	0	SENT_34	[p2l325t2024r685b2096],
5	no	DT	O	no	det	6	SENT_34	[p2l717t2041r793b2081],
6	data	NNS	O	datum	nsubj	8	SENT_34	[p2l824t2024r957b2081],
7	are	VBP	O	be	cop	8	SENT_34	[p2l989t2041r1083b2081],
8	available	JJ	O	available	_	0	SENT_34	[p2l1113t2024r1386b2081],
9	in	IN	O	in	_	0	SENT_34	[p2l1418t2027r1468b2080],
10	the	DT	O	the	det	12	SENT_34	[p2l1499t2024r1601b2081],
11	adjuvant	JJ	O	adjuvant	amod	12	SENT_34	[p2l1630t2024r1905b2096],
12	setting	NN	O	setting	prep_in	8	SENT_34	[p2l1934t2027r2145b2096],
13	on	IN	O	on	_	0	SENT_34	[p2l8t2128r85b2168],
14	genetic	JJ	O	genetic	amod	15	SENT_34	[p2l123t2114r353b2183],
15	polymorphisms	NNS	O	polymorphism	prep_on	12	SENT_34	[p2l392t2111r876b2184],
16	as	IN	O	as	_	0	SENT_34	[p2l911t2128r973b2168],
17	toxicity	NN	O	toxicity	nn	18	SENT_34	[p2l1008t2114r1235b2184],
18	predictors	NNS	O	predictor	prep_as	8	SENT_34	[p2l1271t2111r1582b2183],
19	for	IN	O	for	_	0	SENT_34	[p2l1616t2111r1703b2168],
20	CRC	NN	ORGANIZATION	crc	nn	21	SENT_34	[p2l1737t2113r1861b2168],
21	patients	NNS	O	patient	prep_for	18	SENT_34	[p2l1898t2114r2146b2183],
22	treated	VBN	O	treat	partmod	21	SENT_34	[p2l7t2198r229b2255],
23	with	IN	O	with	_	0	SENT_34	[p2l258t2198r392b2255],
24	oxaliplatin	NN	O	oxaliplatin	nn	27	SENT_34	[p2l422t2198r740b2270],
25	(	CD	NUMBER	(	num	27	SENT_34	[p2l773t2200r1119b2264],
26	FOLFOX4	NN	O	folfox4	nn	27	SENT_34	[p2l773t2200r1119b2264],
27	)	NN	O	)	prep_with	22	SENT_34	[p2l773t2200r1119b2264],
28	.	.	O	.	_	0	SENT_34	[p2l773t2200r1119b2264],

1	Hence	RB	O	hence	advmod	11	SENT_35	[p2l1149t2201r1358b2264],
2	,	,	O	,	_	0	SENT_35	[p2l1149t2201r1358b2264],
3	the	DT	O	the	det	5	SENT_35	[p2l1384t2198r1485b2255],
4	primary	JJ	O	primary	amod	5	SENT_35	[p2l1515t2201r1754b2271],
5	aims	NNS	O	aim	nsubj	11	SENT_35	[p2l1780t2201r1923b2255],
6	of	IN	O	of	_	0	SENT_35	[p2l1951t2198r2016b2255],
7	this	DT	O	this	det	9	SENT_35	[p2l2036t2198r2146b2255],
8	prospective	JJ	O	prospective	amod	9	SENT_35	[p2l11t2288r372b2356],
9	study	NN	O	study	prep_of	5	SENT_35	[p2l431t2285r602b2358],
10	are	VBP	O	be	cop	11	SENT_35	[p2l659t2302r753b2342],
11	(	CD	NUMBER	(	_	0	SENT_35	[p2l813t2286r885b2351],
12	I	PRP	O	I	nsubj	13	SENT_35	[p2l813t2286r885b2351],
13	)	VBP	O	)	rcmod	11	SENT_35	[p2l813t2286r885b2351],
14	to	TO	O	to	aux	15	SENT_35	[p2l945t2294r1008b2342],
15	investigate	VB	O	investigate	xcomp	13	SENT_35	[p2l1068t2288r1406b2357],
16	the	DT	O	the	det	17	SENT_35	[p2l1463t2285r1565b2342],
17	role	NN	O	role	dobj	15	SENT_35	[p2l1626t2285r1739b2342],
18	of	IN	O	of	_	0	SENT_35	[p2l1798t2284r1863b2342],
19	genetic	JJ	O	genetic	amod	20	SENT_35	[p2l1916t2288r2146b2357],
20	polymorphisms	NNS	O	polymorphism	prep_of	17	SENT_35	[p2l11t2372r495b2445],
21	previously	RB	DATE	previously	advmod	22	SENT_35	[p2l535t2372r853b2445],
22	identiﬁed	VBN	O	identiﬁed	partmod	20	SENT_35	[p2l892t2372r1184b2429],
23	in	IN	O	in	_	0	SENT_35	[p2l1227t2375r1278b2428],
24	the	DT	O	the	det	26	SENT_35	[p2l1317t2372r1419b2429],
25	metastatic	JJ	O	metastatic	amod	26	SENT_35	[p2l1459t2375r1781b2429],
26	disease	NN	O	disease	prep_in	22	SENT_35	[p2l1819t2372r2046b2429],
27	as	IN	O	as	amod	26	SENT_35	[p2l2084t2389r2147b2429],

1	1Experimenta	NN	O	1experimenta	dep	135	SENT_36	[p2l11t2498r177b2529],
2	|	NN	O	|	dep	135	SENT_36	[p2l11t2498r177b2529],
3	and	CC	O	and	dep	135	SENT_36	[p2l190t2503r234b2524],
4	Clinical	JJ	O	clinical	dep	135	SENT_36	[p2l246t2503r330b2524],
5	Pharmacology	NN	O	pharmacology	dep	135	SENT_36	[p2l343t2503r515b2530],
6	Unit	NN	O	unit	dep	135	SENT_36	[p2l527t2504r581b2527],
7	,	,	O	,	_	0	SENT_36	[p2l527t2504r581b2527],
8	’	CD	NUMBER	’	dep	135	SENT_36	[p2l593t2503r678b2524],
9	Centro	NNP	O	Centro	dep	135	SENT_36	[p2l593t2503r678b2524],
10	di	FW	O	di	dep	135	SENT_36	[p2l690t2503r710b2524],
11	Riferimento	NNP	O	Riferimento	dep	135	SENT_36	[p2l723t2502r862b2524],
12	Onco	NNP	O	Onco	dep	135	SENT_36	[p2l873t2503r1025b2530],
13	|	NN	O	|	dep	135	SENT_36	[p2l873t2503r1025b2530],
14	ogico	NN	O	ogico	dep	135	SENT_36	[p2l873t2503r1025b2530],
15	’	CD	NUMBER	’	dep	135	SENT_36	[p2l873t2503r1025b2530],
16	National	NNP	ORGANIZATION	National	dep	135	SENT_36	[p2l1037t2503r1135b2524],
17	Cancer	NNP	ORGANIZATION	Cancer	dep	135	SENT_36	[p2l1148t2503r1230b2524],
18	Institute	NNP	ORGANIZATION	Institute	dep	135	SENT_36	[p2l1242t2504r1345b2527],
19	,	,	O	,	_	0	SENT_36	[p2l1242t2504r1345b2527],
20	Aviano	NNP	LOCATION	Aviano	dep	135	SENT_36	[p2l1356t2504r1444b2527],
21	,	,	O	,	_	0	SENT_36	[p2l1356t2504r1444b2527],
22	Italy	NNP	LOCATION	Italy	dep	135	SENT_36	[p2l1456t2503r1510b2530],
23	;	:	O	;	_	0	SENT_36	[p2l1456t2503r1510b2530],
24	2Medica	NNP	O	2Medica	dep	135	SENT_36	[p2l1521t2498r1624b2524],
25	|	NNP	O	|	dep	135	SENT_36	[p2l1521t2498r1624b2524],
26	Oncology	NNP	O	Oncology	dep	135	SENT_36	[p2l1637t2503r1752b2530],
27	Unit	NNP	O	Unit	dep	135	SENT_36	[p2l1764t2504r1818b2527],
28	,	,	O	,	_	0	SENT_36	[p2l1764t2504r1818b2527],
29	‘	CD	NUMBER	‘	dep	135	SENT_36	[p2l1830t2503r1877b2524],
30	San	NNP	LOCATION	San	dep	135	SENT_36	[p2l1830t2503r1877b2524],
31	Filippo	NNP	LOCATION	Filippo	dep	135	SENT_36	[p2l1891t2503r1970b2529],
32	Neri	NNP	LOCATION	Neri	dep	135	SENT_36	[p2l1983t2504r2029b2524],
33	Hospital	NNP	LOCATION	Hospital	dep	135	SENT_36	[p2l2042t2503r2150b2529],
34	’	NN	O	’	dep	135	SENT_36	[p2l2042t2503r2150b2529],
35	,	,	O	,	_	0	SENT_36	[p2l2042t2503r2150b2529],
36	Rome	NNP	LOCATION	Rome	dep	135	SENT_36	[p2l11t2540r84b2563],
37	,	,	O	,	_	0	SENT_36	[p2l11t2540r84b2563],
38	Italy	NNP	LOCATION	Italy	dep	135	SENT_36	[p2l99t2539r153b2566],
39	;	:	O	;	_	0	SENT_36	[p2l99t2539r153b2566],
40	3Medical	JJ	O	3medical	dep	135	SENT_36	[p2l167t2534r270b2560],
41	Oncology	NNP	O	Oncology	dep	135	SENT_36	[p2l285t2539r401b2566],
42	Unit	NN	O	unit	dep	135	SENT_36	[p2l416t2540r464b2560],
43	1	CD	NUMBER	1	dep	135	SENT_36	[p2l480t2541r497b2563],
44	,	,	O	,	_	0	SENT_36	[p2l480t2541r497b2563],
45	lstituto	FW	O	lstituto	dep	135	SENT_36	[p2l512t2540r594b2560],
46	Oncologico	FW	O	oncologico	dep	135	SENT_36	[p2l609t2539r746b2566],
47	Veneto	FW	O	veneto	dep	135	SENT_36	[p2l759t2540r929b2563],
48	—	FW	O	—	dep	135	SENT_36	[p2l759t2540r929b2563],
49	|	FW	O	|	dep	135	SENT_36	[p2l759t2540r929b2563],
50	RCCS	NNS	O	rcc	dep	135	SENT_36	[p2l759t2540r929b2563],
51	,	,	O	,	_	0	SENT_36	[p2l759t2540r929b2563],
52	Padova	NNP	LOCATION	Padova	dep	135	SENT_36	[p2l945t2539r1037b2563],
53	,	,	O	,	_	0	SENT_36	[p2l945t2539r1037b2563],
54	Italy	NNP	LOCATION	Italy	dep	135	SENT_36	[p2l1052t2539r1106b2566],
55	;	:	O	;	_	0	SENT_36	[p2l1052t2539r1106b2566],
56	“	NNP	O	“	dep	135	SENT_36	[p2l1119t2534r1223b2560],
57	Medical	NNP	ORGANIZATION	Medical	dep	135	SENT_36	[p2l1119t2534r1223b2560],
58	Oncology	NNP	ORGANIZATION	Oncology	dep	135	SENT_36	[p2l1238t2539r1354b2566],
59	Unit	NNP	ORGANIZATION	Unit	dep	135	SENT_36	[p2l1369t2540r1423b2563],
60	,	,	O	,	_	0	SENT_36	[p2l1369t2540r1423b2563],
61	University	NNP	ORGANIZATION	University	dep	135	SENT_36	[p2l1438t2540r1556b2566],
62	Hospital	NNP	ORGANIZATION	Hospital	dep	135	SENT_36	[p2l1571t2539r1674b2566],
63	,	,	O	,	_	0	SENT_36	[p2l1571t2539r1674b2566],
64	Udine	NNP	LOCATION	Udine	dep	135	SENT_36	[p2l1689t2539r1764b2563],
65	,	,	O	,	_	0	SENT_36	[p2l1689t2539r1764b2563],
66	Italy	NNP	LOCATION	Italy	dep	135	SENT_36	[p2l1779t2539r1833b2566],
67	;	:	O	;	_	0	SENT_36	[p2l1779t2539r1833b2566],
68	5Medica	NNP	O	5Medica	dep	135	SENT_36	[p2l1847t2534r1950b2560],
69	|	NNP	O	|	dep	135	SENT_36	[p2l1847t2534r1950b2560],
70	Oncology	NNP	O	Oncology	dep	135	SENT_36	[p2l1966t2539r2081b2566],
71	Unit	NNP	O	Unit	dep	135	SENT_36	[p2l2096t2540r2150b2563],
72	,	,	O	,	_	0	SENT_36	[p2l2096t2540r2150b2563],
73	Ospedale	NNP	PERSON	Ospedale	dep	135	SENT_36	[p2l10t2576r122b2603],
74	Civile	NNP	PERSON	Civile	dep	135	SENT_36	[p2l132t2576r195b2597],
75	di	NNP	O	di	dep	135	SENT_36	[p2l206t2576r227b2597],
76	Vittorio	NNP	PERSON	Vittorio	dep	135	SENT_36	[p2l236t2577r325b2597],
77	Veneto	NNP	PERSON	Veneto	dep	135	SENT_36	[p2l334t2577r425b2600],
78	,	,	O	,	_	0	SENT_36	[p2l334t2577r425b2600],
79	Treviso	NNP	LOCATION	Treviso	dep	135	SENT_36	[p2l434t2577r526b2600],
80	,	,	O	,	_	0	SENT_36	[p2l434t2577r526b2600],
81	Italy	NNP	LOCATION	Italy	dep	135	SENT_36	[p2l537t2576r591b2603],
82	;	:	O	;	_	0	SENT_36	[p2l537t2576r591b2603],
83	5Epidemio	NNP	O	5Epidemio	dep	135	SENT_36	[p2l600t2571r777b2603],
84	|	CD	NUMBER	|	dep	135	SENT_36	[p2l600t2571r777b2603],
85	ogy	NN	O	ogy	dep	135	SENT_36	[p2l600t2571r777b2603],
86	and	CC	O	and	dep	135	SENT_36	[p2l787t2576r831b2597],
87	Biostatistics	NNS	O	biostatistic	dep	135	SENT_36	[p2l843t2577r981b2597],
88	Unit	NN	O	unit	dep	135	SENT_36	[p2l993t2577r1047b2600],
89	,	,	O	,	_	0	SENT_36	[p2l993t2577r1047b2600],
90	’	CD	NUMBER	’	dep	135	SENT_36	[p2l1057t2576r1143b2597],
91	Centro	NNP	O	Centro	dep	135	SENT_36	[p2l1057t2576r1143b2597],
92	di	FW	O	di	dep	135	SENT_36	[p2l1153t2576r1173b2597],
93	Riferimento	NNP	O	Riferimento	dep	135	SENT_36	[p2l1185t2575r1324b2597],
94	Onco	NNP	O	Onco	dep	135	SENT_36	[p2l1334t2576r1486b2603],
95	|	NN	O	|	dep	135	SENT_36	[p2l1334t2576r1486b2603],
96	ogico	NN	O	ogico	dep	135	SENT_36	[p2l1334t2576r1486b2603],
97	’	CD	NUMBER	’	dep	135	SENT_36	[p2l1334t2576r1486b2603],
98	National	NNP	ORGANIZATION	National	dep	135	SENT_36	[p2l1497t2576r1594b2597],
99	Cancer	NNP	ORGANIZATION	Cancer	dep	135	SENT_36	[p2l1606t2577r1688b2597],
100	Institute	NNP	ORGANIZATION	Institute	dep	135	SENT_36	[p2l1699t2577r1801b2600],
101	,	,	O	,	_	0	SENT_36	[p2l1699t2577r1801b2600],
102	Aviano	NNP	LOCATION	Aviano	dep	135	SENT_36	[p2l1811t2577r1900b2600],
103	,	,	O	,	_	0	SENT_36	[p2l1811t2577r1900b2600],
104	Italy	NNP	LOCATION	Italy	dep	135	SENT_36	[p2l1911t2576r1959b2603],
105	and	CC	O	and	dep	135	SENT_36	[p2l1968t2576r2012b2597],
106	7Eshe	NNP	O	7Eshe	dep	135	SENT_36	[p2l2024t2571r2149b2597],
107	|	CD	NUMBER	|	dep	135	SENT_36	[p2l2024t2571r2149b2597],
108	man	NN	O	man	dep	135	SENT_36	[p2l2024t2571r2149b2597],
109	School	NNP	ORGANIZATION	School	dep	135	SENT_36	[p2l10t2612r89b2634],
110	of	IN	ORGANIZATION	of	dep	135	SENT_36	[p2l100t2612r125b2634],
111	Pharmacy	NNP	ORGANIZATION	Pharmacy	dep	135	SENT_36	[p2l135t2612r257b2640],
112	,	,	O	,	_	0	SENT_36	[p2l135t2612r257b2640],
113	Institute	NNP	ORGANIZATION	Institute	dep	135	SENT_36	[p2l269t2613r366b2634],
114	for	IN	ORGANIZATION	for	dep	135	SENT_36	[p2l376t2612r409b2634],
115	Pharmacogenomics	NNP	ORGANIZATION	Pharmacogenomics	dep	135	SENT_36	[p2l420t2612r657b2640],
116	and	CC	O	and	dep	135	SENT_36	[p2l668t2612r712b2634],
117	Individualized	NNP	O	Individualized	dep	135	SENT_36	[p2l724t2612r890b2634],
118	Therapy	NN	O	therapy	dep	135	SENT_36	[p2l900t2612r1004b2640],
119	,	,	O	,	_	0	SENT_36	[p2l900t2612r1004b2640],
120	Lineberger	NNP	ORGANIZATION	Lineberger	dep	135	SENT_36	[p2l1015t2612r1145b2640],
121	Comprehensive	NNP	ORGANIZATION	Comprehensive	dep	135	SENT_36	[p2l1155t2612r1343b2640],
122	Cancer	NNP	ORGANIZATION	Cancer	dep	135	SENT_36	[p2l1354t2613r1437b2634],
123	Center	NNP	ORGANIZATION	Center	dep	135	SENT_36	[p2l1447t2613r1532b2637],
124	,	,	O	,	_	0	SENT_36	[p2l1447t2613r1532b2637],
125	University	NNP	ORGANIZATION	University	dep	135	SENT_36	[p2l1543t2613r1662b2640],
126	of	IN	ORGANIZATION	of	dep	135	SENT_36	[p2l1672t2612r1696b2634],
127	North	NNP	ORGANIZATION	North	dep	135	SENT_36	[p2l1706t2612r1772b2634],
128	Carolina	NNP	ORGANIZATION	Carolina	dep	135	SENT_36	[p2l1784t2612r1887b2637],
129	,	,	O	,	_	0	SENT_36	[p2l1784t2612r1887b2637],
130	Chapel	NN	LOCATION	chapel	dep	135	SENT_36	[p2l1898t2612r1979b2640],
131	Hill	NNP	LOCATION	Hill	dep	135	SENT_36	[p2l1992t2612r2034b2637],
132	,	,	O	,	_	0	SENT_36	[p2l1992t2612r2034b2637],
133	NC	NNP	O	NC	dep	135	SENT_36	[p2l2046t2613r2085b2637],
134	,	,	O	,	_	0	SENT_36	[p2l2046t2613r2085b2637],
135	USA	NNP	LOCATION	USA	_	0	SENT_36	[p2l2097t2613r2150b2634],
136	.	.	O	.	_	0	SENT_36	[p2l2097t2613r2150b2634],

1	Correspondence	NN	O	correspondence	_	0	SENT_37	[p2l10t2649r214b2676],
2	:	:	O	:	_	0	SENT_37	[p2l10t2649r214b2676],
3	Dr	NN	O	dr	nn	5	SENT_37	[p2l224t2650r250b2671],
4	G	NN	PERSON	g	nn	5	SENT_37	[p2l258t2650r275b2671],
5	Toffoli	NNS	PERSON	toffolus	conj_and	1	SENT_37	[p2l283t2649r364b2674],
6	,	,	O	,	_	0	SENT_37	[p2l283t2649r364b2674],
7	Experimental	JJ	O	experimental	conj_and	1	SENT_37	[p2l374t2649r529b2676],
8	and	CC	O	and	_	0	SENT_37	[p2l539t2649r583b2671],
9	Clinical	JJ	O	clinical	amod	11	SENT_37	[p2l593t2649r676b2671],
10	Pharmacology	NN	O	pharmacology	nn	11	SENT_37	[p2l687t2649r859b2677],
11	Unit	NN	O	unit	conj_and	1	SENT_37	[p2l868t2650r922b2674],
12	,	,	O	,	_	0	SENT_37	[p2l868t2650r922b2674],
13	’	CD	NUMBER	’	appos	11	SENT_37	[p2l931t2650r1017b2671],
14	Centro	NNP	O	Centro	nn	16	SENT_37	[p2l931t2650r1017b2671],
15	di	FW	O	di	nn	16	SENT_37	[p2l1026t2649r1046b2671],
16	Riferimento	NNP	O	Riferimento	dep	1	SENT_37	[p2l1057t2649r1195b2671],
17	Oncologico	NNP	O	Oncologico	poss	16	SENT_37	[p2l1204t2649r1456b2677],
18	'	POS	O	'	_	0	SENT_37	[p2l1204t2649r1456b2677],
19	.	.	O	.	_	0	SENT_37	[p2l1204t2649r1456b2677],

1	—	NN	O	—	_	0	SENT_38	[p2l1204t2649r1456b2677],
2	.	.	O	.	_	0	SENT_38	[p2l1204t2649r1456b2677],

1	Nationa	NNP	ORGANIZATION	Nationa	nn	4	SENT_39	[p2l1204t2649r1456b2677],
2	|	NNP	ORGANIZATION	|	nn	4	SENT_39	[p2l1204t2649r1456b2677],
3	Cancer	NNP	ORGANIZATION	Cancer	nn	4	SENT_39	[p2l1466t2650r1548b2671],
4	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_39	[p2l1558t2650r1660b2674],
5	,	,	O	,	_	0	SENT_39	[p2l1558t2650r1660b2674],
6	Via	NNP	PERSON	Via	nn	8	SENT_39	[p2l1668t2650r1703b2671],
7	Franco	NNP	PERSON	Franco	nn	8	SENT_39	[p2l1713t2650r1793b2671],
8	Gallini	NNP	PERSON	Gallini	appos	4	SENT_39	[p2l1802t2649r1881b2674],
9	,	,	O	,	_	0	SENT_39	[p2l1802t2649r1881b2674],
10	2	CD	NUMBER	2	appos	4	SENT_39	[p2l1890t2651r1909b2674],
11	,	,	O	,	_	0	SENT_39	[p2l1890t2651r1909b2674],
12	Aviano	NNP	LOCATION	Aviano	appos	4	SENT_39	[p2l1918t2650r2000b2671],
13	33081	CD	NUMBER	33081	num	12	SENT_39	[p2l2009t2651r2087b2674],
14	,	,	O	,	_	0	SENT_39	[p2l2009t2651r2087b2674],
15	Italy	NNP	LOCATION	Italy	appos	4	SENT_39	[p2l2097t2649r2150b2677],
16	.	.	O	.	_	0	SENT_39	[p2l2097t2649r2150b2677],

1	E	NN	O	e	_	0	SENT_40	[p2l11t2686r89b2707],
2	—	CD	NUMBER	—	num	1	SENT_40	[p2l11t2686r89b2707],
3	mai	FW	O	mai	nn	4	SENT_40	[p2l11t2686r89b2707],
4	|	FW	O	|	amod	1	SENT_40	[p2l11t2686r89b2707],
5	:	:	O	:	_	0	SENT_40	[p2l11t2686r89b2707],
6	gtoffo	NN	O	gtoffo	nn	8	SENT_40	[p2l100t2686r267b2713],
7	|	CD	NUMBER	|	num	8	SENT_40	[p2l100t2686r267b2713],
8	i@cro.it	NN	O	i@cro.it	dep	1	SENT_40	[p2l100t2686r267b2713],
9	Received	VBN	O	receive	partmod	8	SENT_40	[p2l11t2723r116b2744],
10	3	CD	DATE	3	dobj	9	SENT_40	[p2l129t2724r141b2744],
11	April	NNP	DATE	April	tmod	9	SENT_40	[p2l153t2723r207b2750],
12	2012	CD	DATE	2012	num	11	SENT_40	[p2l220t2724r283b2747],
13	;	:	O	;	_	0	SENT_40	[p2l220t2724r283b2747],
14	revised	VBN	O	revise	parataxis	8	SENT_40	[p2l295t2723r378b2744],
15	23	CD	DATE	23	dobj	14	SENT_40	[p2l391t2724r418b2744],
16	May	NNP	DATE	May	tmod	14	SENT_40	[p2l431t2724r480b2750],
17	2012	CD	DATE	2012	num	16	SENT_40	[p2l491t2724r555b2747],
18	;	:	O	;	_	0	SENT_40	[p2l491t2724r555b2747],
19	accepted	VBN	O	accept	parataxis	8	SENT_40	[p2l566t2723r674b2750],
20	9	CD	DATE	9	dobj	19	SENT_40	[p2l687t2724r700b2744],
21	July	NNP	DATE	July	tmod	19	SENT_40	[p2l711t2723r757b2750],
22	2012	CD	DATE	2012	num	21	SENT_40	[p2l768t2724r832b2747],
23	;	:	O	;	_	0	SENT_40	[p2l768t2724r832b2747],
24	published	VBN	O	publish	parataxis	8	SENT_40	[p2l843t2723r960b2750],
25	online	NN	O	online	prep	24	SENT_40	[p2l973t2723r1047b2744],
26	7	CD	DATE	7	dep	25	SENT_40	[p2l1059t2724r1071b2744],
27	August	NNP	DATE	August	tmod	24	SENT_40	[p2l1083t2724r1167b2750],
28	2012	CD	DATE	2012	num	27	SENT_40	[p2l1179t2724r1235b2744],

1	_	NN	O	_	nn	3	SENT_41	[p2l95t2949r110b2968],
2	Pharmacogenomic	JJ	O	pharmacogenomic	amod	3	SENT_41	[p2l555t2894r1044b2952],
3	markers	NNS	O	marker	_	0	SENT_41	[p2l1071t2894r1275b2940],
4	of	IN	O	of	_	0	SENT_41	[p2l1300t2893r1353b2940],
5	toxicity	NN	O	toxicity	prep_of	3	SENT_41	[p2l1372t2896r1562b2953],
6	in	IN	O	in	_	0	SENT_41	[p2l1587t2896r1628b2939],
7	adjuvant	JJ	O	adjuvant	amod	8	SENT_41	[p2l1656t2894r1884b2953],
8	FOLFOX4	NN	O	folfox4	prep_in	3	SENT_41	[p2l1910t2895r2150b2940],
9	@	IN	O	@	_	0	SENT_41	[p2l7t2909r126b3025],
10	E	NN	O	e	nn	11	SENT_41	[p2l1757t2975r1782b3019],
11	Cecchin	NN	O	cecchin	prep_@	3	SENT_41	[p2l1807t2973r2010b3019],
12	et	FW	O	et	nn	13	SENT_41	[p2l2036t2980r2084b3019],
13	al	FW	O	al	dep	11	SENT_41	[p2l2105t2973r2152b3019],
14	predictive	JJ	O	predictive	amod	15	SENT_41	[p2l186t3168r469b3234],
15	markers	NNS	O	marker	dep	11	SENT_41	[p2l512t3168r737b3220],
16	of	IN	O	of	_	0	SENT_41	[p2l779t3168r838b3220],
17	toxicity	NN	O	toxicity	nn	20	SENT_41	[p2l873t3171r1081b3235],
18	(	CD	NUMBER	(	num	20	SENT_41	[p2l1123t3168r1333b3235],
19	mainly	RB	O	mainly	advmod	20	SENT_41	[p2l1123t3168r1333b3235],
20	neurotoxicity	NN	O	neurotoxicity	prep_of	15	SENT_41	[p2l1374t3171r1751b3235],
21	and	CC	O	and	_	0	SENT_41	[p2l1790t3168r1895b3220],
22	neutropenia	NN	O	neutropenia	nn	23	SENT_41	[p2l1941t3176r2151b3220, p2l186t3248r360b3312],
23	)	NN	O	)	conj_and	11	SENT_41	[p2l1941t3176r2151b3220, p2l186t3248r360b3312],
24	in	IN	O	in	_	0	SENT_41	[p2l408t3249r455b3298],
25	patients	NNS	O	patient	prep_in	23	SENT_41	[p2l505t3249r733b3312],
26	treated	VBN	O	treat	partmod	3	SENT_41	[p2l778t3247r983b3299],
27	with	IN	O	with	_	0	SENT_41	[p2l1029t3247r1152b3299],
28	adjuvant	JJ	O	adjuvant	amod	29	SENT_41	[p2l1200t3247r1452b3313],
29	FOLFOX4	NN	O	folfox4	prep_with	26	SENT_41	[p2l1500t3248r1778b3306],
30	;	:	O	;	_	0	SENT_41	[p2l1500t3248r1778b3306],
31	and	CC	O	and	_	0	SENT_41	[p2l1823t3247r1929b3299],
32	(	NN	O	(	nn	34	SENT_41	[p2l1979t3248r2045b3306],
33	2	CD	NUMBER	2	num	34	SENT_41	[p2l1979t3248r2045b3306],
34	)	NN	O	)	conj_and	29	SENT_41	[p2l1979t3248r2045b3306],
35	to	TO	O	to	aux	36	SENT_41	[p2l2092t3255r2150b3299],
36	discover	VB	O	discover	xcomp	26	SENT_41	[p2l184t3324r424b3376],
37	associations	NNS	O	association	dobj	36	SENT_41	[p2l449t3327r793b3376],
38	with	IN	O	with	_	0	SENT_41	[p2l820t3324r943b3376],
39	putative	JJ	O	putative	amod	41	SENT_41	[p2l975t3327r1208b3390],
40	novel	JJ	O	novel	amod	41	SENT_41	[p2l1238t3324r1390b3376],
41	biomarkers	NNS	O	biomarker	prep_with	36	SENT_41	[p2l1422t3324r1755b3376],
42	.	.	O	.	_	0	SENT_41	[p2l1422t3324r1755b3376],

1	MATERIALS	NNS	O	material	_	0	SENT_42	[p2l185t3533r544b3583],
2	AND	CC	O	and	_	0	SENT_42	[p2l570t3533r712b3583],
3	METHODS	NNS	O	method	conj_and	1	SENT_42	[p2l740t3533r1057b3583],

1	Patients	NNS	O	patient	_	0	SENT_43	[p2l186t3617r416b3667],
2	and	CC	O	and	_	0	SENT_43	[p2l444t3615r551b3667],
3	study	NN	O	study	nn	4	SENT_43	[p2l582t3615r742b3682],
4	design	NN	O	design	conj_and	1	SENT_43	[p2l769t3615r961b3681],

1	This	DT	O	this	det	3	SENT_44	[p3l181t18r285b64],
2	mu	NN	O	mu	nn	3	SENT_44	[p3l320t18r735b64],
3	|	NN	O	|	nsubjpass	9	SENT_44	[p3l320t18r735b64],
4	ti	NN	O	ti	nn	7	SENT_44	[p3l320t18r735b64],
5	—	CD	NUMBER	—	num	7	SENT_44	[p3l320t18r735b64],
6	institution	NN	O	institution	nn	7	SENT_44	[p3l320t18r735b64],
7	study	NN	O	study	dep	3	SENT_44	[p3l770t18r912b77],
8	was	VBD	O	be	auxpass	9	SENT_44	[p3l943t31r1041b64],
9	sponsored	VBN	O	sponsor	_	0	SENT_44	[p3l1075t18r1345b76],
10	by	IN	O	by	_	0	SENT_44	[p3l1382t18r1443b77],
11	the	DT	O	the	det	12	SENT_44	[p3l1473t18r1557b64],
12	CRO	NNP	O	CRO	agent	9	SENT_44	[p3l1590t18r1938b64],
13	.	.	O	.	_	0	SENT_44	[p3l1590t18r1938b64],

1	—	NN	O	—	_	0	SENT_45	[p3l1590t18r1938b64],
2	.	.	O	.	_	0	SENT_45	[p3l1590t18r1938b64],

1	National	NNP	O	National	nn	3	SENT_46	[p3l1590t18r1938b64],
2	Cancer	NNP	O	Cancer	nn	3	SENT_46	[p3l1972t20r2152b64],
3	Center	NNP	O	Center	_	0	SENT_46	[p3l183t89r356b134],
4	of	IN	O	of	_	0	SENT_46	[p3l390t87r444b134],
5	Aviano	NNP	LOCATION	Aviano	nn	7	SENT_46	[p3l474t90r666b141],
6	,	,	O	,	_	0	SENT_46	[p3l474t90r666b141],
7	Italy	NNP	LOCATION	Italy	prep_of	3	SENT_46	[p3l703t88r819b147],
8	.	.	O	.	_	0	SENT_46	[p3l703t88r819b147],

1	CRC	NN	ORGANIZATION	crc	nn	2	SENT_47	[p3l854t89r957b134],
2	patients	NNS	O	patient	_	0	SENT_47	[p3l994t90r1200b145],
3	(	CD	NUMBER	(	num	4	SENT_47	[p3l1238t89r1466b141],
4	n	NN	O	n	dep	2	SENT_47	[p3l1238t89r1466b141],
5	=	JJ	O	=	amod	7	SENT_47	[p3l1238t89r1466b141],
6	154	CD	NUMBER	154	num	7	SENT_47	[p3l1238t89r1466b141],
7	)	NN	O	)	nsubjpass	9	SENT_47	[p3l1238t89r1466b141],
8	were	VBD	O	be	auxpass	9	SENT_47	[p3l1503t101r1629b134],
9	genotyped	VBN	O	genotype	rcmod	2	SENT_47	[p3l1665t88r1947b147],
10	for	IN	O	for	_	0	SENT_47	[p3l1983t87r2055b134],
11	57	CD	NUMBER	57	num	13	SENT_47	[p3l2090t91r2149b134],
12	genetic	JJ	O	genetic	amod	13	SENT_47	[p3l183t160r376b216],
13	polymorphisms	NNS	O	polymorphism	prep_for	9	SENT_47	[p3l409t157r811b216],
14	in	IN	O	in	_	0	SENT_47	[p3l844t160r886b203],
15	29	CD	NUMBER	29	num	17	SENT_47	[p3l920t160r980b203],
16	candidate	NN	O	candidate	nn	17	SENT_47	[p3l1012t157r1269b203],
17	genes	NNS	O	gene	prep_in	13	SENT_47	[p3l1301t171r1468b216],
18	.	.	O	.	_	0	SENT_47	[p3l1301t171r1468b216],

1	The	DT	O	the	det	3	SENT_48	[p3l1497t157r1593b203],
2	main	JJ	O	main	amod	3	SENT_48	[p3l1626t160r1750b203],
3	endpoint	NN	O	endpoint	nsubj	5	SENT_48	[p3l1784t157r2023b215],
4	was	VBD	O	be	cop	5	SENT_48	[p3l2052t171r2149b203],
5	neurotoxicity	NN	O	neurotoxicity	_	0	SENT_48	[p3l185t230r527b287],
6	during	IN	O	during	_	0	SENT_48	[p3l547t228r716b286],
7	FOLFOX4	NN	O	folfox4	nn	8	SENT_48	[p3l743t229r982b274],
8	therapy	NN	O	therapy	prep_during	5	SENT_48	[p3l1002t228r1204b287],
9	in	IN	O	in	_	0	SENT_48	[p3l1226t230r1267b273],
10	curatively	RB	O	curatively	advmod	8	SENT_48	[p3l1292t228r1783b287],
11	—	CD	NUMBER	—	num	13	SENT_48	[p3l1292t228r1783b287],
12	resected	JJ	O	resected	amod	13	SENT_48	[p3l1292t228r1783b287],
13	patients	NNS	O	patient	prep_in	8	SENT_48	[p3l1810t230r2016b286],
14	with	IN	O	with	_	0	SENT_48	[p3l2037t228r2148b274],
15	stage	NN	O	stage	nn	17	SENT_48	[p3l184t305r322b356],
16	|	CD	NUMBER	|	num	17	SENT_48	[p3l361t300r456b343],
17	|	NN	O	|	prep_with	13	SENT_48	[p3l361t300r456b343],
18	.	.	O	.	_	0	SENT_48	[p3l361t300r456b343],

1	—	NN	O	—	_	0	SENT_49	[p3l361t300r456b343],
2	.	.	O	.	_	0	SENT_49	[p3l361t300r456b343],

1	|	RB	O	|	advmod	4	SENT_50	[p3l361t300r456b343],
2	|	CD	NUMBER	|	number	3	SENT_50	[p3l361t300r456b343],
3	|	CD	NUMBER	|	num	4	SENT_50	[p3l361t300r456b343],
4	CRC	NN	O	crc	_	0	SENT_50	[p3l495t299r610b343],
5	.	.	O	.	_	0	SENT_50	[p3l495t299r610b343],

1	Neutropenia	NN	O	neutropenia	nsubjpass	7	SENT_51	[p3l649t300r970b355],
2	and	CC	O	and	_	0	SENT_51	[p3l1009t297r1103b343],
3	any	DT	O	any	det	5	SENT_51	[p3l1142t311r1235b356],
4	non-hematological	JJ	O	non-hematological	amod	5	SENT_51	[p3l1272t297r1762b356],
5	toxicity	NN	O	toxicity	conj_and	1	SENT_51	[p3l1799t300r1989b356],
6	were	VBD	O	be	auxpass	7	SENT_51	[p3l2024t311r2150b343],
7	evaluated	VBN	O	evaluate	_	0	SENT_51	[p3l183t368r435b414],
8	as	IN	O	as	_	0	SENT_51	[p3l462t381r513b414],
9	secondary	JJ	O	secondary	amod	10	SENT_51	[p3l538t368r805b427],
10	endpoints	NNS	O	endpoint	prep_as	7	SENT_51	[p3l827t368r1103b425],
11	.	.	O	.	_	0	SENT_51	[p3l827t368r1103b425],

1	The	DT	O	the	det	3	SENT_52	[p3l1124t368r1220b414],
2	highest	JJS	O	highest	amod	3	SENT_52	[p3l1246t368r1437b426],
3	grade	NN	O	grade	nsubjpass	27	SENT_52	[p3l1460t368r1609b426],
4	of	IN	O	of	_	0	SENT_52	[p3l1633t367r1686b414],
5	toxicity	NN	O	toxicity	prep_of	3	SENT_52	[p3l1705t370r1894b427],
6	recorded	VBN	O	record	partmod	5	SENT_52	[p3l1918t368r2148b414],
7	during	IN	O	during	_	0	SENT_52	[p3l183t437r352b496],
8	the	DT	O	the	det	9	SENT_52	[p3l387t437r472b483],
9	treatment	NN	O	treatment	prep_during	6	SENT_52	[p3l506t444r767b483],
10	for	IN	O	for	_	0	SENT_52	[p3l799t437r872b483],
11	each	DT	O	each	det	14	SENT_52	[p3l906t437r1024b483],
12	toxicity	NN	O	toxicity	nn	14	SENT_52	[p3l1061t440r1251b496],
13	endpoint	NN	O	endpoint	nn	14	SENT_52	[p3l1284t437r1523b495],
14	(	NN	O	(	prep_for	9	SENT_52	[p3l1559t437r1678b490],
15	that	WDT	O	that	nsubj	18	SENT_52	[p3l1559t437r1678b490],
16	is	VBZ	O	be	cop	18	SENT_52	[p3l1713t440r1760b490],
17	,	,	O	,	_	0	SENT_52	[p3l1713t440r1760b490],
18	neurotoxicity	NN	O	neurotoxicity	rcmod	14	SENT_52	[p3l1797t440r2150b496],
19	,	,	O	,	_	0	SENT_52	[p3l1797t440r2150b496],
20	neutropenia	NN	O	neutropenia	conj_and	18	SENT_52	[p3l185t510r500b566],
21	and	CC	O	and	_	0	SENT_52	[p3l525t508r619b554],
22	any	DT	O	any	det	25	SENT_52	[p3l645t521r738b567],
23	non-hematological	JJ	O	non-hematological	amod	25	SENT_52	[p3l761t508r1251b566],
24	toxicity	NN	O	toxicity	nn	25	SENT_52	[p3l1275t509r1479b567],
25	)	NN	O	)	conj_and	18	SENT_52	[p3l1275t509r1479b567],
26	was	VBD	O	be	auxpass	27	SENT_52	[p3l1503t521r1601b554],
27	used	VBN	O	use	_	0	SENT_52	[p3l1627t508r1745b554],
28	for	IN	O	for	_	0	SENT_52	[p3l1769t507r1841b554],
29	association	NN	O	association	prep_for	27	SENT_52	[p3l1862t510r2148b554],
30	with	IN	O	with	_	0	SENT_52	[p3l182t578r293b624],
31	polymorphisms	NNS	O	polymorphism	prep_with	27	SENT_52	[p3l322t578r738b637],
32	.	.	O	.	_	0	SENT_52	[p3l322t578r738b637],

1	The	DT	O	the	det	4	SENT_53	[p3l760t578r856b624],
2	Institutional	JJ	O	institutional	amod	4	SENT_53	[p3l883t578r1188b624],
3	Review	NNP	O	Review	nn	4	SENT_53	[p3l1217t580r1400b624],
4	Board	NNP	O	Board	nsubj	9	SENT_53	[p3l1426t578r1573b624],
5	of	IN	O	of	_	0	SENT_53	[p3l1600t577r1653b624],
6	each	DT	O	each	det	8	SENT_53	[p3l1674t578r1793b624],
7	participating	VBG	O	participate	amod	8	SENT_53	[p3l1822t580r2148b636],
8	institution	NN	O	institution	prep_of	4	SENT_53	[p3l185t650r445b693],
9	approved	VBD	O	approve	_	0	SENT_53	[p3l472t647r720b705],
10	the	DT	O	the	det	12	SENT_53	[p3l747t647r831b693],
11	study	NN	O	study	nn	12	SENT_53	[p3l856t647r999b706],
12	protocol	NN	O	protocol	dobj	9	SENT_53	[p3l1025t647r1253b705],
13	,	,	O	,	_	0	SENT_53	[p3l1025t647r1253b705],
14	and	CC	O	and	_	0	SENT_53	[p3l1278t647r1373b693],
15	all	DT	O	all	det	16	SENT_53	[p3l1401t647r1454b693],
16	patients	NNS	O	patient	nsubj	17	SENT_53	[p3l1484t650r1690b705],
17	signed	VBD	O	sign	conj_and	9	SENT_53	[p3l1716t647r1886b706],
18	a	DT	O	a	det	21	SENT_53	[p3l1914t661r1939b693],
19	written	VBN	O	write	amod	21	SENT_53	[p3l1965t650r2148b693],
20	informed	VBN	O	inform	amod	21	SENT_53	[p3l185t717r420b764],
21	consent	NN	O	consent	dobj	17	SENT_53	[p3l446t725r653b764],
22	before	IN	O	before	_	0	SENT_53	[p3l679t717r844b764],
23	entering	VBG	O	enter	prepc_before	21	SENT_53	[p3l870t720r1087b776],
24	the	DT	O	the	det	25	SENT_53	[p3l1112t718r1196b764],
25	study	NN	O	study	dobj	23	SENT_53	[p3l1222t718r1375b777],
26	.	.	O	.	_	0	SENT_53	[p3l1222t718r1375b777],

1	Patients	NNS	O	patient	nsubj	4	SENT_54	[p3l249t789r453b833],
2	with	IN	O	with	prep	1	SENT_54	[p3l474t787r585b833],
3	histologically	RB	O	histologically	pcomp	2	SENT_54	[p3l611t787r951b846],
4	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_54	[p3l972t786r1236b833],
5	CRC	NN	ORGANIZATION	crc	dobj	4	SENT_54	[p3l1260t789r1375b840],
6	,	,	O	,	_	0	SENT_54	[p3l1260t789r1375b840],
7	and	CC	O	and	_	0	SENT_54	[p3l1397t787r1491b833],
8	radiologically	RB	O	radiologically	advmod	9	SENT_54	[p3l1518t787r1863b846],
9	conﬁrmed	JJ	O	conﬁrmed	amod	10	SENT_54	[p3l1884t786r2148b833],
10	absence	NN	O	absence	nsubj	15	SENT_54	[p3l183t858r397b904],
11	of	IN	O	of	_	0	SENT_54	[p3l433t857r486b904],
12	distant	JJ	O	distant	amod	13	SENT_54	[p3l518t858r696b904],
13	metastases	NNS	O	metastase	prep_of	10	SENT_54	[p3l733t865r1019b904],
14	were	VBD	O	be	cop	15	SENT_54	[p3l1054t871r1181b904],
15	eligible	JJ	O	eligible	conj_and	4	SENT_54	[p3l1218t858r1418b916],
16	.	.	O	.	_	0	SENT_54	[p3l1218t858r1418b916],

1	Eligibility	NN	O	eligibility	nn	2	SENT_55	[p3l1456t858r1690b917],
2	criteria	NNS	O	criterion	nsubj	3	SENT_55	[p3l1724t860r1899b904],
3	were	VBD	O	be	_	0	SENT_55	[p3l1936t871r2063b904],
4	as	IN	O	as	mark	5	SENT_55	[p3l2099t871r2150b904],
5	follows	VBZ	O	follow	advcl	3	SENT_55	[p3l182t927r380b973],
6	:	:	O	:	_	0	SENT_55	[p3l182t927r380b973],
7	stage	NN	O	stage	nn	9	SENT_55	[p3l408t934r546b986],
8	|	CD	NUMBER	|	num	9	SENT_55	[p3l579t930r674b973],
9	|	NN	O	|	dobj	5	SENT_55	[p3l579t930r674b973],
10	.	.	O	.	_	0	SENT_55	[p3l579t930r674b973],

1	—	NN	O	—	_	0	SENT_56	[p3l579t930r674b973],
2	.	.	O	.	_	0	SENT_56	[p3l579t930r674b973],

1	|	NN	O	|	nn	2	SENT_57	[p3l579t930r674b973],
2	l	NN	O	l	_	0	SENT_57	[p3l579t930r674b973],
3	|	CD	NUMBER	|	num	4	SENT_57	[p3l579t930r674b973],
4	CRC	NN	O	crc	dep	2	SENT_57	[p3l706t929r822b980],
5	;	:	O	;	_	0	SENT_57	[p3l706t929r822b980],
6	age	NN	O	age	dep	2	SENT_57	[p3l851t941r943b986],
7	>	JJR	O	>	amod	6	SENT_57	[p3l982t930r1097b973],
8	18	CD	DURATION	18	num	9	SENT_57	[p3l982t930r1097b973],
9	years	NNS	NUMBER	year	tmod	7	SENT_57	[p3l1125t941r1273b986],
10	;	:	O	;	_	0	SENT_57	[p3l1125t941r1273b986],
11	performance	NN	O	performance	nn	12	SENT_57	[p3l1304t927r1635b985],
12	status	NN	O	status	dep	2	SENT_57	[p3l1666t934r1817b973],
13	(	CD	NUMBER	(	dep	12	SENT_57	[p3l1849t928r2014b980],
14	WHO	WP	O	who	nsubj	15	SENT_57	[p3l1849t928r2014b980],
15	)	VBP	O	)	rcmod	2	SENT_57	[p3l1849t928r2014b980],
16	0-2	CD	NUMBER	0-2	dobj	15	SENT_57	[p3l2045t930r2151b980],
17	;	:	O	;	_	0	SENT_57	[p3l2045t930r2151b980],
18	normal	JJ	O	normal	amod	20	SENT_57	[p3l185t998r365b1044],
19	bone	NN	O	bone	nn	20	SENT_57	[p3l389t998r519b1044],
20	marrow	NN	O	marrow	dep	2	SENT_57	[p3l542t1011r753b1051],
21	,	,	O	,	_	0	SENT_57	[p3l542t1011r753b1051],
22	renal	JJ	O	renal	amod	25	SENT_57	[p3l776t998r900b1044],
23	and	CC	O	and	_	0	SENT_57	[p3l922t998r1017b1044],
24	liver	NN	O	liver	amod	25	SENT_57	[p3l1042t998r1149b1044],
25	function	NN	O	function	appos	20	SENT_57	[p3l1167t997r1397b1044],
26	.	.	O	.	_	0	SENT_57	[p3l1167t997r1397b1044],

1	Patients	NNS	O	patient	nsubjpass	18	SENT_58	[p3l1420t1000r1624b1044],
2	affected	VBN	O	affect	partmod	1	SENT_58	[p3l1645t997r1854b1044],
3	by	IN	O	by	_	0	SENT_58	[p3l1878t998r1939b1057],
4	chronic	JJ	O	chronic	amod	7	SENT_58	[p3l1959t998r2151b1044],
5	inﬂammatory	JJ	O	inﬂammatory	amod	7	SENT_58	[p3l185t1067r533b1127],
6	enteric	JJ	O	enteric	amod	7	SENT_58	[p3l580t1070r758b1114],
7	diseases	NNS	O	disease	agent	2	SENT_58	[p3l806t1068r1034b1121],
8	,	,	O	,	_	0	SENT_58	[p3l806t1068r1034b1121],
9	evidence	NN	O	evidence	appos	7	SENT_58	[p3l1081t1068r1316b1114],
10	of	IN	O	of	_	0	SENT_58	[p3l1364t1067r1417b1114],
11	neurosensory	JJ	O	neurosensory	amod	12	SENT_58	[p3l1463t1081r1815b1127],
12	disease	NN	O	disease	prep_of	9	SENT_58	[p3l1862t1068r2051b1114],
13	or	CC	O	or	_	0	SENT_58	[p3l2099t1081r2151b1114],
14	assuming	VBG	O	assume	amod	16	SENT_58	[p3l183t1140r429b1196],
15	neurotoxic	JJ	O	neurotoxic	amod	16	SENT_58	[p3l461t1140r737b1183],
16	medications	NNS	O	medication	conj_or	1	SENT_58	[p3l768t1137r1083b1183],
17	were	VBD	O	be	auxpass	18	SENT_58	[p3l1111t1151r1238b1183],
18	excluded	VBN	O	exclude	_	0	SENT_58	[p3l1266t1137r1501b1183],
19	from	IN	O	from	_	0	SENT_58	[p3l1530t1137r1651b1183],
20	the	DT	O	the	det	21	SENT_58	[p3l1681t1137r1765b1183],
21	study	NN	O	study	prep_from	18	SENT_58	[p3l1793t1137r1947b1196],
22	.	.	O	.	_	0	SENT_58	[p3l1793t1137r1947b1196],

1	All	PDT	O	all	predet	3	SENT_59	[p3l1975t1137r2036b1183],
2	the	DT	O	the	det	3	SENT_59	[p3l2066t1137r2150b1183],
3	patients	NNS	O	patient	nsubjpass	11	SENT_59	[p3l185t1210r392b1266],
4	were	VBD	O	be	_	0	SENT_59	[p3l421t1221r548b1254],
5	of	IN	O	of	_	0	SENT_59	[p3l578t1207r631b1254],
6	Caucasian	JJ	MISC	caucasian	amod	7	SENT_59	[p3l657t1210r915b1254],
7	ethnicity	NN	O	ethnicity	prep_of	4	SENT_59	[p3l947t1208r1174b1267],
8	and	CC	O	and	_	0	SENT_59	[p3l1202t1208r1297b1254],
9	have	VBP	O	have	aux	11	SENT_59	[p3l1332t1208r1453b1254],
10	been	VBN	O	be	auxpass	11	SENT_59	[p3l1485t1208r1611b1254],
11	enrolled	VBN	O	enrol	conj_and	4	SENT_59	[p3l1643t1208r1854b1254],
12	in	IN	O	in	_	0	SENT_59	[p3l1888t1210r1930b1253],
13	centers	NNS	O	center	prep_in	11	SENT_59	[p3l1962t1215r2150b1254],
14	located	VBN	O	locate	partmod	13	SENT_59	[p3l186t1277r372b1323],
15	in	IN	O	in	_	0	SENT_59	[p3l401t1279r443b1322],
16	northern	JJ	O	northern	amod	19	SENT_59	[p3l471t1277r695b1323],
17	and	CC	O	and	_	0	SENT_59	[p3l722t1277r817b1323],
18	Central	JJ	LOCATION	central	conj_and	16	SENT_59	[p3l844t1277r1026b1323],
19	Italy	NNP	LOCATION	Italy	prep_in	14	SENT_59	[p3l1056t1277r1171b1336],
20	.	.	O	.	_	0	SENT_59	[p3l1056t1277r1171b1336],

1	Eligible	JJ	O	eligible	amod	2	SENT_60	[p3l249t1348r433b1407],
2	patients	NNS	O	patient	nsubjpass	4	SENT_60	[p3l456t1350r663b1406],
3	were	VBD	O	be	auxpass	4	SENT_60	[p3l683t1362r810b1394],
4	treated	VBN	O	treat	dep	64	SENT_60	[p3l830t1348r1015b1394],
5	with	IN	O	with	_	0	SENT_60	[p3l1037t1348r1148b1394],
6	FOLFOX4	NN	O	folfox4	nn	8	SENT_60	[p3l1173t1350r1412b1394],
7	(	CD	NUMBER	(	num	8	SENT_60	[p3l1434t1348r1716b1406],
8	oxaliplatin	NN	O	oxaliplatin	prep_with	4	SENT_60	[p3l1434t1348r1716b1406],
9	85	CD	NUMBER	85	num	8	SENT_60	[p3l1739t1351r1798b1394],
10	mg	NN	O	mg	nn	16	SENT_60	[p3l1816t1362r1896b1407],
11	m	NN	O	m	nn	16	SENT_60	[p3l1914t1362r1959b1393],
12	T2	NN	O	t2	nn	16	SENT_60	[p3l1975t1337r2038b1365],
13	(	NN	O	(	nn	16	SENT_60	[p3l2060t1349r2104b1401],
14	2	CD	NUMBER	2	num	16	SENT_60	[p3l2060t1349r2104b1401],
15	h	NN	O	h	nn	16	SENT_60	[p3l2121t1348r2148b1393],
16	infusion	NN	O	infusion	dobj	4	SENT_60	[p3l185t1418r387b1465],
17	on	IN	O	on	_	0	SENT_60	[p3l417t1433r480b1465],
18	day	NN	DURATION	day	nn	20	SENT_60	[p3l510t1419r603b1478],
19	1	CD	NUMBER	1	num	20	SENT_60	[p3l633t1420r688b1472],
20	)	NN	O	)	prep_on	16	SENT_60	[p3l633t1420r688b1472],
21	,	,	O	,	_	0	SENT_60	[p3l633t1420r688b1472],
22	leucovorin	NN	O	leucovorin	nn	23	SENT_60	[p3l717t1419r986b1465],
23	(	NN	O	(	appos	20	SENT_60	[p3l1017t1420r1126b1472],
24	100	CD	NUMBER	100	num	25	SENT_60	[p3l1017t1420r1126b1472],
25	mgm	NN	O	mgm	dep	23	SENT_60	[p3l1142t1408r1363b1478],
26	'	''	O	'	_	0	SENT_60	[p3l1142t1408r1363b1478],
27	2	CD	NUMBER	2	dep	16	SENT_60	[p3l1142t1408r1363b1478],
28	as	IN	O	as	_	0	SENT_60	[p3l1391t1433r1442b1465],
29	2h	JJ	O	2h	amod	30	SENT_60	[p3l1470t1419r1541b1465],
30	infusion	NN	O	infusion	prep_as	27	SENT_60	[p3l1573t1418r1776b1465],
31	on	IN	O	on	_	0	SENT_60	[p3l1806t1433r1868b1465],
32	day	NN	DURATION	day	nn	34	SENT_60	[p3l1898t1419r1991b1478],
33	1	CD	NUMBER	1	num	34	SENT_60	[p3l2021t1420r2076b1472],
34	)	NN	O	)	prep_on	30	SENT_60	[p3l2021t1420r2076b1472],
35	,	,	O	,	_	0	SENT_60	[p3l2021t1420r2076b1472],
36	5ﬂuorouracil	JJ	O	5ﬂuorouracil	amod	42	SENT_60	[p3l2103t1423r2150b1465, p3l182t1490r475b1537],
37	bolus	NN	O	bolus	nn	42	SENT_60	[p3l500t1490r637b1537],
38	(	NN	O	(	nn	42	SENT_60	[p3l659t1491r768b1544],
39	400	CD	NUMBER	400	num	42	SENT_60	[p3l659t1491r768b1544],
40	mg	NN	O	mg	nn	42	SENT_60	[p3l784t1504r864b1549],
41	m	NN	O	m	nn	42	SENT_60	[p3l882t1480r1021b1544],
42	‘	NN	O	‘	conj_and	30	SENT_60	[p3l882t1480r1021b1544],
43	2	CD	NUMBER	2	num	44	SENT_60	[p3l882t1480r1021b1544],
44	)	NN	O	)	dep	42	SENT_60	[p3l882t1480r1021b1544],
45	and	CC	O	and	_	0	SENT_60	[p3l1043t1490r1138b1537],
46	22	CD	NUMBER	22	num	48	SENT_60	[p3l1161t1493r1220b1536],
47	h	NN	O	h	nn	48	SENT_60	[p3l1238t1490r1264b1536],
48	infusion	NN	O	infusion	prep_as	27	SENT_60	[p3l1288t1490r1491b1537],
49	(	NN	O	(	nn	52	SENT_60	[p3l1515t1491r1624b1544],
50	600	CD	NUMBER	600	num	52	SENT_60	[p3l1515t1491r1624b1544],
51	mg	NN	O	mg	nn	52	SENT_60	[p3l1640t1504r1720b1549],
52	m	NN	O	m	dep	48	SENT_60	[p3l1738t1504r1783b1536],
53	'	''	O	'	_	0	SENT_60	[p3l1799t1480r1878b1544],
54	2	CD	NUMBER	2	num	55	SENT_60	[p3l1799t1480r1878b1544],
55	)	NN	O	)	dep	16	SENT_60	[p3l1799t1480r1878b1544],
56	on	IN	O	on	_	0	SENT_60	[p3l1900t1504r1963b1537],
57	days	NNS	DURATION	day	prep_on	55	SENT_60	[p3l1985t1490r2101b1550],
58	1	CD	NUMBER	1	num	57	SENT_60	[p3l2126t1494r2140b1536],
59	and	CC	O	and	_	0	SENT_60	[p3l183t1561r278b1607],
60	2	CD	NUMBER	2	conj_and	57	SENT_60	[p3l305t1564r332b1606],
61	every	DT	SET	every	det	63	SENT_60	[p3l358t1574r499b1620],
62	2	CD	SET	2	num	63	SENT_60	[p3l523t1564r550b1606],
63	weeks	NNS	NUMBER	week	nsubj	64	SENT_60	[p3l575t1561r752b1614],
64	)	VBP	O	)	_	0	SENT_60	[p3l575t1561r752b1614],
65	for	IN	O	for	mark	68	SENT_60	[p3l777t1560r849b1607],
66	6	CD	DURATION	6	num	67	SENT_60	[p3l873t1564r901b1607],
67	months	NNS	NUMBER	month	nsubj	68	SENT_60	[p3l928t1561r1124b1607],
68	(	VBP	O	(	advcl	64	SENT_60	[p3l1151t1562r1226b1614],
69	12	CD	NUMBER	12	num	70	SENT_60	[p3l1151t1562r1226b1614],
70	cycles	NNS	O	cycle	dobj	68	SENT_60	[p3l1253t1561r1437b1619],
71	)	CD	NUMBER	)	tmod	68	SENT_60	[p3l1253t1561r1437b1619],
72	.	.	O	.	_	0	SENT_60	[p3l1253t1561r1437b1619],

1	Toxicity	NN	O	toxicity	nn	2	SENT_61	[p3l181t1739r408b1803],
2	evaluation	NN	O	evaluation	_	0	SENT_61	[p3l434t1737r737b1789],

1	Objective	NN	O	objective	nn	3	SENT_62	[p3l183t1826r430b1885],
2	clinical	JJ	O	clinical	amod	3	SENT_62	[p3l450t1826r623b1872],
3	evaluation	NN	O	evaluation	nsubjpass	14	SENT_62	[p3l645t1826r928b1879],
4	,	,	O	,	_	0	SENT_62	[p3l645t1826r928b1879],
5	blood	NN	O	blood	nn	6	SENT_62	[p3l950t1826r1096b1872],
6	counts	NNS	O	count	conj_and	3	SENT_62	[p3l1117t1833r1303b1879],
7	,	,	O	,	_	0	SENT_62	[p3l1117t1833r1303b1879],
8	hepatic	JJ	O	hepatic	nsubjpass	14	SENT_62	[p3l1324t1826r1514b1884],
9	and	CC	O	and	_	0	SENT_62	[p3l1533t1826r1628b1872],
10	renal	JJ	O	renal	amod	12	SENT_62	[p3l1651t1826r1775b1872],
11	function	NN	O	function	nn	12	SENT_62	[p3l1795t1825r2010b1872],
12	tests	NNS	O	test	nsubjpass	14	SENT_62	[p3l2031t1833r2150b1872],
13	were	VBD	O	be	auxpass	14	SENT_62	[p3l182t1910r309b1943],
14	performed	VBN	O	perform	_	0	SENT_62	[p3l338t1896r610b1954],
15	within	IN	O	within	_	0	SENT_62	[p3l638t1897r798b1943],
16	48h	NN	O	48h	prep_within	14	SENT_62	[p3l826t1897r931b1943],
17	before	IN	O	before	_	0	SENT_62	[p3l962t1896r1128b1943],
18	each	DT	O	each	det	19	SENT_62	[p3l1155t1897r1274b1943],
19	cycle	NN	O	cycle	prep_before	14	SENT_62	[p3l1303t1897r1444b1956],
20	.	.	O	.	_	0	SENT_62	[p3l1303t1897r1444b1956],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_63	[p3l1473t1899r1677b1943],
2	were	VBD	O	be	auxpass	3	SENT_63	[p3l1703t1910r1830b1943],
3	questioned	VBN	O	question	_	0	SENT_63	[p3l1857t1897r2148b1954],
4	about	IN	O	about	_	0	SENT_63	[p3l183t1966r335b2013],
5	nausea	NN	O	nausea	prep_about	3	SENT_63	[p3l362t1980r540b2013],
6	and	CC	O	and	_	0	SENT_63	[p3l567t1966r662b2012],
7	vomiting	NN	O	vomiting	conj_and	5	SENT_63	[p3l688t1969r935b2025],
8	,	,	O	,	_	0	SENT_63	[p3l688t1969r935b2025],
9	mucositis	NN	O	mucositis	appos	5	SENT_63	[p3l962t1969r1218b2019],
10	,	,	O	,	_	0	SENT_63	[p3l962t1969r1218b2019],
11	diarrhea	NN	O	diarrhea	appos	9	SENT_63	[p3l1243t1966r1470b2019],
12	,	,	O	,	_	0	SENT_63	[p3l1243t1966r1470b2019],
13	asthenia	NN	O	asthenia	nn	14	SENT_63	[p3l1495t1966r1712b2012],
14	(	NN	O	(	appos	9	SENT_63	[p3l1740t1966r1859b2019],
15	that	WDT	O	that	nsubj	16	SENT_63	[p3l1740t1966r1859b2019],
16	is	VBZ	O	be	rcmod	14	SENT_63	[p3l1885t1969r1932b2019],
17	,	,	O	,	_	0	SENT_63	[p3l1885t1969r1932b2019],
18	fatigue	NN	O	fatigue	nn	23	SENT_63	[p3l1956t1966r2150b2025],
19	,	,	O	,	_	0	SENT_63	[p3l1956t1966r2150b2025],
20	malaise	NN	O	malaise	nn	23	SENT_63	[p3l185t2036r378b2082],
21	and	CC	O	and	_	0	SENT_63	[p3l397t2036r491b2082],
22	weakness	NN	O	weakness	nn	23	SENT_63	[p3l512t2036r763b2082],
23	symptoms	NNS	O	symptom	nsubj	24	SENT_63	[p3l782t2037r1084b2095],
24	)	VBP	O	)	ccomp	16	SENT_63	[p3l782t2037r1084b2095],
25	,	,	O	,	_	0	SENT_63	[p3l782t2037r1084b2095],
26	and	CC	O	and	_	0	SENT_63	[p3l1102t2036r1197b2082],
27	appetite	NN	O	appetite	conj_and	14	SENT_63	[p3l1218t2038r1433b2094],
28	at	IN	O	at	_	0	SENT_63	[p3l1452t2043r1500b2082],
29	every	DT	O	every	det	30	SENT_63	[p3l1518t2050r1659b2095],
30	cycle	NN	O	cycle	prep_at	27	SENT_63	[p3l1677t2036r1818b2095],
31	.	.	O	.	_	0	SENT_63	[p3l1677t2036r1818b2095],

1	Toxicity	NN	O	toxicity	nsubjpass	3	SENT_64	[p3l1834t2038r2036b2095],
2	was	VBD	O	be	auxpass	3	SENT_64	[p3l2052t2050r2149b2082],
3	evaluated	VBN	O	evaluate	_	0	SENT_64	[p3l183t2107r434b2153],
4	according	VBG	O	accord	_	0	SENT_64	[p3l454t2107r708b2165],
5	to	TO	O	to	prepc_according_to	3	SENT_64	[p3l727t2114r779b2153],
6	NC	NNP	O	NC	nn	7	SENT_64	[p3l800t2108r1007b2153],
7	|	NNP	O	|	pobj	3	SENT_64	[p3l800t2108r1007b2153],
8	.	.	O	.	_	0	SENT_64	[p3l800t2108r1007b2153],

1	—	NN	O	—	_	0	SENT_65	[p3l800t2108r1007b2153],
2	.	.	O	.	_	0	SENT_65	[p3l800t2108r1007b2153],

1	CTC	NNP	ORGANIZATION	CTC	nn	3	SENT_66	[p3l800t2108r1007b2153],
2	criteria	NNS	O	criterion	nn	3	SENT_66	[p3l1025t2109r1197b2153],
3	version	NN	O	version	_	0	SENT_66	[p3l1217t2109r1401b2153],
4	2.0	CD	NUMBER	2.0	number	5	SENT_66	[p3l1422t2110r1495b2153],
5	(	CD	NUMBER	(	dep	3	SENT_66	[p3l1515t2107r2151b2165],
6	http://ctep.cancer.gov/	NN	O	http://ctep.cancer.gov/	nn	7	SENT_66	[p3l1515t2107r2151b2165],
7	)	NN	O	)	dep	5	SENT_66	[p3l1515t2107r2151b2165],
8	.	.	O	.	_	0	SENT_66	[p3l1515t2107r2151b2165],

1	Neurotoxicity	NN	O	neurotoxicity	nsubjpass	3	SENT_67	[p3l186t2180r530b2238],
2	was	VBD	O	be	auxpass	3	SENT_67	[p3l559t2192r657b2225],
3	evaluated	VBN	O	evaluate	_	0	SENT_67	[p3l689t2178r939b2225],
4	according	VBG	O	accord	_	0	SENT_67	[p3l973t2178r1226b2237],
5	to	TO	O	to	prepc_according_to	3	SENT_67	[p3l1258t2186r1310b2225],
6	the	DT	O	the	det	11	SENT_67	[p3l1341t2178r1424b2225],
7	oxa	NN	O	oxa	nn	11	SENT_67	[p3l1456t2178r1934b2237],
8	|	CD	NUMBER	|	num	11	SENT_67	[p3l1456t2178r1934b2237],
9	ip	NN	O	ip	nn	11	SENT_67	[p3l1456t2178r1934b2237],
10	|	NN	O	|	nn	11	SENT_67	[p3l1456t2178r1934b2237],
11	atin	NN	O	atin	pobj	3	SENT_67	[p3l1456t2178r1934b2237],
12	—	NN	O	—	nn	14	SENT_67	[p3l1456t2178r1934b2237],
13	speciﬁc	NN	O	speciﬁc	nn	14	SENT_67	[p3l1456t2178r1934b2237],
14	sca	NN	O	sca	nsubjpass	27	SENT_67	[p3l1966t2167r2149b2225],
15	|	CD	NUMBER	|	num	18	SENT_67	[p3l1966t2167r2149b2225],
16	e.	NN	O	e.	nn	18	SENT_67	[p3l1966t2167r2149b2225],
17	23	CD	NUMBER	23	num	18	SENT_67	[p3l1966t2167r2149b2225],
18	Patients	NNS	O	patient	dep	14	SENT_67	[p3l186t2250r387b2294],
19	undergoing	VBG	O	undergo	partmod	14	SENT_67	[p3l415t2248r715b2307],
20	at	IN	O	at	quantmod	22	SENT_67	[p3l742t2255r790b2294],
21	least	JJS	O	least	mwe	20	SENT_67	[p3l816t2248r932b2294],
22	one	CD	NUMBER	one	num	23	SENT_67	[p3l956t2262r1053b2294],
23	cycle	NN	O	cycle	dobj	19	SENT_67	[p3l1077t2248r1205b2307],
24	of	IN	O	of	_	0	SENT_67	[p3l1230t2248r1284b2294],
25	chemotherapy	NN	O	chemotherapy	prep_of	23	SENT_67	[p3l1304t2248r1683b2307],
26	were	VBD	O	be	auxpass	27	SENT_67	[p3l1705t2262r1831b2294],
27	included	VBN	O	include	rcmod	11	SENT_67	[p3l1858t2248r2078b2295],
28	in	IN	O	in	_	0	SENT_67	[p3l2106t2251r2148b2294],
29	this	DT	O	this	det	30	SENT_67	[p3l182t2318r273b2364],
30	study	NN	O	study	prep_in	27	SENT_67	[p3l298t2318r450b2377],
31	.	.	O	.	_	0	SENT_67	[p3l298t2318r450b2377],

1	Chemotherapy	NN	O	chemotherapy	nsubjpass	3	SENT_68	[p3l246t2389r636b2448],
2	was	VBD	O	be	auxpass	3	SENT_68	[p3l656t2402r754b2435],
3	delayed	VBN	O	delay	conj_or	3	SENT_68	[p3l777t2389r979b2448],
4	until	IN	O	until	_	0	SENT_68	[p3l1005t2389r1116b2435],
5	recovery	NN	O	recovery	prep_until	3	SENT_68	[p3l1142t2402r1365b2448],
6	from	IN	O	from	_	0	SENT_68	[p3l1383t2388r1504b2435],
7	hematological	JJ	O	hematological	amod	8	SENT_68	[p3l1531t2389r1898b2447],
8	toxicities	NNS	O	toxicity	prep_from	3	SENT_68	[p3l1921t2391r2150b2435],
9	or	CC	O	or	_	0	SENT_68	[p3l183t2472r236b2504],
10	in	IN	O	in	_	0	SENT_68	[p3l262t2461r303b2504],
11	the	DT	O	the	det	12	SENT_68	[p3l330t2458r414b2504],
12	case	NN	O	case	prep_in	3	SENT_68	[p3l441t2472r552b2504],
13	of	IN	O	of	_	0	SENT_68	[p3l579t2458r632b2505],
14	signiﬁcant	NN	O	signiﬁcant	prep_of	12	SENT_68	[p3l653t2458r933b2517],
15	,	,	O	,	_	0	SENT_68	[p3l653t2458r933b2517],
16	persisting	VBG	O	persist	partmod	12	SENT_68	[p3l960t2461r1224b2517],
17	,	,	O	,	_	0	SENT_68	[p3l960t2461r1224b2517],
18	non-hematological	JJ	O	non-hematological	amod	19	SENT_68	[p3l1252t2458r1742b2517],
19	toxicity	NN	O	toxicity	appos	12	SENT_68	[p3l1769t2461r1970b2517],
20	.	.	O	.	_	0	SENT_68	[p3l1769t2461r1970b2517],

1	In	IN	O	in	_	0	SENT_69	[p3l1998t2461r2039b2504],
2	the	DT	O	the	det	3	SENT_69	[p3l2066t2458r2150b2504],
3	event	NN	O	event	prep_in	19	SENT_69	[p3l183t2535r329b2574],
4	of	IN	O	of	_	0	SENT_69	[p3l368t2527r421b2574],
5	severe	JJ	O	severe	amod	7	SENT_69	[p3l457t2541r623b2574],
6	(	NN	O	(	nn	7	SENT_69	[p3l665t2528r830b2586],
7	grade	NN	O	grade	prep_of	3	SENT_69	[p3l665t2528r830b2586],
8	3-4	CD	NUMBER	3-4	num	10	SENT_69	[p3l870t2529r978b2581],
9	)	NN	O	)	nn	10	SENT_69	[p3l870t2529r978b2581],
10	toxicity	NN	O	toxicity	dep	7	SENT_69	[p3l1018t2530r1219b2587],
11	,	,	O	,	_	0	SENT_69	[p3l1018t2530r1219b2587],
12	the	DT	O	the	det	13	SENT_69	[p3l1257t2528r1341b2574],
13	doses	NNS	O	dose	nsubjpass	19	SENT_69	[p3l1382t2528r1529b2574],
14	of	IN	O	of	_	0	SENT_69	[p3l1569t2527r1622b2574],
15	oxaliplatin	NN	O	oxaliplatin	prep_of	13	SENT_69	[p3l1658t2528r1924b2586],
16	and	CC	O	and	_	0	SENT_69	[p3l1966t2528r2061b2574],
17	5ﬂuorouracil	NN	O	5ﬂuorouracil	prep_of	13	SENT_69	[p3l2103t2532r2150b2574, p3l182t2598r475b2645],
18	were	VBD	O	be	auxpass	19	SENT_69	[p3l523t2612r650b2645],
19	reduced	VBN	O	reduce	_	0	SENT_69	[p3l698t2599r908b2645],
20	by	IN	O	by	_	0	SENT_69	[p3l958t2599r1019b2658],
21	25	CD	NUMBER	25	num	24	SENT_69	[p3l1065t2602r1123b2645],
22	or	CC	O	or	_	0	SENT_69	[p3l1172t2612r1224b2645],
23	50	CD	PERCENT	50	num	24	SENT_69	[p3l1270t2602r1380b2645],
24	%	NN	PERCENT	%	agent	19	SENT_69	[p3l1270t2602r1380b2645],
25	based	VBN	O	base	_	0	SENT_69	[p3l1429t2599r1579b2645],
26	on	IN	O	on	prepc_based_on	24	SENT_69	[p3l1627t2612r1691b2645],
27	the	DT	O	the	det	28	SENT_69	[p3l1738t2599r1822b2645],
28	physician	NN	O	physician	poss	30	SENT_69	[p3l1871t2599r2150b2658],
29	's	POS	O	's	_	0	SENT_69	[p3l1871t2599r2150b2658],
30	evaluation	NN	O	evaluation	pobj	24	SENT_69	[p3l183t2669r467b2715],
31	.	.	O	.	_	0	SENT_69	[p3l183t2669r467b2715],

1	Treatment	NN	O	treatment	nsubjpass	3	SENT_70	[p3l484t2671r757b2715],
2	was	VBD	O	be	auxpass	3	SENT_70	[p3l774t2682r873b2715],
3	discontinued	VBN	O	discontinue	_	0	SENT_70	[p3l893t2669r1230b2715],
4	either	CC	O	either	dep	3	SENT_70	[p3l1252t2669r1403b2715],
5	in	IN	O	in	_	0	SENT_70	[p3l1423t2671r1464b2714],
6	the	DT	O	the	det	7	SENT_70	[p3l1485t2669r1569b2715],
7	event	NN	O	event	prep_in	3	SENT_70	[p3l1590t2676r1736b2715],
8	of	IN	O	of	_	0	SENT_70	[p3l1754t2668r1807b2715],
9	anaphylactic	JJ	O	anaphylactic	amod	10	SENT_70	[p3l1822t2669r2151b2728],
10	reaction	NN	O	reaction	prep_of	7	SENT_70	[p3l185t2741r407b2791],
11	,	,	O	,	_	0	SENT_70	[p3l185t2741r407b2791],
12	or	CC	O	or	_	0	SENT_70	[p3l431t2752r483b2784],
13	repeated	VBN	O	repeat	amod	15	SENT_70	[p3l508t2738r736b2796],
14	severe	JJ	O	severe	amod	15	SENT_70	[p3l764t2752r930b2784],
15	toxicity	NN	O	toxicity	conj_or	7	SENT_70	[p3l953t2741r1143b2797],
16	in	IN	O	in	_	0	SENT_70	[p3l1168t2741r1209b2784],
17	spite	NN	O	spite	prep_in	15	SENT_70	[p3l1237t2741r1359b2796],
18	of	IN	O	of	_	0	SENT_70	[p3l1384t2738r1437b2784],
19	dose	NN	O	dose	nn	20	SENT_70	[p3l1457t2738r1579b2785],
20	reduction	NN	O	reduction	prep_of	15	SENT_70	[p3l1607t2738r1867b2791],
21	,	,	O	,	_	0	SENT_70	[p3l1607t2738r1867b2791],
22	or	CC	O	or	_	0	SENT_70	[p3l1891t2752r1943b2784],
23	patient	NN	O	patient	nn	24	SENT_70	[p3l1969t2741r2151b2796],
24	refusal	NN	O	refusal	conj_or	7	SENT_70	[p3l185t2808r367b2855],
25	.	.	O	.	_	0	SENT_70	[p3l185t2808r367b2855],

1	Selection	NN	O	selection	nsubjpass	11	SENT_71	[p3l184t2985r448b3037],
2	of	IN	O	of	_	0	SENT_71	[p3l479t2984r539b3037],
3	candidate	NN	O	candidate	nn	4	SENT_71	[p3l562t2985r852b3037],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_71	[p3l882t2985r1335b3052],
5	and	CC	O	and	_	0	SENT_71	[p3l1364t2985r1471b3037],
6	genotyping	VBG	O	genotype	amod	9	SENT_71	[p3l1502t2988r1839b3052],
7	assay	NN	O	assay	nn	9	SENT_71	[p3l1870t3000r2025b3052],
8	Genomic	JJ	O	genomic	amod	9	SENT_71	[p3l183t3076r416b3120],
9	DNA	NN	O	dna	conj_and	4	SENT_71	[p3l446t3076r563b3119],
10	was	VBD	O	be	auxpass	11	SENT_71	[p3l588t3087r686b3120],
11	extracted	VBN	O	extract	_	0	SENT_71	[p3l714t3074r956b3120],
12	from	IN	O	from	_	0	SENT_71	[p3l985t3073r1106b3120],
13	peripheral	JJ	O	peripheral	amod	14	SENT_71	[p3l1138t3074r1399b3131],
14	blood	NN	O	blood	prep_from	11	SENT_71	[p3l1431t3074r1577b3120],
15	using	VBG	O	use	partmod	14	SENT_71	[p3l1609t3076r1745b3132],
16	the	DT	O	the	det	19	SENT_71	[p3l1773t3074r1857b3120],
17	High	JJ	O	high	amod	19	SENT_71	[p3l1887t3074r2004b3132],
18	Pure	JJ	O	pure	amod	19	SENT_71	[p3l2036t3076r2150b3120],
19	PCR	NN	O	pcr	nsubj	26	SENT_71	[p3l186t3145r284b3189],
20	Template	NN	O	template	nn	26	SENT_71	[p3l325t3143r571b3201],
21	Preparation	NNP	O	Preparation	nn	26	SENT_71	[p3l617t3145r915b3201],
22	Kit	NN	O	kit	nn	26	SENT_71	[p3l963t3146r1027b3189],
23	(	CD	NUMBER	(	num	26	SENT_71	[p3l1072t3143r1247b3196],
24	Roche	NNP	ORGANIZATION	Roche	nn	26	SENT_71	[p3l1072t3143r1247b3196],
25	Diagnostics	NNPS	ORGANIZATION	Diagnostics	nn	26	SENT_71	[p3l1293t3145r1590b3202],
26	GmbH	NN	ORGANIZATION	gmbh	xcomp	15	SENT_71	[p3l1634t3143r1814b3196],
27	,	,	O	,	_	0	SENT_71	[p3l1634t3143r1814b3196],
28	Mannheim	NNP	PERSON	Mannheim	nn	30	SENT_71	[p3l1859t3143r2150b3196],
29	,	,	O	,	_	0	SENT_71	[p3l1859t3143r2150b3196],
30	Germany	NNP	LOCATION	Germany	appos	14	SENT_71	[p3l183t3215r450b3273],
31	)	CD	NUMBER	)	num	30	SENT_71	[p3l183t3215r450b3273],
32	.	.	O	.	_	0	SENT_71	[p3l183t3215r450b3273],

1	Positive	JJ	O	positive	amod	2	SENT_72	[p3l474t3216r671b3260],
2	controls	NNS	O	control	nsubjpass	4	SENT_72	[p3l693t3214r900b3260],
3	were	VBD	O	be	auxpass	4	SENT_72	[p3l921t3227r1048b3260],
4	included	VBN	O	include	_	0	SENT_72	[p3l1072t3214r1293b3260],
5	in	IN	O	in	_	0	SENT_72	[p3l1318t3216r1360b3259],
6	the	DT	O	the	det	7	SENT_72	[p3l1382t3214r1467b3260],
7	analyses	NNS	O	analysis	prep_in	4	SENT_72	[p3l1488t3214r1705b3273],
8	(	VBP	O	(	rcmod	7	SENT_72	[p3l1729t3214r1848b3267],
9	that	DT	O	that	nsubj	10	SENT_72	[p3l1729t3214r1848b3267],
10	is	VBZ	O	be	ccomp	8	SENT_72	[p3l1870t3216r1917b3267],
11	,	,	O	,	_	0	SENT_72	[p3l1870t3216r1917b3267],
12	for	IN	O	for	_	0	SENT_72	[p3l1936t3213r2009b3260],
13	each	DT	O	each	det	14	SENT_72	[p3l2029t3214r2148b3260],
14	polymorphism	NN	O	polymorphism	prep_for	10	SENT_72	[p3l185t3283r576b3342],
15	,	,	O	,	_	0	SENT_72	[p3l185t3283r576b3342],
16	three	CD	NUMBER	three	num	18	SENT_72	[p3l600t3283r736b3329],
17	DNA	NN	O	dna	nn	18	SENT_72	[p3l765t3285r880b3329],
18	samples	NNS	O	sample	appos	14	SENT_72	[p3l906t3283r1116b3341],
19	for	IN	O	for	mark	31	SENT_72	[p3l1140t3283r1212b3329],
20	each	DT	O	each	det	21	SENT_72	[p3l1237t3283r1356b3329],
21	genotype	NN	O	genotype	nsubjpass	31	SENT_72	[p3l1384t3291r1645b3342],
22	,	,	O	,	_	0	SENT_72	[p3l1384t3291r1645b3342],
23	determined	VBN	O	determine	partmod	21	SENT_72	[p3l1671t3283r1974b3330],
24	by	IN	O	by	_	0	SENT_72	[p3l2004t3283r2064b3342],
25	an	DT	O	a	det	28	SENT_72	[p3l2089t3297r2148b3329],
26	alternative	JJ	O	alternative	amod	28	SENT_72	[p3l183t3353r458b3399],
27	genotyping	NN	O	genotyping	nn	28	SENT_72	[p3l491t3356r790b3412],
28	procedure	NN	O	procedure	agent	23	SENT_72	[p3l827t3353r1106b3411],
29	,	,	O	,	_	0	SENT_72	[p3l827t3353r1106b3411],
30	were	VBD	O	be	auxpass	31	SENT_72	[p3l1137t3367r1264b3399],
31	used	VBN	O	use	advcl	10	SENT_72	[p3l1298t3353r1417b3399],
32	as	IN	O	as	_	0	SENT_72	[p3l1451t3367r1502b3399],
33	reference	NN	O	reference	nn	34	SENT_72	[p3l1537t3353r1811b3406],
34	)	NN	O	)	prep_as	31	SENT_72	[p3l1537t3353r1811b3406],
35	.	.	O	.	_	0	SENT_72	[p3l1537t3353r1811b3406],

1	Genotyping	VBG	O	genotype	nsubjpass	3	SENT_73	[p3l1843t3355r2148b3412],
2	was	VBD	O	be	auxpass	3	SENT_73	[p3l182t3437r281b3470],
3	performed	VBN	O	perform	_	0	SENT_73	[p3l307t3423r580b3482],
4	blinded	VBN	O	blind	dep	3	SENT_73	[p3l609t3424r803b3470],
5	to	TO	O	to	_	0	SENT_73	[p3l829t3431r880b3470],
6	the	DT	O	the	det	8	SENT_73	[p3l904t3424r988b3470],
7	clinical	JJ	O	clinical	amod	8	SENT_73	[p3l1014t3424r1187b3470],
8	data	NNS	O	datum	prep_to	4	SENT_73	[p3l1214t3424r1340b3470],
9	.	.	O	.	_	0	SENT_73	[p3l1214t3424r1340b3470],

1	Two	CD	NUMBER	two	num	3	SENT_74	[p3l244t3496r354b3540],
2	different	JJ	O	different	amod	3	SENT_74	[p3l376t3493r598b3539],
3	criteria	NNS	O	criterion	nsubjpass	5	SENT_74	[p3l619t3496r793b3539],
4	were	VBD	O	be	auxpass	5	SENT_74	[p3l815t3507r942b3539],
5	used	VBN	O	use	_	0	SENT_74	[p3l966t3493r1084b3540],
6	for	IN	O	for	_	0	SENT_74	[p3l1107t3493r1179b3539],
7	the	DT	O	the	det	8	SENT_74	[p3l1198t3493r1282b3539],
8	selection	NN	O	selection	prep_for	5	SENT_74	[p3l1304t3493r1533b3539],
9	of	IN	O	of	_	0	SENT_74	[p3l1556t3493r1610b3539],
10	candidate	NN	O	candidate	nn	11	SENT_74	[p3l1626t3493r1884b3540],
11	genes	NNS	O	gene	prep_of	8	SENT_74	[p3l1905t3507r2059b3552],
12	for	IN	O	for	_	0	SENT_74	[p3l2079t3493r2151b3540],
13	the	DT	O	the	det	15	SENT_74	[p3l182t3564r266b3610],
14	pharmacogenomic	JJ	O	pharmacogenomic	amod	15	SENT_74	[p3l305t3564r796b3622],
15	analysis	NN	O	analysis	prep_for	11	SENT_74	[p3l832t3564r1045b3623],
16	:	:	O	:	_	0	SENT_74	[p3l832t3564r1045b3623],
17	(	CD	NUMBER	(	number	18	SENT_74	[p3l1083t3565r1143b3617],
18	1	CD	NUMBER	1	num	21	SENT_74	[p3l1083t3565r1143b3617],
19	)	NN	O	)	nn	21	SENT_74	[p3l1083t3565r1143b3617],
20	gene	NN	O	gene	nn	21	SENT_74	[p3l1182t3577r1310b3622],
21	variants	NNS	O	variant	nsubj	22	SENT_74	[p3l1345t3566r1549b3610],
22	included	VBD	O	include	parataxis	5	SENT_74	[p3l1587t3564r1808b3610],
23	in	IN	O	in	_	0	SENT_74	[p3l1848t3566r1890b3609],
24	previous	JJ	O	previous	amod	27	SENT_74	[p3l1930t3566r2150b3621],
25	pharmacogenomic	JJ	O	pharmacogenomic	amod	27	SENT_74	[p3l185t3633r677b3692],
26	association	NN	O	association	nn	27	SENT_74	[p3l749t3636r1034b3679],
27	studies	NNS	O	study	prep_in	22	SENT_74	[p3l1108t3633r1290b3679],
28	of	IN	O	of	_	0	SENT_74	[p3l1362t3633r1415b3679],
29	FOLFOX	NNP	ORGANIZATION	FOLFOX	prep_of	27	SENT_74	[p3l1485t3635r1692b3679],
30	in	IN	O	in	_	0	SENT_74	[p3l1765t3636r1806b3679],
31	metastatic	JJ	O	metastatic	amod	33	SENT_74	[p3l1883t3636r2150b3679],
32	CRC	NN	O	crc	nn	33	SENT_74	[p3l183t3693r534b3751],
33	.18	NN	NUMBER	.18	prep_in	29	SENT_74	[p3l183t3693r534b3751],
34	'	''	DATE	'	_	0	SENT_74	[p3l183t3693r534b3751],
35	19	CD	DATE	19	dobj	22	SENT_74	[p3l183t3693r534b3751],
36	'	''	DATE	'	_	0	SENT_74	[p3l183t3693r534b3751],
37	24	CD	DATE	24	number	38	SENT_74	[p3l183t3693r534b3751],
38	'27	CD	DATE	'27	num	42	SENT_74	[p3l183t3693r534b3751],
39	(	NN	O	(	nn	42	SENT_74	[p3l573t3705r634b3758],
40	2	CD	NUMBER	2	number	41	SENT_74	[p3l573t3705r634b3758],
41	)	CD	NUMBER	)	num	42	SENT_74	[p3l573t3705r634b3758],
42	Variants	NNS	O	variant	npadvmod	22	SENT_74	[p3l671t3706r880b3751],
43	in	IN	O	in	_	0	SENT_74	[p3l920t3706r961b3750],
44	genes	NNS	O	gene	prep_in	22	SENT_74	[p3l1001t3718r1155b3763],
45	in	IN	O	in	_	0	SENT_74	[p3l1195t3707r1236b3750],
46	cellular	JJ	O	cellular	amod	47	SENT_74	[p3l1277t3704r1463b3751],
47	pathways	NNS	O	pathway	prep_in	22	SENT_74	[p3l1501t3704r1747b3764],
48	known	VBN	O	know	partmod	47	SENT_74	[p3l1787t3704r1958b3751],
49	to	TO	O	to	aux	51	SENT_74	[p3l1997t3711r2049b3751],
50	be	VB	O	be	auxpass	51	SENT_74	[p3l2089t3704r2150b3751],
51	involved	VBN	O	involve	xcomp	48	SENT_74	[p3l185t3774r404b3821],
52	in	IN	O	in	_	0	SENT_74	[p3l439t3777r481b3820],
53	the	DT	O	the	det	54	SENT_74	[p3l515t3774r599b3820],
54	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	51	SENT_74	[p3l634t3774r1092b3832],
55	and	CC	O	and	_	0	SENT_74	[p3l1125t3774r1220b3820],
56	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	54	SENT_74	[p3l1256t3774r1767b3833],
57	of	IN	O	of	_	0	SENT_74	[p3l1800t3774r1854b3821],
58	oxaliplatin	NN	O	oxaliplatin	prep_of	54	SENT_74	[p3l1882t3774r2148b3832],

1	(	NN	O	(	_	0	SENT_75	[p4l185t17r754b76],
2	www.pharmgkb.org	NN	O	www.pharmgkb.org	nn	3	SENT_75	[p4l185t17r754b76],
3	)	NN	O	)	dep	1	SENT_75	[p4l185t17r754b76],
4	.	.	O	.	_	0	SENT_75	[p4l185t17r754b76],

1	Genes	NNS	O	gene	nsubjpass	9	SENT_76	[p4l784t19r957b70],
2	,	,	O	,	_	0	SENT_76	[p4l784t19r957b70],
3	variants	NNS	O	variant	nsubjpass	9	SENT_76	[p4l985t20r1202b70],
4	,	,	O	,	_	0	SENT_76	[p4l985t20r1202b70],
5	pathways	NNS	O	pathway	nsubjpass	9	SENT_76	[p4l1234t17r1479b76],
6	and	CC	O	and	_	0	SENT_76	[p4l1510t17r1605b63],
7	assays	NNS	O	assay	conj_and	1	SENT_76	[p4l1637t31r1798b76],
8	are	VBP	O	be	auxpass	9	SENT_76	[p4l1828t31r1906b63],
9	listed	VBN	O	list	_	0	SENT_76	[p4l1939t17r2072b63],
10	in	IN	O	in	_	0	SENT_76	[p4l2106t20r2148b63],
11	Supplementary	NNP	O	Supplementary	nn	12	SENT_76	[p4l184t88r583b147],
12	Table	NNP	O	Table	prep_in	9	SENT_76	[p4l604t88r745b134],
13	1	CD	NUMBER	1	num	12	SENT_76	[p4l774t92r811b134],
14	.	.	O	.	_	0	SENT_76	[p4l774t92r811b134],

1	For	IN	O	for	_	0	SENT_77	[p4l249t160r326b204],
2	pyrosequencing	VBG	O	pyrosequence	prepc_for	4	SENT_77	[p4l355t160r756b217],
3	we	PRP	O	we	dobj	2	SENT_77	[p4l785t171r858b204],
4	used	VBD	O	use	_	0	SENT_77	[p4l889t158r1004b204],
5	PSQ96MA	NN	O	psq96ma	dobj	4	SENT_77	[p4l1036t160r1285b209],
6	(	CD	NUMBER	(	num	7	SENT_77	[p4l1314t159r1528b216],
7	Biotage	NN	O	biotage	nsubj	4	SENT_77	[p4l1314t159r1528b216],
8	,	,	O	,	_	0	SENT_77	[p4l1314t159r1528b216],
9	Uppsala	NNP	LOCATION	Uppsala	appos	7	SENT_77	[p4l1559t158r1768b216],
10	,	,	O	,	_	0	SENT_77	[p4l1559t158r1768b216],
11	Sweden	NNP	LOCATION	Sweden	appos	9	SENT_77	[p4l1797t158r2025b211],
12	)	CD	NUMBER	)	num	11	SENT_77	[p4l1797t158r2025b211],
13	.	.	O	.	_	0	SENT_77	[p4l1797t158r2025b211],

1	PCR	NN	O	pcr	nn	2	SENT_78	[p4l2056t160r2151b204],
2	ampliﬁcations	NNS	O	ampliﬁcations	nsubjpass	4	SENT_78	[p4l183t227r531b285],
3	were	VBD	O	be	auxpass	4	SENT_78	[p4l558t241r681b274],
4	performed	VBN	O	perform	_	0	SENT_78	[p4l711t227r973b285],
5	in	IN	O	in	_	0	SENT_78	[p4l1004t230r1045b273],
6	an	DT	O	a	det	9	SENT_78	[p4l1075t241r1132b274],
7	Eppendorf	NN	MISC	eppendorf	nn	9	SENT_78	[p4l1165t227r1430b285],
8	Mastercycler	NN	MISC	mastercycler	nn	9	SENT_78	[p4l1455t228r1767b287],
9	gradient	NN	O	gradient	prep_in	4	SENT_78	[p4l1793t228r2014b286],
10	,	,	O	,	_	0	SENT_78	[p4l1793t228r2014b286],
11	with	IN	O	with	dep	18	SENT_78	[p4l2041t228r2148b274],
12	TaqGold	NN	O	taqgold	nn	13	SENT_78	[p4l181t297r391b355],
13	DNA	NN	O	dna	pobj	11	SENT_78	[p4l420t299r532b343],
14	Polymerase	NN	O	polymerase	nn	18	SENT_78	[p4l558t297r843b356],
15	(	CD	NUMBER	(	num	18	SENT_78	[p4l869t298r950b350],
16	AB	NNP	O	AB	nn	18	SENT_78	[p4l869t298r950b350],
17	Applied	NNP	O	Applied	nn	18	SENT_78	[p4l974t297r1166b355],
18	Biosystems	NNP	O	Biosystems	dep	4	SENT_78	[p4l1195t299r1480b356],
19	,	,	O	,	_	0	SENT_78	[p4l1195t299r1480b356],
20	Warrington	NNP	ORGANIZATION	Warrington	appos	18	SENT_78	[p4l1503t300r1798b356],
21	,	,	O	,	_	0	SENT_78	[p4l1503t300r1798b356],
22	UK	NNP	LOCATION	UK	nn	23	SENT_78	[p4l1824t298r1919b350],
23	)	NNP	O	)	appos	18	SENT_78	[p4l1824t298r1919b350],
24	.	.	O	.	_	0	SENT_78	[p4l1824t298r1919b350],

1	Detailed	JJ	O	detailed	amod	4	SENT_79	[p4l1945t297r2147b343],
2	Pyrosequencing	NN	O	pyrosequencing	nn	4	SENT_79	[p4l186t370r584b427],
3	genotyping	NN	O	genotyping	nn	4	SENT_79	[p4l632t370r920b427],
4	protocols	NNS	O	protocol	nsubj	6	SENT_79	[p4l970t368r1200b426],
5	are	VBP	O	be	cop	6	SENT_79	[p4l1247t381r1322b414],
6	available	JJ	O	available	_	0	SENT_79	[p4l1369t368r1586b414],
7	upon	IN	O	upon	_	0	SENT_79	[p4l1634t381r1761b426],
8	request	NN	O	request	prep_upon	6	SENT_79	[p4l1811t375r2007b426],
9	.	.	O	.	_	0	SENT_79	[p4l1811t375r2007b426],

1	Predesigned	NNP	O	Predesigned	nsubj	6	SENT_80	[p4l2055t370r2150b414, p4l183t437r411b496],
2	or	CC	O	or	_	0	SENT_80	[p4l468t451r518b483],
3	custom	NN	O	custom	nn	5	SENT_80	[p4l570t444r753b483],
4	Taq	NN	MISC	taq	nn	5	SENT_80	[p4l806t440r896b495],
5	Man	NN	MISC	man	nsubj	6	SENT_80	[p4l954t440r1059b483],
6	sing	VB	O	sing	_	0	SENT_80	[p4l1116t437r1545b496],
7	|	RB	O	|	advmod	6	SENT_80	[p4l1116t437r1545b496],
8	e	SYM	O	e	dep	10	SENT_80	[p4l1116t437r1545b496],
9	—	CD	NUMBER	—	num	10	SENT_80	[p4l1116t437r1545b496],
10	nuc	NN	O	nuc	dep	20	SENT_80	[p4l1116t437r1545b496],
11	|	NN	O	|	nn	18	SENT_80	[p4l1116t437r1545b496],
12	eotide	NN	O	eotide	nn	18	SENT_80	[p4l1116t437r1545b496],
13	polymorphism	NN	O	polymorphism	nn	18	SENT_80	[p4l1601t437r1962b496],
14	(	NN	O	(	nn	18	SENT_80	[p4l2019t438r2148b490],
15	SNP	NN	O	snp	nn	18	SENT_80	[p4l2019t438r2148b490],
16	)	CD	NUMBER	)	num	18	SENT_80	[p4l2019t438r2148b490],
17	genotyping	NN	O	genotyping	nn	18	SENT_80	[p4l183t510r471b566],
18	assays	NNS	O	assay	nsubjpass	20	SENT_80	[p4l507t521r662b566],
19	were	VBD	O	be	auxpass	20	SENT_80	[p4l696t521r819b553],
20	used	VBN	O	use	dep	7	SENT_80	[p4l856t507r970b553],
21	for	IN	O	for	_	0	SENT_80	[p4l1005t507r1075b553],
22	the	DT	O	the	det	25	SENT_80	[p4l1106t507r1188b553],
23	allelic	JJ	O	allelic	amod	25	SENT_80	[p4l1222t507r1359b553],
24	discrimination	NN	O	discrimination	nn	25	SENT_80	[p4l1394t507r1746b553],
25	reactions	NNS	O	reaction	prep_for	20	SENT_80	[p4l1784t510r2019b553],
26	.	.	O	.	_	0	SENT_80	[p4l1784t510r2019b553],

1	Predesigned	NNP	O	Predesigned	nn	3	SENT_81	[p4l2056t509r2151b553, p4l183t578r412b636],
2	Taq	NN	MISC	taq	nn	3	SENT_81	[p4l447t580r538b636],
3	Man	NN	MISC	man	nsubj	4	SENT_81	[p4l577t580r683b624],
4	Copy	VBP	MISC	copy	_	0	SENT_81	[p4l720t580r850b637],
5	Number	NN	MISC	number	nn	6	SENT_81	[p4l886t578r1091b624],
6	assays	NNS	O	assay	nsubjpass	8	SENT_81	[p4l1125t591r1279b637],
7	were	VBD	O	be	auxpass	8	SENT_81	[p4l1314t591r1436b624],
8	used	VBN	O	use	ccomp	4	SENT_81	[p4l1474t578r1589b624],
9	on	IN	O	on	_	0	SENT_81	[p4l1626t591r1688b624],
10	ABI	NNP	O	ABI	nn	15	SENT_81	[p4l1725t580r1803b624],
11	7900HT	NNP	O	7900HT	nn	15	SENT_81	[p4l1842t580r2034b624],
12	(	NNP	O	(	nn	15	SENT_81	[p4l2069t579r2150b631],
13	AB	NNP	O	AB	nn	15	SENT_81	[p4l2069t579r2150b631],
14	Applied	NNP	O	Applied	nn	15	SENT_81	[p4l183t648r375b706],
15	Biosystems	NNP	O	Biosystems	prep_on	8	SENT_81	[p4l408t650r694b707],
16	,	,	O	,	_	0	SENT_81	[p4l408t650r694b707],
17	Foster	NNP	LOCATION	Foster	nn	22	SENT_81	[p4l724t650r875b694],
18	City	NNP	LOCATION	City	nn	22	SENT_81	[p4l902t650r1006b707],
19	,	,	O	,	_	0	SENT_81	[p4l902t650r1006b707],
20	CA	NNP	LOCATION	CA	appos	22	SENT_81	[p4l1034t650r1115b701],
21	,	,	O	,	_	0	SENT_81	[p4l1034t650r1115b701],
22	USA	NNP	LOCATION	USA	appos	15	SENT_81	[p4l1146t649r1261b701],
23	)	CD	NUMBER	)	num	22	SENT_81	[p4l1146t649r1261b701],
24	for	IN	O	for	_	0	SENT_81	[p4l1290t647r1359b694],
25	the	DT	O	the	det	26	SENT_81	[p4l1385t648r1467b694],
26	analysis	NN	O	analysis	prep_for	22	SENT_81	[p4l1496t648r1687b707],
27	of	IN	O	of	_	0	SENT_81	[p4l1716t647r1767b694],
28	gene	NN	O	gene	nn	30	SENT_81	[p4l1792t661r1917b706],
29	deletion	NN	O	deletion	nn	30	SENT_81	[p4l1945t648r2148b694],
30	polymorphisms	NNS	O	polymorphism	prep_of	26	SENT_81	[p4l185t718r584b777],
31	.	.	O	.	_	0	SENT_81	[p4l185t718r584b777],

1	All	PDT	O	all	predet	6	SENT_82	[p4l614t718r673b763],
2	the	DT	O	the	det	6	SENT_82	[p4l705t718r787b764],
3	commercial	JJ	O	commercial	amod	6	SENT_82	[p4l818t718r1107b764],
4	Taq	NN	MISC	taq	nn	6	SENT_82	[p4l1137t720r1228b775],
5	Man	NN	MISC	man	nn	6	SENT_82	[p4l1262t720r1368b764],
6	assays	NNS	O	assay	nsubjpass	8	SENT_82	[p4l1401t731r1555b777],
7	were	VBD	O	be	auxpass	8	SENT_82	[p4l1586t731r1709b764],
8	purchased	VBN	O	purchase	_	0	SENT_82	[p4l1742t718r1999b775],
9	from	IN	O	from	_	0	SENT_82	[p4l2031t717r2148b764],
10	Applied	NNP	O	Applied	nn	11	SENT_82	[p4l183t787r375b845],
11	Biosystems	NNP	O	Biosystems	prep_from	8	SENT_82	[p4l412t789r686b846],
12	(	CD	NUMBER	(	num	13	SENT_82	[p4l720t787r1497b846],
13	www	NN	O	www	dep	11	SENT_82	[p4l720t787r1497b846],
14	.	.	O	.	_	0	SENT_82	[p4l720t787r1497b846],

1	app	NN	O	app	nsubj	4	SENT_83	[p4l720t787r1497b846],
2	|	SYM	O	|	dep	4	SENT_83	[p4l720t787r1497b846],
3	iedbiosystems.com	FW	O	iedbiosystems.com	nn	4	SENT_83	[p4l720t787r1497b846],
4	)	FW	O	)	_	0	SENT_83	[p4l720t787r1497b846],
5	.	.	O	.	_	0	SENT_83	[p4l720t787r1497b846],

1	Analyses	NNS	O	analysis	nsubjpass	7	SENT_84	[p4l1529t787r1745b846],
2	with	IN	O	with	_	0	SENT_84	[p4l1777t787r1884b833],
3	Taq	NN	MISC	taq	nn	5	SENT_84	[p4l1916t790r2006b845],
4	Man	NN	MISC	man	nn	5	SENT_84	[p4l2042t790r2148b833],
5	assays	NNS	O	assay	prep_with	1	SENT_84	[p4l183t871r338b917],
6	were	VBD	O	be	auxpass	7	SENT_84	[p4l355t871r478b904],
7	performed	VBN	O	perform	_	0	SENT_84	[p4l497t857r759b916],
8	with	IN	O	with	_	0	SENT_84	[p4l778t858r885b904],
9	the	DT	O	the	det	15	SENT_84	[p4l903t858r985b904],
10	Applera	NNP	O	Applera	nn	15	SENT_84	[p4l1002t858r1195b916],
11	Taq	NN	O	taq	nn	15	SENT_84	[p4l1212t860r1302b916],
12	Man	NN	O	man	nn	15	SENT_84	[p4l1323t860r1429b904],
13	Universal	NNP	O	Universal	nn	15	SENT_84	[p4l1451t858r1675b904],
14	Master	NNP	O	Master	nn	15	SENT_84	[p4l1696t860r1864b904],
15	mix	NN	O	mix	prep_with	7	SENT_84	[p4l1883t860r1971b903],
16	on	IN	O	on	_	0	SENT_84	[p4l1988t871r2050b904],
17	ABI	NN	O	abus	prep_on	7	SENT_84	[p4l2069t860r2147b904],

1	The	DT	O	the	det	3	SENT_85	[p4l181t1060r277b1106],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_85	[p4l304t1060r818b1118],
3	Journal	NNP	O	Journal	_	0	SENT_85	[p4l841t1060r1028b1106],
4	(	CD	NUMBER	(	num	6	SENT_85	[p4l1057t1061r1229b1113],
5	2013	CD	DATE	2013	num	6	SENT_85	[p4l1057t1061r1229b1113],
6	)	NN	O	)	dep	3	SENT_85	[p4l1057t1061r1229b1113],
7	,	,	O	,	_	0	SENT_85	[p4l1057t1061r1229b1113],
8	403-409	CD	NUMBER	403-409	appos	6	SENT_85	[p4l1262t1063r1506b1106],

1	7900HT	CD	NUMBER	7900ht	number	2	SENT_86	[p4l10t1134r218b1181],
2	(	CD	NUMBER	(	num	4	SENT_86	[p4l243t1132r332b1189],
3	AB	NNP	O	AB	nn	4	SENT_86	[p4l243t1132r332b1189],
4	Applied	NNP	O	Applied	_	0	SENT_86	[p4l358t1131r567b1194],
5	Biosystems	NNP	O	Biosystems	dep	4	SENT_86	[p4l598t1132r912b1195],
6	)	CD	NUMBER	)	num	5	SENT_86	[p4l598t1132r912b1195],
7	according	VBG	O	accord	_	0	SENT_86	[p4l940t1131r1207b1195],
8	to	TO	O	to	prepc_according_to	5	SENT_86	[p4l1233t1139r1289b1181],
9	the	DT	O	the	det	11	SENT_86	[p4l1313t1131r1402b1181],
10	manufacturer	NN	O	manufacturer	nn	11	SENT_86	[p4l1430t1131r1797b1181],
11	instructions	NNS	O	instruction	pobj	5	SENT_86	[p4l1823t1134r2148b1181],
12	.	.	O	.	_	0	SENT_86	[p4l1823t1134r2148b1181],

1	Automated	VBN	O	automate	amod	3	SENT_87	[p4l8t1207r315b1257],
2	fragment	NN	O	fragment	nn	3	SENT_87	[p4l351t1206r604b1270],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_87	[p4l637t1207r845b1271],
4	was	VBD	O	be	auxpass	5	SENT_87	[p4l879t1222r983b1257],
5	performed	VBN	O	perform	_	0	SENT_87	[p4l1020t1206r1305b1270],
6	on	IN	O	on	_	0	SENT_87	[p4l1342t1222r1410b1257],
7	ABI	NNP	O	ABI	nn	8	SENT_87	[p4l1446t1209r1532b1257],
8	Prism	NNP	O	Prism	prep_on	5	SENT_87	[p4l1571t1209r1715b1257],
9	3130	CD	NUMBER	3130	num	13	SENT_87	[p4l1753t1210r1884b1257],
10	(	NNP	O	(	nn	13	SENT_87	[p4l1921t1207r2145b1270],
11	Applied	NNP	O	Applied	nn	13	SENT_87	[p4l1921t1207r2145b1270],
12	Biosystems	NNP	O	Biosystems	nn	13	SENT_87	[p4l11t1286r340b1349],
13	)	NN	O	)	dep	21	SENT_87	[p4l11t1286r340b1349],
14	,	,	O	,	_	0	SENT_87	[p4l11t1286r340b1349],
15	with	IN	O	with	_	0	SENT_87	[p4l358t1285r474b1335],
16	Gene	NNP	PERSON	Gene	nn	17	SENT_87	[p4l495t1287r638b1335],
17	Scan	NNP	O	Scan	prep_with	13	SENT_87	[p4l658t1286r782b1335],
18	software	NN	O	software	dep	21	SENT_87	[p4l804t1284r1036b1335],
19	(	CD	NUMBER	(	num	18	SENT_87	[p4l1057t1285r1281b1347],
20	Applied	NNP	O	Applied	nn	21	SENT_87	[p4l1057t1285r1281b1347],
21	Biosystems	NNP	O	Biosystems	dep	8	SENT_87	[p4l1305t1286r1633b1349],
22	)	NN	O	)	dep	21	SENT_87	[p4l1305t1286r1633b1349],
23	.	.	O	.	_	0	SENT_87	[p4l1305t1286r1633b1349],

1	Detailed	JJ	O	detailed	amod	3	SENT_88	[p4l1655t1285r1875b1335],
2	fragment	NN	O	fragment	nn	3	SENT_88	[p4l1895t1284r2148b1348],
3	analysis	NN	O	analysis	nsubj	10	SENT_88	[p4l9t1360r216b1425],
4	and	CC	O	and	_	0	SENT_88	[p4l255t1360r355b1410],
5	gel	NN	O	gel	nn	6	SENT_88	[p4l396t1360r474b1424],
6	electrophoresis	NN	O	electrophoresis	nsubj	10	SENT_88	[p4l515t1360r927b1424],
7	genotyping	VBG	O	genotype	partmod	3	SENT_88	[p4l966t1363r1279b1425],
8	protocols	NNS	O	protocol	dobj	7	SENT_88	[p4l1321t1360r1571b1424],
9	are	VBP	O	be	cop	10	SENT_88	[p4l1610t1375r1692b1410],
10	available	JJ	O	available	_	0	SENT_88	[p4l1730t1360r1967b1410],
11	upon	IN	O	upon	_	0	SENT_88	[p4l2008t1375r2145b1424],
12	request	NN	O	request	prep_upon	10	SENT_88	[p4l11t1446r225b1501],
13	.	.	O	.	_	0	SENT_88	[p4l11t1446r225b1501],

1	AGXT	NNP	ORGANIZATION	AGXT	nn	2	SENT_89	[p4l246t1440r399b1488],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	4	SENT_89	[p4l418t1438r839b1502],
3	were	VBD	O	be	auxpass	4	SENT_89	[p4l864t1453r997b1488],
4	analyzed	VBN	O	analyze	_	0	SENT_89	[p4l1023t1438r1261b1502],
5	as	IN	O	as	mark	7	SENT_89	[p4l1289t1453r1343b1488],
6	previously	RB	DATE	previously	advmod	7	SENT_89	[p4l1371t1438r1648b1502],
7	reported	VBN	O	report	advcl	4	SENT_89	[p4l1674t1426r1969b1501],
8	.25	CD	NUMBER	.25	dobj	7	SENT_89	[p4l1674t1426r1969b1501],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_90	[p4l10t1658r307b1715],
2	analysis	NN	O	analysis	nsubjpass	7	SENT_90	[p4l341t1658r585b1731],
3	The	DT	O	the	det	4	SENT_90	[p4l6t1755r111b1805],
4	study	NN	O	study	dep	2	SENT_90	[p4l148t1755r302b1819],
5	was	VBD	O	be	auxpass	7	SENT_90	[p4l337t1770r443b1805],
6	prospectively	RB	O	prospectively	advmod	7	SENT_90	[p4l483t1755r860b1819],
7	designed	VBN	O	design	_	0	SENT_90	[p4l895t1755r1153b1819],
8	to	TO	O	to	aux	9	SENT_90	[p4l1191t1763r1248b1805],
9	test	VB	O	test	xcomp	7	SENT_90	[p4l1283t1763r1387b1805],
10	the	DT	O	the	det	11	SENT_90	[p4l1422t1755r1513b1805],
11	association	NN	O	association	dobj	9	SENT_90	[p4l1550t1758r1861b1805],
12	between	IN	O	between	_	0	SENT_90	[p4l1902t1755r2146b1805],
13	genetic	JJ	O	genetic	amod	14	SENT_90	[p4l9t1834r218b1895],
14	polymorphisms	NNS	O	polymorphism	prep_between	11	SENT_90	[p4l241t1831r678b1895],
15	and	CC	O	and	_	0	SENT_90	[p4l700t1831r803b1881],
16	oxaliplatin	NN	O	oxaliplatin	conj_and	11	SENT_90	[p4l827t1831r1117b1894],
17	neurological	JJ	O	neurological	amod	20	SENT_90	[p4l1142t1831r1488b1895],
18	toxicity	NN	O	toxicity	nn	20	SENT_90	[p4l1511t1834r1717b1895],
19	(	NN	O	(	nn	20	SENT_90	[p4l1738t1831r1918b1895],
20	grade	NN	O	grade	dep	16	SENT_90	[p4l1738t1831r1918b1895],
21	22	CD	NUMBER	22	num	22	SENT_90	[p4l1949t1832r2071b1889],
22	)	NN	O	)	dep	16	SENT_90	[p4l1949t1832r2071b1889],
23	,	,	O	,	_	0	SENT_90	[p4l1949t1832r2071b1889],
24	as	IN	O	as	_	0	SENT_90	[p4l2092t1846r2147b1881],
25	the	DT	O	the	det	27	SENT_90	[p4l8t1907r99b1957],
26	primary	JJ	O	primary	amod	27	SENT_90	[p4l134t1909r351b1971],
27	endpoint	NN	O	endpoint	prep_as	9	SENT_90	[p4l383t1907r655b1970],
28	.	.	O	.	_	0	SENT_90	[p4l383t1907r655b1970],

1	Severe	JJ	O	severe	amod	2	SENT_91	[p4l689t1909r876b1957],
2	neutropenia	NN	O	neutropenia	nsubjpass	13	SENT_91	[p4l912t1909r1254b1970],
3	and	CC	O	and	_	0	SENT_91	[p4l1289t1907r1392b1957],
4	any	DT	O	any	det	11	SENT_91	[p4l1428t1922r1529b1971],
5	severe	JJ	O	severe	amod	11	SENT_91	[p4l1561t1922r1742b1957],
6	non	JJ	O	non	amod	11	SENT_91	[p4l1778t1907r2149b1957],
7	—	NN	O	—	nn	11	SENT_91	[p4l1778t1907r2149b1957],
8	hemato	NN	O	hemato	nn	11	SENT_91	[p4l1778t1907r2149b1957],
9	—	CD	NUMBER	—	num	11	SENT_91	[p4l1778t1907r2149b1957],
10	logical	JJ	O	logical	amod	11	SENT_91	[p4l11t1985r189b2048],
11	toxicity	NN	O	toxicity	nsubjpass	13	SENT_91	[p4l248t1987r455b2049],
12	were	VBD	O	be	auxpass	13	SENT_91	[p4l512t1999r650b2035],
13	evaluated	VBN	O	evaluate	_	0	SENT_91	[p4l710t1985r984b2035],
14	as	IN	O	as	_	0	SENT_91	[p4l1046t1999r1101b2035],
15	secondary	JJ	O	secondary	amod	16	SENT_91	[p4l1161t1985r1452b2049],
16	endpoints	NNS	O	endpoint	prep_as	13	SENT_91	[p4l1509t1985r1809b2048],
17	.	.	O	.	_	0	SENT_91	[p4l1509t1985r1809b2048],

1	For	IN	O	for	dep	5	SENT_92	[p4l1871t1987r1958b2035],
2	each	DT	O	each	det	3	SENT_92	[p4l2016t1985r2145b2035],
3	polymorphism	NN	O	polymorphism	pobj	1	SENT_92	[p4l11t2059r435b2123],
4	,	,	O	,	_	0	SENT_92	[p4l11t2059r435b2123],
5	deviation	NN	O	deviation	_	0	SENT_92	[p4l474t2059r735b2109],
6	from	IN	O	from	_	0	SENT_92	[p4l774t2059r906b2109],
7	Hardy	NNP	PERSON	Hardy	prep_from	5	SENT_92	[p4l950t2059r1424b2123],
8	.	.	O	.	_	0	SENT_92	[p4l950t2059r1424b2123],

1	—	NN	O	—	_	0	SENT_93	[p4l950t2059r1424b2123],
2	.	.	O	.	_	0	SENT_93	[p4l950t2059r1424b2123],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_94	[p4l950t2059r1424b2123],
2	equilibrium	NN	O	equilibrium	nsubjpass	4	SENT_94	[p4l1466t2059r1787b2122],
3	was	VBD	O	be	auxpass	4	SENT_94	[p4l1827t2074r1934b2109],
4	tested	VBN	O	test	dep	14	SENT_94	[p4l1971t2059r2145b2109],
5	by	IN	O	by	_	0	SENT_94	[p4l11t2135r77b2199],
6	Fisher	NNP	PERSON	Fisher	poss	9	SENT_94	[p4l99t2135r303b2185],
7	's	POS	O	's	_	0	SENT_94	[p4l99t2135r303b2185],
8	exact	JJ	O	exact	amod	9	SENT_94	[p4l325t2143r474b2185],
9	test	NN	O	test	agent	4	SENT_94	[p4l492t2143r596b2185],
10	and	CC	O	and	_	0	SENT_94	[p4l617t2135r719b2185],
11	no	DT	O	no	det	12	SENT_94	[p4l745t2150r814b2185],
12	deviation	NN	O	deviation	agent	4	SENT_94	[p4l835t2135r1097b2185],
13	was	VBD	O	be	auxpass	14	SENT_94	[p4l1118t2150r1225b2185],
14	found	VBN	O	find	_	0	SENT_94	[p4l1245t2134r1412b2185],
15	(	NN	O	(	nn	16	SENT_94	[p4l1437t2136r1543b2193],
16	P	NN	O	p	nsubj	17	SENT_94	[p4l1437t2136r1543b2193],
17	>	JJR	O	>	xcomp	14	SENT_94	[p4l1437t2136r1543b2193],
18	0.05	CD	NUMBER	0.05	num	19	SENT_94	[p4l1558t2136r1705b2193],
19	)	NN	O	)	nsubjpass	14	SENT_94	[p4l1558t2136r1705b2193],
20	.	.	O	.	_	0	SENT_94	[p4l1558t2136r1705b2193],

1	Odds	NNS	O	odds	nn	2	SENT_95	[p4l1727t2135r1873b2185],
2	ratio	NN	O	ratio	nsubjpass	9	SENT_95	[p4l1897t2138r2021b2185],
3	and	CC	O	and	_	0	SENT_95	[p4l2042t2135r2146b2185],
4	95	CD	PERCENT	95	number	5	SENT_95	[p4l9t2216r129b2263],
5	%	NN	PERCENT	%	amod	7	SENT_95	[p4l9t2216r129b2263],
6	conﬁdence	NN	O	conﬁdence	nn	7	SENT_95	[p4l157t2212r471b2263],
7	interval	NN	O	interval	nsubjpass	9	SENT_95	[p4l500t2213r706b2263],
8	were	VBD	O	be	auxpass	9	SENT_95	[p4l736t2227r873b2263],
9	estimated	VBN	O	estimate	_	0	SENT_95	[p4l902t2213r1180b2263],
10	by	IN	O	by	_	0	SENT_95	[p4l1213t2213r1278b2277],
11	unconditional	JJ	O	unconditional	amod	13	SENT_95	[p4l1307t2213r1696b2263],
12	logistic	JJ	O	logistic	amod	13	SENT_95	[p4l1729t2213r1925b2276],
13	regression	NN	O	regression	agent	9	SENT_95	[p4l1955t2227r2148b2276, p4l9t2290r137b2337],
14	.	.	O	.	_	0	SENT_95	[p4l1955t2227r2148b2276, p4l9t2290r137b2337],

1	We	PRP	O	we	nsubj	2	SENT_96	[p4l167t2290r256b2337],
2	investigated	VBD	O	investigate	_	0	SENT_96	[p4l290t2287r634b2351],
3	three	CD	NUMBER	three	num	5	SENT_96	[p4l666t2287r814b2337],
4	genetic	JJ	O	genetic	amod	5	SENT_96	[p4l847t2290r1056b2351],
5	models	NNS	O	model	nsubj	6	SENT_96	[p4l1089t2287r1293b2337],
6	(	VBP	O	(	ccomp	2	SENT_96	[p4l1327t2287r1457b2345],
7	that	DT	O	that	nsubj	15	SENT_96	[p4l1327t2287r1457b2345],
8	is	VBZ	O	be	cop	15	SENT_96	[p4l1489t2290r1540b2345],
9	,	,	O	,	_	0	SENT_96	[p4l1489t2290r1540b2345],
10	dominant	JJ	O	dominant	amod	15	SENT_96	[p4l1572t2287r1862b2345],
11	,	,	O	,	_	0	SENT_96	[p4l1572t2287r1862b2345],
12	recessive	JJ	O	recessive	amod	15	SENT_96	[p4l1895t2290r2148b2337],
13	and	CC	O	and	_	0	SENT_96	[p4l9t2363r112b2413],
14	additive	JJ	O	additive	conj_and	12	SENT_96	[p4l144t2363r388b2421],
15	)	NN	O	)	ccomp	6	SENT_96	[p4l144t2363r388b2421],
16	for	IN	O	for	_	0	SENT_96	[p4l418t2363r496b2413],
17	the	DT	O	the	det	18	SENT_96	[p4l523t2363r614b2413],
18	association	NN	O	association	prep_for	15	SENT_96	[p4l644t2366r970b2421],
19	,	,	O	,	_	0	SENT_96	[p4l644t2366r970b2421],
20	and	CC	O	and	_	0	SENT_96	[p4l999t2363r1103b2413],
21	the	DT	O	the	det	29	SENT_96	[p4l1133t2363r1224b2413],
22	most	RBS	O	most	advmod	24	SENT_96	[p4l1257t2371r1395b2413],
23	statistically	RB	O	statistically	advmod	24	SENT_96	[p4l1424t2363r1733b2427],
24	signiﬁcant	JJ	O	signiﬁcant	amod	29	SENT_96	[p4l1762t2363r2052b2427],
25	by	IN	O	by	_	0	SENT_96	[p4l2083t2363r2149b2427],
26	Wald	NNP	PERSON	Wald	prep_by	24	SENT_96	[p4l8t2440r148b2491],
27	X2	NN	O	x2	nn	29	SENT_96	[p4l181t2428r366b2504],
28	—	CD	NUMBER	—	num	29	SENT_96	[p4l181t2428r366b2504],
29	test	NN	O	test	nsubjpass	31	SENT_96	[p4l181t2428r366b2504],
30	was	VBD	O	be	auxpass	31	SENT_96	[p4l396t2455r503b2491],
31	reported	VBN	O	report	conj_and	2	SENT_96	[p4l538t2440r795b2504],
32	.	.	O	.	_	0	SENT_96	[p4l538t2440r795b2504],

1	All	DT	O	all	det	3	SENT_97	[p4l827t2440r894b2490],
2	P	NN	O	p	nn	3	SENT_97	[p4l928t2443r962b2490],
3	values	NNS	O	value	nsubj	6	SENT_97	[p4l990t2440r1167b2491],
4	were	VBD	O	be	cop	6	SENT_97	[p4l1198t2455r1336b2491],
5	two	CD	NUMBER	two	num	6	SENT_97	[p4l1367t2440r1663b2491],
6	—	CD	NUMBER	—	_	0	SENT_97	[p4l1367t2440r1663b2491],
7	sided	VBD	O	side	rcmod	6	SENT_97	[p4l1367t2440r1663b2491],
8	.	.	O	.	_	0	SENT_97	[p4l1367t2440r1663b2491],

1	Logistic	JJ	O	logistic	amod	2	SENT_98	[p4l1697t2443r1910b2504],
2	models	NNS	O	model	nsubjpass	33	SENT_98	[p4l1944t2440r2148b2491],
3	adjusting	VBG	O	adjust	partmod	2	SENT_98	[p4l9t2518r268b2581],
4	for	IN	O	for	_	0	SENT_98	[p4l293t2517r371b2568],
5	age	NN	O	age	prep_for	3	SENT_98	[p4l393t2532r494b2581],
6	and	CC	O	and	_	0	SENT_98	[p4l518t2518r621b2568],
7	sex	NN	O	sex	prep_for	3	SENT_98	[p4l648t2532r738b2568],
8	of	IN	O	of	_	0	SENT_98	[p4l760t2517r818b2568],
9	the	DT	O	the	det	10	SENT_98	[p4l836t2518r927b2568],
10	patients	NNS	O	patient	prep_of	5	SENT_98	[p4l953t2520r1192b2580],
11	,	,	O	,	_	0	SENT_98	[p4l953t2520r1192b2580],
12	neo	FW	O	neo	nn	15	SENT_98	[p4l1218t2518r1593b2581],
13	—	FW	O	—	nn	15	SENT_98	[p4l1218t2518r1593b2581],
14	adjuvant	JJ	O	adjuvant	amod	15	SENT_98	[p4l1218t2518r1593b2581],
15	treatment	NN	O	treatment	conj_and	5	SENT_98	[p4l1615t2525r1899b2568],
16	(	CD	NUMBER	(	num	18	SENT_98	[p4l1923t2519r2146b2581],
17	yes/no	JJ	O	yes/no	amod	18	SENT_98	[p4l1923t2519r2146b2581],
18	)	NN	O	)	dep	15	SENT_98	[p4l1923t2519r2146b2581],
19	and	CC	O	and	_	0	SENT_98	[p4l9t2595r109b2645],
20	cumulative	JJ	O	cumulative	amod	22	SENT_98	[p4l137t2595r436b2645],
21	oxaliplatin	NN	O	oxaliplatin	nn	22	SENT_98	[p4l461t2595r737b2658],
22	dose	NN	O	dose	prep_for	3	SENT_98	[p4l765t2595r894b2645],
23	normalized	VBN	O	normalize	partmod	22	SENT_98	[p4l921t2595r1221b2645],
24	by	IN	O	by	_	0	SENT_98	[p4l1251t2595r1316b2659],
25	body	NN	O	body	nn	27	SENT_98	[p4l1342t2595r1479b2659],
26	surface	NN	O	surface	nn	27	SENT_98	[p4l1504t2594r1695b2645],
27	area	NN	O	area	agent	23	SENT_98	[p4l1721t2610r1833b2645],
28	(	CD	NUMBER	(	num	31	SENT_98	[p4l1862t2596r1966b2659],
29	mg	NN	O	mg	nn	31	SENT_98	[p4l1862t2596r1966b2659],
30	m_2	NN	O	m_2	nn	31	SENT_98	[p4l1985t2583r2133b2653],
31	)	NN	O	)	dep	27	SENT_98	[p4l1985t2583r2133b2653],
32	were	VBD	O	be	auxpass	33	SENT_98	[p4l8t2685r146b2720],
33	run	VBN	O	run	_	0	SENT_98	[p4l185t2685r290b2720],
34	.	.	O	.	_	0	SENT_98	[p4l185t2685r290b2720],

1	The	DT	O	the	det	4	SENT_99	[p4l325t2670r429b2720],
2	potential	JJ	O	potential	amod	4	SENT_99	[p4l469t2670r718b2733],
3	confounding	JJ	O	confounding	amod	4	SENT_99	[p4l758t2669r1120b2733],
4	effect	NN	O	effect	nsubjpass	12	SENT_99	[p4l1160t2669r1319b2720],
5	of	IN	O	of	_	0	SENT_99	[p4l1355t2669r1413b2720],
6	pre	JJ	O	pre	amod	9	SENT_99	[p4l1449t2672r1828b2733],
7	—	NN	O	—	nn	9	SENT_99	[p4l1449t2672r1828b2733],
8	operative	NN	O	operative	nn	9	SENT_99	[p4l1449t2672r1828b2733],
9	treatment	NN	O	treatment	prep_of	4	SENT_99	[p4l1865t2678r2148b2720],
10	was	VBD	O	be	auxpass	12	SENT_99	[p4l8t2762r115b2798],
11	also	RB	O	also	advmod	12	SENT_99	[p4l145t2748r254b2798],
12	tested	VBN	O	test	_	0	SENT_99	[p4l283t2748r457b2798],
13	through	IN	O	through	_	0	SENT_99	[p4l488t2748r716b2811],
14	a	DT	O	a	det	16	SENT_99	[p4l749t2762r776b2798],
15	sensitivity	NN	O	sensitivity	nn	16	SENT_99	[p4l809t2750r1088b2812],
16	analysis	NN	O	analysis	prep_through	12	SENT_99	[p4l1118t2748r1335b2812],
17	by	IN	O	by	_	0	SENT_99	[p4l1368t2748r1434b2811],
18	excluding	VBG	O	exclude	agent	12	SENT_99	[p4l1463t2748r1737b2811],
19	patients	NNS	O	patient	dobj	18	SENT_99	[p4l1771t2750r1996b2810],
20	who	WP	O	who	nsubj	21	SENT_99	[p4l2026t2748r2148b2798],
21	underwent	VBD	O	undergo	rcmod	19	SENT_99	[p4l11t2824r320b2874],
22	pre	JJ	O	pre	amod	25	SENT_99	[p4l372t2826r752b2887],
23	—	NN	O	—	nn	25	SENT_99	[p4l372t2826r752b2887],
24	operative	NN	O	operative	nn	25	SENT_99	[p4l372t2826r752b2887],
25	radio	NN	O	radio	nsubj	26	SENT_99	[p4l804t2824r966b2874],
26	—	CD	NUMBER	—	xcomp	21	SENT_99	[p4l804t2824r966b2874],
27	or	CC	O	or	_	0	SENT_99	[p4l1016t2838r1072b2874],
28	chemotherapy	NN	O	chemotherapy	conj_or	26	SENT_99	[p4l1121t2824r1549b2888],
29	.	.	O	.	_	0	SENT_99	[p4l1121t2824r1549b2888],

1	The	DT	O	the	det	5	SENT_100	[p4l1596t2824r1700b2874],
2	SAS	NNP	O	SAS	nn	5	SENT_100	[p4l1751t2826r1855b2874],
3	software	NN	O	software	nn	5	SENT_100	[p4l1906t2823r2148b2874],
4	(	NN	O	(	nn	5	SENT_100	[p4l11t2900r229b2956],
5	version	NN	O	version	nsubjpass	18	SENT_100	[p4l11t2900r229b2956],
6	9.2	CD	NUMBER	9.2	number	7	SENT_100	[p4l258t2900r355b2956],
7	)	CD	NUMBER	)	num	8	SENT_100	[p4l258t2900r355b2956],
8	(	CD	NUMBER	(	dep	5	SENT_100	[p4l386t2900r507b2956],
9	SAS	NNP	ORGANIZATION	SAS	nn	16	SENT_100	[p4l386t2900r507b2956],
10	Institute	NNP	ORGANIZATION	Institute	nn	16	SENT_100	[p4l538t2901r766b2948],
11	lnc.	NNP	O	lnc.	nn	16	SENT_100	[p4l795t2901r900b2956],
12	,	,	O	,	_	0	SENT_100	[p4l795t2901r900b2956],
13	Milan	NNP	LOCATION	Milan	appos	16	SENT_100	[p4l929t2898r1095b2956],
14	,	,	O	,	_	0	SENT_100	[p4l929t2898r1095b2956],
15	Italy	NNP	LOCATION	Italy	appos	16	SENT_100	[p4l1124t2898r1253b2962],
16	)	NNP	O	)	dep	5	SENT_100	[p4l1124t2898r1253b2962],
17	was	VBD	O	be	auxpass	18	SENT_100	[p4l1281t2913r1388b2948],
18	used	VBN	O	use	_	0	SENT_100	[p4l1417t2898r1546b2948],
19	for	IN	O	for	_	0	SENT_100	[p4l1574t2898r1652b2948],
20	all	PDT	O	all	predet	22	SENT_100	[p4l1678t2898r1736b2948],
21	the	DT	O	the	det	22	SENT_100	[p4l1764t2898r1855b2948],
22	analyses	NNS	O	analysis	prep_for	18	SENT_100	[p4l1882t2898r2132b2962],
23	.	.	O	.	_	0	SENT_100	[p4l1882t2898r2132b2962],

1	To	TO	O	to	aux	2	SENT_101	[p4l75t2976r144b3024],
2	control	VB	O	control	dep	32	SENT_101	[p4l181t2974r377b3024],
3	for	IN	O	for	_	0	SENT_101	[p4l415t2973r493b3024],
4	multiple	JJ	O	multiple	amod	5	SENT_101	[p4l530t2974r761b3037],
5	testing	NN	O	testing	prep_for	2	SENT_101	[p4l796t2976r1005b3037],
6	,	,	O	,	_	0	SENT_101	[p4l796t2976r1005b3037],
7	q	VB	O	q	parataxis	32	SENT_101	[p4l1041t2974r1246b3037],
8	—	CD	NUMBER	—	num	11	SENT_101	[p4l1041t2974r1246b3037],
9	va	NN	O	va	nn	11	SENT_101	[p4l1041t2974r1246b3037],
10	|	NN	O	|	nn	11	SENT_101	[p4l1041t2974r1246b3037],
11	ue	NN	O	ue	dobj	7	SENT_101	[p4l1041t2974r1246b3037],
12	(	CD	NUMBER	(	nsubj	7	SENT_101	[p4l1285t2975r1329b3032],
13	a	DT	O	a	det	22	SENT_101	[p4l1285t2975r1329b3032],
14	false	JJ	O	false	amod	22	SENT_101	[p4l1366t2973r1493b3024],
15	discovery	NN	O	discovery	nn	22	SENT_101	[p4l1530t2974r1799b3038],
16	rate	NN	O	rate	nn	22	SENT_101	[p4l1836t2982r1941b3024],
17	(	CD	NUMBER	(	num	22	SENT_101	[p4l1980t2975r2148b3032, p4l9t3051r250b3114],
18	FDR	NNP	O	FDR	nn	22	SENT_101	[p4l1980t2975r2148b3032, p4l9t3051r250b3114],
19	)	CD	NUMBER	)	num	22	SENT_101	[p4l1980t2975r2148b3032, p4l9t3051r250b3114],
20	adjusted	JJ	O	adjusted	amod	22	SENT_101	[p4l1980t2975r2148b3032, p4l9t3051r250b3114],
21	P	NN	O	p	nn	22	SENT_101	[p4l273t3053r308b3100],
22	value	NN	O	value	nsubj	32	SENT_101	[p4l324t3051r489b3108],
23	,	,	O	,	_	0	SENT_101	[p4l324t3051r489b3108],
24	FDR	NNP	O	FDR	nsubj	32	SENT_101	[p4l513t3053r621b3100],
25	0.1	CD	NUMBER	0.1	num	26	SENT_101	[p4l642t3052r739b3108],
26	)	NN	O	)	nsubjpass	28	SENT_101	[p4l642t3052r739b3108],
27	was	VBD	O	be	auxpass	28	SENT_101	[p4l762t3065r868b3101],
28	calculated	VBN	O	calculate	rcmod	24	SENT_101	[p4l890t3051r1175b3101],
29	for	IN	O	for	_	0	SENT_101	[p4l1197t3050r1276b3101],
30	each	DT	O	each	det	31	SENT_101	[p4l1296t3051r1425b3101],
31	SNP	NN	O	snp	prep_for	28	SENT_101	[p4l1450t3052r1560b3101],
32	implemented	VBD	O	implement	_	0	SENT_101	[p4l1584t3051r1962b3113],
33	in	IN	O	in	_	0	SENT_101	[p4l1988t3053r2033b3100],
34	the	DT	O	the	det	37	SENT_101	[p4l2056t3051r2148b3101],
35	R	NN	O	r	nn	37	SENT_101	[p4l11t3116r368b3192],
36	—	NN	O	—	nn	37	SENT_101	[p4l11t3116r368b3192],
37	package	NN	O	package	prep_in	32	SENT_101	[p4l11t3116r368b3192],
38	.28	CD	NUMBER	.28	tmod	32	SENT_101	[p4l11t3116r368b3192],

1	During	IN	O	during	_	0	SENT_102	[p4l80t3205r267b3266],
2	the	DT	O	the	det	4	SENT_102	[p4l294t3203r386b3253],
3	review	NN	O	review	nn	4	SENT_102	[p4l415t3205r600b3253],
4	process	NN	O	process	prep_during	16	SENT_102	[p4l628t3218r839b3266],
5	of	IN	O	of	_	0	SENT_102	[p4l865t3202r923b3253],
6	this	DT	O	this	det	7	SENT_102	[p4l944t3203r1044b3253],
7	paper	NN	O	paper	prep_of	4	SENT_102	[p4l1073t3218r1248b3266],
8	,	,	O	,	_	0	SENT_102	[p4l1073t3218r1248b3266],
9	a	DT	O	a	det	11	SENT_102	[p4l1274t3218r1301b3253],
10	post	NN	O	post	nn	11	SENT_102	[p4l1327t3203r1568b3266],
11	—	NN	O	—	appos	7	SENT_102	[p4l1327t3203r1568b3266],
12	hoc	FW	O	hoc	dep	11	SENT_102	[p4l1327t3203r1568b3266],
13	power	NN	O	power	nn	14	SENT_102	[p4l1595t3218r1772b3266],
14	analysis	NN	O	analysis	nsubjpass	16	SENT_102	[p4l1797t3203r2014b3267],
15	was	VBD	O	be	auxpass	16	SENT_102	[p4l2040t3218r2147b3253],
16	performed	VBN	O	perform	_	0	SENT_102	[p4l11t3280r298b3343],
17	for	IN	O	for	_	0	SENT_102	[p4l327t3280r403b3331],
18	the	DT	O	the	det	21	SENT_102	[p4l429t3281r518b3331],
19	main	JJ	O	main	amod	21	SENT_102	[p4l550t3283r681b3331],
20	study	NN	O	study	nn	21	SENT_102	[p4l713t3281r862b3345],
21	endpoint	NN	O	endpoint	nsubj	29	SENT_102	[p4l890t3281r1153b3343],
22	,	,	O	,	_	0	SENT_102	[p4l890t3281r1153b3343],
23	that	WDT	O	that	nsubj	27	SENT_102	[p4l1180t3281r1290b3331],
24	is	VBZ	O	be	cop	27	SENT_102	[p4l1320t3283r1368b3338],
25	,	,	O	,	_	0	SENT_102	[p4l1320t3283r1368b3338],
26	severe	JJ	O	severe	amod	27	SENT_102	[p4l1397t3295r1572b3331],
27	neurotoxicity	NN	O	neurotoxicity	rcmod	21	SENT_102	[p4l1603t3283r1972b3344],
28	,	,	O	,	_	0	SENT_102	[p4l1603t3283r1972b3344],
29	using	VBG	O	use	prepc_for	16	SENT_102	[p4l2003t3283r2146b3344],
30	the	DT	O	the	det	37	SENT_102	[p4l8t3358r96b3409],
31	Genetic	JJ	O	genetic	amod	37	SENT_102	[p4l116t3360r324b3409],
32	Power	NN	O	power	nn	37	SENT_102	[p4l346t3360r517b3409],
33	Calculator	NN	O	calculator	nn	37	SENT_102	[p4l534t3358r807b3409],
34	(	CD	NUMBER	(	num	37	SENT_102	[p4l827t3358r1669b3422],
35	http://pngu.mgh.harvard.edu/	NN	O	http://pngu.mgh.harvard.edu/	nn	37	SENT_102	[p4l827t3358r1669b3422],
36	~	NN	O	~	nn	37	SENT_102	[p4l1678t3382r1723b3398],
37	purcell/gpc	NN	O	purcell/gpc	dobj	29	SENT_102	[p4l1738t3346r2149b3422],
38	/	:	O	/	punct	42	SENT_102	[p4l1738t3346r2149b3422],
39	)	CD	NUMBER	)	number	40	SENT_102	[p4l1738t3346r2149b3422],
40	.29	CD	NUMBER	.29	num	42	SENT_102	[p4l1738t3346r2149b3422],
41	This	DT	O	this	det	42	SENT_102	[p4l6t3433r115b3483],
42	study	NN	O	study	dep	37	SENT_102	[p4l139t3433r288b3497],
43	has	VBZ	O	have	rcmod	42	SENT_102	[p4l312t3433r400b3483],
44	a	DT	O	a	det	45	SENT_102	[p4l424t3448r451b3483],
45	power	NN	O	power	dobj	43	SENT_102	[p4l477t3448r650b3496],
46	of	IN	O	of	_	0	SENT_102	[p4l672t3433r729b3483],
47	79.2	CD	NUMBER	79.2	prep_of	45	SENT_102	[p4l748t3437r871b3491],
48	,	,	O	,	_	0	SENT_102	[p4l748t3437r871b3491],
49	57.8	CD	NUMBER	57.8	num	52	SENT_102	[p4l894t3437r1004b3483],
50	and	CC	O	and	_	0	SENT_102	[p4l1027t3433r1128b3483],
51	30.2	CD	PERCENT	30.2	num	52	SENT_102	[p4l1154t3437r1319b3484],
52	%	NN	PERCENT	%	appos	47	SENT_102	[p4l1154t3437r1319b3484],
53	to	TO	O	to	aux	54	SENT_102	[p4l1339t3441r1395b3483],
54	detect	VB	O	detect	infmod	45	SENT_102	[p4l1418t3433r1591b3483],
55	a	DT	O	a	det	58	SENT_102	[p4l1613t3448r1640b3483],
56	genotype	NN	O	genotype	nn	58	SENT_102	[p4l1665t3441r1926b3497],
57	relative	JJ	O	relative	amod	58	SENT_102	[p4l1952t3433r2147b3483],
58	risk	NN	O	risk	dobj	54	SENT_102	[p4l11t3509r101b3559],
59	of	IN	O	of	_	0	SENT_102	[p4l120t3508r177b3559],
60	1.5	CD	NUMBER	1.5	prep_of	58	SENT_102	[p4l199t3513r270b3559],
61	with	IN	O	with	_	0	SENT_102	[p4l292t3509r409b3559],
62	an	DT	O	a	det	69	SENT_102	[p4l433t3524r496b3559],
63	a	DT	O	a	det	67	SENT_102	[p4l520t3509r814b3572],
64	|	NN	O	|	nn	67	SENT_102	[p4l520t3509r814b3572],
65	pha	NN	O	pha	nn	67	SENT_102	[p4l520t3509r814b3572],
66	—	CD	NUMBER	—	num	67	SENT_102	[p4l520t3509r814b3572],
67	|	NN	O	|	nn	69	SENT_102	[p4l520t3509r814b3572],
68	eve	NN	O	eve	nn	69	SENT_102	[p4l520t3509r814b3572],
69	|	NN	O	|	prep_with	42	SENT_102	[p4l520t3509r814b3572],
70	of	IN	O	of	_	0	SENT_102	[p4l838t3508r895b3559],
71	0.05	CD	NUMBER	0.05	prep_of	69	SENT_102	[p4l912t3512r1036b3567],
72	,	,	O	,	_	0	SENT_102	[p4l912t3512r1036b3567],
73	0.01	CD	NUMBER	0.01	num	71	SENT_102	[p4l1057t3512r1158b3559],
74	and	CC	O	and	_	0	SENT_102	[p4l1190t3509r1291b3559],
75	0.001	CD	NUMBER	0.001	prep_of	69	SENT_102	[p4l1315t3512r1473b3567],
76	,	,	O	,	_	0	SENT_102	[p4l1315t3512r1473b3567],
77	respectively	RB	O	respectively	dep	42	SENT_102	[p4l1497t3509r1832b3573],
78	.	.	O	.	_	0	SENT_102	[p4l1497t3509r1832b3573],

1	The	DT	O	the	det	2	SENT_103	[p4l1850t3509r1952b3559],
2	power	NN	O	power	nsubjpass	4	SENT_103	[p4l1976t3524r2149b3572],
3	was	VBD	O	be	auxpass	4	SENT_103	[p4l8t3600r112b3636],
4	evaluated	VBN	O	evaluate	_	0	SENT_103	[p4l142t3586r407b3636],
5	under	IN	O	under	_	0	SENT_103	[p4l441t3586r602b3636],
6	the	DT	O	the	det	7	SENT_103	[p4l629t3586r718b3636],
7	assumption	NN	O	assumption	prep_under	4	SENT_103	[p4l747t3588r1064b3648],
8	of	IN	O	of	_	0	SENT_103	[p4l1095t3585r1152b3636],
9	the	DT	O	the	det	11	SENT_103	[p4l1176t3586r1265b3636],
10	following	VBG	O	follow	amod	11	SENT_103	[p4l1293t3585r1547b3649],
11	parameters	NNS	O	parameter	prep_of	7	SENT_103	[p4l1580t3593r1900b3648],
12	:	:	O	:	_	0	SENT_103	[p4l1580t3593r1900b3648],
13	additive	JJ	O	additive	amod	15	SENT_103	[p4l1929t3586r2147b3636],
14	inheritance	NN	O	inheritance	nn	15	SENT_103	[p4l11t3661r316b3711],
15	model	NN	O	model	dep	7	SENT_103	[p4l346t3661r530b3719],
16	,	,	O	,	_	0	SENT_103	[p4l346t3661r530b3719],
17	prevalence	NN	O	prevalence	appos	15	SENT_103	[p4l562t3661r858b3724],
18	of	IN	O	of	_	0	SENT_103	[p4l888t3661r944b3711],
19	severe	JJ	O	severe	amod	21	SENT_103	[p4l969t3676r1143b3711],
20	neurotoxicity	NN	O	neurotoxicity	nn	21	SENT_103	[p4l1175t3664r1532b3725],
21	phenotype	NN	O	phenotype	prep_of	17	SENT_103	[p4l1562t3661r2016b3725],
22	=	JJ	O	=	amod	21	SENT_103	[p4l1562t3661r2016b3725],
23	0.4	CD	NUMBER	0.4	tmod	22	SENT_103	[p4l1562t3661r2016b3725],
24	and	CC	O	and	_	0	SENT_103	[p4l2045t3661r2145b3711],
25	average	JJ	O	average	amod	28	SENT_103	[p4l9t3752r225b3800],
26	risk	NN	O	risk	nn	28	SENT_103	[p4l253t3737r343b3787],
27	allele	NN	O	allele	nn	28	SENT_103	[p4l366t3737r505b3787],
28	frequency	NN	O	frequency	conj_and	7	SENT_103	[p4l529t3736r806b3801],
29	=	JJ	O	=	amod	28	SENT_103	[p4l821t3761r867b3777],
30	0.30	CD	NUMBER	0.30	tmod	29	SENT_103	[p4l884t3740r1009b3787],
31	.	.	O	.	_	0	SENT_103	[p4l884t3740r1009b3787],

1	I	PRP	O	I	_	0	SENT_104	[p4l2137t2635r2148b2653],

1	Pairwise	JJ	MISC	pairwise	amod	7	SENT_105	[p5l80t15r308b63],
2	linkage	NN	O	linkage	nn	7	SENT_105	[p5l355t13r556b76],
3	disequilibrium	NN	O	disequilibrium	nn	7	SENT_105	[p5l602t13r1004b76],
4	(	CD	NUMBER	(	num	7	SENT_105	[p5l1054t14r1162b71],
5	LD	NN	O	ld	nn	7	SENT_105	[p5l1054t14r1162b71],
6	)	NN	O	)	nn	7	SENT_105	[p5l1054t14r1162b71],
7	analysis	NN	O	analysis	nsubjpass	14	SENT_105	[p5l1210t13r1427b77],
8	for	IN	O	for	_	0	SENT_105	[p5l1471t12r1550b63],
9	ABCC1	NN	O	abcc1	nn	12	SENT_105	[p5l1589t15r1767b63],
10	and	CC	O	and	_	0	SENT_105	[p5l1818t13r1921b63],
11	ABCC2	NN	O	abcc2	nn	12	SENT_105	[p5l1964t15r2149b63],
12	polymorphisms	NNS	O	polymorphism	prep_for	7	SENT_105	[p5l11t91r448b156],
13	was	VBD	O	be	auxpass	14	SENT_105	[p5l493t106r600b142],
14	performed	VBN	O	perform	_	0	SENT_105	[p5l648t90r944b155],
15	by	IN	O	by	_	0	SENT_105	[p5l994t91r1060b156],
16	Hap	NN	PERSON	hap	nn	18	SENT_105	[p5l1106t91r1408b155],
17	|	JJ	O	|	amod	18	SENT_105	[p5l1106t91r1408b155],
18	oView	NN	O	oview	agent	14	SENT_105	[p5l1106t91r1408b155],
19	3.32.30	CD	NUMBER	3.32.30	num	20	SENT_105	[p5l1452t79r1633b142],
20	Haplotypes	NNS	O	haplotype	nsubjpass	24	SENT_105	[p5l1680t91r1996b156],
21	and	CC	O	and	_	0	SENT_105	[p5l2042t91r2146b142],
22	diplotypes	NNS	O	diplotype	conj_and	20	SENT_105	[p5l9t168r304b232],
23	were	VBD	O	be	auxpass	24	SENT_105	[p5l331t183r469b218],
24	inferred	VBN	O	infer	rcmod	18	SENT_105	[p5l497t167r715b218],
25	by	IN	O	by	_	0	SENT_105	[p5l746t168r812b232],
26	Phase	NN	O	phase	nn	27	SENT_105	[p5l840t168r1002b218],
27	version	NN	O	version	agent	24	SENT_105	[p5l1028t170r1231b218],
28	2.1.1.3132	CD	DATE	2.1.1.3132	num	27	SENT_105	[p5l1260t156r1517b218],

1	RESULTS	NNS	O	result	_	0	SENT_106	[p5l11t388r307b443],
2	Patient	NN	O	patient	nn	3	SENT_106	[p5l12t474r233b528],
3	characteristics	NNS	O	characteristic	dep	1	SENT_106	[p5l263t472r713b528],

1	Ten	CD	NUMBER	ten	nsubj	6	SENT_107	[p5l6t577r121b631],
2	of	IN	O	of	_	0	SENT_107	[p5l156t573r221b631],
3	the	DT	O	the	det	5	SENT_107	[p5l247t574r350b631],
4	154	CD	NUMBER	154	num	5	SENT_107	[p5l389t579r498b631],
5	patients	NNS	O	patient	prep_of	1	SENT_107	[p5l532t577r785b645],
6	enrolled	VBD	O	enrol	_	0	SENT_107	[p5l819t574r1077b631],
7	into	IN	O	into	_	0	SENT_107	[p5l1115t577r1235b631],
8	the	DT	O	the	det	9	SENT_107	[p5l1266t574r1369b631],
9	study	NN	O	study	prep_into	6	SENT_107	[p5l1403t574r1577b647],
10	were	VBD	O	be	auxpass	11	SENT_107	[p5l1607t591r1761b631],
11	considered	VBN	O	consider	rcmod	9	SENT_107	[p5l1795t574r2144b631],
12	ineligible	JJ	O	ineligible	acomp	11	SENT_107	[p5l11t660r299b732],
13	for	IN	O	for	_	0	SENT_107	[p5l344t660r432b717],
14	this	DT	O	this	det	16	SENT_107	[p5l475t660r587b717],
15	pharmacogenomic	JJ	O	pharmacogenomic	amod	16	SENT_107	[p5l636t660r1239b732],
16	analysis	NN	O	analysis	prep_for	12	SENT_107	[p5l1284t660r1529b733],
17	according	VBG	O	accord	_	0	SENT_107	[p5l1576t660r1889b732],
18	to	TO	O	to	prepc_according_to	11	SENT_107	[p5l1936t669r2000b717],
19	the	DT	O	the	det	20	SENT_107	[p5l2044t660r2147b717],
20	study	NN	O	study	pobj	11	SENT_107	[p5l10t746r184b819],
21	criteria	NNS	O	criterion	nsubj	22	SENT_107	[p5l206t749r420b803],
22	(	VBP	O	(	rcmod	20	SENT_107	[p5l448t747r490b812],
23	1	CD	NUMBER	1	nsubj	25	SENT_107	[p5l448t747r490b812],
24	was	VBD	O	be	aux	25	SENT_107	[p5l525t763r645b803],
25	stage	NN	O	stage	ccomp	22	SENT_107	[p5l670t755r839b818],
26	I	CD	NUMBER	i	dobj	25	SENT_107	[p5l866t749r892b812],
27	;	:	O	;	_	0	SENT_107	[p5l866t749r892b812],
28	2	CD	NUMBER	2	nsubj	32	SENT_107	[p5l916t750r949b802],
29	were	VBD	O	be	cop	32	SENT_107	[p5l973t763r1128b803],
30	completely	RB	O	completely	advmod	31	SENT_107	[p5l1152t746r1508b819],
31	resected	JJ	O	resected	amod	32	SENT_107	[p5l1532t746r1797b803],
32	stage	NN	O	stage	parataxis	6	SENT_107	[p5l1825t755r1993b818],
33	IV	CD	NUMBER	iv	advmod	32	SENT_107	[p5l2021t749r2090b812],
34	;	:	O	;	_	0	SENT_107	[p5l2021t749r2090b812],
35	1	CD	NUMBER	1	nsubj	36	SENT_107	[p5l2118t751r2135b802],
36	received	VBD	O	receive	parataxis	6	SENT_107	[p5l12t832r276b889],
37	5	CD	NUMBER	5	num	39	SENT_107	[p5l317t831r737b889],
38	—	CD	NUMBER	—	num	39	SENT_107	[p5l317t831r737b889],
39	ﬂuorouraci	NNS	O	ﬂuorouraci	iobj	36	SENT_107	[p5l317t831r737b889],
40	|	NN	O	|	dobj	36	SENT_107	[p5l317t831r737b889],
41	alone	RB	O	alone	advmod	36	SENT_107	[p5l777t832r967b898],
42	;	:	O	;	_	0	SENT_107	[p5l777t832r967b898],
43	1	CD	NUMBER	1	nsubj	44	SENT_107	[p5l1010t837r1027b888],
44	received	VBD	O	receive	parataxis	6	SENT_107	[p5l1079t832r1343b889],
45	FOLFOX	NNP	O	FOLFOX	nsubjpass	53	SENT_107	[p5l1387t834r1640b889],
46	plus	CC	O	plus	_	0	SENT_107	[p5l1680t832r1806b903],
47	bevacizu	FW	O	bevacizu	conj_plus	45	SENT_107	[p5l1847t832r2148b889],
48	—	FW	O	—	nn	49	SENT_107	[p5l1847t832r2148b889],
49	mab	FW	O	mab	dep	47	SENT_107	[p5l12t918r165b984],
50	,	,	O	,	_	0	SENT_107	[p5l12t918r165b984],
51	5	CD	NUMBER	5	conj_plus	45	SENT_107	[p5l213t923r244b975],
52	were	VBD	O	be	auxpass	53	SENT_107	[p5l293t935r448b975],
53	lost	VBN	O	lose	ccomp	44	SENT_107	[p5l498t918r607b975],
54	during	IN	O	during	_	0	SENT_107	[p5l653t918r860b990],
55	follow	VB	O	follow	prepc_during	53	SENT_107	[p5l908t918r1250b990],
56	—	CD	NUMBER	—	number	58	SENT_107	[p5l908t918r1250b990],
57	up	IN	O	up	quantmod	58	SENT_107	[p5l908t918r1250b990],
58	)	CD	NUMBER	)	dobj	55	SENT_107	[p5l908t918r1250b990],
59	,	,	O	,	_	0	SENT_107	[p5l908t918r1250b990],
60	thus	RB	O	thus	advmod	6	SENT_107	[p5l1295t918r1432b975],
61	leaving	VBG	O	leave	dep	6	SENT_107	[p5l1482t918r1706b990],
62	144	CD	NUMBER	144	num	64	SENT_107	[p5l1761t923r1871b974],
63	eligible	JJ	O	eligible	amod	64	SENT_107	[p5l1918t918r2147b990],
64	patients	NNS	O	patient	dobj	61	SENT_107	[p5l12t1007r280b1076],
65	.	.	O	.	_	0	SENT_107	[p5l12t1007r280b1076],

1	The	DT	O	the	det	2	SENT_108	[p5l308t1005r425b1061],
2	majority	NN	O	majority	nsubj	10	SENT_108	[p5l459t1007r719b1077],
3	of	IN	O	of	_	0	SENT_108	[p5l748t1004r813b1061],
4	the	DT	O	the	det	5	SENT_108	[p5l837t1005r940b1061],
5	patients	NNS	O	patient	prep_of	2	SENT_108	[p5l973t1007r1226b1076],
6	(	IN	O	(	_	0	SENT_108	[p5l1260t1006r1434b1070],
7	56	CD	PERCENT	56	num	8	SENT_108	[p5l1260t1006r1434b1070],
8	%	NN	PERCENT	%	prep_(	5	SENT_108	[p5l1260t1006r1434b1070],
9	)	CD	NUMBER	)	dep	8	SENT_108	[p5l1260t1006r1434b1070],
10	completed	VBD	O	complete	_	0	SENT_108	[p5l1468t1005r1808b1076],
11	all	PDT	O	all	predet	15	SENT_108	[p5l1842t1005r1907b1061],
12	the	DT	O	the	det	15	SENT_108	[p5l1939t1005r2041b1061],
13	12	CD	NUMBER	12	num	15	SENT_108	[p5l2078t1008r2146b1060],
14	planned	VBN	O	plan	amod	15	SENT_108	[p5l12t1090r268b1161],
15	cycles	NNS	O	cycle	dobj	10	SENT_108	[p5l299t1090r486b1163],
16	of	IN	O	of	_	0	SENT_108	[p5l515t1089r580b1147],
17	chemotherapy	NN	O	chemotherapy	nn	19	SENT_108	[p5l603t1090r1071b1163],
18	(	CD	NUMBER	(	num	19	SENT_108	[p5l1100t1091r1295b1156],
19	mean	NN	O	mean	prep_of	15	SENT_108	[p5l1100t1091r1295b1156],
20	of	IN	O	of	_	0	SENT_108	[p5l1326t1089r1390b1147],
21	10	CD	NUMBER	10	num	26	SENT_108	[p5l1419t1094r1488b1147],
22	cycles	NNS	O	cycle	nn	26	SENT_108	[p5l1516t1090r1720b1163],
23	,	,	O	,	_	0	SENT_108	[p5l1516t1090r1720b1163],
24	range	NN	O	range	dep	26	SENT_108	[p5l1750t1107r1929b1162],
25	1-12	CD	NUMBER	1-12	num	26	SENT_108	[p5l1963t1091r2147b1156],
26	)	NN	O	)	prep_of	19	SENT_108	[p5l1963t1091r2147b1156],
27	.	.	O	.	_	0	SENT_108	[p5l1963t1091r2147b1156],

1	Nineteen	CD	NUMBER	nineteen	num	2	SENT_109	[p5l12t1179r297b1233],
2	patients	NNS	O	patient	nsubj	7	SENT_109	[p5l348t1179r600b1248],
3	(	IN	O	(	_	0	SENT_109	[p5l649t1178r823b1242],
4	13	CD	PERCENT	13	num	5	SENT_109	[p5l649t1178r823b1242],
5	%	NN	PERCENT	%	prep_(	2	SENT_109	[p5l649t1178r823b1242],
6	)	CD	NUMBER	)	dep	5	SENT_109	[p5l649t1178r823b1242],
7	underwent	VBD	O	undergo	conj_or	7	SENT_109	[p5l874t1176r1223b1233],
8	neo	NN	O	neo	npadvmod	10	SENT_109	[p5l1270t1176r1693b1248],
9	—	CD	NUMBER	—	num	8	SENT_109	[p5l1270t1176r1693b1248],
10	adjuvant	JJ	O	adjuvant	amod	11	SENT_109	[p5l1270t1176r1693b1248],
11	radiotherapy	NN	O	radiotherapy	dobj	7	SENT_109	[p5l1740t1176r2148b1249],
12	with	IN	O	with	_	0	SENT_109	[p5l8t1263r144b1319],
13	or	CC	O	or	_	0	SENT_109	[p5l177t1279r240b1319],
14	without	IN	O	without	_	0	SENT_109	[p5l269t1263r517b1319],
15	systemic	JJ	O	systemic	amod	16	SENT_109	[p5l547t1265r820b1335],
16	chemotherapy	NN	O	chemotherapy	prep_without	7	SENT_109	[p5l851t1263r1319b1335],
17	(	CD	NUMBER	(	num	18	SENT_109	[p5l1349t1263r1539b1328],
18	Table	NNP	O	Table	dep	16	SENT_109	[p5l1349t1263r1539b1328],
19	1	CD	NUMBER	1	num	18	SENT_109	[p5l1575t1264r1642b1328],
20	)	CD	NUMBER	)	prep_with	7	SENT_109	[p5l1575t1264r1642b1328],
21	.	.	O	.	_	0	SENT_109	[p5l1575t1264r1642b1328],

1	Grade	NNP	O	Grade	nn	3	SENT_110	[p5l87t1348r274b1405],
2	3-4	CD	NUMBER	3-4	num	3	SENT_110	[p5l320t1352r432b1405],
3	toxicity	NN	O	toxicity	nsubjpass	8	SENT_110	[p5l475t1351r703b1421],
4	of	IN	O	of	_	0	SENT_110	[p5l747t1347r812b1405],
5	any	DT	O	any	det	6	SENT_110	[p5l852t1365r964b1421],
6	type	NN	O	type	prep_of	3	SENT_110	[p5l1007t1357r1145b1421],
7	was	VBD	O	be	auxpass	8	SENT_110	[p5l1190t1365r1309b1405],
8	experienced	VBN	O	experience	dep	23	SENT_110	[p5l1356t1348r1739b1419],
9	by	IN	O	by	_	0	SENT_110	[p5l1789t1348r1864b1421],
10	48	CD	PERCENT	48	num	11	SENT_110	[p5l1906t1352r2042b1405],
11	%	NN	PERCENT	%	agent	8	SENT_110	[p5l1906t1352r2042b1405],
12	of	IN	O	of	_	0	SENT_110	[p5l2088t1347r2153b1405],
13	patients	NNS	O	patient	prep_of	11	SENT_110	[p5l12t1437r259b1506],
14	(	IN	O	(	_	0	SENT_110	[p5l321t1436r591b1500],
15	69/144	CD	NUMBER	69/144	number	16	SENT_110	[p5l321t1436r591b1500],
16	)	CD	NUMBER	)	prep_(	8	SENT_110	[p5l321t1436r591b1500],
17	:	:	O	:	_	0	SENT_110	[p5l321t1436r591b1500],
18	18	CD	PERCENT	18	num	19	SENT_110	[p5l656t1438r785b1491],
19	%	NN	PERCENT	%	dep	16	SENT_110	[p5l656t1438r785b1491],
20	(	CD	NUMBER	(	number	21	SENT_110	[p5l846t1436r1100b1500],
21	26/144	CD	NUMBER	26/144	num	22	SENT_110	[p5l846t1436r1100b1500],
22	)	NN	O	)	dep	19	SENT_110	[p5l846t1436r1100b1500],
23	developed	VBD	O	develop	_	0	SENT_110	[p5l1161t1434r1491b1506],
24	non-hematological	JJ	O	non-hematological	amod	25	SENT_110	[p5l1556t1434r2145b1506],
25	grade	NN	O	grade	dobj	23	SENT_110	[p5l9t1520r189b1592],
26	3-4	CD	NUMBER	3-4	num	27	SENT_110	[p5l237t1524r349b1577],
27	toxicity	NN	O	toxicity	nsubj	34	SENT_110	[p5l395t1523r621b1593],
28	and	CC	O	and	_	0	SENT_110	[p5l668t1520r782b1577],
29	39	CD	PERCENT	39	num	30	SENT_110	[p5l834t1524r967b1577],
30	%	NN	PERCENT	%	conj_and	27	SENT_110	[p5l834t1524r967b1577],
31	(	CD	NUMBER	(	number	32	SENT_110	[p5l1018t1522r1271b1586],
32	56/144	CD	NUMBER	56/144	num	33	SENT_110	[p5l1018t1522r1271b1586],
33	)	NN	O	)	dep	30	SENT_110	[p5l1018t1522r1271b1586],
34	developed	VBD	O	develop	dep	23	SENT_110	[p5l1321t1520r1650b1592],
35	hematological	JJ	O	hematological	amod	36	SENT_110	[p5l1704t1520r2145b1592],
36	grade	NN	O	grade	dobj	34	SENT_110	[p5l9t1607r189b1679],
37	3-4	CD	NUMBER	3-4	num	38	SENT_110	[p5l238t1610r349b1663],
38	toxicity	NN	O	toxicity	nsubj	23	SENT_110	[p5l395t1609r636b1679],
39	.	.	O	.	_	0	SENT_110	[p5l395t1609r636b1679],

1	Neutropenia	NN	O	neutropenia	nsubj	12	SENT_111	[p5l686t1609r1072b1678],
2	(	CD	PERCENT	(	number	3	SENT_111	[p5l1124t1608r1296b1672],
3	38	CD	PERCENT	38	num	4	SENT_111	[p5l1124t1608r1296b1672],
4	%	NN	PERCENT	%	dep	1	SENT_111	[p5l1124t1608r1296b1672],
5	)	CD	NUMBER	)	dep	1	SENT_111	[p5l1124t1608r1296b1672],
6	was	VBD	O	be	cop	12	SENT_111	[p5l1346t1623r1465b1663],
7	the	DT	O	the	det	12	SENT_111	[p5l1512t1607r1613b1663],
8	most	RBS	O	most	advmod	10	SENT_111	[p5l1665t1615r1819b1663],
9	common	JJ	O	common	amod	10	SENT_111	[p5l1866t1623r2145b1663],
10	severe	JJ	O	severe	amod	12	SENT_111	[p5l10t1709r209b1749],
11	hematological	JJ	O	hematological	amod	12	SENT_111	[p5l246t1692r686b1764],
12	toxicity	NN	O	toxicity	_	0	SENT_111	[p5l722t1695r963b1765],
13	,	,	O	,	_	0	SENT_111	[p5l722t1695r963b1765],
14	whereas	IN	O	whereas	mark	32	SENT_111	[p5l994t1692r1256b1749],
15	diarrhea	NN	O	diarrhea	nsubj	32	SENT_111	[p5l1290t1692r1545b1749],
16	(	CD	PERCENT	(	number	17	SENT_111	[p5l1583t1694r1755b1758],
17	11	CD	PERCENT	11	num	18	SENT_111	[p5l1583t1694r1755b1758],
18	%	NN	PERCENT	%	dep	15	SENT_111	[p5l1583t1694r1755b1758],
19	)	CD	NUMBER	)	dep	15	SENT_111	[p5l1583t1694r1755b1758],
20	and	CC	O	and	_	0	SENT_111	[p5l1791t1692r1905b1749],
21	neurotoxicity	NN	O	neurotoxicity	nn	22	SENT_111	[p5l1945t1709r2148b1749, p5l8t1781r234b1851],
22	(	NN	O	(	nsubj	32	SENT_111	[p5l279t1780r412b1844],
23	7	CD	PERCENT	7	number	24	SENT_111	[p5l279t1780r412b1844],
24	%	NN	PERCENT	%	amod	22	SENT_111	[p5l279t1780r412b1844],
25	)	CD	NUMBER	)	dep	22	SENT_111	[p5l279t1780r412b1844],
26	were	VBD	O	be	cop	32	SENT_111	[p5l457t1795r610b1835],
27	the	DT	O	the	det	32	SENT_111	[p5l652t1778r754b1835],
28	most	RBS	O	most	advmod	29	SENT_111	[p5l801t1787r955b1835],
29	frequent	JJ	O	frequent	amod	32	SENT_111	[p5l995t1778r1267b1850],
30	non-hematological	JJ	O	non-hematological	amod	32	SENT_111	[p5l1312t1778r1901b1850],
31	severe	JJ	O	severe	amod	32	SENT_111	[p5l1948t1795r2147b1835],
32	toxicities	NNS	O	toxicity	advcl	12	SENT_111	[p5l8t1867r297b1921],
33	.	.	O	.	_	0	SENT_111	[p5l8t1867r297b1921],

1	Neurotoxicity	NN	O	neurotoxicity	nsubj	8	SENT_112	[p5l329t1867r746b1937],
2	was	VBD	O	be	cop	8	SENT_112	[p5l774t1881r892b1921],
3	also	RB	O	also	advmod	8	SENT_112	[p5l923t1865r1044b1921],
4	the	DT	O	the	det	8	SENT_112	[p5l1073t1865r1174b1921],
5	most	RBS	O	most	advmod	6	SENT_112	[p5l1206t1873r1361b1921],
6	common	JJ	O	common	amod	8	SENT_112	[p5l1390t1881r1669b1921],
7	adverse	JJ	O	adverse	amod	8	SENT_112	[p5l1701t1865r1943b1921],
8	event	NN	O	event	_	0	SENT_112	[p5l1973t1873r2149b1921],
9	of	IN	O	of	_	0	SENT_112	[p5l9t1950r74b2007],
10	any	DT	O	any	det	11	SENT_112	[p5l107t1968r219b2023],
11	grade	NN	O	grade	prep_of	8	SENT_112	[p5l257t1951r436b2023],
12	developed	VBN	O	develop	partmod	11	SENT_112	[p5l476t1951r806b2022],
13	during	IN	O	during	_	0	SENT_112	[p5l848t1951r1051b2023],
14	the	DT	O	the	det	16	SENT_112	[p5l1091t1951r1193b2007],
15	treatment	NN	O	treatment	nn	16	SENT_112	[p5l1231t1959r1546b2007],
16	(	NN	O	(	prep_during	12	SENT_112	[p5l1586t1952r1775b2016],
17	83	CD	PERCENT	83	number	18	SENT_112	[p5l1586t1952r1775b2016],
18	%	NN	PERCENT	%	amod	16	SENT_112	[p5l1586t1952r1775b2016],
19	)	CD	NUMBER	)	tmod	12	SENT_112	[p5l1586t1952r1775b2016],
20	.	.	O	.	_	0	SENT_112	[p5l1586t1952r1775b2016],

1	A	DT	O	a	det	3	SENT_113	[p5l1813t1953r1857b2007],
2	detailed	JJ	O	detailed	amod	3	SENT_113	[p5l1896t1951r2144b2007],
3	description	NN	O	description	nsubj	7	SENT_113	[p5l9t2036r356b2108],
4	of	IN	O	of	_	0	SENT_113	[p5l388t2036r453b2093],
5	patient	NN	O	patient	nn	6	SENT_113	[p5l479t2039r699b2108],
6	toxicity	NN	O	toxicity	prep_of	3	SENT_113	[p5l725t2039r953b2109],
7	is	VBZ	O	be	_	0	SENT_113	[p5l982t2039r1023b2093],
8	in	IN	O	in	_	0	SENT_113	[p5l1055t2039r1106b2092],
9	Table	NNP	O	Table	prep_in	7	SENT_113	[p5l1135t2036r1304b2093],
10	2	CD	NUMBER	2	num	9	SENT_113	[p5l1336t2040r1385b2093],
11	.	.	O	.	_	0	SENT_113	[p5l1336t2040r1385b2093],

1	Validation	NN	O	validation	nsubj	27	SENT_114	[p5l7t2266r325b2322],
2	of	IN	O	of	_	0	SENT_114	[p5l356t2265r422b2322],
3	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_114	[p5l447t2266r940b2338],
4	previously	RB	DATE	previously	advmod	5	SENT_114	[p5l972t2266r1298b2338],
5	associated	VBN	O	associate	partmod	3	SENT_114	[p5l1325t2266r1654b2322],
6	with	IN	O	with	_	0	SENT_114	[p5l1685t2266r1820b2322],
7	FOLFOX4	NN	O	folfox4	nn	8	SENT_114	[p5l1855t2267r2148b2322],
8	toxicity	NN	O	toxicity	prep_with	5	SENT_114	[p5l8t2345r240b2415],
9	in	IN	O	in	_	0	SENT_114	[p5l271t2345r322b2398],
10	the	DT	O	the	det	12	SENT_114	[p5l353t2342r456b2399],
11	metastatic	JJ	O	metastatic	amod	12	SENT_114	[p5l490t2345r818b2399],
12	setting	NN	O	setting	prep_in	5	SENT_114	[p5l849t2345r1064b2414],
13	We	PRP	O	we	nsubj	14	SENT_114	[p5l8t2447r108b2500],
14	included	VBD	O	include	rcmod	12	SENT_114	[p5l139t2444r410b2500],
15	in	IN	O	in	_	0	SENT_114	[p5l443t2447r494b2500],
16	the	DT	O	the	det	17	SENT_114	[p5l524t2444r627b2500],
17	analysis	NN	O	analysis	prep_in	14	SENT_114	[p5l656t2444r900b2517],
18	23	CD	NUMBER	23	num	20	SENT_114	[p5l930t2448r1001b2500],
19	genetic	JJ	O	genetic	amod	20	SENT_114	[p5l1032t2447r1268b2516],
20	polymorphisms	NNS	O	polymorphism	dobj	14	SENT_114	[p5l1299t2444r1792b2517],
21	previously	RB	DATE	previously	advmod	22	SENT_114	[p5l1824t2444r2149b2517],
22	investigated	VBN	O	investigate	partmod	20	SENT_114	[p5l11t2530r398b2602],
23	in	IN	O	in	_	0	SENT_114	[p5l430t2532r481b2585],
24	metastatic	JJ	O	metastatic	amod	26	SENT_114	[p5l513t2532r841b2586],
25	CRC	NN	ORGANIZATION	crc	nn	26	SENT_114	[p5l868t2532r994b2586],
26	patients	NNS	O	patient	prep_in	22	SENT_114	[p5l1024t2532r1276b2601],
27	treated	VBN	O	treat	_	0	SENT_114	[p5l1302t2530r1529b2586],
28	with	IN	O	with	_	0	SENT_114	[p5l1558t2530r1693b2586],
29	FOLFOX4	NN	O	folfox4	prep_with	27	SENT_114	[p5l1726t2531r2034b2586],
30	.	.	O	.	_	0	SENT_114	[p5l1726t2531r2034b2586],

1	Six	CD	NUMBER	six	nsubjpass	5	SENT_115	[p5l2062t2532r2149b2586],
2	of	IN	O	of	_	0	SENT_115	[p5l9t2615r74b2672],
3	them	PRP	O	they	prep_of	1	SENT_115	[p5l96t2616r261b2672],
4	were	VBD	O	be	auxpass	5	SENT_115	[p5l291t2633r447b2672],
5	associated	VBN	O	associate	_	0	SENT_115	[p5l475t2616r805b2672],
6	with	IN	O	with	_	0	SENT_115	[p5l835t2616r971b2672],
7	severe	JJ	O	severe	amod	9	SENT_115	[p5l1003t2633r1207b2672],
8	toxicity	NN	O	toxicity	nn	9	SENT_115	[p5l1234t2619r1467b2688],
9	(	NN	O	(	prep_with	5	SENT_115	[p5l1496t2616r1700b2681],
10	either	CC	O	either	prep	9	SENT_115	[p5l1496t2616r1700b2681],
11	neurotoxicity	NN	O	neurotoxicity	nn	14	SENT_115	[p5l1730t2619r2149b2688],
12	or	CC	O	or	_	0	SENT_115	[p5l9t2719r73b2758],
13	neutropenia	NN	O	neutropenia	conj_or	11	SENT_115	[p5l131t2703r539b2773],
14	)	NN	O	)	dep	10	SENT_115	[p5l131t2703r539b2773],
15	in	IN	O	in	_	0	SENT_115	[p5l601t2705r652b2758],
16	at	IN	O	at	quantmod	18	SENT_115	[p5l713t2711r771b2758],
17	least	JJS	O	least	mwe	16	SENT_115	[p5l831t2702r973b2758],
18	one	CD	NUMBER	one	num	19	SENT_115	[p5l1030t2719r1149b2758],
19	study	NN	O	study	prep_in	5	SENT_115	[p5l1207t2702r1395b2775],
20	.	.	O	.	_	0	SENT_115	[p5l1207t2702r1395b2775],

1	GSTP1	NN	O	gstp1	_	0	SENT_116	[p5l1452t2704r1971b2758],
2	—	CD	NUMBER	—	num	1	SENT_116	[p5l1452t2704r1971b2758],
3	rs947894	NN	O	rs947894	dep	1	SENT_116	[p5l1452t2704r1971b2758],
4	and	CC	O	and	_	0	SENT_116	[p5l2028t2702r2144b2758],
5	rs1138272	NN	O	rs1138272	dep	1	SENT_116	[p5l12t2789r352b2850],
6	,	,	O	,	_	0	SENT_116	[p5l12t2789r352b2850],
7	AGXT	NN	O	agxt	nn	9	SENT_116	[p5l414t2787r959b2850],
8	—	CD	NUMBER	—	num	9	SENT_116	[p5l414t2787r959b2850],
9	rs4426527	NN	O	rs4426527	conj_and	3	SENT_116	[p5l414t2787r959b2850],
10	,	,	O	,	_	0	SENT_116	[p5l414t2787r959b2850],
11	rs34116584	NN	O	rs34116584	dep	1	SENT_116	[p5l1024t2789r1389b2841],
12	and	CC	O	and	_	0	SENT_116	[p5l1451t2785r1567b2841],
13	de	IN	O	de	amod	14	SENT_116	[p5l1633t2785r1930b2855],
14	|	CD	NUMBER	|	conj_and	3	SENT_116	[p5l1633t2785r1930b2855],
15	.	.	O	.	_	0	SENT_116	[p5l1633t2785r1930b2855],

1	—	NN	O	—	_	0	SENT_117	[p5l1633t2785r1930b2855],
2	.	.	O	.	_	0	SENT_117	[p5l1633t2785r1930b2855],

1	74bp	JJ	O	74bp	nsubjpass	3	SENT_118	[p5l1633t2785r1930b2855],
2	were	VBD	O	be	auxpass	3	SENT_118	[p5l1992t2802r2147b2841],
3	associated	VBN	O	associate	_	0	SENT_118	[p5l9t2872r339b2928],
4	with	IN	O	with	_	0	SENT_118	[p5l376t2872r511b2928],
5	neurological	JJ	O	neurological	amod	6	SENT_118	[p5l552t2872r942b2944],
6	toxicity	NN	O	toxicity	prep_with	3	SENT_118	[p5l979t2874r1225b2944],
7	,	,	O	,	_	0	SENT_118	[p5l979t2874r1225b2944],
8	whereas	IN	O	whereas	mark	16	SENT_118	[p5l1259t2872r1524b2928],
9	GSTM1	NN	O	gstm1	nsubjpass	16	SENT_118	[p5l1561t2872r1924b2928],
10	—	CD	NUMBER	—	num	9	SENT_118	[p5l1561t2872r1924b2928],
11	nu	NN	O	nu	nn	14	SENT_118	[p5l1561t2872r1924b2928],
12	|	CD	NUMBER	|	num	14	SENT_118	[p5l1561t2872r1924b2928],
13	|	NN	O	|	nn	14	SENT_118	[p5l1561t2872r1924b2928],
14	genotype	NN	O	genotype	dep	9	SENT_118	[p5l1962t2889r2148b2944, p5l8t2967r147b3031],
15	was	VBD	O	be	auxpass	16	SENT_118	[p5l178t2975r298b3014],
16	related	VBN	O	relate	advcl	3	SENT_118	[p5l332t2958r548b3014],
17	to	TO	O	to	_	0	SENT_118	[p5l580t2967r644b3014],
18	severe	JJ	O	severe	amod	19	SENT_118	[p5l676t2975r879b3014],
19	neutropenia	NN	O	neutropenia	prep_to	16	SENT_118	[p5l913t2961r1299b3029],
20	(	CD	NUMBER	(	num	22	SENT_118	[p5l1335t2958r1844b3031],
21	Supplementary	NNP	O	Supplementary	nn	22	SENT_118	[p5l1335t2958r1844b3031],
22	Table	NNP	O	Table	dep	19	SENT_118	[p5l1871t2958r2044b3014],
23	1	CD	NUMBER	1	number	24	SENT_118	[p5l2081t2959r2148b3023],
24	)	CD	NUMBER	)	dep	22	SENT_118	[p5l2081t2959r2148b3023],
25	.	.	O	.	_	0	SENT_118	[p5l2081t2959r2148b3023],

1	©	RB	O	©	dep	2	SENT_119	[p5l1069t3192r1114b3237],
2	2013	CD	DATE	2013	dep	4	SENT_119	[p5l1141t3190r1274b3237],
3	Macmillan	NNP	ORGANIZATION	Macmillan	nn	4	SENT_119	[p5l1305t3187r1591b3237],
4	Publishers	NNPS	ORGANIZATION	Publishers	_	0	SENT_119	[p5l1623t3187r1909b3237],
5	Limited	NNP	ORGANIZATION	Limited	dep	4	SENT_119	[p5l1938t3187r2146b3237],

1	Table	NNP	O	Table	_	0	SENT_120	[p6l43t130r178b181],
2	1	CD	NUMBER	1	dep	1	SENT_120	[p6l207t133r249b181],
3	.	.	O	.	_	0	SENT_120	[p6l207t133r249b181],

1	Demographic	JJ	MISC	demographic	amod	4	SENT_121	[p6l329t131r726b195],
2	and	CC	O	and	_	0	SENT_121	[p6l752t131r859b182],
3	clinical	JJ	O	clinical	conj_and	1	SENT_121	[p6l888t131r1083b182],
4	characteristics	NNS	O	characteristic	dep	9	SENT_121	[p6l1113t131r1525b182],
5	of	IN	O	of	_	0	SENT_121	[p6l1553t131r1613b182],
6	the	DT	O	the	det	8	SENT_121	[p6l1635t131r1729b182],
7	patient	NN	O	patient	nn	8	SENT_121	[p6l1758t133r1963b195],
8	population	NN	O	population	prep_of	4	SENT_121	[p6l47t217r363b280],
9	eligible	NN	O	eligible	_	0	SENT_121	[p6l392t217r604b281],
10	for	IN	O	for	dep	9	SENT_121	[p6l629t216r710b267],
11	the	DT	O	the	det	13	SENT_121	[p6l735t217r829b267],
12	pharmacogenomic	JJ	O	pharmacogenomic	amod	13	SENT_121	[p6l859t217r1410b281],
13	study	NN	O	study	pobj	10	SENT_121	[p6l1437t217r1597b281],

1	Characteristic	JJ	O	characteristic	amod	2	SENT_122	[p6l71t376r448b426],
2	N	NN	O	n	_	0	SENT_122	[p6l1769t379r1811b426],
3	(	CD	PERCENT	(	num	4	SENT_122	[p6l1838t377r1922b434],
4	%	NN	PERCENT	%	dep	2	SENT_122	[p6l1838t377r1922b434],
5	)	CD	NUMBER	)	dep	2	SENT_122	[p6l1838t377r1922b434],

1	Total	JJ	O	total	_	0	SENT_123	[p6l68t525r206b575],
2	144	CD	NUMBER	144	num	3	SENT_123	[p6l1799t529r1899b575],
3	Sex	NN	O	sex	dep	1	SENT_123	[p6l69t604r164b652],

1	Male	JJ	O	male	_	0	SENT_124	[p6l141t680r277b730],
2	82	CD	NUMBER	82	number	3	SENT_124	[p6l1675t683r1742b730],
3	(	CD	NUMBER	(	num	5	SENT_124	[p6l1771t681r1924b738],
4	56.9	CD	NUMBER	56.9	number	5	SENT_124	[p6l1771t681r1924b738],
5	)	CD	NUMBER	)	npadvmod	6	SENT_124	[p6l1771t681r1924b738],
6	Female	JJ	O	female	amod	1	SENT_124	[p6l142t757r347b808],
7	62	CD	NUMBER	62	number	8	SENT_124	[p6l1675t761r1742b808],
8	(	CD	NUMBER	(	dep	1	SENT_124	[p6l1771t759r1924b815],
9	43.0	CD	NUMBER	43.0	num	10	SENT_124	[p6l1771t759r1924b815],
10	)	NN	O	)	dep	8	SENT_124	[p6l1771t759r1924b815],

1	Age	NNP	O	Age	nn	2	SENT_125	[p6l67t914r174b976],
2	(	NNP	O	(	_	0	SENT_125	[p6l202t913r384b970],
3	Mean	NN	O	mean	dep	2	SENT_125	[p6l202t913r384b970],
4	,	,	O	,	_	0	SENT_125	[p6l202t913r384b970],
5	range	NN	O	range	appos	3	SENT_125	[p6l412t913r588b976],
6	)	CD	NUMBER	)	number	7	SENT_125	[p6l412t913r588b976],
7	59	CD	NUMBER	59	num	8	SENT_125	[p6l1676t915r1743b962],
8	(	NN	O	(	dep	5	SENT_125	[p6l1771t913r1980b970],
9	25-82	CD	NUMBER	25-82	num	10	SENT_125	[p6l1771t913r1980b970],
10	)	NN	O	)	dep	2	SENT_125	[p6l1771t913r1980b970],

1	Primary	JJ	O	primary	amod	3	SENT_126	[p6l70t1069r287b1132],
2	tumor	NN	O	tumor	nn	3	SENT_126	[p6l312t1075r481b1118],
3	site	NN	O	site	_	0	SENT_126	[p6l502t1069r595b1118],

1	Colon	NN	O	colon	dep	5	SENT_127	[p6l139t1144r306b1195],
2	111	CD	NUMBER	111	dep	1	SENT_127	[p6l1644t1149r1732b1194],
3	(	NN	O	(	dep	5	SENT_127	[p6l1771t1146r1874b1203],
4	77	CD	NUMBER	77	num	3	SENT_127	[p6l1771t1146r1874b1203],
5	)	CD	NUMBER	)	dep	10	SENT_127	[p6l1771t1146r1874b1203],
6	Right	NNP	O	Right	dep	5	SENT_127	[p6l207t1222r352b1286],
7	39	CD	NUMBER	39	number	8	SENT_127	[p6l1678t1226r1745b1272],
8	(	CD	NUMBER	(	num	10	SENT_127	[p6l1771t1223r1871b1280],
9	35	CD	NUMBER	35	number	10	SENT_127	[p6l1771t1223r1871b1280],
10	)	CD	NUMBER	)	_	0	SENT_127	[p6l1771t1223r1871b1280],
11	Left	VBN	O	leave	partmod	10	SENT_127	[p6l207t1299r309b1350],
12	68	CD	NUMBER	68	number	13	SENT_127	[p6l1679t1303r1744b1350],
13	(	CD	NUMBER	(	dobj	11	SENT_127	[p6l1771t1301r1871b1357],
14	61	CD	NUMBER	61	num	16	SENT_127	[p6l1771t1301r1871b1357],
15	)	CD	NUMBER	)	num	16	SENT_127	[p6l1771t1301r1871b1357],
16	Transverse	NN	O	transverse	dep	13	SENT_127	[p6l210t1380r500b1427],
17	3	CD	NUMBER	3	num	18	SENT_127	[p6l1712t1381r1742b1427],
18	(	NN	O	(	dep	28	SENT_127	[p6l1771t1378r1837b1435],
19	3	CD	NUMBER	3	num	21	SENT_127	[p6l1771t1378r1837b1435],
20	)	NN	O	)	nn	21	SENT_127	[p6l1771t1378r1837b1435],
21	Sigma	NNP	O	Sigma	dep	18	SENT_127	[p6l206t1456r379b1518],
22	1	CD	NUMBER	1	number	23	SENT_127	[p6l1722t1459r1737b1504],
23	(	CD	NUMBER	(	num	25	SENT_127	[p6l1771t1455r1837b1512],
24	1	CD	NUMBER	1	number	25	SENT_127	[p6l1771t1455r1837b1512],
25	)	CD	NUMBER	)	dep	21	SENT_127	[p6l1771t1455r1837b1512],
26	Rectum	NN	ORGANIZATION	rectum	dep	28	SENT_127	[p6l142t1560r358b1608],
27	33	CD	NUMBER	33	num	26	SENT_127	[p6l1676t1561r1741b1608],
28	(	CD	NUMBER	(	dep	13	SENT_127	[p6l1771t1559r1874b1615],
29	23	CD	NUMBER	23	num	30	SENT_127	[p6l1771t1559r1874b1615],
30	)	NN	O	)	dep	28	SENT_127	[p6l1771t1559r1874b1615],

1	Stage	NN	O	stage	dep	10	SENT_128	[p6l69t1715r224b1777],
2	of	IN	O	of	_	0	SENT_128	[p6l249t1712r310b1763],
3	disease	NN	O	disease	prep_of	1	SENT_128	[p6l327t1713r525b1763],
4	at	IN	O	at	_	0	SENT_128	[p6l550t1721r607b1763],
5	diagnosisa	NN	O	diagnosisa	prep_at	3	SENT_128	[p6l631t1708r913b1777],
6	ll	NN	O	ll	dep	10	SENT_128	[p6l142t1793r165b1840],
7	21	CD	NUMBER	21	num	6	SENT_128	[p6l1676t1794r1732b1840],
8	(	CD	NUMBER	(	num	10	SENT_128	[p6l1771t1791r1874b1848],
9	15	CD	NUMBER	15	num	10	SENT_128	[p6l1771t1791r1874b1848],
10	)	NN	O	)	dep	15	SENT_128	[p6l1771t1791r1874b1848],
11	III	CD	NUMBER	iii	number	12	SENT_128	[p6l142t1870r182b1917],
12	123	CD	NUMBER	123	dep	10	SENT_128	[p6l1644t1871r1741b1918],
13	(	NN	O	(	dep	12	SENT_128	[p6l1771t1869r1874b1925],
14	85	CD	NUMBER	85	num	15	SENT_128	[p6l1771t1869r1874b1925],
15	)	NN	O	)	_	0	SENT_128	[p6l1771t1869r1874b1925],

1	Neo	NNP	O	Neo	_	0	SENT_129	[p6l70t2022r449b2086],
2	—	CD	NUMBER	—	num	1	SENT_129	[p6l70t2022r449b2086],
3	adjuvant	JJ	O	adjuvant	amod	4	SENT_129	[p6l70t2022r449b2086],
4	radiotherapy	NN	O	radiotherapy	dep	1	SENT_129	[p6l471t2023r831b2087],
5	(	CD	NUMBER	(	npadvmod	6	SENT_129	[p6l856t2023r991b2087],
6	only	RB	O	only	advmod	4	SENT_129	[p6l856t2023r991b2087],
7	for	IN	O	for	_	0	SENT_129	[p6l1014t2022r1091b2073],
8	rectum	NN	O	rectum	prep_for	4	SENT_129	[p6l1114t2024r1324b2080],
9	)	CD	NUMBER	)	num	8	SENT_129	[p6l1114t2024r1324b2080],

1	Yes	UH	O	yes	dep	2	SENT_130	[p6l138t2102r231b2150],
2	19	CD	NUMBER	19	_	0	SENT_130	[p6l1680t2103r1743b2150],
3	(	CD	NUMBER	(	advmod	2	SENT_130	[p6l1771t2101r1874b2158],
4	58	CD	NUMBER	58	dep	2	SENT_130	[p6l1771t2101r1874b2158],
5	)	CD	NUMBER	)	dep	4	SENT_130	[p6l1771t2101r1874b2158],
6	No	DT	O	no	dep	8	SENT_130	[p6l142t2180r220b2228],
7	14	CD	NUMBER	14	number	8	SENT_130	[p6l1680t2182r1744b2227],
8	(	NN	O	(	prep	4	SENT_130	[p6l1771t2179r1874b2235],
9	42	CD	NUMBER	42	num	10	SENT_130	[p6l1771t2179r1874b2235],
10	)	NN	O	)	dep	8	SENT_130	[p6l1771t2179r1874b2235],

1	Neo	NNP	O	Neo	_	0	SENT_131	[p6l70t2333r449b2396],
2	—	CD	NUMBER	—	num	1	SENT_131	[p6l70t2333r449b2396],
3	adjuvant	JJ	O	adjuvant	amod	4	SENT_131	[p6l70t2333r449b2396],
4	chemotherapy	NN	O	chemotherapy	dep	1	SENT_131	[p6l472t2333r874b2397],
5	(	CD	NUMBER	(	npadvmod	6	SENT_131	[p6l898t2333r1034b2397],
6	only	RB	O	only	advmod	4	SENT_131	[p6l898t2333r1034b2397],
7	for	IN	O	for	_	0	SENT_131	[p6l1057t2332r1134b2383],
8	rectum	NN	O	rectum	prep_for	4	SENT_131	[p6l1157t2334r1366b2390],
9	)	CD	NUMBER	)	num	8	SENT_131	[p6l1157t2334r1366b2390],

1	5	CD	NUMBER	5	_	0	SENT_132	[p6l140t2412r269b2460],
2	.	.	O	.	_	0	SENT_132	[p6l140t2412r269b2460],

1	—	NN	O	—	_	0	SENT_133	[p6l140t2412r269b2460],
2	.	.	O	.	_	0	SENT_133	[p6l140t2412r269b2460],

1	FU	NNP	O	FU	_	0	SENT_134	[p6l140t2412r269b2460],
2	10	CD	NUMBER	10	num	1	SENT_134	[p6l1680t2413r1743b2460],
3	(	CD	NUMBER	(	number	4	SENT_134	[p6l1771t2411r1874b2468],
4	30	CD	NUMBER	30	dep	1	SENT_134	[p6l1771t2411r1874b2468],
5	)	NN	O	)	dep	4	SENT_134	[p6l1771t2411r1874b2468],
6	5	CD	NUMBER	5	num	5	SENT_134	[p6l140t2490r413b2537],
7	.	.	O	.	_	0	SENT_134	[p6l140t2490r413b2537],

1	—	NN	O	—	_	0	SENT_135	[p6l140t2490r413b2537],
2	.	.	O	.	_	0	SENT_135	[p6l140t2490r413b2537],

1	FU	NNP	O	FU	_	0	SENT_136	[p6l140t2490r413b2537],
2	.	.	O	.	_	0	SENT_136	[p6l140t2490r413b2537],

1	—	NN	O	—	_	0	SENT_137	[p6l140t2490r413b2537],
2	.	.	O	.	_	0	SENT_137	[p6l140t2490r413b2537],

1	FA	NN	ORGANIZATION	fa	_	0	SENT_138	[p6l140t2490r413b2537],
2	and	CC	O	and	_	0	SENT_138	[p6l440t2487r547b2537],
3	oxaliplatin	NN	O	oxaliplatin	conj_and	1	SENT_138	[p6l576t2487r876b2551],
4	3	CD	NUMBER	3	num	5	SENT_138	[p6l1711t2491r1741b2537],
5	(	NN	O	(	dep	1	SENT_138	[p6l1771t2488r1838b2545],
6	9	CD	NUMBER	9	num	7	SENT_138	[p6l1771t2488r1838b2545],
7	)	NN	O	)	dep	1	SENT_138	[p6l1771t2488r1838b2545],

1	Number	NN	O	number	dep	10	SENT_139	[p6l73t2642r309b2692],
2	of	IN	O	of	_	0	SENT_139	[p6l335t2641r395b2692],
3	cycles	NNS	O	cycle	prep_of	1	SENT_139	[p6l417t2642r589b2707],
4	(	CD	NUMBER	(	num	5	SENT_139	[p6l618t2643r810b2700],
5	Mean	NN	O	mean	dep	3	SENT_139	[p6l618t2643r810b2700],
6	,	,	O	,	_	0	SENT_139	[p6l618t2643r810b2700],
7	range	NN	O	range	appos	3	SENT_139	[p6l839t2643r1020b2706],
8	)	NN	O	)	dep	10	SENT_139	[p6l839t2643r1020b2706],
9	10.4	CD	NUMBER	10.4	num	8	SENT_139	[p6l1630t2646r1744b2692],
10	(	CD	NUMBER	(	dep	13	SENT_139	[p6l1771t2643r1944b2700],
11	1-12	CD	NUMBER	1-12	dep	10	SENT_139	[p6l1771t2643r1944b2700],
12	)	CD	NUMBER	)	num	13	SENT_139	[p6l1771t2643r1944b2700],
13	Patients	NNS	O	patient	_	0	SENT_139	[p6l73t2721r300b2770],
14	who	WP	O	who	nsubj	15	SENT_139	[p6l326t2720r453b2770],
15	received	VBD	O	receive	rcmod	13	SENT_139	[p6l482t2720r722b2770],
16	all	DT	O	all	det	19	SENT_139	[p6l752t2720r812b2770],
17	12	CD	NUMBER	12	num	19	SENT_139	[p6l847t2723r908b2769],
18	planned	VBN	O	plan	amod	19	SENT_139	[p6l938t2720r1174b2783],
19	cycles	NNS	O	cycle	dobj	15	SENT_139	[p6l1203t2720r1375b2784],
20	81	CD	NUMBER	81	tmod	19	SENT_139	[p6l1675t2723r1731b2770],
21	(	CD	NUMBER	(	number	22	SENT_139	[p6l1771t2721r1874b2778],
22	56	CD	NUMBER	56	dep	19	SENT_139	[p6l1771t2721r1874b2778],
23	)	NN	O	)	dep	22	SENT_139	[p6l1771t2721r1874b2778],

1	Total	JJ	O	total	_	0	SENT_140	[p6l72t2875r211b2925],
2	(	CD	NUMBER	(	num	3	SENT_140	[p6l237t2876r361b2938],
3	mg	NN	O	mg	dep	1	SENT_140	[p6l237t2876r361b2938],
4	)	NN	O	)	nn	6	SENT_140	[p6l237t2876r361b2938],
5	oxaliplatin	NN	O	oxaliplatin	nn	6	SENT_140	[p6l388t2875r678b2938],
6	dose	NN	O	dose	dep	1	SENT_140	[p6l706t2875r831b2925],

1	Median	JJ	MISC	median	amod	3	SENT_141	[p6l141t2952r354b3002],
2	(	NN	O	(	nn	3	SENT_141	[p6l385t2953r586b3016],
3	range	NN	O	range	dep	9	SENT_141	[p6l385t2953r586b3016],
4	)	CD	NUMBER	)	number	5	SENT_141	[p6l385t2953r586b3016],
5	1460	CD	DATE	1460	dep	3	SENT_141	[p6l1609t2956r1743b3002],
6	(	CD	NUMBER	(	dep	5	SENT_141	[p6l1771t2953r2088b3010],
7	145-2166	CD	NUMBER	145-2166	dep	9	SENT_141	[p6l1771t2953r2088b3010],
8	)	CD	NUMBER	)	num	9	SENT_141	[p6l1771t2953r2088b3010],
9	Dose	NN	O	dose	dep	15	SENT_141	[p6l142t3032r284b3080],
10	per	IN	O	per	_	0	SENT_141	[p6l313t3045r406b3093],
11	m2	NN	O	m2	nn	14	SENT_141	[p6l434t3018r513b3079],
12	(	CD	NUMBER	(	num	14	SENT_141	[p6l542t3030r652b3094],
13	mg	NN	O	mg	nn	14	SENT_141	[p6l542t3030r652b3094],
14	m_2	NN	O	m_2	prep_per	9	SENT_141	[p6l671t3018r841b3087],
15	)	CD	NUMBER	)	_	0	SENT_141	[p6l671t3018r841b3087],
16	:	:	O	:	_	0	SENT_141	[p6l671t3018r841b3087],
17	median	JJ	O	median	amod	20	SENT_141	[p6l870t3029r1085b3080],
18	(	NN	O	(	nn	20	SENT_141	[p6l1116t3030r1317b3094],
19	range	NN	O	range	nn	20	SENT_141	[p6l1116t3030r1317b3094],
20	)	NN	O	)	dep	25	SENT_141	[p6l1116t3030r1317b3094],
21	886	CD	NUMBER	886	dep	20	SENT_141	[p6l1639t3033r1743b3080],
22	(	NN	O	(	dep	25	SENT_141	[p6l1771t3030r2052b3087],
23	85-1020	CD	NUMBER	85-1020	num	22	SENT_141	[p6l1771t3030r2052b3087],
24	)	CD	NUMBER	)	num	25	SENT_141	[p6l1771t3030r2052b3087],
25	Dose	NN	O	dose	dep	38	SENT_141	[p6l142t3109r284b3157],
26	per	IN	O	per	_	0	SENT_141	[p6l313t3122r406b3170],
27	m2	NN	O	m2	prep_per	25	SENT_141	[p6l434t3095r513b3156],
28	per	IN	O	per	_	0	SENT_141	[p6l543t3122r636b3170],
29	week	NN	DURATION	week	prep_per	27	SENT_141	[p6l661t3107r828b3157],
30	:	:	O	:	_	0	SENT_141	[p6l661t3107r828b3157],
31	median	JJ	O	median	amod	33	SENT_141	[p6l857t3107r1071b3157],
32	(	NN	O	(	nn	33	SENT_141	[p6l1102t3108r1303b3171],
33	range	NN	O	range	dep	27	SENT_141	[p6l1102t3108r1303b3171],
34	)	CD	NUMBER	)	number	35	SENT_141	[p6l1102t3108r1303b3171],
35	35	CD	NUMBER	35	num	36	SENT_141	[p6l1676t3110r1741b3157],
36	(	NN	O	(	dep	33	SENT_141	[p6l1771t3108r1980b3164],
37	17-54	CD	NUMBER	17-54	num	38	SENT_141	[p6l1771t3108r1980b3164],
38	)	NN	O	)	dep	15	SENT_141	[p6l1771t3108r1980b3164],

1	aTNM	NN	O	atnm	_	0	SENT_142	[p6l44t3235r193b3286],
2	scale	NN	O	scale	dep	1	SENT_142	[p6l220t3239r365b3287],
3	.	.	O	.	_	0	SENT_142	[p6l220t3239r365b3287],

1	None	NN	O	none	nsubjpass	14	SENT_143	[p6l14t3456r180b3510],
2	of	IN	O	of	_	0	SENT_143	[p6l229t3453r294b3510],
3	the	DT	O	the	det	4	SENT_143	[p6l336t3454r439b3510],
4	associations	NNS	O	association	prep_of	1	SENT_143	[p6l488t3456r870b3510],
5	reported	VBN	O	report	partmod	4	SENT_143	[p6l922t3454r1193b3525],
6	in	IN	O	in	_	0	SENT_143	[p6l1247t3456r1298b3510],
7	previous	JJ	O	previous	amod	8	SENT_143	[p6l1352t3456r1621b3525],
8	studies	NNS	O	study	prep_in	5	SENT_143	[p6l1671t3454r1893b3510],
9	in	IN	O	in	_	0	SENT_143	[p6l1945t3456r1996b3509],
10	the	DT	O	the	det	12	SENT_143	[p6l2046t3454r2148b3510],
11	metastatic	JJ	O	metastatic	amod	12	SENT_143	[p6l13t3542r341b3596],
12	setting	NN	O	setting	prep_in	8	SENT_143	[p6l373t3542r588b3612],
13	were	VBD	O	be	auxpass	14	SENT_143	[p6l619t3557r774b3596],
14	replicated	VBN	O	replicate	_	0	SENT_143	[p6l807t3540r1119b3611],
15	in	IN	O	in	_	0	SENT_143	[p6l1155t3542r1206b3595],
16	the	DT	O	the	det	18	SENT_143	[p6l1237t3540r1340b3596],
17	present	JJ	DATE	present	amod	18	SENT_143	[p6l1374t3548r1612b3611],
18	study	NN	O	study	prep_in	14	SENT_143	[p6l1642t3540r1816b3612],
19	(	CD	NUMBER	(	num	22	SENT_143	[p6l1847t3540r2037b3605],
20	Table	NNP	O	Table	nn	22	SENT_143	[p6l1847t3540r2037b3605],
21	3	CD	NUMBER	3	num	22	SENT_143	[p6l2068t3541r2140b3605],
22	)	NN	O	)	xcomp	14	SENT_143	[p6l2068t3541r2140b3605],
23	.	.	O	.	_	0	SENT_143	[p6l2068t3541r2140b3605],

1	New	NNP	O	New	nn	2	SENT_144	[p7l14t89r153b143],
2	discoveries	NNS	O	discovery	nsubj	17	SENT_144	[p7l182t86r533b143],
3	of	IN	O	of	_	0	SENT_144	[p7l565t85r629b143],
4	genetic	JJ	O	genetic	amod	5	SENT_144	[p7l655t89r891b158],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_144	[p7l923t86r1416b159],
6	and	CC	O	and	_	0	SENT_144	[p7l1448t86r1564b143],
7	neurological	JJ	O	neurological	amod	9	SENT_144	[p7l1600t86r1990b158],
8	toxicity	NN	O	toxicity	nn	9	SENT_144	[p7l9t165r241b234],
9	Neurotoxicity	NN	O	neurotoxicity	conj_and	2	SENT_144	[p7l14t265r440b335],
10	of	IN	O	of	_	0	SENT_144	[p7l483t262r548b319],
11	grade	NN	O	grade	prep_of	9	SENT_144	[p7l588t263r769b335],
12	>	RBR	O	>	amod	11	SENT_144	[p7l826t266r924b327],
13	2	CD	NUMBER	2	dep	12	SENT_144	[p7l826t266r924b327],
14	was	VBD	O	be	cop	17	SENT_144	[p7l969t279r1089b319],
15	the	DT	O	the	det	17	SENT_144	[p7l1134t263r1237b319],
16	primary	JJ	O	primary	amod	17	SENT_144	[p7l1284t265r1528b335],
17	endpoint	NN	O	endpoint	_	0	SENT_144	[p7l1571t263r1864b334],
18	for	IN	O	for	_	0	SENT_144	[p7l1906t262r1994b319],
19	this	DT	O	this	det	20	SENT_144	[p7l2036t263r2148b319],
20	analysis	NN	O	analysis	prep_for	17	SENT_144	[p7l11t349r271b421],
21	,	,	O	,	_	0	SENT_144	[p7l11t349r271b421],
22	because	IN	O	because	mark	36	SENT_144	[p7l314t349r571b405],
23	of	IN	O	of	_	0	SENT_144	[p7l612t348r677b405],
24	its	PRP$	O	its	poss	25	SENT_144	[p7l714t351r779b405],
25	prevalence	NN	O	prevalence	prep_of	36	SENT_144	[p7l823t349r1169b420],
26	(	CD	PERCENT	(	number	27	SENT_144	[p7l1212t350r1386b414],
27	39	CD	PERCENT	39	num	28	SENT_144	[p7l1212t350r1386b414],
28	%	NN	PERCENT	%	nsubj	36	SENT_144	[p7l1212t350r1386b414],
29	)	CD	NUMBER	)	dep	28	SENT_144	[p7l1212t350r1386b414],
30	and	CC	O	and	_	0	SENT_144	[p7l1429t349r1545b405],
31	clinical	JJ	O	clinical	amod	34	SENT_144	[p7l1588t349r1800b405],
32	relevance	NN	O	relevance	nn	34	SENT_144	[p7l1845t349r2148b405],
33	(	NN	O	(	nn	34	SENT_144	[p7l13t435r214b507],
34	grade	NN	O	grade	nsubj	36	SENT_144	[p7l13t435r214b507],
35	2	CD	NUMBER	2	dep	34	SENT_144	[p7l275t439r308b490],
36	indicates	VBZ	O	indicate	advcl	17	SENT_144	[p7l372t435r652b491],
37	moderate	JJ	O	moderate	amod	39	SENT_144	[p7l715t435r1022b491],
38	motor	NN	O	motor	nn	39	SENT_144	[p7l1085t443r1278b491],
39	symptoms	NNS	O	symptom	dobj	36	SENT_144	[p7l1337t443r1668b507],
40	and	CC	O	and	_	0	SENT_144	[p7l1729t435r1844b491],
41	sensory	JJ	O	sensory	amod	42	SENT_144	[p7l1908t452r2150b507],
42	symptoms	NNS	O	symptom	conj_and	39	SENT_144	[p7l11t529r342b593],
43	extended	VBN	O	extend	partmod	42	SENT_144	[p7l384t521r683b577],
44	to	TO	O	to	_	0	SENT_144	[p7l726t529r789b577],
45	ankle	NN	O	ankle	prep_to	43	SENT_144	[p7l830t521r998b577],
46	and	CC	O	and	_	0	SENT_144	[p7l1039t521r1156b577],
47	wrist	NN	O	wrist	prep_to	43	SENT_144	[p7l1198t523r1365b586],
48	,	,	O	,	_	0	SENT_144	[p7l1198t523r1365b586],
49	and	CC	O	and	_	0	SENT_144	[p7l1406t521r1522b577],
50	grade	NN	O	grade	nsubj	52	SENT_144	[p7l1566t521r1748b593],
51	3	CD	NUMBER	3	num	50	SENT_144	[p7l1790t524r1822b577],
52	indicates	VBZ	O	indicate	conj_and	17	SENT_144	[p7l1867t521r2148b577],
53	motor	NN	O	motor	nn	54	SENT_144	[p7l13t615r206b663],
54	symptoms	NNS	O	symptom	dobj	52	SENT_144	[p7l228t615r559b679],
55	requiring	VBG	O	require	partmod	54	SENT_144	[p7l585t609r871b679],
56	help/assistance	JJ	O	help/assistance	amod	59	SENT_144	[p7l900t607r1385b678],
57	and	CC	O	and	_	0	SENT_144	[p7l1409t607r1525b663],
58	sensory	JJ	O	sensory	conj_and	56	SENT_144	[p7l1552t623r1794b679],
59	symptoms	NNS	O	symptom	dobj	55	SENT_144	[p7l1817t615r2148b679],
60	extended	VBN	O	extend	partmod	59	SENT_144	[p7l11t692r310b748],
61	to	TO	O	to	_	0	SENT_144	[p7l341t700r405b748],
62	knee	NN	O	knee	nn	65	SENT_144	[p7l438t692r587b748],
63	and	CC	O	and	_	0	SENT_144	[p7l618t692r734b748],
64	elbow	NN	O	elbow	conj_and	62	SENT_144	[p7l767t692r998b756],
65	)	NN	O	)	prep_to	60	SENT_144	[p7l767t692r998b756],
66	.	.	O	.	_	0	SENT_144	[p7l767t692r998b756],

1	Polymorphisms	NNS	O	polymorphism	nsubjpass	7	SENT_145	[p7l91t777r581b850],
2	in	IN	O	in	_	0	SENT_145	[p7l615t780r666b833],
3	ABCC1	NN	O	abcc1	prep_in	1	SENT_145	[p7l696t779r897b834],
4	and	CC	O	and	_	0	SENT_145	[p7l934t777r1050b834],
5	ABCC2	NN	O	abcc2	prep_in	1	SENT_145	[p7l1080t779r1287b834],
6	were	VBD	O	be	auxpass	7	SENT_145	[p7l1317t794r1472b834],
7	associated	VBN	O	associate	_	0	SENT_145	[p7l1504t777r1834b834],
8	with	IN	O	with	_	0	SENT_145	[p7l1867t777r2003b834],
9	this	DT	O	this	det	10	SENT_145	[p7l2036t777r2148b834],
10	phenotype	NN	O	phenotype	prep_with	7	SENT_145	[p7l13t864r359b936],
11	(	CD	NUMBER	(	num	12	SENT_145	[p7l402t864r591b929],
12	Table	NNP	O	Table	dep	10	SENT_145	[p7l402t864r591b929],
13	4	CD	NUMBER	4	number	14	SENT_145	[p7l631t865r704b929],
14	)	CD	NUMBER	)	dep	12	SENT_145	[p7l631t865r704b929],
15	.	.	O	.	_	0	SENT_145	[p7l631t865r704b929],

1	The	DT	O	the	det	4	SENT_146	[p7l742t864r858b920],
2	minor	JJ	O	minor	amod	4	SENT_146	[p7l902t866r1088b920],
3	frequency	NN	O	frequency	nn	4	SENT_146	[p7l1125t863r1448b936],
4	alleles	NNS	O	allele	nsubjpass	12	SENT_146	[p7l1486t864r1680b920],
5	of	IN	O	of	_	0	SENT_146	[p7l1721t863r1786b920],
6	rs2074087	NN	O	rs2074087	prep_of	4	SENT_146	[p7l1823t867r2148b920],
7	and	CC	O	and	_	0	SENT_146	[p7l11t949r126b1005],
8	rs35587	NN	O	rs35587	prep_of	4	SENT_146	[p7l175t953r420b1005],
9	in	IN	O	in	_	0	SENT_146	[p7l466t952r517b1004],
10	ABCC1	NN	O	abcc1	prep_in	6	SENT_146	[p7l558t951r759b1005],
11	were	VBD	O	be	auxpass	12	SENT_146	[p7l806t965r961b1005],
12	associated	VBN	O	associate	_	0	SENT_146	[p7l1005t949r1334b1005],
13	with	IN	O	with	_	0	SENT_146	[p7l1379t949r1515b1005],
14	a	DT	O	a	det	16	SENT_146	[p7l1561t965r1591b1005],
15	reduced	VBN	O	reduce	amod	16	SENT_146	[p7l1639t949r1895b1005],
16	risk	NN	O	risk	prep_with	12	SENT_146	[p7l1943t949r2048b1005],
17	of	IN	O	of	_	0	SENT_146	[p7l2089t948r2154b1005],
18	neurotoxicity	NN	O	neurotoxicity	prep_of	16	SENT_146	[p7l13t1038r445b1108],
19	.	.	O	.	_	0	SENT_146	[p7l13t1038r445b1108],

1	The	DT	O	the	det	4	SENT_147	[p7l523t1035r641b1091],
2	minor	JJ	O	minor	amod	4	SENT_147	[p7l724t1038r911b1091],
3	frequency	NN	O	frequency	nn	4	SENT_147	[p7l988t1034r1311b1108],
4	alleles	NNS	O	allele	nsubjpass	16	SENT_147	[p7l1390t1035r1583b1091],
5	of	IN	O	of	_	0	SENT_147	[p7l1665t1034r1730b1091],
6	rs3740066	NN	O	rs3740066	prep_of	4	SENT_147	[p7l1808t1039r2149b1100],
7	,	,	O	,	_	0	SENT_147	[p7l1808t1039r2149b1100],
8	rs1885301	NN	O	rs1885301	prep_of	4	SENT_147	[p7l13t1123r353b1184],
9	,	,	O	,	_	0	SENT_147	[p7l13t1123r353b1184],
10	rs4148396	NN	O	rs4148396	prep_of	4	SENT_147	[p7l401t1123r726b1176],
11	and	CC	O	and	_	0	SENT_147	[p7l771t1120r887b1176],
12	rs71762O	NN	O	rs71762o	prep_of	4	SENT_147	[p7l938t1123r1223b1176],
13	in	IN	O	in	_	0	SENT_147	[p7l1271t1122r1322b1175],
14	ABCC2	NN	O	abcc2	prep_in	4	SENT_147	[p7l1365t1121r1572b1176],
15	were	VBD	O	be	auxpass	16	SENT_147	[p7l1616t1136r1771b1176],
16	associated	VBN	O	associate	_	0	SENT_147	[p7l1816t1120r2146b1176],
17	with	IN	O	with	_	0	SENT_147	[p7l9t1206r145b1262],
18	an	DT	O	a	det	20	SENT_147	[p7l206t1223r278b1262],
19	increased	VBN	O	increase	amod	20	SENT_147	[p7l342t1206r641b1262],
20	risk	NN	O	risk	prep_with	16	SENT_147	[p7l705t1206r810b1262],
21	of	IN	O	of	_	0	SENT_147	[p7l866t1205r932b1262],
22	neurotoxicity	NN	O	neurotoxicity	prep_of	20	SENT_147	[p7l987t1208r1419b1278],
23	,	,	O	,	_	0	SENT_147	[p7l987t1208r1419b1278],
24	whereas	IN	O	whereas	mark	32	SENT_147	[p7l1477t1206r1742b1262],
25	the	DT	O	the	det	28	SENT_147	[p7l1800t1206r1902b1262],
26	minor	JJ	O	minor	amod	28	SENT_147	[p7l1964t1209r2150b1262],
27	frequency	NN	O	frequency	nn	28	SENT_147	[p7l9t1291r332b1364],
28	allele	NN	O	allele	nsubjpass	32	SENT_147	[p7l361t1292r524b1348],
29	of	IN	O	of	_	0	SENT_147	[p7l555t1291r620b1348],
30	rs2273697	NN	O	rs2273697	prep_of	28	SENT_147	[p7l649t1296r973b1348],
31	was	VBD	O	be	auxpass	32	SENT_147	[p7l1003t1309r1124b1348],
32	associated	VBN	O	associate	advcl	16	SENT_147	[p7l1156t1292r1485b1348],
33	with	IN	O	with	_	0	SENT_147	[p7l1518t1292r1653b1348],
34	a	DT	O	a	det	36	SENT_147	[p7l1687t1309r1718b1348],
35	reduced	VBN	O	reduce	amod	36	SENT_147	[p7l1754t1292r2010b1348],
36	risk	NN	O	risk	prep_with	32	SENT_147	[p7l2046t1292r2151b1348],
37	of	IN	O	of	_	0	SENT_147	[p7l11t1377r76b1435],
38	neurotoxicity	NN	O	neurotoxicity	prep_of	36	SENT_147	[p7l123t1381r555b1451],
39	.	.	O	.	_	0	SENT_147	[p7l123t1381r555b1451],

1	The	DT	O	the	det	4	SENT_148	[p7l602t1378r719b1434],
2	minor	JJ	O	minor	amod	4	SENT_148	[p7l773t1381r959b1435],
3	frequency	NN	O	frequency	nn	4	SENT_148	[p7l1005t1377r1329b1451],
4	allele	NN	O	allele	nsubjpass	11	SENT_148	[p7l1377t1378r1540b1434],
5	of	IN	O	of	_	0	SENT_148	[p7l1590t1377r1655b1434],
6	rs2622604	NN	O	rs2622604	prep_of	4	SENT_148	[p7l1702t1382r2043b1443],
7	,	,	O	,	_	0	SENT_148	[p7l1702t1382r2043b1443],
8	in	IN	O	in	_	0	SENT_148	[p7l2095t1381r2146b1434],
9	ABCG2	NN	O	abcg2	prep_in	6	SENT_148	[p7l6t1466r218b1520],
10	was	VBD	O	be	auxpass	11	SENT_148	[p7l242t1481r363b1520],
11	associated	VBN	O	associate	_	0	SENT_148	[p7l389t1464r719b1520],
12	with	IN	O	with	_	0	SENT_148	[p7l747t1464r883b1520],
13	an	DT	O	a	det	15	SENT_148	[p7l913t1481r985b1520],
14	increased	VBN	O	increase	amod	15	SENT_148	[p7l1016t1464r1315b1520],
15	risk	NN	O	risk	prep_with	11	SENT_148	[p7l1348t1464r1453b1520],
16	of	IN	O	of	_	0	SENT_148	[p7l1477t1463r1542b1520],
17	neurotoxicity	NN	O	neurotoxicity	prep_of	15	SENT_148	[p7l1566t1467r1998b1536],
18	.	.	O	.	_	0	SENT_148	[p7l1566t1467r1998b1536],

1	FDR	NNP	O	FDR	nn	2	SENT_149	[p7l2027t1466r2150b1520],
2	analysis	NN	O	analysis	nsubj	3	SENT_149	[p7l11t1550r255b1623],
3	pointed	VBD	O	point	_	0	SENT_149	[p7l284t1550r527b1621],
4	out	RP	O	out	prt	3	SENT_149	[p7l556t1558r661b1606],
5	that	IN	O	that	complm	12	SENT_149	[p7l684t1550r812b1606],
6	ﬁve	NN	O	ﬁve	nsubj	12	SENT_149	[p7l834t1549r947b1606],
7	out	IN	O	out	_	0	SENT_149	[p7l974t1558r1079b1606],
8	of	IN	O	of	_	0	SENT_149	[p7l1104t1549r1168b1606],
9	eight	CD	NUMBER	eight	num	11	SENT_149	[p7l1189t1550r1352b1622],
10	predictive	JJ	O	predictive	amod	11	SENT_149	[p7l1379t1550r1693b1621],
11	markers	NNS	O	marker	prep_out_of	6	SENT_149	[p7l1722t1550r1971b1606],
12	have	VBP	O	have	ccomp	3	SENT_149	[p7l2000t1550r2148b1606],
13	a	DT	O	a	det	15	SENT_149	[p7l11t1650r41b1690],
14	q-value	NN	O	q-value	dep	15	SENT_149	[p7l73t1634r304b1704],
15	<	JJR	O	<	dobj	12	SENT_149	[p7l346t1638r516b1690],
16	O.	NNP	O	O.	tmod	12	SENT_149	[p7l346t1638r516b1690],
17	1	CD	NUMBER	1	num	16	SENT_149	[p7l346t1638r516b1690],
18	.	.	O	.	_	0	SENT_149	[p7l346t1638r516b1690],

1	Analysis	NN	O	analysis	nsubj	27	SENT_150	[p7l87t1720r342b1792],
2	of	IN	O	of	_	0	SENT_150	[p7l374t1719r438b1776],
3	LD	NN	O	ld	prep_of	1	SENT_150	[p7l467t1722r547b1776],
4	among	IN	O	among	_	0	SENT_150	[p7l577t1736r799b1792],
5	the	DT	O	the	det	7	SENT_150	[p7l830t1720r933b1776],
6	above	JJ	O	above	amod	7	SENT_150	[p7l964t1720r1158b1776],
7	SNPs	NNS	O	snp	prep_among	3	SENT_150	[p7l1189t1722r1343b1776],
8	identiﬁed	VBN	O	identiﬁed	partmod	7	SENT_150	[p7l1377t1719r1675b1776],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_150	[p7l1709t1719r2037b1792],
10	LD	NN	O	ld	dobj	8	SENT_150	[p7l2069t1722r2149b1776],
11	among	IN	O	among	_	0	SENT_150	[p7l11t1823r232b1878],
12	the	DT	O	the	det	14	SENT_150	[p7l265t1806r368b1862],
13	ABCC2	NN	O	abcc2	nn	14	SENT_150	[p7l395t1808r602b1862],
14	polymorphisms	NNS	O	polymorphism	prep_among	8	SENT_150	[p7l636t1806r1129b1878],
15	(	CD	NUMBER	(	num	25	SENT_150	[p7l1163t1807r1381b1878],
16	Figure	NN	O	figure	nn	25	SENT_150	[p7l1163t1807r1381b1878],
17	1	CD	NUMBER	1	num	18	SENT_150	[p7l1419t1807r1485b1871],
18	)	NN	O	)	dep	16	SENT_150	[p7l1419t1807r1485b1871],
19	,	,	O	,	_	0	SENT_150	[p7l1419t1807r1485b1871],
20	but	CC	O	but	_	0	SENT_150	[p7l1519t1806r1623b1862],
21	not	RB	O	not	neg	22	SENT_150	[p7l1657t1814r1760b1862],
22	among	IN	O	among	conj_but	16	SENT_150	[p7l1791t1823r2013b1878],
23	the	DT	O	the	det	24	SENT_150	[p7l2045t1806r2148b1862],
24	ABCC7	NN	O	abcc7	pobj	22	SENT_150	[p7l6t1894r206b1948],
25	polymorphisms	NNS	O	polymorphism	nsubj	26	SENT_150	[p7l289t1892r782b1965],
26	(	VBP	O	(	rcmod	14	SENT_150	[p7l860t1892r1084b1957],
27	results	VBZ	O	result	_	0	SENT_150	[p7l860t1892r1084b1957],
28	not	RB	O	not	neg	27	SENT_150	[p7l1162t1901r1266b1948],
29	shown	VBN	O	show	dep	27	SENT_150	[p7l1340t1892r1586b1957],
30	)	NN	O	)	dobj	29	SENT_150	[p7l1340t1892r1586b1957],
31	.	.	O	.	_	0	SENT_150	[p7l1340t1892r1586b1957],

1	Therefore	RB	O	therefore	advmod	4	SENT_151	[p7l1658t1891r1983b1957],
2	,	,	O	,	_	0	SENT_151	[p7l1658t1891r1983b1957],
3	we	PRP	O	we	nsubj	4	SENT_151	[p7l2057t1909r2148b1948],
4	performed	VBD	O	perform	_	0	SENT_151	[p7l13t1976r346b2048],
5	a	DT	O	a	det	7	SENT_151	[p7l375t1994r405b2034],
6	haplotype	NN	O	haplotype	nn	7	SENT_151	[p7l435t1977r754b2050],
7	analysis	NN	O	analysis	dobj	4	SENT_151	[p7l780t1977r1024b2050],
8	on	IN	O	on	_	0	SENT_151	[p7l1051t1994r1128b2034],
9	ABCC2	NN	O	abcc2	nn	10	SENT_151	[p7l1152t1979r1359b2034],
10	variants	NNS	O	variant	prep_on	4	SENT_151	[p7l1382t1980r1630b2034],
11	to	TO	O	to	aux	12	SENT_151	[p7l1655t1986r1719b2034],
12	test	VB	O	test	xcomp	4	SENT_151	[p7l1742t1986r1860b2034],
13	whether	IN	O	whether	complm	17	SENT_151	[p7l1883t1977r2150b2034],
14	haplotypes	NNS	O	haplotype	nsubj	17	SENT_151	[p7l13t2064r362b2136],
15	are	VBP	O	be	cop	17	SENT_151	[p7l397t2081r493b2120],
16	more	RBR	O	more	advmod	17	SENT_151	[p7l530t2081r692b2120],
17	predictive	JJ	O	predictive	ccomp	12	SENT_151	[p7l730t2064r1044b2135],
18	than	IN	O	than	_	0	SENT_151	[p7l1077t2064r1218b2120],
19	single	JJ	O	single	amod	20	SENT_151	[p7l1256t2064r1441b2136],
20	variants	NNS	O	variant	prep_than	17	SENT_151	[p7l1474t2067r1738b2120],
21	.	.	O	.	_	0	SENT_151	[p7l1474t2067r1738b2120],

1	Haplotype	NN	O	haplotype	nsubj	23	SENT_152	[p7l1775t2064r2101b2137],
2	I	PRP	O	I	nsubj	3	SENT_152	[p7l2138t2066r2146b2119],
3	(	VBP	O	(	rcmod	1	SENT_152	[p7l13t2149r183b2212],
4	16	CD	PERCENT	16	num	5	SENT_152	[p7l13t2149r183b2212],
5	%	NN	PERCENT	%	dobj	3	SENT_152	[p7l13t2149r183b2212],
6	,	,	O	,	_	0	SENT_152	[p7l13t2149r183b2212],
7	all	PDT	O	all	dep	10	SENT_152	[p7l207t2148r273b2204],
8	the	DT	O	the	det	10	SENT_152	[p7l298t2148r401b2204],
9	protective	JJ	O	protective	amod	10	SENT_152	[p7l428t2151r747b2218],
10	alleles	NNS	O	allele	dobj	3	SENT_152	[p7l773t2148r986b2212],
11	)	NN	O	)	dep	10	SENT_152	[p7l773t2148r986b2212],
12	and	CC	O	and	_	0	SENT_152	[p7l1012t2148r1128b2204],
13	II	CD	PERCENT	ii	conj_and	10	SENT_152	[p7l1158t2151r1183b2203],
14	(	CD	PERCENT	(	number	15	SENT_152	[p7l1213t2149r1384b2212],
15	19	CD	PERCENT	19	num	16	SENT_152	[p7l1213t2149r1384b2212],
16	%	NN	PERCENT	%	dep	13	SENT_152	[p7l1213t2149r1384b2212],
17	,	,	O	,	_	0	SENT_152	[p7l1213t2149r1384b2212],
18	all	PDT	O	all	predet	21	SENT_152	[p7l1407t2148r1472b2204],
19	the	DT	O	the	det	21	SENT_152	[p7l1498t2148r1601b2204],
20	risk	NN	O	risk	nn	21	SENT_152	[p7l1628t2148r1733b2204],
21	alleles	NNS	O	allele	conj_and	10	SENT_152	[p7l1755t2148r1968b2212],
22	)	CD	NUMBER	)	dep	21	SENT_152	[p7l1755t2148r1968b2212],
23	were	VBD	O	be	_	0	SENT_152	[p7l1993t2164r2148b2204],

1	©	RB	O	©	dep	2	SENT_153	[p7l10t2379r55b2424],
2	2013	CD	DATE	2013	dep	4	SENT_153	[p7l81t2377r215b2424],
3	Macmillan	NNP	ORGANIZATION	Macmillan	nn	4	SENT_153	[p7l245t2374r532b2424],
4	Publishers	NNPS	ORGANIZATION	Publishers	_	0	SENT_153	[p7l564t2374r849b2424],
5	Limited	NNP	ORGANIZATION	Limited	dep	4	SENT_153	[p7l879t2374r1086b2424],

1	Pharmacogenomic	JJ	O	pharmacogenomic	amod	2	SENT_154	[p7l11t2567r502b2625],
2	markers	NNS	O	marker	_	0	SENT_154	[p7l528t2567r733b2613],
3	of	IN	O	of	_	0	SENT_154	[p7l757t2566r811b2613],
4	toxicity	NN	O	toxicity	prep_of	2	SENT_154	[p7l830t2569r1020b2626],
5	in	IN	O	in	_	0	SENT_154	[p7l1045t2569r1087b2612],
6	adjuvant	JJ	O	adjuvant	amod	10	SENT_154	[p7l1114t2567r1343b2626],
7	FOLFOX4	NN	O	folfox4	nn	10	SENT_154	[p7l1369t2568r1609b2613],
8	_	NN	O	_	nn	10	SENT_154	[p7l2123t2622r2138b2641],
9	E	NN	O	e	nn	10	SENT_154	[p7l11t2648r36b2692],
10	Cecchin	NNP	O	Cecchin	prep_in	4	SENT_154	[p7l61t2646r264b2692],
11	et	FW	O	et	dep	2	SENT_154	[p7l291t2653r339b2692],
12	al	FW	O	al	nn	13	SENT_154	[p7l360t2646r407b2692],
13	®	FW	O	®	amod	11	SENT_154	[p7l2035t2582r2154b2698],

1	Table	NNP	O	Table	_	0	SENT_155	[p8l39t50r163b98],
2	2	CD	NUMBER	2	dep	1	SENT_155	[p8l188t53r229b98],
3	.	.	O	.	_	0	SENT_155	[p8l188t53r229b98],

1	Common	JJ	O	common	amod	2	SENT_156	[p8l300t53r548b98],
2	toxicities	NNS	O	toxicity	_	0	SENT_156	[p8l573t53r810b98],
3	in	IN	O	in	_	0	SENT_156	[p8l837t53r881b97],
4	patients	NNS	O	patient	prep_in	2	SENT_156	[p8l910t53r1123b110],
5	treated	VBN	O	treat	partmod	4	SENT_156	[p8l1147t52r1338b98],
6	with	IN	O	with	_	0	SENT_156	[p8l1364t52r1479b98],
7	FOLFOX4	NN	O	folfox4	prep_with	5	SENT_156	[p8l1509t53r1758b98],

1	Toxicity	NN	O	toxicity	nn	2	SENT_157	[p8l66t197r247b251],
2	Patients	NNS	O	patient	_	0	SENT_157	[p8l1253t197r1442b239],

1	Any	DT	O	any	det	3	SENT_158	[p8l768t368r863b421],
2	grade	NN	O	grade	nn	3	SENT_158	[p8l882t365r1019b421],
3	%	NN	O	%	_	0	SENT_158	[p8l1166t369r1211b409],
4	Grade	NNP	O	Grade	nn	6	SENT_158	[p8l1395t365r1537b409],
5	3-43	CD	NUMBER	3-43	num	6	SENT_158	[p8l1559t362r1665b409],
6	No.	NN	O	no.	dep	3	SENT_158	[p8l772t431r847b472],
7	of	IN	O	of	_	0	SENT_158	[p8l872t429r925b472],
8	No.	NN	O	no.	prep_of	6	SENT_158	[p8l1350t431r1429b472],
9	of	IN	O	of	_	0	SENT_158	[p8l1452t429r1505b472],
10	patients	NNS	O	patient	nn	11	SENT_158	[p8l1517t431r1710b484],
11	patients	NNS	O	patient	prep_of	8	SENT_158	[p8l769t494r962b547],

1	Non	JJ	O	non	amod	2	SENT_159	[p8l64t621r527b677],
2	—	NN	O	—	_	0	SENT_159	[p8l64t621r527b677],
3	hematological	JJ	O	hematological	amod	5	SENT_159	[p8l64t621r527b677],
4	toxic	JJ	O	toxic	amod	5	SENT_159	[p8l550t623r661b665],
5	effects	NNS	O	effect	dep	2	SENT_159	[p8l683t621r832b665],

1	Diarrhea	NNP	O	Diarrhea	nsubj	3	SENT_160	[p8l126t685r336b728],
2	53	CD	NUMBER	53	num	1	SENT_160	[p8l887t688r943b728],
3	Nausea	NN	O	nausea	_	0	SENT_160	[p8l126t750r305b792],
4	68	CD	NUMBER	68	dobj	3	SENT_160	[p8l886t751r945b792],
5	Vomiting	VBG	O	vomit	partmod	4	SENT_160	[p8l122t813r351b867],
6	30	CD	NUMBER	30	num	9	SENT_160	[p8l887t815r945b855],
7	Asthenia	NNP	O	Asthenia	nn	9	SENT_160	[p8l123t875r342b918],
8	44	CD	NUMBER	44	num	9	SENT_160	[p8l885t878r946b918],
9	Alopecia	NNP	ORGANIZATION	Alopecia	dobj	5	SENT_160	[p8l123t938r340b993],
10	19	CD	NUMBER	19	num	11	SENT_160	[p8l890t941r945b982],
11	Mucositis	NNP	O	Mucositis	dep	9	SENT_160	[p8l125t1003r359b1046],
12	32	CD	NUMBER	32	num	11	SENT_160	[p8l887t1005r944b1046],
13	Hepatic	JJ	O	hepatic	amod	19	SENT_160	[p8l126t1067r316b1120],
14	6	CD	NUMBER	6	number	15	SENT_160	[p8l917t1068r945b1109],
15	4.2	CD	NUMBER	4.2	amod	19	SENT_160	[p8l1168t1068r1239b1109],
16	(	NN	O	(	nn	19	SENT_160	[p8l130t1129r642b1185],
17	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	19	SENT_160	[p8l130t1129r642b1185],
18	)	CD	NUMBER	)	num	19	SENT_160	[p8l130t1129r642b1185],
19	Infection	NN	O	infection	dep	11	SENT_160	[p8l126t1191r343b1236],
20	without	IN	O	without	_	0	SENT_160	[p8l368t1192r566b1236],
21	9	CD	NUMBER	9	number	22	SENT_160	[p8l918t1195r945b1236],
22	6.2	CD	NUMBER	6.2	num	25	SENT_160	[p8l1169t1195r1239b1236],
23	severe	JJ	O	severe	amod	25	SENT_160	[p8l129t1269r290b1299],
24	neutropenia	NN	O	neutropenia	nn	25	SENT_160	[p8l314t1257r621b1310],
25	Neurotoxicityb	NN	O	neurotoxicityb	prep_without	5	SENT_160	[p8l126t1307r489b1375],
26	83.3	CD	NUMBER	83.3	dep	25	SENT_160	[p8l1138t1322r1238b1363],

1	Hematological	JJ	O	hematological	_	0	SENT_161	[p8l64t1446r415b1501],
2	toxic	JJ	O	toxic	amod	3	SENT_161	[p8l437t1448r549b1490],
3	effects	NNS	O	effect	dep	1	SENT_161	[p8l570t1446r720b1490],

1	Anemia	NN	O	anemia	_	0	SENT_162	[p8l123t1511r315b1553],
2	64	CD	NUMBER	64	dep	1	SENT_162	[p8l886t1513r946b1553],
3	44.4	CD	NUMBER	44.4	rcmod	2	SENT_162	[p8l1137t1513r1241b1553],
4	Neutropenia	NNP	O	Neutropenia	prep	3	SENT_162	[p8l126t1575r438b1628],
5	91	CD	NUMBER	91	num	6	SENT_162	[p8l886t1576r935b1617],
6	63.2	CD	NUMBER	63.2	dep	4	SENT_162	[p8l1138t1576r1239b1617],
7	Leukopenia	NNP	O	Leukopenia	dep	3	SENT_162	[p8l126t1636r416b1691],
8	54	CD	NUMBER	54	num	7	SENT_162	[p8l887t1640r946b1680],
9	37.5	CD	NUMBER	37.5	num	10	SENT_162	[p8l1139t1639r1238b1680],
10	Fever	NN	O	fever	dep	7	SENT_162	[p8l126t1702r259b1743],
11	with	IN	O	with	_	0	SENT_162	[p8l281t1700r389b1743],
12	severe	JJ	O	severe	amod	13	SENT_162	[p8l415t1713r576b1743],
13	4	CD	NUMBER	4	prep_with	10	SENT_162	[p8l916t1703r946b1743],
14	2.8	CD	NUMBER	2.8	dep	10	SENT_162	[p8l1170t1703r1240b1743],
15	neutropenia	NN	O	neutropenia	prep	14	SENT_162	[p8l130t1765r436b1818],
16	Th	NN	O	th	dep	15	SENT_162	[p8l121t1827r182b1869],
17	rombocytopenia	NN	O	rombocytopenia	prep	14	SENT_162	[p8l190t1827r608b1882],
18	59	CD	NUMBER	59	num	19	SENT_162	[p8l887t1830r945b1870],
19	41.0	CD	NUMBER	41.0	dep	17	SENT_162	[p8l1137t1830r1240b1870],
20	"	``	O	"	punct	14	SENT_162	[p8l40t1940r319b1999],
21	"	''	O	"	punct	3	SENT_162	[p8l40t1940r319b1999],

1	According	VBG	O	accord	_	0	SENT_163	[p8l40t1940r319b1999],
2	to	TO	O	to	pcomp	1	SENT_163	[p8l343t1950r394b1987],
3	the	DT	O	the	det	5	SENT_163	[p8l416t1943r498b1987],
4	NC	NN	O	nc	nn	5	SENT_163	[p8l524t1945r727b1987],
5	|	NN	O	|	pobj	2	SENT_163	[p8l524t1945r727b1987],
6	.	.	O	.	_	0	SENT_163	[p8l524t1945r727b1987],

1	—	NN	O	—	_	0	SENT_164	[p8l524t1945r727b1987],
2	.	.	O	.	_	0	SENT_164	[p8l524t1945r727b1987],

1	CTC	NNP	ORGANIZATION	CTC	_	0	SENT_165	[p8l524t1945r727b1987],
2	version	NN	O	version	prep	1	SENT_165	[p8l750t1945r931b1987],
3	3	CD	NUMBER	3	dep	2	SENT_165	[p8l957t1947r996b1987],
4	.	.	O	.	_	0	SENT_165	[p8l957t1947r996b1987],
5	'	''	O	'	_	0	SENT_165	[p8l41t2003r323b2071],

1	°	RB	O	°	_	0	SENT_166	[p8l41t2003r323b2071],
2	According	VBG	O	accord	_	0	SENT_166	[p8l41t2003r323b2071],
3	to	TO	O	to	prepc_according_to	1	SENT_166	[p8l347t2022r398b2059],
4	the	DT	O	the	det	9	SENT_166	[p8l420t2015r502b2059],
5	oxa	NN	O	oxa	nn	9	SENT_166	[p8l526t2015r995b2070],
6	|	CD	NUMBER	|	num	9	SENT_166	[p8l526t2015r995b2070],
7	ip	NN	O	ip	nn	9	SENT_166	[p8l526t2015r995b2070],
8	|	NN	O	|	nn	9	SENT_166	[p8l526t2015r995b2070],
9	atin	NN	O	atin	pobj	1	SENT_166	[p8l526t2015r995b2070],
10	—	NN	O	—	nn	12	SENT_166	[p8l526t2015r995b2070],
11	speciﬁc	NN	O	speciﬁc	nn	12	SENT_166	[p8l526t2015r995b2070],
12	scale	NN	O	scale	dep	9	SENT_166	[p8l1019t2015r1140b2059],
13	(	CD	NUMBER	(	number	14	SENT_166	[p8l1165t2016r1268b2066],
14	23	CD	NUMBER	23	num	15	SENT_166	[p8l1165t2016r1268b2066],
15	)	NN	O	)	dep	12	SENT_166	[p8l1165t2016r1268b2066],
16	.	.	O	.	_	0	SENT_166	[p8l1165t2016r1268b2066],

1	selected	VBN	O	select	dep	13	SENT_167	[p8l10t2236r249b2288],
2	but	CC	O	but	_	0	SENT_167	[p8l283t2236r379b2288],
3	no	DT	O	no	det	5	SENT_167	[p8l409t2251r480b2288],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_167	[p8l509t2235r811b2302],
5	association	NN	O	association	conj_but	1	SENT_167	[p8l839t2239r1161b2288],
6	with	IN	O	with	_	0	SENT_167	[p8l1191t2236r1316b2288],
7	grade	NN	O	grade	prep_with	5	SENT_167	[p8l1348t2236r1515b2302],
8	22	CD	NUMBER	22	num	9	SENT_167	[p8l1555t2240r1645b2295],
9	neurotoxi	NN	O	neurotoxus	nsubjpass	13	SENT_167	[p8l1678t2239r1979b2288],
10	—	CD	NUMBER	—	num	11	SENT_167	[p8l1678t2239r1979b2288],
11	city	NN	O	city	dep	9	SENT_167	[p8l9t2317r111b2381],
12	was	VBD	O	be	auxpass	13	SENT_167	[p8l137t2330r247b2366],
13	found	VBN	O	find	_	0	SENT_167	[p8l274t2314r446b2366],
14	(	RB	O	(	advmod	13	SENT_167	[p8l479t2314r654b2374],
15	Table	NNP	O	Table	prep	13	SENT_167	[p8l479t2314r654b2374],
16	4	CD	NUMBER	4	num	17	SENT_167	[p8l680t2315r749b2374],
17	)	CD	NUMBER	)	dep	15	SENT_167	[p8l680t2315r749b2374],
18	.	.	O	.	_	0	SENT_167	[p8l680t2315r749b2374],

1	New	NNP	O	New	nn	2	SENT_168	[p8l12t2527r141b2576],
2	discoveries	NNS	O	discovery	nsubjpass	19	SENT_168	[p8l162t2524r485b2576],
3	of	IN	O	of	_	0	SENT_168	[p8l508t2524r568b2576],
4	genetic	JJ	O	genetic	amod	5	SENT_168	[p8l585t2527r802b2590],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_168	[p8l827t2524r1281b2591],
6	and	CC	O	and	_	0	SENT_168	[p8l1304t2524r1411b2576],
7	severe	JJ	O	severe	amod	9	SENT_168	[p8l1436t2540r1623b2576],
8	(	NN	O	(	nn	9	SENT_168	[p8l1648t2524r1834b2590],
9	grade	NN	O	grade	dep	10	SENT_168	[p8l1648t2524r1834b2590],
10	>	JJR	O	>	conj_and	2	SENT_168	[p8l1867t2525r1977b2584],
11	3	CD	NUMBER	3	num	13	SENT_168	[p8l1867t2525r1977b2584],
12	)	NN	O	)	nn	13	SENT_168	[p8l1867t2525r1977b2584],
13	toxicity	NN	O	toxicity	dep	10	SENT_168	[p8l8t2598r221b2662],
14	Grade	NNP	O	Grade	nn	16	SENT_168	[p8l9t2688r183b2740],
15	23	CD	NUMBER	23	num	16	SENT_168	[p8l217t2691r306b2746],
16	neutropenia	NN	O	neutropenia	dep	10	SENT_168	[p8l334t2690r690b2753],
17	was	VBD	O	be	auxpass	19	SENT_168	[p8l714t2703r825b2740],
18	signiﬁcantly	RB	O	signiﬁcantly	advmod	19	SENT_168	[p8l849t2687r1200b2754],
19	associated	VBN	O	associate	_	0	SENT_168	[p8l1222t2688r1526b2740],
20	to	TO	O	to	_	0	SENT_168	[p8l1550t2695r1609b2740],
21	polymorphisms	NNS	O	polymorphism	prep_to	19	SENT_168	[p8l1635t2688r1979b2754, p8l11t2769r136b2818],
22	in	IN	O	in	_	0	SENT_168	[p8l207t2769r255b2818],
23	hMSH6	NN	O	hmsh6	prep_in	21	SENT_168	[p8l326t2767r528b2818],
24	(	CD	NUMBER	(	num	23	SENT_168	[p8l598t2768r952b2826],
25	rs3136228	CD	NUMBER	rs3136228	num	26	SENT_168	[p8l598t2768r952b2826],
26	)	NN	O	)	dobj	19	SENT_168	[p8l598t2768r952b2826],
27	,	,	O	,	_	0	SENT_168	[p8l598t2768r952b2826],
28	ABCC1	NN	O	abcc1	nn	31	SENT_168	[p8l1017t2769r1202b2819],
29	(	CD	NUMBER	(	num	31	SENT_168	[p8l1278t2768r1543b2826],
30	rs35587	NN	O	rs35587	nn	31	SENT_168	[p8l1278t2768r1543b2826],
31	)	NN	O	)	dobj	19	SENT_168	[p8l1278t2768r1543b2826],
32	and	CC	O	and	_	0	SENT_168	[p8l1614t2767r1721b2818],
33	ABCC2	NN	O	abcc2	nn	36	SENT_168	[p8l1789t2769r1980b2818],
34	(	CD	NUMBER	(	num	36	SENT_168	[p8l11t2846r329b2904],
35	rs717620	NN	O	rs717620	nn	36	SENT_168	[p8l11t2846r329b2904],
36	)	NN	O	)	dobj	19	SENT_168	[p8l11t2846r329b2904],
37	.	.	O	.	_	0	SENT_168	[p8l11t2846r329b2904],

1	One	CD	NUMBER	one	nsubj	4	SENT_169	[p8l395t2847r514b2897],
2	of	IN	O	of	_	0	SENT_169	[p8l581t2844r641b2897],
3	them	PRP	O	they	prep_of	1	SENT_169	[p8l701t2845r853b2897],
4	was	VBD	O	be	_	0	SENT_169	[p8l921t2860r1032b2897],
5	below	IN	O	below	_	0	SENT_169	[p8l1101t2845r1279b2897],
6	the	DT	O	the	det	8	SENT_169	[p8l1342t2845r1437b2897],
7	FDR	NNP	O	FDR	nn	8	SENT_169	[p8l1506t2847r1619b2896],
8	threshold	NN	O	threshold	prep_below	4	SENT_169	[p8l1684t2845r1979b2897],
9	.	.	O	.	_	0	SENT_169	[p8l1684t2845r1979b2897],

1	Polymorphisms	NNS	O	polymorphism	nsubjpass	30	SENT_170	[p8l12t2922r463b2988],
2	in	IN	O	in	_	0	SENT_170	[p8l558t2924r605b2973],
3	XRCC3	NN	O	xrcc3	nn	5	SENT_170	[p8l695t2923r883b2974],
4	(	CD	NUMBER	(	num	5	SENT_170	[p8l977t2923r1311b2981],
5	rs1799794	NN	O	rs1799794	prep_in	1	SENT_170	[p8l977t2923r1311b2981],
6	,	,	O	,	_	0	SENT_170	[p8l977t2923r1311b2981],
7	rs861539	NN	O	rs861539	nn	8	SENT_170	[p8l1405t2923r1703b2982],
8	)	NN	O	)	conj_and	5	SENT_170	[p8l1405t2923r1703b2982],
9	,	,	O	,	_	0	SENT_170	[p8l1405t2923r1703b2982],
10	XRCC7	NN	O	xrcc7	nn	13	SENT_170	[p8l1791t2923r1973b2974],
11	(	CD	NUMBER	(	num	13	SENT_170	[p8l11t3002r365b3060],
12	rs3213239	NN	O	rs3213239	nn	13	SENT_170	[p8l11t3002r365b3060],
13	)	NN	O	)	conj_and	5	SENT_170	[p8l11t3002r365b3060],
14	,	,	O	,	_	0	SENT_170	[p8l11t3002r365b3060],
15	APE1	NN	O	ape1	nn	18	SENT_170	[p8l397t3003r535b3052],
16	(	CD	NUMBER	(	num	18	SENT_170	[p8l580t3002r934b3060],
17	rs1130409	NN	O	rs1130409	nn	18	SENT_170	[p8l580t3002r934b3060],
18	)	NN	O	)	conj_and	5	SENT_170	[p8l580t3002r934b3060],
19	,	,	O	,	_	0	SENT_170	[p8l580t3002r934b3060],
20	PARP	NN	O	parp	nn	23	SENT_170	[p8l970t3003r1118b3052],
21	(	CD	NUMBER	(	num	23	SENT_170	[p8l1153t3002r1490b3060],
22	rs1136410	NN	O	rs1136410	nn	23	SENT_170	[p8l1153t3002r1490b3060],
23	)	NN	O	)	conj_and	5	SENT_170	[p8l1153t3002r1490b3060],
24	and	CC	O	and	_	0	SENT_170	[p8l1529t3001r1636b3052],
25	the	DT	O	the	det	28	SENT_170	[p8l1673t3001r1768b3052],
26	GS7T1	NN	O	gs7t1	nn	28	SENT_170	[p8l1806t3003r1973b3052],
27	null	JJ	O	null	amod	28	SENT_170	[p8l11t3078r113b3130],
28	genotype	NN	O	genotype	conj_and	5	SENT_170	[p8l159t3086r439b3144],
29	were	VBD	O	be	auxpass	30	SENT_170	[p8l482t3093r625b3130],
30	associated	VBN	O	associate	_	0	SENT_170	[p8l669t3078r973b3130],
31	with	IN	O	with	_	0	SENT_170	[p8l1018t3078r1143b3130],
32	severe	JJ	O	severe	amod	39	SENT_170	[p8l1189t3093r1377b3130],
33	non	JJ	O	non	amod	39	SENT_170	[p8l1423t3078r1976b3144],
34	—	NN	O	—	nn	39	SENT_170	[p8l1423t3078r1976b3144],
35	hemato	NN	O	hemato	nn	39	SENT_170	[p8l1423t3078r1976b3144],
36	|	NN	O	|	nn	39	SENT_170	[p8l1423t3078r1976b3144],
37	ogica	NN	O	ogica	nn	39	SENT_170	[p8l1423t3078r1976b3144],
38	|	NN	O	|	nn	39	SENT_170	[p8l1423t3078r1976b3144],
39	toxicity	NN	O	toxicity	prep_with	30	SENT_170	[p8l8t3158r234b3223],
40	,	,	O	,	_	0	SENT_170	[p8l8t3158r234b3223],
41	but	CC	O	but	_	0	SENT_170	[p8l260t3156r356b3208],
42	only	RB	O	only	advmod	43	SENT_170	[p8l379t3156r504b3223],
43	XRCC3	NN	O	xrcc3	nsubj	46	SENT_170	[p8l522t3158r1038b3208],
44	—	CD	NUMBER	—	num	45	SENT_170	[p8l522t3158r1038b3208],
45	rs1799794	NN	O	rs1799794	dep	43	SENT_170	[p8l522t3158r1038b3208],
46	passed	VBD	O	pass	conj_but	30	SENT_170	[p8l1064t3156r1261b3221],
47	the	DT	O	the	det	49	SENT_170	[p8l1286t3156r1380b3208],
48	FDR	NNP	O	FDR	nn	49	SENT_170	[p8l1407t3158r1520b3208],
49	cutoff	NN	O	cutoff	dobj	46	SENT_170	[p8l1543t3155r1717b3208],
50	and	CC	O	and	_	0	SENT_170	[p8l1736t3156r1843b3208],
51	was	VBD	O	be	auxpass	52	SENT_170	[p8l1868t3171r1978b3208],
52	associated	VBN	O	associate	conj_and	46	SENT_170	[p8l9t3234r313b3286],
53	with	IN	O	with	_	0	SENT_170	[p8l342t3234r467b3286],
54	an	DT	O	a	det	56	SENT_170	[p8l498t3249r565b3286],
55	increased	VBN	O	increase	amod	56	SENT_170	[p8l597t3234r873b3286],
56	risk	NN	O	risk	prep_with	52	SENT_170	[p8l906t3234r1003b3286],
57	of	IN	O	of	_	0	SENT_170	[p8l1029t3233r1088b3286],
58	toxicity	NN	O	toxicity	nn	60	SENT_170	[p8l1111t3236r1324b3300],
59	(	CD	NUMBER	(	num	60	SENT_170	[p8l1353t3234r1528b3294],
60	Table	NNP	O	Table	prep_of	56	SENT_170	[p8l1353t3234r1528b3294],
61	5	CD	NUMBER	5	num	62	SENT_170	[p8l1557t3235r1623b3294],
62	)	NN	O	)	dep	60	SENT_170	[p8l1557t3235r1623b3294],
63	.	.	O	.	_	0	SENT_170	[p8l1557t3235r1623b3294],

1	For	IN	O	for	_	0	SENT_171	[p8l83t3314r173b3364],
2	any	DT	O	any	prep_for	31	SENT_171	[p8l212t3327r316b3378],
3	of	IN	O	of	_	0	SENT_171	[p8l355t3311r415b3364],
4	the	DT	O	the	det	6	SENT_171	[p8l449t3312r544b3364],
5	above	JJ	O	above	amod	6	SENT_171	[p8l584t3312r762b3364],
6	associations	NNS	O	association	prep_of	2	SENT_171	[p8l803t3314r1170b3372],
7	,	,	O	,	_	0	SENT_171	[p8l803t3314r1170b3372],
8	the	DT	O	the	det	9	SENT_171	[p8l1209t3312r1304b3364],
9	exclusion	NN	O	exclusion	nsubj	31	SENT_171	[p8l1345t3312r1615b3364],
10	of	IN	O	of	_	0	SENT_171	[p8l1659t3311r1719b3364],
11	19	CD	NUMBER	19	num	15	SENT_171	[p8l1759t3315r1822b3364],
12	pretreated	JJ	O	pretreated	amod	15	SENT_171	[p8l1865t3327r1979b3377, p8l8t3390r217b3442],
13	rectal	JJ	O	rectal	amod	15	SENT_171	[p8l267t3390r422b3442],
14	cancer	NN	O	cancer	nn	15	SENT_171	[p8l470t3405r663b3442],
15	patients	NNS	O	patient	prep_of	9	SENT_171	[p8l710t3393r957b3455],
16	,	,	O	,	_	0	SENT_171	[p8l710t3393r957b3455],
17	did	VBD	O	do	aux	19	SENT_171	[p8l1003t3390r1093b3442],
18	not	RB	O	not	neg	19	SENT_171	[p8l1143t3398r1238b3442],
19	result	VB	O	result	partmod	15	SENT_171	[p8l1285t3390r1444b3442],
20	in	IN	O	in	_	0	SENT_171	[p8l1491t3393r1538b3441],
21	a	DT	O	a	det	23	SENT_171	[p8l1586t3405r1614b3442],
22	substantial	JJ	O	substantial	amod	23	SENT_171	[p8l1662t3390r1976b3442],
23	modiﬁcation	NN	O	modiﬁcation	prep_in	19	SENT_171	[p8l11t3466r377b3519],
24	of	IN	O	of	_	0	SENT_171	[p8l411t3466r470b3519],
25	the	DT	O	the	det	27	SENT_171	[p8l495t3467r590b3519],
26	statistical	JJ	O	statistical	amod	27	SENT_171	[p8l621t3467r888b3519],
27	meaning	NN	O	meaning	prep_of	23	SENT_171	[p8l925t3470r1180b3533],
28	of	IN	O	of	_	0	SENT_171	[p8l1212t3466r1272b3519],
29	the	DT	O	the	det	30	SENT_171	[p8l1297t3467r1391b3519],
30	results	NNS	O	result	prep_of	27	SENT_171	[p8l1425t3467r1611b3519],
31	(	VBP	O	(	_	0	SENT_171	[p8l1644t3467r1850b3527],
32	results	VBZ	O	result	ccomp	31	SENT_171	[p8l1644t3467r1850b3527],
33	not	RB	O	not	neg	32	SENT_171	[p8l1884t3475r1980b3519],
34	shown	VBN	O	show	dep	32	SENT_171	[p8l10t3547r237b3606],
35	)	NN	O	)	dobj	34	SENT_171	[p8l10t3547r237b3606],
36	.	.	O	.	_	0	SENT_171	[p8l10t3547r237b3606],

1	DISCUSSION	NN	O	discussion	_	0	SENT_172	[p8l11t3749r396b3799],

1	To	TO	O	to	_	0	SENT_173	[p9l6t33r78b83],
2	our	PRP$	O	we	poss	3	SENT_173	[p9l107t46r205b83],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_173	[p9l235t31r573b97],
4	,	,	O	,	_	0	SENT_173	[p9l235t31r573b97],
5	this	DT	O	this	nsubj	9	SENT_173	[p9l601t31r704b83],
6	is	VBZ	O	be	cop	9	SENT_173	[p9l736t33r774b83],
7	the	DT	O	the	det	9	SENT_173	[p9l802t31r896b83],
8	ﬁrst	NN	O	ﬁrst	nn	9	SENT_173	[p9l925t30r1034b83],
9	study	NN	O	study	_	0	SENT_173	[p9l1063t30r1223b97],
10	investigating	VBG	O	investigate	partmod	9	SENT_173	[p9l1253t33r1629b97],
11	pharmacogenomic	JJ	O	pharmacogenomic	amod	12	SENT_173	[p9l1663t31r1979b96, p9l9t111r266b175],
12	markers	NNS	O	marker	dobj	10	SENT_173	[p9l329t109r559b161],
13	of	IN	O	of	_	0	SENT_173	[p9l621t108r681b161],
14	toxicity	NN	O	toxicity	prep_of	12	SENT_173	[p9l735t111r949b175],
15	in	IN	O	in	_	0	SENT_173	[p9l1011t111r1058b160],
16	a	DT	O	a	det	17	SENT_173	[p9l1122t124r1150b161],
17	group	NN	O	group	prep_in	10	SENT_173	[p9l1213t124r1389b175],
18	of	IN	O	of	_	0	SENT_173	[p9l1450t108r1510b161],
19	CRC	NN	ORGANIZATION	crc	nn	20	SENT_173	[p9l1566t111r1682b161],
20	patients	NNS	O	patient	prep_of	17	SENT_173	[p9l1745t111r1978b174],
21	homogeneously	RB	O	homogeneously	advmod	22	SENT_173	[p9l12t186r488b253],
22	treated	VBN	O	treat	partmod	20	SENT_173	[p9l512t186r722b238],
23	with	IN	O	with	_	0	SENT_173	[p9l751t186r876b238],
24	adjuvant	JJ	O	adjuvant	amod	25	SENT_173	[p9l906t186r1164b252],
25	FOLFOX4	NN	O	folfox4	prep_with	22	SENT_173	[p9l1193t188r1477b246],
26	,	,	O	,	_	0	SENT_173	[p9l1193t188r1477b246],
27	whereas	IN	O	whereas	mark	32	SENT_173	[p9l1503t186r1747b238],
28	several	JJ	O	several	amod	29	SENT_173	[p9l1776t186r1976b238],
29	studies	NNS	O	study	nsubjpass	32	SENT_173	[p9l9t266r214b318],
30	have	VBP	O	have	aux	32	SENT_173	[p9l257t266r393b318],
31	been	VBN	O	be	auxpass	32	SENT_173	[p9l436t266r577b318],
32	published	VBN	O	publish	advcl	22	SENT_173	[p9l622t266r908b331],
33	in	IN	O	in	_	0	SENT_173	[p9l951t268r999b317],
34	the	DT	O	the	det	37	SENT_173	[p9l1039t266r1134b318],
35	advanced	JJ	O	advanced	amod	37	SENT_173	[p9l1174t266r1457b318],
36	disease	NN	O	disease	nn	37	SENT_173	[p9l1500t254r1977b318],
37	.18	NN	NUMBER	.18	prep_in	32	SENT_173	[p9l1500t254r1977b318],
38	'	''	DATE	'	_	0	SENT_173	[p9l1500t254r1977b318],
39	19	CD	DATE	19	dobj	32	SENT_173	[p9l1500t254r1977b318],
40	'	''	DATE	'	_	0	SENT_173	[p9l1500t254r1977b318],
41	26	CD	DATE	26	number	42	SENT_173	[p9l1500t254r1977b318],
42	'33	CD	DATE	'33	dep	39	SENT_173	[p9l1500t254r1977b318],
43	There	EX	O	there	expl	44	SENT_173	[p9l6t344r173b396],
44	is	VBZ	O	be	rcmod	42	SENT_173	[p9l215t346r252b396],
45	a	DT	O	a	det	48	SENT_173	[p9l293t359r321b396],
46	great	JJ	O	great	amod	48	SENT_173	[p9l362t352r514b410],
47	clinical	JJ	O	clinical	amod	48	SENT_173	[p9l553t344r748b396],
48	interest	NN	O	interest	nsubj	44	SENT_173	[p9l793t346r1012b396],
49	in	IN	O	in	_	0	SENT_173	[p9l1052t346r1099b395],
50	the	DT	O	the	det	51	SENT_173	[p9l1140t344r1235b396],
51	discovery	NN	O	discovery	prep_in	48	SENT_173	[p9l1275t344r1554b410],
52	of	IN	O	of	_	0	SENT_173	[p9l1592t343r1652b396],
53	predictive	JJ	O	predictive	amod	54	SENT_173	[p9l1689t344r1978b409],
54	biomarkers	NNS	O	biomarker	prep_of	51	SENT_173	[p9l11t422r336b474],
55	of	IN	O	of	_	0	SENT_173	[p9l366t421r425b474],
56	treatment	NN	O	treatment	nn	57	SENT_173	[p9l448t430r743b474],
57	outcome	NN	O	outcome	prep_of	54	SENT_173	[p9l770t430r1031b474],
58	and	CC	O	and	_	0	SENT_173	[p9l1060t422r1168b474],
59	toxicity	NN	O	toxicity	prep_of	54	SENT_173	[p9l1197t424r1411b489],
60	in	IN	O	in	_	0	SENT_173	[p9l1441t425r1488b473],
61	the	DT	O	the	det	63	SENT_173	[p9l1517t422r1612b474],
62	oncological	JJ	O	oncological	amod	63	SENT_173	[p9l1642t422r1976b488],
63	ﬁeld	NN	O	ﬁeld	prep_in	48	SENT_173	[p9l7t499r131b552],
64	and	CC	O	and	_	0	SENT_173	[p9l160t500r266b552],
65	important	JJ	O	important	amod	66	SENT_173	[p9l297t502r589b565],
66	results	NNS	O	result	nsubjpass	69	SENT_173	[p9l617t499r803b552],
67	have	VBP	O	have	aux	69	SENT_173	[p9l832t500r968b552],
68	been	VBN	O	be	auxpass	69	SENT_173	[p9l997t500r1138b552],
69	obtained	VBN	O	obtain	rcmod	42	SENT_173	[p9l1167t500r1445b559],
70	,	,	O	,	_	0	SENT_173	[p9l1167t500r1445b559],
71	especially	RB	O	especially	advmod	39	SENT_173	[p9l1471t500r1756b566],
72	for	IN	O	for	_	0	SENT_173	[p9l1779t499r1860b552],
73	the	DT	O	the	det	75	SENT_173	[p9l1884t499r1979b552],
74	gastrointestinal	JJ	O	gastrointestinal	amod	75	SENT_173	[p9l9t578r460b644],
75	disease	NN	O	disease	prep_for	39	SENT_173	[p9l491t566r813b630],
76	.	.	O	.	_	0	SENT_173	[p9l491t566r813b630],
77	"	''	O	"	punct	9	SENT_173	[p9l491t566r813b630],

1	34	CD	NUMBER	34	_	0	SENT_174	[p9l491t566r813b630],

1	The	DT	O	the	det	2	SENT_175	[p9l77t656r186b708],
2	introduction	NN	O	introduction	nsubj	6	SENT_175	[p9l224t656r584b708],
3	of	IN	O	of	_	0	SENT_175	[p9l624t655r683b708],
4	FOLFOX4	NN	O	folfox4	prep_of	2	SENT_175	[p9l718t658r988b708],
5	has	VBZ	O	have	aux	6	SENT_175	[p9l1026t656r1121b708],
6	led	VBN	O	lead	_	0	SENT_175	[p9l1160t656r1243b708],
7	to	TO	O	to	_	0	SENT_175	[p9l1281t664r1340b708],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_175	[p9l1377t655r1679b722],
9	improvements	NNS	O	improvement	prep_to	6	SENT_175	[p9l1716t659r1979b721, p9l11t743r190b787],
10	in	IN	O	in	_	0	SENT_175	[p9l215t738r262b786],
11	the	DT	O	the	det	13	SENT_175	[p9l287t735r381b787],
12	clinical	JJ	O	clinical	amod	13	SENT_175	[p9l405t735r600b787],
13	outcome	NN	O	outcome	prep_in	6	SENT_175	[p9l627t743r888b787],
14	of	IN	O	of	_	0	SENT_175	[p9l912t734r971b787],
15	CRC	NN	ORGANIZATION	crc	nn	16	SENT_175	[p9l989t737r1105b787],
16	patients	NNS	O	patient	prep_of	13	SENT_175	[p9l1130t723r1469b800],
17	.7	CD	NUMBER	.7	number	18	SENT_175	[p9l1130t723r1469b800],
18	'35	CD	NUMBER	'35	num	19	SENT_175	[p9l1130t723r1469b800],
19	FOLFOX4	NN	O	folfox4	nsubj	20	SENT_175	[p9l1497t737r1767b787],
20	has	VBZ	O	have	rcmod	16	SENT_175	[p9l1792t735r1886b787],
21	an	DT	O	a	det	24	SENT_175	[p9l1909t750r1976b787],
22	acceptable	JJ	O	acceptable	amod	24	SENT_175	[p9l9t813r327b878],
23	toxicity	NN	O	toxicity	nn	24	SENT_175	[p9l396t815r611b879],
24	proﬁle	NN	O	proﬁle	dobj	20	SENT_175	[p9l682t812r880b878],
25	,	,	O	,	_	0	SENT_175	[p9l682t812r880b878],
26	with	IN	O	with	_	0	SENT_175	[p9l949t813r1074b865],
27	neutropenia	NN	O	neutropenia	nn	31	SENT_175	[p9l1149t815r1505b878],
28	and	CC	O	and	_	0	SENT_175	[p9l1577t813r1684b865],
29	sensory	JJ	O	sensory	conj_and	27	SENT_175	[p9l1757t828r1980b879],
30	peripheral	JJ	O	peripheral	amod	31	SENT_175	[p9l11t891r306b956],
31	neuropathy	NN	O	neuropathy	prep_with	20	SENT_175	[p9l364t891r704b957],
32	as	IN	O	as	_	0	SENT_175	[p9l756t906r814b943],
33	the	DT	O	the	det	36	SENT_175	[p9l866t891r961b943],
34	most	RBS	O	most	advmod	36	SENT_175	[p9l1017t899r1161b943],
35	clinically	RB	O	clinically	advmod	36	SENT_175	[p9l1213t891r1463b957],
36	signiﬁcant	JJ	O	signiﬁcant	prep_as	31	SENT_175	[p9l1515t890r1817b957],
37	and	CC	O	and	_	0	SENT_175	[p9l1869t891r1976b943],
38	often	RB	O	often	advmod	31	SENT_175	[p9l9t968r160b1021],
39	dose	NN	O	dose	conj_and	31	SENT_175	[p9l212t969r596b1035],
40	—	CD	NUMBER	—	num	43	SENT_175	[p9l212t969r596b1035],
41	|	NN	O	|	nn	43	SENT_175	[p9l212t969r596b1035],
42	imiting	NN	O	imiting	nn	43	SENT_175	[p9l212t969r596b1035],
43	toxicities	NNS	O	toxicity	dep	39	SENT_175	[p9l647t971r920b1021],
44	.	.	O	.	_	0	SENT_175	[p9l647t971r920b1021],

1	Nonetheless	RB	O	nonetheless	advmod	16	SENT_176	[p9l973t969r1348b1029],
2	,	,	O	,	_	0	SENT_176	[p9l973t969r1348b1029],
3	the	DT	O	the	det	4	SENT_176	[p9l1395t969r1490b1021],
4	persistence	NN	O	persistence	nsubjpass	16	SENT_176	[p9l1543t972r1873b1034],
5	of	IN	O	of	_	0	SENT_176	[p9l1924t968r1984b1021],
6	neurological	JJ	O	neurological	amod	7	SENT_176	[p9l11t1048r370b1114],
7	toxicity	NN	O	toxicity	prep_of	4	SENT_176	[p9l402t1050r616b1114],
8	after	IN	O	after	_	0	SENT_176	[p9l646t1047r780b1100],
9	the	DT	O	the	det	10	SENT_176	[p9l807t1048r902b1100],
10	interruption	NN	O	interruption	prep_after	7	SENT_176	[p9l934t1050r1282b1113],
11	of	IN	O	of	_	0	SENT_176	[p9l1316t1047r1376b1100],
12	FOLFOX4	NN	O	folfox4	prep_of	10	SENT_176	[p9l1404t1050r1674b1100],
13	has	VBZ	O	have	aux	16	SENT_176	[p9l1707t1048r1801b1100],
14	been	VBN	O	be	auxpass	16	SENT_176	[p9l1835t1048r1976b1100],
15	recently	RB	DATE	recently	advmod	16	SENT_176	[p9l11t1127r245b1193],
16	reported	VBN	O	report	_	0	SENT_176	[p9l283t1127r533b1192],
17	in	IN	O	in	_	0	SENT_176	[p9l575t1130r622b1178],
18	a	DT	O	a	det	20	SENT_176	[p9l663t1142r691b1179],
19	high	JJ	O	high	amod	20	SENT_176	[p9l733t1127r858b1193],
20	percentage	NN	O	percentage	prep_in	16	SENT_176	[p9l901t1135r1232b1193],
21	of	IN	O	of	_	0	SENT_176	[p9l1270t1126r1330b1179],
22	patients	NNS	O	patient	prep_of	20	SENT_176	[p9l1365t1130r1598b1192],
23	(	IN	O	(	_	0	SENT_176	[p9l1638t1115r1978b1187],
24	58	CD	PERCENT	58	number	25	SENT_176	[p9l1638t1115r1978b1187],
25	—	CD	PERCENT	—	prep_(	16	SENT_176	[p9l1638t1115r1978b1187],
26	83	CD	PERCENT	83	number	27	SENT_176	[p9l1638t1115r1978b1187],
27	%	NN	PERCENT	%	amod	25	SENT_176	[p9l1638t1115r1978b1187],
28	)	CD	NUMBER	)	tmod	16	SENT_176	[p9l1638t1115r1978b1187],
29	.	.	O	.	_	0	SENT_176	[p9l1638t1115r1978b1187],

1	‘	NN	O	‘	nsubj	7	SENT_177	[p9l1638t1115r1978b1187],
2	2	CD	NUMBER	2	num	3	SENT_177	[p9l1638t1115r1978b1187],
3	Symptoms	NNS	O	symptom	dep	1	SENT_177	[p9l10t1207r321b1272],
4	of	IN	O	of	_	0	SENT_177	[p9l364t1204r424b1257],
5	neurotoxicity	NN	O	neurotoxicity	prep_of	1	SENT_177	[p9l464t1208r849b1272],
6	could	MD	O	could	aux	7	SENT_177	[p9l890t1205r1049b1257],
7	persist	VB	O	persist	_	0	SENT_177	[p9l1096t1208r1285b1270],
8	also	RB	O	also	advmod	7	SENT_177	[p9l1326t1205r1439b1257],
9	in	IN	O	in	_	0	SENT_177	[p9l1483t1208r1531b1256],
10	patients	NNS	O	patient	prep_in	7	SENT_177	[p9l1577t1208r1810b1270],
11	who	WP	O	who	nsubj	12	SENT_177	[p9l1852t1205r1979b1257],
12	experienced	VBD	O	experience	rcmod	10	SENT_177	[p9l9t1282r368b1347],
13	grade	NN	O	grade	nn	15	SENT_177	[p9l416t1282r583b1348],
14	2	CD	NUMBER	2	num	15	SENT_177	[p9l629t1286r659b1333],
15	toxicity	NN	O	toxicity	dobj	12	SENT_177	[p9l703t1285r917b1349],
16	during	IN	O	during	_	0	SENT_177	[p9l961t1282r1151b1348],
17	the	DT	O	the	det	18	SENT_177	[p9l1197t1282r1291b1334],
18	course	NN	O	course	prep_during	12	SENT_177	[p9l1337t1297r1528b1334],
19	of	IN	O	of	_	0	SENT_177	[p9l1573t1281r1633b1334],
20	treatment	NN	O	treatment	prep_of	18	SENT_177	[p9l1671t1290r1979b1334],
21	.	.	O	.	_	0	SENT_177	[p9l1671t1290r1979b1334],

1	Therefore	RB	O	therefore	advmod	4	SENT_178	[p9l6t1360r306b1421],
2	,	,	O	,	_	0	SENT_178	[p9l6t1360r306b1421],
3	there	EX	O	there	expl	4	SENT_178	[p9l325t1361r479b1413],
4	is	VBZ	O	be	_	0	SENT_178	[p9l502t1363r540b1413],
5	an	DT	O	a	det	7	SENT_178	[p9l562t1376r628b1413],
6	urgent	JJ	O	urgent	amod	7	SENT_178	[p9l654t1369r848b1427],
7	need	NN	O	need	nsubj	4	SENT_178	[p9l870t1361r1012b1413],
8	to	TO	O	to	aux	9	SENT_178	[p9l1034t1369r1093b1413],
9	identify	VB	O	identify	infmod	7	SENT_178	[p9l1116t1360r1337b1428],
10	predictive	JJ	O	predictive	amod	11	SENT_178	[p9l1359t1361r1648b1426],
11	markers	NNS	O	marker	dobj	9	SENT_178	[p9l1672t1361r1902b1413],
12	of	IN	O	of	_	0	SENT_178	[p9l1924t1360r1984b1413],
13	mi	FW	O	mi	nn	15	SENT_178	[p9l11t1439r434b1491],
14	|	FW	O	|	nn	15	SENT_178	[p9l11t1439r434b1491],
15	d	NN	O	d	prep_of	11	SENT_178	[p9l11t1439r434b1491],
16	—	CD	NUMBER	—	number	18	SENT_178	[p9l11t1439r434b1491],
17	to	TO	O	to	dep	18	SENT_178	[p9l11t1439r434b1491],
18	—	CD	NUMBER	—	dep	15	SENT_178	[p9l11t1439r434b1491],
19	severe	JJ	O	severe	amod	20	SENT_178	[p9l11t1439r434b1491],
20	toxicity	NN	O	toxicity	dep	18	SENT_178	[p9l482t1442r696b1506],
21	in	IN	O	in	mark	24	SENT_178	[p9l745t1442r792b1490],
22	order	NN	O	order	dep	24	SENT_178	[p9l844t1439r1001b1491],
23	to	TO	O	to	aux	24	SENT_178	[p9l1047t1447r1106b1491],
24	avoid	VB	O	avoid	purpcl	9	SENT_178	[p9l1155t1439r1312b1491],
25	long-term	JJ	O	long-term	amod	26	SENT_178	[p9l1366t1439r1652b1505],
26	disability	NN	O	disability	dobj	24	SENT_178	[p9l1705t1439r1979b1506],
27	,	,	O	,	_	0	SENT_178	[p9l1705t1439r1979b1506],

1	The	DT	O	the	det	3	SENT_179	[p9l651t1649r748b1695],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_179	[p9l775t1649r1290b1707],
3	Journal	NNP	O	Journal	_	0	SENT_179	[p9l1313t1649r1501b1695],
4	(	CD	NUMBER	(	num	6	SENT_179	[p9l1529t1650r1701b1702],
5	2013	CD	DATE	2013	num	6	SENT_179	[p9l1529t1650r1701b1702],
6	)	NN	O	)	dep	3	SENT_179	[p9l1529t1650r1701b1702],
7	,	,	O	,	_	0	SENT_179	[p9l1529t1650r1701b1702],
8	403-409	CD	NUMBER	403-409	appos	6	SENT_179	[p9l1735t1652r1979b1695],

1	_	NN	O	_	_	0	SENT_180	[p9l52t1811r60b1821],
2	Pharmacogenomic	JJ	O	pharmacogenomic	amod	3	SENT_180	[p9l293t1782r550b1813],
3	markers	NNS	O	marker	dep	1	SENT_180	[p9l564t1782r671b1807],
4	of	IN	O	of	_	0	SENT_180	[p9l684t1782r712b1807],
5	toxicity	NN	O	toxicity	prep_of	3	SENT_180	[p9l722t1784r822b1813],
6	in	IN	O	in	_	0	SENT_180	[p9l834t1784r856b1806],
7	adjuvant	JJ	O	adjuvant	amod	8	SENT_180	[p9l871t1782r991b1813],
8	FOLFOX4	NN	O	folfox4	prep_in	5	SENT_180	[p9l1004t1783r1130b1807],
9	@	IN	O	@	_	0	SENT_180	[p9l6t1790r69b1851],
10	E	NN	O	e	nn	11	SENT_180	[p9l924t1825r937b1848],
11	Cecchin	NN	O	cecchin	prep_@	8	SENT_180	[p9l950t1824r1056b1848],
12	et	FW	O	et	nn	13	SENT_180	[p9l1070t1828r1095b1848],
13	al	FW	O	al	dep	1	SENT_180	[p9l1106t1824r1131b1848],

1	406	CD	NUMBER	406	_	0	SENT_181	[p9l6t1884r65b1912],
2	Table	NNP	O	Table	dep	1	SENT_181	[p9l23t1935r88b1961],
3	3	CD	NUMBER	3	num	2	SENT_181	[p9l101t1937r122b1961],
4	.	.	O	.	_	0	SENT_181	[p9l101t1937r122b1961],

1	Associations	NNS	O	association	_	0	SENT_182	[p9l159t1937r333b1961],
2	between	IN	O	between	_	0	SENT_182	[p9l348t1936r468b1961],
3	genetic	JJ	O	genetic	amod	4	SENT_182	[p9l483t1937r587b1967],
4	polymorphisms	NNS	O	polymorphism	prep_between	1	SENT_182	[p9l601t1936r818b1967],
5	previously	RB	DATE	previously	advmod	6	SENT_182	[p9l833t1936r977b1968],
6	related	VBN	O	relate	amod	1	SENT_182	[p9l990t1936r1085b1961],
7	to	TO	O	to	_	0	SENT_182	[p9l1099t1940r1127b1961],
8	toxicity	NN	O	toxicity	prep_to	1	SENT_182	[p9l1139t1937r1242b1968],
9	in	IN	O	in	_	0	SENT_182	[p9l1255t1937r1278b1960],
10	FOLFOX4	NN	O	folfox4	nn	12	SENT_182	[p9l1294t1937r1424b1961],
11	metastatic	JJ	O	metastatic	amod	12	SENT_182	[p9l1437t1937r1581b1961],
12	CRC	NN	O	crc	prep_in	8	SENT_182	[p9l1594t1937r1651b1961],

1	SNP	NN	O	snp	nn	5	SENT_183	[p9l35t2014r89b2037],
2	Gene	NN	O	gene	nn	5	SENT_183	[p9l372t2014r438b2037],
3	Base	NN	O	base	nn	5	SENT_183	[p9l642t2014r703b2037],
4	change	NN	O	change	nn	5	SENT_183	[p9l715t2013r813b2044],
5	MAF	NN	O	maf	_	0	SENT_183	[p9l1168t2014r1229b2037],
6	Most	JJS	O	most	dep	5	SENT_183	[p9l1620t2014r1686b2037],
7	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_183	[p9l1697t2013r1836b2044],
8	genetic	JJ	O	genetic	amod	9	SENT_183	[p9l1846t2014r1943b2044],
9	model	NN	O	model	dep	5	SENT_183	[p9l1954t2013r2038b2037],

1	Grade	NNP	O	Grade	dep	8	SENT_184	[p9l921t2106r1000b2131],
2	22	CD	NUMBER	22	num	4	SENT_184	[p9l1017t2108r1059b2134],
3	toxicity	NN	O	toxicity	nn	4	SENT_184	[p9l1073t2107r1168b2138],
4	Grade	NNP	O	Grade	dep	1	SENT_184	[p9l1230t2106r1309b2131],
5	0-1	CD	NUMBER	0-1	num	6	SENT_184	[p9l1322t2108r1366b2131],
6	toxicity	NN	O	toxicity	dep	8	SENT_184	[p9l1382t2107r1478b2137],
7	Model	NNP	O	Model	nn	8	SENT_184	[p9l1568t2106r1651b2131],
8	OR	NN	O	or	dep	12	SENT_184	[p9l1773t2107r1811b2131],
9	(	CD	PERCENT	(	num	11	SENT_184	[p9l1824t2107r1888b2134],
10	95	CD	PERCENT	95	num	11	SENT_184	[p9l1824t2107r1888b2134],
11	%	NN	PERCENT	%	dep	8	SENT_184	[p9l1824t2107r1888b2134],
12	Cl	NN	O	cl	dep	14	SENT_184	[p9l1901t2107r1934b2134],
13	)	CD	NUMBER	)	num	12	SENT_184	[p9l1901t2107r1934b2134],
14	Pa	NNP	O	Pa	_	0	SENT_184	[p9l2060t2104r2086b2130],

1	Neurological	JJ	O	neurological	amod	5	SENT_185	[p9l36t2178r205b2209],
2	toxicity	NN	O	toxicity	nn	5	SENT_185	[p9l217t2179r313b2209],
3	rs947894	NN	O	rs947894	nn	5	SENT_185	[p9l37t2217r163b2240],
4	GSTP1	NN	O	gstp1	nn	5	SENT_185	[p9l363t2216r444b2240],
5	A	NN	O	a	dep	15	SENT_185	[p9l690t2217r709b2239],
6	>	JJR	O	>	amod	7	SENT_185	[p9l716t2222r737b2240],
7	G	NN	O	g	dep	5	SENT_185	[p9l744t2216r764b2239],
8	0.321	CD	NUMBER	0.321	number	9	SENT_185	[p9l1006t2217r1075b2240],
9	0.301	CD	NUMBER	0.301	num	12	SENT_185	[p9l1316t2217r1385b2240],
10	Dominant	JJ	O	dominant	quantmod	12	SENT_185	[p9l1540t2216r1680b2240],
11	1.16	CD	NUMBER	1.16	number	12	SENT_185	[p9l1746t2217r1800b2240],
12	(	CD	NUMBER	(	dep	7	SENT_185	[p9l1814t2216r1962b2243],
13	0.59	CD	NUMBER	0.59	num	14	SENT_185	[p9l1814t2216r1962b2243],
14	—	NN	O	—	dep	15	SENT_185	[p9l1814t2216r1962b2243],
15	2.30	CD	NUMBER	2.30	dep	23	SENT_185	[p9l1814t2216r1962b2243],
16	)	CD	NUMBER	)	number	17	SENT_185	[p9l1814t2216r1962b2243],
17	0.6647	CD	NUMBER	0.6647	dep	15	SENT_185	[p9l2027t2217r2118b2240],
18	r51	NN	O	r51	nn	21	SENT_185	[p9l37t2255r71b2277],
19	138272	CD	NUMBER	138272	num	21	SENT_185	[p9l80t2254r179b2277],
20	G5TPl	NN	O	g5tpl	nn	21	SENT_185	[p9l363t2254r444b2277],
21	C	NN	O	c	dep	17	SENT_185	[p9l693t2254r711b2277],
22	>	JJR	O	>	amod	23	SENT_185	[p9l718t2259r739b2277],
23	T	NN	O	t	dep	30	SENT_185	[p9l745t2254r763b2277],
24	0.071	CD	NUMBER	0.071	number	25	SENT_185	[p9l1006t2255r1075b2277],
25	0.080	CD	NUMBER	0.080	dep	23	SENT_185	[p9l1316t2254r1390b2277],
26	Additive	JJ	O	additive	amod	27	SENT_185	[p9l1550t2253r1669b2277],
27	0.91	CD	NUMBER	0.91	dep	25	SENT_185	[p9l1743t2254r1795b2277],
28	(	CD	NUMBER	(	num	30	SENT_185	[p9l1814t2253r1962b2281],
29	0.35	CD	NUMBER	0.35	num	30	SENT_185	[p9l1814t2253r1962b2281],
30	—	NN	O	—	dep	38	SENT_185	[p9l1814t2253r1962b2281],
31	2.38	CD	NUMBER	2.38	number	32	SENT_185	[p9l1814t2253r1962b2281],
32	)	CD	NUMBER	)	dep	30	SENT_185	[p9l1814t2253r1962b2281],
33	0.8433	CD	NUMBER	0.8433	num	36	SENT_185	[p9l2027t2254r2117b2277],
34	rs4426527	NN	O	rs4426527	nn	36	SENT_185	[p9l37t2292r179b2315],
35	AGXT	NN	O	agxt	nn	36	SENT_185	[p9l367t2291r444b2314],
36	A	NN	O	a	dep	32	SENT_185	[p9l690t2291r737b2314],
37	>	JJR	O	>	amod	38	SENT_185	[p9l690t2291r737b2314],
38	G	NN	O	g	dep	40	SENT_185	[p9l744t2291r764b2314],
39	0.241	CD	NUMBER	0.241	num	40	SENT_185	[p9l1006t2292r1075b2315],
40	0.247	CD	NUMBER	0.247	dep	55	SENT_185	[p9l1316t2292r1390b2315],
41	Additive	JJ	O	additive	amod	42	SENT_185	[p9l1550t2290r1669b2315],
42	0.93	CD	NUMBER	0.93	dep	40	SENT_185	[p9l1743t2292r1799b2315],
43	(	CD	NUMBER	(	num	53	SENT_185	[p9l1814t2291r1962b2318],
44	O.	NNP	O	O.	nn	53	SENT_185	[p9l1814t2291r1962b2318],
45	52	CD	NUMBER	52	num	53	SENT_185	[p9l1814t2291r1962b2318],
46	—	CD	NUMBER	—	num	53	SENT_185	[p9l1814t2291r1962b2318],
47	1.65	CD	NUMBER	1.65	num	53	SENT_185	[p9l1814t2291r1962b2318],
48	)	NN	O	)	nn	53	SENT_185	[p9l1814t2291r1962b2318],
49	0.7946	CD	NUMBER	0.7946	num	53	SENT_185	[p9l2027t2292r2118b2315],
50	rs341	NN	O	rs341	nn	53	SENT_185	[p9l37t2329r105b2352],
51	16584	CD	NUMBER	16584	num	53	SENT_185	[p9l115t2329r197b2352],
52	AGXT	NN	O	agxt	nn	53	SENT_185	[p9l367t2329r444b2352],
53	C	NN	O	c	rcmod	42	SENT_185	[p9l693t2328r711b2352],
54	>	JJR	O	>	amod	55	SENT_185	[p9l718t2329r763b2352],
55	T	NN	O	t	dep	62	SENT_185	[p9l718t2329r763b2352],
56	0.277	CD	NUMBER	0.277	number	57	SENT_185	[p9l1006t2329r1080b2352],
57	0.227	CD	NUMBER	0.227	dep	55	SENT_185	[p9l1316t2329r1390b2352],
58	Additive	JJ	O	additive	amod	59	SENT_185	[p9l1550t2327r1669b2352],
59	1.29	CD	NUMBER	1.29	dep	57	SENT_185	[p9l1746t2329r1800b2352],
60	(	CD	NUMBER	(	num	62	SENT_185	[p9l1814t2328r1962b2356],
61	0.73	CD	NUMBER	0.73	num	62	SENT_185	[p9l1814t2328r1962b2356],
62	—	NN	O	—	dep	69	SENT_185	[p9l1814t2328r1962b2356],
63	2.27	CD	NUMBER	2.27	number	64	SENT_185	[p9l1814t2328r1962b2356],
64	)	CD	NUMBER	)	dep	62	SENT_185	[p9l1814t2328r1962b2356],
65	0.3863	CD	NUMBER	0.3863	num	67	SENT_185	[p9l2027t2329r2117b2352],
66	N/A	NN	O	n/a	nn	67	SENT_185	[p9l37t2366r89b2390],
67	AGXT	NN	O	agxt	dep	64	SENT_185	[p9l367t2366r444b2389],
68	del-74	CD	NUMBER	del-74	num	69	SENT_185	[p9l662t2365r749b2389],
69	bp	NN	O	bp	dep	75	SENT_185	[p9l757t2365r793b2395],
70	0.232	CD	NUMBER	0.232	number	71	SENT_185	[p9l1006t2366r1080b2389],
71	0.276	CD	NUMBER	0.276	dep	69	SENT_185	[p9l1316t2366r1390b2389],
72	Additive	JJ	O	additive	amod	73	SENT_185	[p9l1550t2365r1669b2389],
73	0.73	CD	NUMBER	0.73	dep	71	SENT_185	[p9l1743t2366r1799b2389],
74	(	CD	NUMBER	(	num	75	SENT_185	[p9l1814t2365r1962b2393],
75	0.40-1	CD	NUMBER	0.40-1	dep	78	SENT_185	[p9l1814t2365r1962b2393],
76	.32	CD	NUMBER	.32	num	77	SENT_185	[p9l1814t2365r1962b2393],
77	)	NN	O	)	dep	75	SENT_185	[p9l1814t2365r1962b2393],
78	0.3029	CD	NUMBER	0.3029	_	0	SENT_185	[p9l2027t2366r2118b2389],

1	Neutropenia	NNP	O	Neutropenia	nn	2	SENT_186	[p9l37t2440r211b2470],
2	Grade	NNP	O	Grade	dep	11	SENT_186	[p9l275t2439r359b2464],
3	23	CD	NUMBER	23	num	5	SENT_186	[p9l376t2441r419b2467],
4	toxicity	NN	O	toxicity	nn	5	SENT_186	[p9l432t2440r535b2471],
5	Grade	NNP	O	Grade	dep	2	SENT_186	[p9l597t2439r681b2464],
6	0-2	CD	NUMBER	0-2	num	7	SENT_186	[p9l694t2441r742b2464],
7	toxicity	NN	O	toxicity	dep	11	SENT_186	[p9l755t2440r858b2471],
8	N/A	NN	O	n/a	nn	11	SENT_186	[p9l37t2478r89b2502],
9	GSTM1	NN	O	gstm1	nn	11	SENT_186	[p9l355t2478r449b2501],
10	Gene	NN	O	gene	nn	11	SENT_186	[p9l626t2478r700b2501],
11	deletion	NN	O	deletion	dep	17	SENT_186	[p9l712t2477r827b2501],
12	0.192	CD	NUMBER	0.192	number	13	SENT_186	[p9l1006t2478r1080b2501],
13	0.237	CD	NUMBER	0.237	dep	11	SENT_186	[p9l1316t2478r1390b2501],
14	Additive	JJ	O	additive	amod	15	SENT_186	[p9l1550t2477r1669b2501],
15	0.73	CD	NUMBER	0.73	dep	13	SENT_186	[p9l1743t2478r1799b2501],
16	(	CD	NUMBER	(	num	17	SENT_186	[p9l1814t2477r1962b2505],
17	0.41-1	CD	NUMBER	0.41-1	dep	20	SENT_186	[p9l1814t2477r1962b2505],
18	.32	CD	NUMBER	.32	num	19	SENT_186	[p9l1814t2477r1962b2505],
19	)	NN	O	)	dep	17	SENT_186	[p9l1814t2477r1962b2505],
20	0.2995	CD	NUMBER	0.2995	_	0	SENT_186	[p9l2027t2478r2117b2501],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_187	[p9l23t2541r214b2563],
2	:	:	O	:	_	0	SENT_187	[p9l23t2541r214b2563],
3	Cl	NN	O	cl	dep	1	SENT_187	[p9l227t2541r258b2567],
4	,	,	O	,	_	0	SENT_187	[p9l227t2541r258b2567],
5	conﬁdence	NN	O	conﬁdence	nn	6	SENT_187	[p9l270t2540r417b2563],
6	interval	NN	O	interval	appos	3	SENT_187	[p9l430t2541r534b2567],
7	;	:	O	;	_	0	SENT_187	[p9l430t2541r534b2567],
8	MAF	NN	O	maf	dep	1	SENT_187	[p9l547t2542r609b2567],
9	,	,	O	,	_	0	SENT_187	[p9l547t2542r609b2567],
10	minor	JJ	O	minor	amod	12	SENT_187	[p9l622t2541r700b2563],
11	allele	NN	O	allele	nn	12	SENT_187	[p9l711t2540r779b2563],
12	frequency	NN	O	frequency	appos	8	SENT_187	[p9l790t2540r931b2570],
13	;	:	O	;	_	0	SENT_187	[p9l790t2540r931b2570],
14	OR	NN	O	or	dep	1	SENT_187	[p9l943t2541r987b2567],
15	,	,	O	,	_	0	SENT_187	[p9l943t2541r987b2567],
16	odds	NNS	O	odds	nn	17	SENT_187	[p9l1000t2540r1064b2563],
17	ratio	NN	O	ratio	appos	14	SENT_187	[p9l1078t2541r1142b2567],
18	;	:	O	;	_	0	SENT_187	[p9l1078t2541r1142b2567],
19	SNP	NN	ORGANIZATION	snp	dep	1	SENT_187	[p9l1155t2541r1209b2567],
20	,	,	O	,	_	0	SENT_187	[p9l1155t2541r1209b2567],
21	single-nucleotide	JJ	O	single-nucleotide	amod	22	SENT_187	[p9l1221t2541r1450b2570],
22	polymorphism	NN	O	polymorphism	appos	19	SENT_187	[p9l1464t2541r1662b2570],
23	.	.	O	.	_	0	SENT_187	[p9l1464t2541r1662b2570],

1	“	NN	O	“	nsubj	2	SENT_188	[p9l23t2576r152b2607],
2	Adjusted	VBN	O	adjust	_	0	SENT_188	[p9l23t2576r152b2607],
3	for	IN	O	for	_	0	SENT_188	[p9l164t2578r201b2601],
4	sex	NN	O	sex	prep_for	2	SENT_188	[p9l213t2585r261b2604],
5	,	,	O	,	_	0	SENT_188	[p9l213t2585r261b2604],
6	age	NN	O	age	conj_and	4	SENT_188	[p9l273t2585r327b2607],
7	,	,	O	,	_	0	SENT_188	[p9l273t2585r327b2607],
8	neo	NN	O	neo	conj_and	4	SENT_188	[p9l340t2578r515b2607],
9	—	CD	NUMBER	—	num	11	SENT_188	[p9l340t2578r515b2607],
10	adjuvant	JJ	O	adjuvant	amod	11	SENT_188	[p9l340t2578r515b2607],
11	therapy	NN	O	therapy	dep	8	SENT_188	[p9l527t2578r629b2607],
12	and	CC	O	and	_	0	SENT_188	[p9l640t2578r689b2601],
13	oxaliplatin	NN	O	oxaliplatin	nn	15	SENT_188	[p9l702t2578r838b2607],
14	cumulative	JJ	O	cumulative	amod	15	SENT_188	[p9l851t2578r998b2601],
15	dose	NN	O	dose	prep_for	2	SENT_188	[p9l1010t2578r1072b2601],
16	normalized	VBN	O	normalize	partmod	15	SENT_188	[p9l1085t2578r1231b2601],
17	by	IN	O	by	_	0	SENT_188	[p9l1246t2578r1277b2607],
18	BSA	NN	O	bsa	nn	19	SENT_188	[p9l1289t2579r1339b2601],
19	(	NN	O	(	agent	16	SENT_188	[p9l1352t2578r1397b2604],
20	for	IN	O	for	_	0	SENT_188	[p9l1352t2578r1397b2604],
21	neurological	JJ	O	neurological	amod	23	SENT_188	[p9l1409t2578r1571b2607],
22	toxicity	NN	O	toxicity	nn	23	SENT_188	[p9l1584t2578r1695b2607],
23	)	NN	O	)	prep_for	19	SENT_188	[p9l1584t2578r1695b2607],
24	.	.	O	.	_	0	SENT_188	[p9l1584t2578r1695b2607],

1	Table	NNP	O	Table	_	0	SENT_189	[p9l23t2730r88b2755],
2	4	CD	NUMBER	4	dep	1	SENT_189	[p9l101t2732r122b2755],
3	.	.	O	.	_	0	SENT_189	[p9l101t2732r122b2755],

1	Signiﬁcant	JJ	O	signiﬁcant	amod	2	SENT_190	[p9l160t2731r308b2762],
2	associations	NNS	O	association	_	0	SENT_190	[p9l320t2732r490b2755],
3	between	IN	O	between	_	0	SENT_190	[p9l504t2731r624b2755],
4	genetic	JJ	O	genetic	amod	5	SENT_190	[p9l638t2732r743b2762],
5	polymorphisms	NNS	O	polymorphism	prep_between	2	SENT_190	[p9l756t2731r974b2762],
6	and	CC	O	and	_	0	SENT_190	[p9l987t2731r1039b2755],
7	grade	NN	O	grade	conj_and	5	SENT_190	[p9l1053t2731r1134b2762],
8	22	CD	NUMBER	22	num	10	SENT_190	[p9l1151t2733r1194b2758],
9	neurological	JJ	O	neurological	amod	10	SENT_190	[p9l1208t2731r1381b2762],
10	toxicity	NN	O	toxicity	dep	7	SENT_190	[p9l1395t2732r1502b2762],
11	.	.	O	.	_	0	SENT_190	[p9l1395t2732r1502b2762],

1	Associations	NNS	O	association	nsubj	6	SENT_191	[p9l1515t2732r1689b2755],
2	with	IN	O	with	_	0	SENT_191	[p9l1702t2731r1762b2755],
3	q	NN	O	q	prep_with	1	SENT_191	[p9l1776t2733r1884b2761],
4	<	JJR	O	<	dep	3	SENT_191	[p9l1776t2733r1884b2761],
5	0.10	CD	NUMBER	0.10	dep	4	SENT_191	[p9l1776t2733r1884b2761],
6	are	VBP	O	be	_	0	SENT_191	[p9l1897t2738r1940b2755],
7	in	IN	O	in	_	0	SENT_191	[p9l1953t2732r1976b2755],
8	bold	JJ	O	bold	prep_in	6	SENT_191	[p9l1992t2731r2053b2755],

1	SNP	NN	O	snp	nn	4	SENT_192	[p9l35t2809r89b2832],
2	Gene	NN	O	gene	nn	4	SENT_192	[p9l310t2809r377b2832],
3	Base	NN	O	base	nn	4	SENT_192	[p9l503t2809r563b2832],
4	MAF	NN	O	maf	_	0	SENT_192	[p9l943t2809r1004b2832],
5	Most	JJS	O	most	dep	4	SENT_192	[p9l1524t2809r1590b2832],
6	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_192	[p9l1600t2807r1739b2839],
7	genetic	JJ	O	genetic	amod	9	SENT_192	[p9l1750t2809r1846b2839],
8	model	NN	O	model	nn	9	SENT_192	[p9l1858t2808r1942b2832],
9	change	NN	O	change	dep	4	SENT_192	[p9l484t2845r582b2876],

1	Grade	NNP	O	Grade	dep	145	SENT_193	[p9l683t2904r762b2929],
2	2	CD	NUMBER	2	dep	145	SENT_193	[p9l779t2908r800b2932],
3	2	CD	NUMBER	2	dep	145	SENT_193	[p9l805t2906r821b2928],
4	Grade	NNP	O	Grade	dep	145	SENT_193	[p9l933t2904r1013b2929],
5	0-1	CD	NUMBER	0-1	dep	145	SENT_193	[p9l1025t2906r1069b2929],
6	Model	NNP	O	Model	dep	145	SENT_193	[p9l1376t2904r1459b2929],
7	OR	NN	O	or	dep	145	SENT_193	[p9l1599t2905r1636b2929],
8	(	CD	PERCENT	(	dep	145	SENT_193	[p9l1649t2905r1689b2932],
9	95	CD	PERCENT	95	dep	145	SENT_193	[p9l1649t2905r1689b2932],
10	%	NN	PERCENT	%	dep	145	SENT_193	[p9l1691t2906r1714b2929],
11	Cl	NN	O	cl	dep	145	SENT_193	[p9l1727t2905r1760b2932],
12	)	CD	NUMBER	)	dep	145	SENT_193	[p9l1727t2905r1760b2932],
13	Pa	NNP	O	Pa	dep	145	SENT_193	[p9l1904t2902r1930b2928],
14	q	VBD	O	q	dep	145	SENT_193	[p9l2046t2905r2092b2935],
15	**	CD	NUMBER	**	dep	145	SENT_193	[p9l2046t2905r2092b2935],
16	toxicity	NN	O	toxicity	dep	145	SENT_193	[p9l705t2943r801b2973],
17	toxicity	NN	O	toxicity	dep	145	SENT_193	[p9l956t2943r1051b2973],
18	rs2074087	NN	O	rs2074087	dep	145	SENT_193	[p9l37t3015r179b3038],
19	ABCC1	NN	O	abcc1	dep	145	SENT_193	[p9l298t3014r384b3038],
20	G	NN	O	g	dep	145	SENT_193	[p9l496t3014r515b3038],
21	>	JJR	O	>	dep	145	SENT_193	[p9l523t3020r544b3038],
22	C	NN	O	c	dep	145	SENT_193	[p9l551t3014r569b3038],
23	0.0750	CD	NUMBER	0.0750	dep	145	SENT_193	[p9l706t3015r798b3038],
24	0.2529	CD	NUMBER	0.2529	dep	145	SENT_193	[p9l957t3015r1048b3038],
25	Additive	JJ	O	additive	dep	145	SENT_193	[p9l1358t3013r1476b3038],
26	0.43	CD	NUMBER	0.43	dep	145	SENT_193	[p9l1560t3015r1616b3038],
27	(	CD	NUMBER	(	dep	145	SENT_193	[p9l1631t3014r1780b3041],
28	0.22-0	CD	NUMBER	0.22-0	dep	145	SENT_193	[p9l1631t3014r1780b3041],
29	.86	CD	NUMBER	.86	dep	145	SENT_193	[p9l1631t3014r1780b3041],
30	)	NN	O	)	dep	145	SENT_193	[p9l1631t3014r1780b3041],
31	0.0170	CD	NUMBER	0.0170	dep	145	SENT_193	[p9l1871t3015r1962b3038],
32	0.0881	CD	NUMBER	0.0881	dep	145	SENT_193	[p9l2018t3015r2113b3038],
33	rs35587	NN	O	rs35587	dep	145	SENT_193	[p9l37t3052r145b3075],
34	ABCC1	NN	O	abcc1	dep	145	SENT_193	[p9l298t3052r384b3075],
35	T	NN	O	t	dep	145	SENT_193	[p9l497t3052r515b3075],
36	>	JJR	O	>	dep	145	SENT_193	[p9l521t3057r542b3075],
37	C	NN	O	c	dep	145	SENT_193	[p9l548t3052r566b3075],
38	0.2455	CD	NUMBER	0.2455	dep	145	SENT_193	[p9l706t3052r797b3075],
39	0.3000	CD	NUMBER	0.3000	dep	145	SENT_193	[p9l957t3052r1048b3075],
40	Dominant	JJ	O	dominant	dep	145	SENT_193	[p9l1348t3052r1488b3075],
41	0.47	CD	NUMBER	0.47	dep	145	SENT_193	[p9l1560t3052r1617b3075],
42	(	CD	NUMBER	(	dep	145	SENT_193	[p9l1631t3051r1780b3079],
43	0.23-0	CD	NUMBER	0.23-0	dep	145	SENT_193	[p9l1631t3051r1780b3079],
44	.96	CD	NUMBER	.96	dep	145	SENT_193	[p9l1631t3051r1780b3079],
45	)	NN	O	)	dep	145	SENT_193	[p9l1631t3051r1780b3079],
46	0.0375	CD	NUMBER	0.0375	dep	145	SENT_193	[p9l1871t3052r1961b3075],
47	0.1049	CD	NUMBER	0.1049	dep	145	SENT_193	[p9l2019t3052r2111b3075],
48	rs1885301	NN	O	rs1885301	dep	145	SENT_193	[p9l37t3090r174b3112],
49	ABCC2	NN	O	abcc2	dep	145	SENT_193	[p9l298t3089r387b3112],
50	G	NN	O	g	dep	145	SENT_193	[p9l495t3089r515b3112],
51	>	JJR	O	>	dep	145	SENT_193	[p9l522t3094r543b3112],
52	A	DT	O	a	dep	145	SENT_193	[p9l550t3089r570b3112],
53	0.5982	CD	NUMBER	0.5982	dep	145	SENT_193	[p9l706t3090r797b3112],
54	0.4419	CD	NUMBER	0.4419	dep	145	SENT_193	[p9l957t3090r1048b3112],
55	Recessive	JJ	O	recessive	dep	145	SENT_193	[p9l1351t3089r1484b3112],
56	3.06	CD	NUMBER	3.06	dep	145	SENT_193	[p9l1561t3090r1617b3112],
57	(	NN	O	(	dep	145	SENT_193	[p9l1631t3089r1650b3116],
58	1	CD	NUMBER	1	dep	145	SENT_193	[p9l1631t3089r1650b3116],
59	.35	CD	NUMBER	.35	dep	145	SENT_193	[p9l1657t3089r1780b3116],
60	—	NN	O	—	dep	145	SENT_193	[p9l1657t3089r1780b3116],
61	6.92	CD	NUMBER	6.92	dep	145	SENT_193	[p9l1657t3089r1780b3116],
62	)	CD	NUMBER	)	dep	145	SENT_193	[p9l1657t3089r1780b3116],
63	0.0072	CD	NUMBER	0.0072	dep	145	SENT_193	[p9l1871t3090r1962b3112],
64	0.0747	CD	NUMBER	0.0747	dep	145	SENT_193	[p9l2018t3090r2118b3112],
65	rs717620	NN	O	rs717620	dep	145	SENT_193	[p9l37t3127r162b3150],
66	ABCC2	NN	O	abcc2	dep	145	SENT_193	[p9l298t3126r387b3150],
67	C	NN	O	c	dep	145	SENT_193	[p9l498t3126r516b3150],
68	>	JJR	O	>	dep	145	SENT_193	[p9l523t3127r568b3150],
69	T	NN	O	t	dep	145	SENT_193	[p9l523t3127r568b3150],
70	0.2455	CD	NUMBER	0.2455	dep	145	SENT_193	[p9l706t3127r797b3150],
71	0.1782	CD	NUMBER	0.1782	dep	145	SENT_193	[p9l957t3127r1048b3150],
72	Recessive	JJ	O	recessive	dep	145	SENT_193	[p9l1351t3126r1484b3150],
73	14.39	CD	NUMBER	14.39	dep	145	SENT_193	[p9l1546t3127r1617b3150],
74	(	CD	NUMBER	(	dep	145	SENT_193	[p9l1631t3126r1814b3153],
75	1.63	CD	NUMBER	1.63	dep	145	SENT_193	[p9l1631t3126r1814b3153],
76	—	NN	O	—	dep	145	SENT_193	[p9l1631t3126r1814b3153],
77	127.02	CD	NUMBER	127.02	dep	145	SENT_193	[p9l1631t3126r1814b3153],
78	)	CD	NUMBER	)	dep	145	SENT_193	[p9l1631t3126r1814b3153],
79	0.0164	CD	NUMBER	0.0164	dep	145	SENT_193	[p9l1871t3127r1963b3150],
80	0.0881	CD	NUMBER	0.0881	dep	145	SENT_193	[p9l2018t3127r2113b3150],
81	rs2273697	NN	O	rs2273697	dep	145	SENT_193	[p9l37t3165r179b3187],
82	ABCC2	NN	O	abcc2	dep	145	SENT_193	[p9l298t3164r387b3187],
83	G	NN	O	g	dep	145	SENT_193	[p9l495t3164r515b3187],
84	>	JJR	O	>	dep	145	SENT_193	[p9l522t3169r543b3187],
85	A	DT	O	a	dep	145	SENT_193	[p9l550t3164r570b3187],
86	0.1340	CD	NUMBER	0.1340	dep	145	SENT_193	[p9l706t3165r798b3187],
87	0.2300	CD	NUMBER	0.2300	dep	145	SENT_193	[p9l957t3165r1048b3187],
88	Dominant	JJ	O	dominant	dep	145	SENT_193	[p9l1348t3164r1488b3187],
89	0.44	CD	NUMBER	0.44	dep	145	SENT_193	[p9l1560t3165r1618b3187],
90	(	CD	NUMBER	(	dep	145	SENT_193	[p9l1631t3164r1780b3191],
91	0.20	CD	NUMBER	0.20	dep	145	SENT_193	[p9l1631t3164r1780b3191],
92	—	NN	O	—	dep	145	SENT_193	[p9l1631t3164r1780b3191],
93	0.98	CD	NUMBER	0.98	dep	145	SENT_193	[p9l1631t3164r1780b3191],
94	)	CD	NUMBER	)	dep	145	SENT_193	[p9l1631t3164r1780b3191],
95	0.0434	CD	NUMBER	0.0434	dep	145	SENT_193	[p9l1871t3165r1963b3187],
96	0.1049	CD	NUMBER	0.1049	dep	145	SENT_193	[p9l2019t3165r2111b3187],
97	rs4148396	NN	O	rs4148396	dep	145	SENT_193	[p9l37t3202r179b3225],
98	ABCC2	NN	O	abcc2	dep	145	SENT_193	[p9l298t3201r387b3225],
99	C	NN	O	c	dep	145	SENT_193	[p9l498t3201r516b3225],
100	>	JJR	O	>	dep	145	SENT_193	[p9l523t3207r545b3224],
101	T	NN	O	t	dep	145	SENT_193	[p9l550t3202r568b3224],
102	0.4629	CD	NUMBER	0.4629	dep	145	SENT_193	[p9l706t3202r798b3225],
103	0.3512	CD	NUMBER	0.3512	dep	145	SENT_193	[p9l957t3202r1048b3225],
104	Recessive	JJ	O	recessive	dep	145	SENT_193	[p9l1351t3201r1484b3225],
105	4.69	CD	NUMBER	4.69	dep	145	SENT_193	[p9l1560t3202r1617b3225],
106	(	NN	O	(	dep	145	SENT_193	[p9l1631t3201r1650b3228],
107	1	CD	NUMBER	1	dep	145	SENT_193	[p9l1631t3201r1650b3228],
108	.60	CD	NUMBER	.60	dep	145	SENT_193	[p9l1657t3202r1725b3225],
109	-1	CD	NUMBER	-1	dep	145	SENT_193	[p9l1657t3202r1725b3225],
110	3.74	CD	NUMBER	3.74	dep	145	SENT_193	[p9l1732t3201r1797b3228],
111	)	NN	O	)	dep	145	SENT_193	[p9l1732t3201r1797b3228],
112	0.0048	CD	NUMBER	0.0048	dep	145	SENT_193	[p9l1871t3202r1962b3225],
113	0.0747	CD	NUMBER	0.0747	dep	145	SENT_193	[p9l2018t3202r2118b3225],
114	rs3740066	NN	O	rs3740066	dep	145	SENT_193	[p9l37t3239r179b3262],
115	ABCC2	NN	O	abcc2	dep	145	SENT_193	[p9l298t3239r387b3262],
116	C	NN	O	c	dep	145	SENT_193	[p9l498t3239r516b3262],
117	>	JJR	O	>	dep	145	SENT_193	[p9l523t3244r544b3262],
118	T	NN	O	t	dep	145	SENT_193	[p9l550t3239r568b3262],
119	0.4545	CD	NUMBER	0.4545	dep	145	SENT_193	[p9l706t3239r797b3262],
120	0.3353	CD	NUMBER	0.3353	dep	145	SENT_193	[p9l957t3239r1047b3262],
121	Recessive	JJ	O	recessive	dep	145	SENT_193	[p9l1351t3238r1484b3262],
122	2.99	CD	NUMBER	2.99	dep	145	SENT_193	[p9l1561t3239r1617b3262],
123	(	CD	NUMBER	(	dep	145	SENT_193	[p9l1631t3238r1780b3266],
124	1.16-7	CD	NUMBER	1.16-7	dep	145	SENT_193	[p9l1631t3238r1780b3266],
125	.70	CD	NUMBER	.70	dep	145	SENT_193	[p9l1631t3238r1780b3266],
126	)	NN	O	)	dep	145	SENT_193	[p9l1631t3238r1780b3266],
127	0.0231	CD	NUMBER	0.0231	dep	145	SENT_193	[p9l1871t3239r1957b3262],
128	0.0958	CD	NUMBER	0.0958	dep	145	SENT_193	[p9l2018t3239r2118b3262],
129	rs2622604	NN	O	rs2622604	dep	145	SENT_193	[p9l37t3277r180b3299],
130	ABCG2	NN	O	abcg2	dep	145	SENT_193	[p9l296t3276r388b3299],
131	C	NN	O	c	dep	145	SENT_193	[p9l498t3276r516b3299],
132	>	JJR	O	>	dep	145	SENT_193	[p9l523t3276r568b3299],
133	T	NN	O	t	dep	145	SENT_193	[p9l523t3276r568b3299],
134	0.3092	CD	NUMBER	0.3092	dep	145	SENT_193	[p9l706t3277r797b3299],
135	0.21	CD	NUMBER	0.21	dep	145	SENT_193	[p9l957t3277r1008b3299],
136	18	CD	NUMBER	18	dep	145	SENT_193	[p9l1018t3277r1048b3299],
137	Recessive	JJ	O	recessive	dep	145	SENT_193	[p9l1351t3276r1484b3299],
138	3.61	CD	NUMBER	3.61	dep	145	SENT_193	[p9l1561t3277r1612b3299],
139	(	CD	NUMBER	(	dep	145	SENT_193	[p9l1631t3275r1797b3303],
140	1.01	CD	NUMBER	1.01	dep	145	SENT_193	[p9l1631t3275r1797b3303],
141	—	NN	O	—	dep	145	SENT_193	[p9l1631t3275r1797b3303],
142	12.88	CD	NUMBER	12.88	dep	145	SENT_193	[p9l1631t3275r1797b3303],
143	)	CD	NUMBER	)	dep	145	SENT_193	[p9l1631t3275r1797b3303],
144	0.0478	CD	NUMBER	0.0478	dep	145	SENT_193	[p9l1871t3277r1962b3299],
145	0.1049	CD	NUMBER	0.1049	_	0	SENT_193	[p9l2019t3277r2111b3299],

1	ABCC2	NN	O	abcc2	nn	2	SENT_194	[p9l34t3385r124b3408],
2	rs	NNS	O	r	dep	12	SENT_194	[p9l276t3391r297b3408],
3	1885301	CD	NUMBER	1885301	num	4	SENT_194	[p9l303t3386r408b3408],
4	rs717620	NN	O	rs717620	dep	2	SENT_194	[p9l473t3386r593b3408],
5	rs2273697	NN	O	rs2273697	nn	8	SENT_194	[p9l684t3386r821b3408],
6	rs4148396	NN	O	rs4148396	nn	8	SENT_194	[p9l935t3386r1070b3408],
7	rs3740066	NN	O	rs3740066	nn	8	SENT_194	[p9l1155t3386r1291b3408],
8	Model	NNP	O	Model	dep	4	SENT_194	[p9l1376t3384r1459b3408],
9	OR	NN	O	or	dep	12	SENT_194	[p9l1599t3385r1636b3408],
10	(	CD	PERCENT	(	num	9	SENT_194	[p9l1649t3385r1689b3412],
11	95	CD	PERCENT	95	num	12	SENT_194	[p9l1649t3385r1689b3412],
12	%	NN	PERCENT	%	dep	18	SENT_194	[p9l1691t3386r1714b3408],
13	Cl	NN	O	cl	nn	16	SENT_194	[p9l1727t3385r1760b3412],
14	)	CD	NUMBER	)	num	16	SENT_194	[p9l1727t3385r1760b3412],
15	P	NN	O	p	nn	16	SENT_194	[p9l1909t3385r1925b3408],
16	q	NN	O	q	dep	12	SENT_194	[p9l2046t3385r2092b3415],
17	**	CD	NUMBER	**	num	18	SENT_194	[p9l2046t3385r2092b3415],
18	haplotype	NN	O	haplotype	_	0	SENT_194	[p9l36t3421r169b3453],

1	(	NN	O	(	dep	13	SENT_195	[p9l37t3494r63b3521],
2	I	CD	NUMBER	i	num	1	SENT_195	[p9l37t3494r63b3521],
3	)	CD	NUMBER	)	num	6	SENT_195	[p9l37t3494r63b3521],
4	G	NN	O	g	nn	6	SENT_195	[p9l333t3494r353b3517],
5	C	NN	O	c	nn	6	SENT_195	[p9l523t3494r541b3518],
6	A	NN	O	a	dep	1	SENT_195	[p9l742t3494r761b3517],
7	C	NN	O	c	dep	9	SENT_195	[p9l993t3494r1011b3518],
8	C	NN	O	c	dep	9	SENT_195	[p9l1214t3494r1232b3518],
9	Additive	JJ	O	additive	amod	6	SENT_195	[p9l1358t3493r1476b3518],
10	0.60	CD	NUMBER	0.60	dep	13	SENT_195	[p9l1560t3495r1617b3518],
11	(	CD	NUMBER	(	num	13	SENT_195	[p9l1631t3494r1780b3521],
12	0.30	CD	NUMBER	0.30	num	13	SENT_195	[p9l1631t3494r1780b3521],
13	—	NN	O	—	dep	20	SENT_195	[p9l1631t3494r1780b3521],
14	1.16	CD	NUMBER	1.16	number	15	SENT_195	[p9l1631t3494r1780b3521],
15	)	CD	NUMBER	)	dep	13	SENT_195	[p9l1631t3494r1780b3521],
16	0.1296	CD	NUMBER	0.1296	num	17	SENT_195	[p9l1871t3495r1963b3518],
17	—	NN	O	—	dep	15	SENT_195	[p9l2052t3507r2084b3510],
18	(	CD	NUMBER	(	num	20	SENT_195	[p9l37t3531r196b3559],
19	Protective	JJ	O	protective	amod	20	SENT_195	[p9l37t3531r196b3559],
20	)	NN	O	)	dep	23	SENT_195	[p9l37t3531r196b3559],
21	(	CD	NUMBER	(	num	22	SENT_195	[p9l37t3568r73b3596],
22	ll	NN	O	ll	dep	20	SENT_195	[p9l37t3568r73b3596],
23	)	NN	O	)	dep	31	SENT_195	[p9l37t3568r73b3596],
24	(	CD	NUMBER	(	num	23	SENT_195	[p9l87t3568r158b3596],
25	Risk	NN	O	risk	nn	31	SENT_195	[p9l87t3568r158b3596],
26	)	NN	O	)	nn	31	SENT_195	[p9l87t3568r158b3596],
27	A	NN	O	a	nn	31	SENT_195	[p9l333t3569r353b3592],
28	T	NN	O	t	nn	31	SENT_195	[p9l524t3569r541b3592],
29	G	NN	O	g	nn	31	SENT_195	[p9l742t3569r761b3592],
30	T	NN	O	t	nn	31	SENT_195	[p9l994t3569r1011b3592],
31	T	NN	O	t	dep	39	SENT_195	[p9l1214t3569r1232b3592],
32	Additive	JJ	O	additive	amod	34	SENT_195	[p9l1358t3568r1476b3592],
33	1.72	CD	NUMBER	1.72	number	34	SENT_195	[p9l1563t3570r1617b3592],
34	(	CD	NUMBER	(	dep	31	SENT_195	[p9l1631t3568r1780b3596],
35	0.95-3	CD	NUMBER	0.95-3	num	37	SENT_195	[p9l1631t3568r1780b3596],
36	.09	CD	NUMBER	.09	num	37	SENT_195	[p9l1631t3568r1780b3596],
37	)	NN	O	)	dep	34	SENT_195	[p9l1631t3568r1780b3596],
38	0.0722	CD	NUMBER	0.0722	num	39	SENT_195	[p9l1871t3569r1962b3592],
39	—	NN	O	—	_	0	SENT_195	[p9l2052t3582r2084b3584],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_196	[p9l23t3631r214b3654],
2	:	:	O	:	_	0	SENT_196	[p9l23t3631r214b3654],
3	Cl	NN	O	cl	dep	1	SENT_196	[p9l227t3632r258b3658],
4	,	,	O	,	_	0	SENT_196	[p9l227t3632r258b3658],
5	conﬁdence	NN	O	conﬁdence	nn	6	SENT_196	[p9l270t3631r417b3654],
6	interval	NN	O	interval	appos	3	SENT_196	[p9l430t3631r534b3658],
7	;	:	O	;	_	0	SENT_196	[p9l430t3631r534b3658],
8	MAF	NN	O	maf	dep	1	SENT_196	[p9l547t3633r609b3658],
9	,	,	O	,	_	0	SENT_196	[p9l547t3633r609b3658],
10	minor	JJ	O	minor	amod	12	SENT_196	[p9l622t3632r700b3654],
11	allele	NN	O	allele	nn	12	SENT_196	[p9l711t3631r779b3654],
12	frequency	NN	O	frequency	appos	8	SENT_196	[p9l790t3631r931b3661],
13	;	:	O	;	_	0	SENT_196	[p9l790t3631r931b3661],
14	OR	NN	O	or	dep	1	SENT_196	[p9l943t3632r987b3658],
15	,	,	O	,	_	0	SENT_196	[p9l943t3632r987b3658],
16	odds	NNS	O	odds	nn	17	SENT_196	[p9l1000t3631r1064b3654],
17	ratio	NN	O	ratio	appos	14	SENT_196	[p9l1078t3632r1142b3654],
18	.	.	O	.	_	0	SENT_196	[p9l1078t3632r1142b3654],

1	**	NN	O	**	nsubj	4	SENT_197	[p9l23t3669r226b3698],
2	FDR	NNP	O	FDR	dep	1	SENT_197	[p9l23t3669r226b3698],
3	—	CD	NUMBER	—	num	2	SENT_197	[p9l23t3669r226b3698],
4	adjusted	VBN	O	adjust	_	0	SENT_197	[p9l23t3669r226b3698],
5	P	NN	O	p	nn	8	SENT_197	[p9l239t3669r340b3692],
6	—	CD	NUMBER	—	num	8	SENT_197	[p9l239t3669r340b3692],
7	va	NN	O	va	nn	8	SENT_197	[p9l239t3669r340b3692],
8	|	NN	O	|	tmod	4	SENT_197	[p9l239t3669r340b3692],
9	ue	NN	O	ue	dep	8	SENT_197	[p9l239t3669r340b3692],
10	.	.	O	.	_	0	SENT_197	[p9l239t3669r340b3692],

1	aAdjusted	VBN	O	aadjust	partmod	15	SENT_198	[p9l23t3704r152b3735],
2	for	IN	O	for	_	0	SENT_198	[p9l164t3706r201b3729],
3	sex	NN	O	sex	prep_for	1	SENT_198	[p9l213t3713r261b3733],
4	,	,	O	,	_	0	SENT_198	[p9l213t3713r261b3733],
5	age	NN	O	age	nsubj	15	SENT_198	[p9l273t3713r327b3735],
6	,	,	O	,	_	0	SENT_198	[p9l273t3713r327b3735],
7	neo	NN	O	neo	appos	5	SENT_198	[p9l340t3706r515b3735],
8	—	CD	NUMBER	—	num	7	SENT_198	[p9l340t3706r515b3735],
9	adjuvant	JJ	O	adjuvant	amod	10	SENT_198	[p9l340t3706r515b3735],
10	therapy	NN	O	therapy	dep	7	SENT_198	[p9l527t3706r629b3736],
11	and	CC	O	and	_	0	SENT_198	[p9l640t3706r689b3729],
12	oxaliplatin	NN	O	oxaliplatin	nn	14	SENT_198	[p9l702t3706r838b3735],
13	cumulative	JJ	O	cumulative	amod	14	SENT_198	[p9l851t3706r998b3729],
14	dose	NN	O	dose	dep	7	SENT_198	[p9l1010t3706r1072b3729],
15	normalized	VBN	O	normalize	_	0	SENT_198	[p9l1085t3706r1231b3729],
16	by	IN	O	by	_	0	SENT_198	[p9l1246t3706r1277b3736],
17	BSA	NN	ORGANIZATION	bsa	prep_by	15	SENT_198	[p9l1289t3707r1346b3729],
18	.	.	O	.	_	0	SENT_198	[p9l1289t3707r1346b3729],

1	especially	RB	O	especially	advmod	2	SENT_199	[p10l10t128r320b201],
2	in	IN	O	in	_	0	SENT_199	[p10l347t131r398b184],
3	patients	NNS	O	patient	pobj	2	SENT_199	[p10l430t131r683b199],
4	with	IN	O	with	_	0	SENT_199	[p10l710t128r845b184],
5	favorable	JJ	O	favorable	amod	6	SENT_199	[p10l874t127r1172b184],
6	prognosis	NN	O	prognosis	prep_with	3	SENT_199	[p10l1202t131r1527b200],
7	.	.	O	.	_	0	SENT_199	[p10l1202t131r1527b200],

1	In	IN	O	in	_	0	SENT_200	[p10l1557t131r1608b184],
2	agreement	NN	O	agreement	prep_in	12	SENT_200	[p10l1637t137r1988b200],
3	with	IN	O	with	_	0	SENT_200	[p10l2012t128r2148b184],
4	similar	JJ	O	similar	amod	6	SENT_200	[p10l10t214r217b271],
5	previous	JJ	O	previous	amod	6	SENT_200	[p10l247t217r516b286],
6	studies	NNS	O	study	prep_with	2	SENT_200	[p10l546t202r814b280],
7	,7	CD	PERCENT	,7	number	8	SENT_200	[p10l546t202r814b280],
8	39	CD	PERCENT	39	num	9	SENT_200	[p10l844t218r979b271],
9	%	NN	PERCENT	%	nsubj	12	SENT_200	[p10l844t218r979b271],
10	of	IN	O	of	_	0	SENT_200	[p10l1008t214r1072b271],
11	patients	NNS	O	patient	prep_of	9	SENT_200	[p10l1099t217r1352b286],
12	developed	VBD	O	develop	_	0	SENT_200	[p10l1381t214r1718b286],
13	grade	NN	O	grade	dobj	12	SENT_200	[p10l1750t214r1932b286],
14	2	CD	NUMBER	2	num	13	SENT_200	[p10l1962t218r1994b270],
15	or	CC	O	or	_	0	SENT_200	[p10l2025t231r2089b271],
16	3	CD	NUMBER	3	num	17	SENT_200	[p10l2117t218r2149b271],
17	toxicity	NN	O	toxicity	conj_or	13	SENT_200	[p10l8t303r240b373],
18	in	IN	O	in	_	0	SENT_200	[p10l295t303r347b356],
19	our	PRP$	O	we	poss	20	SENT_200	[p10l404t317r510b357],
20	study	NN	O	study	prep_in	12	SENT_200	[p10l563t301r751b373],
21	.	.	O	.	_	0	SENT_200	[p10l563t301r751b373],

1	This	DT	O	this	det	2	SENT_201	[p10l802t301r929b357],
2	toxicity	NN	O	toxicity	nsubj	10	SENT_201	[p10l983t303r1216b373],
3	is	VBZ	O	be	cop	7	SENT_201	[p10l1270t303r1311b357],
4	common	JJ	O	common	dep	7	SENT_201	[p10l1367t317r1650b357],
5	and	CC	O	and	_	0	SENT_201	[p10l1707t301r1823b357],
6	clinically	RB	O	clinically	advmod	7	SENT_201	[p10l1881t301r2152b373],
7	relevant	JJ	O	relevant	_	0	SENT_201	[p10l12t386r283b452],
8	,	,	O	,	_	0	SENT_201	[p10l12t386r283b452],
9	and	CC	O	and	_	0	SENT_201	[p10l321t386r437b443],
10	deserves	VBZ	O	deserve	conj_and	7	SENT_201	[p10l479t386r757b443],
11	a	DT	O	a	det	13	SENT_201	[p10l796t403r827b443],
12	thorough	JJ	O	thorough	amod	13	SENT_201	[p10l867t386r1165b458],
13	investigation	NN	O	investigation	dobj	10	SENT_201	[p10l1209t389r1617b458],
14	of	IN	O	of	_	0	SENT_201	[p10l1659t385r1724b443],
15	its	PRP$	O	its	poss	18	SENT_201	[p10l1759t389r1826b443],
16	potential	JJ	O	potential	amod	18	SENT_201	[p10l1868t386r2148b457],
17	genetic	JJ	O	genetic	amod	18	SENT_201	[p10l10t475r245b544],
18	basis	NN	O	basis	prep_of	13	SENT_201	[p10l282t472r450b529],
19	.	.	O	.	_	0	SENT_201	[p10l282t472r450b529],

1	We	PRP	O	we	nsubj	2	SENT_202	[p10l484t475r584b529],
2	aimed	VBD	O	aim	_	0	SENT_202	[p10l619t472r814b529],
3	to	TO	O	to	aux	4	SENT_202	[p10l850t481r913b529],
4	validate	VB	O	validate	xcomp	2	SENT_202	[p10l947t472r1198b529],
5	previous	JJ	O	previous	amod	6	SENT_202	[p10l1235t475r1504b544],
6	associations	NNS	O	association	dobj	4	SENT_202	[p10l1539t475r1923b529],
7	in	IN	O	in	_	0	SENT_202	[p10l1960t475r2011b528],
8	the	DT	O	the	det	10	SENT_202	[p10l2047t472r2150b529],
9	metastatic	JJ	O	metastatic	amod	10	SENT_202	[p10l12t561r340b615],
10	setting	NN	O	setting	prep_in	4	SENT_202	[p10l375t561r608b631],
11	,	,	O	,	_	0	SENT_202	[p10l375t561r608b631],
12	and	CC	O	and	_	0	SENT_202	[p10l642t559r759b615],
13	discover	VB	O	discover	xcomp	2	SENT_202	[p10l796t559r1062b615],
14	new	JJ	O	new	amod	16	SENT_202	[p10l1097t575r1230b615],
15	putative	JJ	O	putative	amod	16	SENT_202	[p10l1265t561r1524b630],
16	marker	NN	O	marker	dobj	13	SENT_202	[p10l1561t559r1782b615],
17	for	IN	O	for	_	0	SENT_202	[p10l1813t558r1901b615],
18	further	JJ	O	further	amod	19	SENT_202	[p10l1932t558r2152b615],
19	investigation	NN	O	investigation	prep_for	16	SENT_202	[p10l11t647r438b717],
20	.	.	O	.	_	0	SENT_202	[p10l11t647r438b717],

1	A	DT	O	a	det	3	SENT_203	[p10l86t733r130b786],
2	comprehensive	JJ	O	comprehensive	amod	3	SENT_203	[p10l158t730r651b802],
3	panel	NN	O	panel	nsubjpass	7	SENT_203	[p10l683t730r852b802],
4	of	IN	O	of	_	0	SENT_203	[p10l884t730r949b787],
5	SNPs	NNS	O	snp	prep_of	3	SENT_203	[p10l973t732r1128b787],
6	was	VBD	O	be	auxpass	7	SENT_203	[p10l1156t747r1277b787],
7	selected	VBN	O	select	_	0	SENT_203	[p10l1307t730r1567b787],
8	to	TO	O	to	aux	9	SENT_203	[p10l1598t739r1661b787],
9	include	VB	O	include	xcomp	7	SENT_203	[p10l1692t730r1923b787],
10	all	PDT	O	all	predet	11	SENT_203	[p10l1952t730r2017b787],
11	the	DT	O	the	dobj	9	SENT_203	[p10l2047t730r2150b787],
12	most	RBS	O	most	advmod	13	SENT_203	[p10l12t825r168b873],
13	relevant	JJ	O	relevant	amod	14	SENT_203	[p10l208t817r465b873],
14	polymorphisms	NNS	O	polymorphism	tmod	9	SENT_203	[p10l505t817r999b889],
15	previously	RB	DATE	previously	advmod	16	SENT_203	[p10l1041t817r1367b889],
16	reported	VBN	O	report	partmod	14	SENT_203	[p10l1407t817r1679b888],
17	as	IN	O	as	_	0	SENT_203	[p10l1721t833r1784b873],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_203	[p10l1824t816r2151b889],
19	markers	NNS	O	marker	prep_as	16	SENT_203	[p10l12t903r262b959],
20	of	IN	O	of	_	0	SENT_203	[p10l322t902r387b959],
21	toxicity	NN	O	toxicity	dep	30	SENT_203	[p10l440t905r673b975],
22	in	IN	O	in	_	0	SENT_203	[p10l733t905r784b958],
23	FOLFOX4	NN	O	folfox4	prep_in	21	SENT_203	[p10l850t904r1143b959],
24	in	IN	O	in	_	0	SENT_203	[p10l1204t905r1255b958],
25	metastatic	JJ	O	metastatic	amod	27	SENT_203	[p10l1321t905r1649b959],
26	CRC	NN	ORGANIZATION	crc	nn	27	SENT_203	[p10l1710t905r1835b959],
27	patients	NNS	O	patient	prep_in	23	SENT_203	[p10l1897t905r2150b974],
28	(	CD	NUMBER	(	num	30	SENT_203	[p10l11t989r522b1061],
29	Supplementary	NNP	O	Supplementary	nn	30	SENT_203	[p10l11t989r522b1061],
30	Table	NNP	O	Table	prep_of	19	SENT_203	[p10l542t989r715b1045],
31	1	CD	NUMBER	1	num	32	SENT_203	[p10l745t990r812b1054],
32	)	CD	NUMBER	)	dep	14	SENT_203	[p10l745t990r812b1054],
33	.	.	O	.	_	0	SENT_203	[p10l745t990r812b1054],

1	In	IN	O	in	_	0	SENT_204	[p10l840t991r890b1045],
2	the	DT	O	the	det	4	SENT_204	[p10l916t989r1019b1045],
3	present	JJ	DATE	present	amod	4	SENT_204	[p10l1046t997r1285b1060],
4	study	NN	O	study	prep_in	8	SENT_204	[p10l1309t989r1483b1061],
5	we	PRP	O	we	nsubj	8	SENT_204	[p10l1505t1006r1597b1045],
6	did	VBD	O	do	aux	8	SENT_204	[p10l1622t989r1719b1045],
7	not	RB	O	not	neg	8	SENT_204	[p10l1749t997r1853b1045],
8	replicate	VB	O	replicate	_	0	SENT_204	[p10l1879t989r2150b1060],
9	the	DT	O	the	det	11	SENT_204	[p10l8t1074r111b1131],
10	predictive	JJ	O	predictive	amod	11	SENT_204	[p10l169t1074r484b1146],
11	role	NN	O	role	iobj	8	SENT_204	[p10l542t1074r657b1131],
12	of	IN	O	of	_	0	SENT_204	[p10l714t1074r779b1131],
13	the	DT	O	the	det	14	SENT_204	[p10l827t1074r930b1131],
14	GSTP7	NN	O	gstp7	prep_of	11	SENT_204	[p10l987t1076r1494b1131],
15	—	CD	NUMBER	—	num	17	SENT_204	[p10l987t1076r1494b1131],
16	rs947894	NN	O	rs947894	nn	17	SENT_204	[p10l987t1076r1494b1131],
17	polymorphism	NN	O	polymorphism	dobj	8	SENT_204	[p10l1552t1074r2012b1147],
18	on	IN	O	on	_	0	SENT_204	[p10l2071t1091r2148b1131],
19	neurotoxicity	NN	O	neurotoxicity	prep_on	8	SENT_204	[p10l12t1163r431b1233],
20	previously	RB	DATE	previously	advmod	21	SENT_204	[p10l494t1161r819b1233],
21	reported	VBN	O	report	partmod	19	SENT_204	[p10l881t1161r1153b1232],
22	in	IN	O	in	_	0	SENT_204	[p10l1220t1163r1271b1217],
23	advanced	JJ	O	advanced	amod	25	SENT_204	[p10l1336t1161r1643b1217],
24	CRC	NN	ORGANIZATION	crc	nn	25	SENT_204	[p10l1707t1163r1833b1217],
25	patients	NNS	O	patient	prep_in	21	SENT_204	[p10l1897t1163r2150b1232],
26	treated	VBN	O	treat	partmod	25	SENT_204	[p10l8t1247r235b1304],
27	with	IN	O	with	_	0	SENT_204	[p10l303t1247r438b1304],
28	FOLFOX4	NN	O	folfox4	prep_with	26	SENT_204	[p10l510t1233r1091b1304],
29	.	.	O	.	_	0	SENT_204	[p10l510t1233r1091b1304],

1	l8	NN	O	l8	nn	3	SENT_205	[p10l510t1233r1091b1304],
2	'	''	O	'	_	0	SENT_205	[p10l510t1233r1091b1304],
3	l9	NN	O	l9	_	0	SENT_205	[p10l510t1233r1091b1304],
4	'	''	DATE	'	_	0	SENT_205	[p10l510t1233r1091b1304],
5	24	CD	DATE	24	number	6	SENT_205	[p10l510t1233r1091b1304],
6	'26	CD	DATE	'26	num	9	SENT_205	[p10l510t1233r1091b1304],
7	The	DT	O	the	det	9	SENT_205	[p10l1154t1247r1271b1304],
8	clinical	JJ	O	clinical	amod	9	SENT_205	[p10l1338t1247r1551b1304],
9	validity	NN	O	validity	nsubjpass	16	SENT_205	[p10l1618t1247r1849b1319],
10	of	IN	O	of	_	0	SENT_205	[p10l1913t1246r1978b1304],
11	this	DT	O	this	det	12	SENT_205	[p10l2038t1247r2150b1304],
12	marker	NN	O	marker	prep_of	9	SENT_205	[p10l12t1333r233b1389],
13	has	VBZ	O	have	aux	16	SENT_205	[p10l268t1333r371b1389],
14	been	VBN	O	be	auxpass	16	SENT_205	[p10l408t1333r562b1389],
15	already	RB	O	already	advmod	16	SENT_205	[p10l599t1333r832b1405],
16	put	VBN	O	put	rcmod	3	SENT_205	[p10l867t1342r972b1404],
17	into	IN	O	into	_	0	SENT_205	[p10l1007t1335r1127b1389],
18	question	NN	O	question	prep_into	16	SENT_205	[p10l1162t1320r1657b1404],
19	.25	CD	NUMBER	.25	num	18	SENT_205	[p10l1162t1320r1657b1404],
20	'	''	DATE	'	_	0	SENT_205	[p10l1162t1320r1657b1404],
21	27	CD	DATE	27	num	22	SENT_205	[p10l1162t1320r1657b1404],
22	'36	CD	DATE	'36	nsubj	27	SENT_205	[p10l1162t1320r1657b1404],
23	Moreover	RB	O	moreover	advmod	27	SENT_205	[p10l1693t1335r2013b1398],
24	,	,	O	,	_	0	SENT_205	[p10l1693t1335r2013b1398],
25	our	PRP$	O	we	poss	26	SENT_205	[p10l2047t1349r2152b1389],
26	study	NN	O	study	nsubj	27	SENT_205	[p10l10t1419r184b1491],
27	seems	VBZ	O	seem	rcmod	18	SENT_205	[p10l218t1435r416b1475],
28	to	TO	O	to	aux	29	SENT_205	[p10l451t1427r515b1475],
29	suggest	VB	O	suggest	xcomp	27	SENT_205	[p10l550t1427r799b1491],
30	that	IN	O	that	complm	32	SENT_205	[p10l832t1419r960b1475],
31	its	PRP$	O	its	poss	32	SENT_205	[p10l997t1421r1063b1475],
32	effect	NN	O	effect	dep	29	SENT_205	[p10l1099t1418r1278b1475],
33	(	CD	NUMBER	(	dep	32	SENT_205	[p10l1314t1418r1375b1484],
34	if	IN	O	if	mark	40	SENT_205	[p10l1314t1418r1375b1484],
35	any	DT	O	any	det	36	SENT_205	[p10l1405t1420r1536b1491],
36	)	NN	O	)	nsubj	40	SENT_205	[p10l1405t1420r1536b1491],
37	might	MD	O	might	aux	40	SENT_205	[p10l1577t1419r1764b1491],
38	be	VB	O	be	cop	40	SENT_205	[p10l1801t1419r1876b1475],
39	context	NN	O	context	npadvmod	40	SENT_205	[p10l1912t1427r2152b1475],
40	dependent	JJ	O	dependent	advcl	16	SENT_205	[p10l10t1505r378b1576],
41	.	.	O	.	_	0	SENT_205	[p10l10t1505r378b1576],

1	GSTP1	NN	O	gstp1	nsubj	4	SENT_206	[p10l420t1507r610b1561],
2	is	VBZ	O	be	cop	4	SENT_206	[p10l668t1508r709b1561],
3	an	DT	O	a	det	4	SENT_206	[p10l752t1522r825b1561],
4	enzyme	NN	O	enzyme	_	0	SENT_206	[p10l871t1522r1119b1577],
5	mediating	VBG	O	mediate	partmod	4	SENT_206	[p10l1166t1505r1487b1577],
6	glutathione-related	JJ	O	glutathione-related	amod	7	SENT_206	[p10l1532t1505r2148b1577],
7	detoxiﬁcation	NN	O	detoxiﬁcation	dobj	5	SENT_206	[p10l10t1590r444b1647],
8	of	IN	O	of	_	0	SENT_206	[p10l475t1590r541b1647],
9	oxaliplatin	NN	O	oxaliplatin	prep_of	7	SENT_206	[p10l563t1591r908b1662],
10	.	.	O	.	_	0	SENT_206	[p10l563t1591r908b1662],

1	This	DT	O	this	det	3	SENT_207	[p10l933t1591r1060b1647],
2	detoxiﬁcation	NN	O	detoxiﬁcation	nn	3	SENT_207	[p10l1089t1590r1523b1647],
3	pathway	NN	O	pathway	nsubj	6	SENT_207	[p10l1557t1591r1830b1664],
4	might	MD	O	might	aux	6	SENT_207	[p10l1859t1591r2046b1663],
5	be	VB	O	be	cop	6	SENT_207	[p10l2075t1591r2150b1647],
6	dependent	JJ	O	dependent	_	0	SENT_207	[p10l10t1677r363b1748],
7	upon	IN	O	upon	_	0	SENT_207	[p10l395t1693r556b1748],
8	systemic	JJ	O	systemic	amod	10	SENT_207	[p10l590t1679r863b1749],
9	oxidative	JJ	O	oxidative	amod	10	SENT_207	[p10l895t1677r1184b1733],
10	stress	NN	O	stress	prep_upon	6	SENT_207	[p10l1216t1685r1407b1742],
11	,	,	O	,	_	0	SENT_207	[p10l1216t1685r1407b1742],
12	which	WDT	O	which	nsubjpass	14	SENT_207	[p10l1437t1677r1625b1733],
13	is	VBZ	O	be	auxpass	14	SENT_207	[p10l1661t1679r1702b1733],
14	known	VBN	O	know	rcmod	10	SENT_207	[p10l1736t1677r1946b1733],
15	to	TO	O	to	aux	17	SENT_207	[p10l1978t1685r2042b1733],
16	be	VB	O	be	cop	17	SENT_207	[p10l2075t1677r2150b1733],
17	impaired	JJ	O	impaired	xcomp	14	SENT_207	[p10l11t1762r290b1833],
18	in	IN	O	in	_	0	SENT_207	[p10l325t1765r377b1818],
19	patients	NNS	O	patient	prep_in	17	SENT_207	[p10l413t1765r665b1833],
20	with	IN	O	with	_	0	SENT_207	[p10l695t1762r831b1819],
21	metastatic	JJ	O	metastatic	amod	22	SENT_207	[p10l867t1765r1196b1819],
22	disease	NN	O	disease	prep_with	19	SENT_207	[p10l1227t1749r1534b1819],
23	.	.	O	.	_	0	SENT_207	[p10l1227t1749r1534b1819],

1	”	NN	O	”	_	0	SENT_208	[p10l1227t1749r1534b1819],

1	The	DT	O	the	det	3	SENT_209	[p10l7t1989r111b2039],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_209	[p10l141t1989r700b2052],
3	Journal	NNP	O	Journal	_	0	SENT_209	[p10l725t1989r929b2039],
4	(	CD	NUMBER	(	num	6	SENT_209	[p10l961t1990r1148b2046],
5	2013	CD	DATE	2013	num	6	SENT_209	[p10l961t1990r1148b2046],
6	)	NN	O	)	dep	3	SENT_209	[p10l961t1990r1148b2046],
7	,	,	O	,	_	0	SENT_209	[p10l961t1990r1148b2046],
8	403-409	CD	NUMBER	403-409	appos	6	SENT_209	[p10l1184t1992r1450b2039],

1	a	DT	O	a	det	3	SENT_210	[p10l19t2223r63b2271],
2	b	NN	O	b	nn	3	SENT_210	[p10l1131t2208r1177b2271],
3	l	NN	O	l	_	0	SENT_210	[p10l1604t2370r1651b2401],
4	‘	SYM	O	‘	dep	3	SENT_210	[p10l1604t2370r1651b2401],
5	-	:	O	-	_	0	SENT_210	[p10l1604t2370r1651b2401],
6	(	NN	O	(	nn	7	SENT_210	[p10l1845t2370r1892b2401],
7	D	NN	O	d	dep	3	SENT_210	[p10l1845t2370r1892b2401],
8	(	CD	NUMBER	(	num	9	SENT_210	[p10l2066t2373r2113b2404],
9	O	NN	O	o	dep	7	SENT_210	[p10l2066t2373r2113b2404],

1	l	NN	O	l	_	0	SENT_211	[p10l490t2393r537b2423],
2	\	SYM	O	\	dep	1	SENT_211	[p10l490t2393r537b2423],
3	-	:	O	-	_	0	SENT_211	[p10l490t2393r537b2423],
4	(	NN	O	(	nn	5	SENT_211	[p10l730t2393r778b2423],
5	O	NN	O	o	dep	1	SENT_211	[p10l730t2393r778b2423],
6	(	CD	NUMBER	(	num	7	SENT_211	[p10l951t2396r999b2427],
7	O	NN	O	o	dep	5	SENT_211	[p10l951t2396r999b2427],
8	‘	CD	NUMBER	‘	num	9	SENT_211	[p10l1155t2393r1202b2410, p10l40t2415r88b2472],
9	S	NN	O	s	dep	5	SENT_211	[p10l1155t2393r1202b2410, p10l40t2415r88b2472],

1	O	NN	O	o	nn	2	SENT_212	[p10l262t2432r309b2462],
2	o	NN	O	o	_	0	SENT_212	[p10l489t2428r537b2459],
3	?	.	O	?	_	0	SENT_212	[p10l489t2428r537b2459],

1	o	NN	O	o	_	0	SENT_213	[p10l730t2428r778b2459],
2	>	JJR	O	>	dep	1	SENT_213	[p10l730t2428r778b2459],
3	<	JJR	O	<	amod	4	SENT_213	[p10l951t2432r999b2462],
4	o	NN	O	o	dep	8	SENT_213	[p10l951t2432r999b2462],
5	‘	NN	O	‘	dep	4	SENT_213	[p10l1155t2419r1202b2449],
6	D	NN	O	d	dep	8	SENT_213	[p10l1155t2419r1202b2449],
7	8	CD	NUMBER	8	num	6	SENT_213	[p10l1376t2412r1423b2476],
8	$	$	MONEY	$	dep	22	SENT_213	[p10l1604t2406r1651b2469],
9	8	CD	MONEY	8	num	8	SENT_213	[p10l1845t2406r1892b2469],
10	8	CD	MONEY	8	num	8	SENT_213	[p10l2066t2409r2113b2472],
11	or	CC	O	or	_	0	SENT_213	[p10l40t2474r87b2505],
12	)	CD	NUMBER	)	num	13	SENT_213	[p10l40t2474r87b2505],
13	N	NN	O	n	conj_or	8	SENT_213	[p10l262t2464r309b2495],
14	(	CD	NUMBER	(	num	17	SENT_213	[p10l490t2461r537b2492],
15	O	NN	O	o	nn	17	SENT_213	[p10l490t2461r537b2492],
16	oo	NN	O	oo	nn	17	SENT_213	[p10l730t2461r778b2492],
17	o	NN	O	o	nsubj	22	SENT_213	[p10l951t2465r999b2495],
18	$	$	MONEY	$	dep	21	SENT_213	[p10l1155t2451r1202b2515],
19	(	CD	MONEY	(	number	18	SENT_213	[p10l1376t2477r1423b2508],
20	9	CD	MONEY	9	number	18	SENT_213	[p10l1376t2477r1423b2508],
21	(	NN	O	(	dep	17	SENT_213	[p10l1604t2471r1651b2502],
22	O	NN	O	o	ccomp	1	SENT_213	[p10l1604t2471r1651b2502],
23	Q	NNP	O	Q	nn	24	SENT_213	[p10l1845t2471r1892b2502],
24	o	NN	O	o	dobj	22	SENT_213	[p10l2066t2474r2113b2505],
25	Lo	NNP	O	Lo	prep	34	SENT_213	[p10l40t2507r88b2538],
26	(	CD	NUMBER	(	num	30	SENT_213	[p10l262t2497r309b2528],
27	o	NN	O	o	nn	30	SENT_213	[p10l262t2497r309b2528],
28	(	NN	O	(	nn	30	SENT_213	[p10l489t2494r537b2525],
29	'	''	O	'	_	0	SENT_213	[p10l489t2494r537b2525],
30	o	NN	O	o	dep	25	SENT_213	[p10l489t2494r537b2525],
31	Q	NNP	O	Q	dep	32	SENT_213	[p10l730t2494r778b2525],
32	o	NN	O	o	amod	30	SENT_213	[p10l952t2497r999b2528],
33	I	PRP	O	I	nsubj	34	SENT_213	[p10l1376t2513r1423b2544],
34	‘	VBP	O	‘	rcmod	24	SENT_213	[p10l1376t2513r1423b2544],
35	p.	NN	O	p.	nn	36	SENT_213	[p10l1604t2507r1651b2538],
36	gr	NN	O	gr	dobj	34	SENT_213	[p10l1845t2507r1892b2541],
37	‘	CD	NUMBER	‘	dep	36	SENT_213	[p10l2066t2510r2113b2544, p10l40t2542r87b2573],
38	Ion	NN	O	ion	prep	37	SENT_213	[p10l2066t2510r2113b2544, p10l40t2542r87b2573],
39	I	PRP	O	I	dep	38	SENT_213	[p10l262t2533r309b2564],
40	\	SYM	O	\	dep	37	SENT_213	[p10l262t2533r309b2564],
41	-	:	O	-	_	0	SENT_213	[p10l262t2533r309b2564],
42	l	NN	O	l	dep	36	SENT_213	[p10l489t2530r537b2560],
43	‘	SYM	O	‘	dep	36	SENT_213	[p10l489t2530r537b2560],
44	-	:	O	-	_	0	SENT_213	[p10l489t2530r537b2560],
45	wr	NN	O	wr	nn	46	SENT_213	[p10l730t2530r778b2564],
46	~	NN	O	~	parataxis	34	SENT_213	[p10l952t2533r999b2567],
47	:	:	O	:	_	0	SENT_213	[p10l952t2533r999b2567],
48	r	NN	O	r	nsubj	57	SENT_213	[p10l952t2533r999b2567],
49	°	CD	NUMBER	°	num	48	SENT_213	[p10l1155t2520r1202b2550],
50	1	LS	NUMBER	1	dep	57	SENT_213	[p10l1376t2556r1423b2573],
51	-	:	O	-	_	0	SENT_213	[p10l1376t2556r1423b2573],
52	N	NN	O	n	dep	57	SENT_213	[p10l1604t2539r1651b2570],
53	1	CD	NUMBER	1	num	52	SENT_213	[p10l1845t2549r1892b2567],
54	-	:	O	-	_	0	SENT_213	[p10l1845t2549r1892b2567],
55	rco	NN	O	rco	nn	56	SENT_213	[p10l2066t2543r2113b2573, p10l40t2575r88b2606],
56	F	NN	O	f	dep	52	SENT_213	[p10l262t2575r309b2593],
57	N	NN	O	n	dep	46	SENT_213	[p10l489t2562r537b2593],
58	"	''	O	"	punct	57	SENT_213	[p10l730t2572r778b2590],
59	"	``	O	"	punct	46	SENT_213	[p10l951t2565r999b2596],
60	'	''	O	'	_	0	SENT_213	[p10l951t2565r999b2596],
61	~	FW	O	~	dep	24	SENT_213	[p10l951t2565r999b2596],
62	°	FW	O	°	nn	63	SENT_213	[p10l1155t2553r1202b2583],
63	°	FW	O	°	rcmod	61	SENT_213	[p10l1155t2553r1202b2583],
64	l	NN	O	l	tmod	63	SENT_213	[p10l1376t2578r1423b2609],
65	‘	SYM	O	‘	dep	63	SENT_213	[p10l1376t2578r1423b2609],
66	-	:	O	-	_	0	SENT_213	[p10l1376t2578r1423b2609],
67	N	NN	O	n	dep	61	SENT_213	[p10l1604t2572r1651b2603],
68	V	NN	O	v	dep	67	SENT_213	[p10l1845t2572r1892b2606],
69	to	TO	O	to	_	0	SENT_213	[p10l2066t2575r2113b2606],
70	1	LS	NUMBER	1	prep_to	68	SENT_213	[p10l40t2618r88b2635],
71	-	:	O	-	_	0	SENT_213	[p10l40t2618r88b2635],
72	|	NN	O	|	dep	70	SENT_213	[p10l262t2598r309b2629],
73	‘	SYM	O	‘	dep	68	SENT_213	[p10l262t2598r309b2629],
74	-	:	O	-	_	0	SENT_213	[p10l262t2598r309b2629],
75	N	NN	O	n	dep	67	SENT_213	[p10l489t2595r537b2626],
76	V	NN	O	v	nn	79	SENT_213	[p10l730t2595r778b2629],
77	(	CD	NUMBER	(	num	79	SENT_213	[p10l952t2598r999b2629],
78	O	NN	O	o	nn	79	SENT_213	[p10l952t2598r999b2629],
79	E	NN	O	e	dobj	75	SENT_213	[p10l1155t2595r1202b2648],
80	9	CD	NUMBER	9	dep	79	SENT_213	[p10l1389t2614r1423b2642],
81	,	,	O	,	_	0	SENT_213	[p10l1389t2614r1423b2642],
82	m	NN	O	m	appos	80	SENT_213	[p10l1617t2608r1651b2635],
83	an	DT	O	a	det	84	SENT_213	[p10l1858t2608r1892b2635],
84	gr	NN	O	gr	dep	82	SENT_213	[p10l2079t2611r2113b2639],
85	;	:	O	;	_	0	SENT_213	[p10l2079t2611r2113b2639],
86	2	CD	NUMBER	2	dep	82	SENT_213	[p10l53t2644r88b2691],
87	2	CD	NUMBER	2	number	88	SENT_213	[p10l275t2634r309b2681],
88	22	CD	NUMBER	22	num	90	SENT_213	[p10l502t2631r537b2678],
89	2	CD	NUMBER	2	number	90	SENT_213	[p10l743t2631r778b2678],
90	2	CD	NUMBER	2	dep	86	SENT_213	[p10l964t2634r999b2681],
91	e	SYM	O	e	dep	79	SENT_213	[p10l1168t2650r1202b2668],
92	-	:	O	-	_	0	SENT_213	[p10l1389t2644r1423b2662],
93	~	NN	O	~	dep	61	SENT_213	[p10l1617t2637r1651b2655],
94	~	NN	O	~	nn	95	SENT_213	[p10l1858t2637r1892b2655],
95	~	NN	O	~	dep	93	SENT_213	[p10l2079t2641r2113b2658],

1	9g	NN	O	9g	_	0	SENT_214	[p10l1525t2888r1884b3363],
2	.	.	O	.	_	0	SENT_214	[p10l1525t2888r1884b3363],

1	Figure	NNP	O	Figure	_	0	SENT_215	[p11l9t41r164b107],
2	1	CD	NUMBER	1	dep	1	SENT_215	[p11l213t44r255b93],
3	.	.	O	.	_	0	SENT_215	[p11l213t44r255b93],

1	Pairwise	JJ	MISC	pairwise	amod	4	SENT_216	[p11l336t41r586b93],
2	linkage	NN	O	linkage	nn	4	SENT_216	[p11l637t39r859b108],
3	disequilibrium	NN	O	disequilibrium	nn	4	SENT_216	[p11l907t39r1353b107],
4	analysis	NN	O	analysis	nsubj	8	SENT_216	[p11l1404t39r1643b108],
5	among	IN	O	among	_	0	SENT_216	[p11l1692t55r1909b108],
6	ABCC2	NN	O	abcc2	nn	7	SENT_216	[p11l1956t41r2153b93],
7	polymorphisms	NNS	O	polymorphism	prep_among	4	SENT_216	[p11l9t117r492b186],
8	associated	VBN	O	associate	_	0	SENT_216	[p11l534t117r855b170],
9	to	TO	O	to	_	0	SENT_216	[p11l898t125r961b170],
10	neurotoxicity	NN	O	neurotoxicity	nn	11	SENT_216	[p11l1004t118r1415b186],
11	grade	NN	O	grade	prep_to	8	SENT_216	[p11l1454t117r1632b185],
12	22	CD	NUMBER	22	num	11	SENT_216	[p11l1683t120r1794b178],
13	.	.	O	.	_	0	SENT_216	[p11l1683t120r1794b178],

1	The	DT	O	the	det	2	SENT_217	[p11l1832t117r1948b170],
2	value	NN	O	value	nsubj	6	SENT_217	[p11l1987t117r2153b170],
3	within	IN	O	within	_	0	SENT_217	[p11l6t193r198b247],
4	each	DT	O	each	det	5	SENT_217	[p11l235t193r376b247],
5	diamond	NN	O	diamond	prep_within	2	SENT_217	[p11l413t193r691b247],
6	represents	VBZ	O	represent	_	0	SENT_217	[p11l729t201r1052b261],
7	the	DT	O	the	det	9	SENT_217	[p11l1085t193r1186b247],
8	pairwise	JJ	O	pairwise	amod	9	SENT_217	[p11l1222t195r1477b261],
9	correlation	NN	O	correlation	dobj	6	SENT_217	[p11l1511t193r1843b247],
10	between	IN	O	between	_	0	SENT_217	[p11l1883t193r2150b247],
11	polymorphims	NNS	O	polymorphim	prep_between	9	SENT_217	[p11l9t271r462b340],
12	(	RB	O	(	advmod	13	SENT_217	[p11l503t271r826b333],
13	measured	VBN	O	measure	partmod	11	SENT_217	[p11l503t271r826b333],
14	as	IN	O	as	_	0	SENT_217	[p11l868t287r929b325],
15	D’	NN	O	d’	prep_as	13	SENT_217	[p11l971t268r1030b324],
16	(	CD	NUMBER	(	num	15	SENT_217	[p11l1073t272r1145b333],
17	a	DT	O	a	det	18	SENT_217	[p11l1073t272r1145b333],
18	)	NN	O	)	dep	15	SENT_217	[p11l1073t272r1145b333],
19	or	CC	O	or	_	0	SENT_217	[p11l1186t287r1249b325],
20	r2	NN	O	r2	nn	22	SENT_217	[p11l1286t259r1334b324],
21	(	NN	O	(	nn	22	SENT_217	[p11l1375t271r1491b333],
22	b	NN	O	b	conj_or	15	SENT_217	[p11l1375t271r1491b333],
23	)	CD	NUMBER	)	num	24	SENT_217	[p11l1375t271r1491b333],
24	)	NN	O	)	dep	22	SENT_217	[p11l1375t271r1491b333],
25	.	.	O	.	_	0	SENT_217	[p11l1375t271r1491b333],

1	The	DT	O	the	det	2	SENT_218	[p11l1527t271r1642b325],
2	black	JJ	O	black	nsubj	7	SENT_218	[p11l1683t271r1845b325],
3	to	TO	O	to	_	0	SENT_218	[p11l1879t279r1942b325],
4	white	JJ	O	white	amod	6	SENT_218	[p11l1979t271r2153b325],
5	gradient	NN	O	gradient	nn	6	SENT_218	[p11l7t349r270b417],
6	reﬂects	NNS	O	reﬂects	prep_to	2	SENT_218	[p11l303t348r523b402],
7	higher	JJR	O	higher	_	0	SENT_218	[p11l557t349r757b447],
8	to	TO	O	to	aux	9	SENT_218	[p11l787t357r850b402],
9	lower	VB	O	lower	xcomp	7	SENT_218	[p11l884t349r1054b402],
10	values	NNS	O	value	dobj	9	SENT_218	[p11l1083t349r1295b402],
11	.	.	O	.	_	0	SENT_218	[p11l1083t349r1295b402],

1	The	DT	O	the	det	2	SENT_219	[p11l1322t349r1438b402],
2	plots	NNS	O	plot	nsubjpass	4	SENT_219	[p11l1471t349r1620b416],
3	were	VBD	O	be	auxpass	4	SENT_219	[p11l1650t365r1802b402],
4	generated	VBN	O	generate	_	0	SENT_219	[p11l1833t349r2149b417],
5	by	IN	O	by	_	0	SENT_219	[p11l9t427r83b496],
6	Hap	NN	O	hap	nn	8	SENT_219	[p11l112t427r446b494],
7	|	JJ	O	|	amod	8	SENT_219	[p11l112t427r446b494],
8	oView	NN	O	oview	agent	4	SENT_219	[p11l112t427r446b494],
9	3.32	CD	NUMBER	3.32	dep	8	SENT_219	[p11l474t431r614b481],
10	.	.	O	.	_	0	SENT_219	[p11l474t431r614b481],

1	o	NN	O	o	_	0	SENT_220	[p11l646t414r672b447],

1	©	RB	O	©	dep	2	SENT_221	[p11l1071t657r1116b702],
2	2013	CD	DATE	2013	dep	4	SENT_221	[p11l1143t655r1277b702],
3	Macmillan	NNP	ORGANIZATION	Macmillan	nn	4	SENT_221	[p11l1307t652r1595b702],
4	Publishers	NNPS	ORGANIZATION	Publishers	_	0	SENT_221	[p11l1626t652r1913b702],
5	Limited	NNP	ORGANIZATION	Limited	dep	4	SENT_221	[p11l1943t652r2151b702],

1	Pharmacogenomic	JJ	O	pharmacogenomic	amod	2	SENT_222	[p11l1032t777r1289b808],
2	markers	NNS	O	marker	_	0	SENT_222	[p11l1303t777r1410b802],
3	of	IN	O	of	_	0	SENT_222	[p11l1423t777r1451b802],
4	toxicity	NN	O	toxicity	prep_of	2	SENT_222	[p11l1461t779r1561b808],
5	in	IN	O	in	_	0	SENT_222	[p11l1573t779r1595b801],
6	adjuvant	JJ	O	adjuvant	amod	7	SENT_222	[p11l1610t777r1730b808],
7	FOLFOX4	NN	O	folfox4	prep_in	2	SENT_222	[p11l1743t778r1869b802],
8	E	NN	O	e	dep	7	SENT_222	[p11l1032t820r1045b843],
9	Cecchin	NNP	O	Cecchin	dobj	8	SENT_222	[p11l1058t819r1165b843],
10	et	FW	O	et	nn	11	SENT_222	[p11l1179t823r1204b843],
11	al	FW	O	al	dep	9	SENT_222	[p11l1215t819r1239b843],
12	@	SYM	O	@	dep	9	SENT_222	[p11l2092t785r2154b846],

1	Table	NNP	O	Table	_	0	SENT_223	[p11l23t930r88b956],
2	5	CD	NUMBER	5	dep	1	SENT_223	[p11l101t932r122b956],
3	.	.	O	.	_	0	SENT_223	[p11l101t932r122b956],

1	Signiﬁcant	JJ	O	signiﬁcant	amod	2	SENT_224	[p11l160t931r308b962],
2	associations	NNS	O	association	_	0	SENT_224	[p11l320t932r490b956],
3	between	IN	O	between	_	0	SENT_224	[p11l503t931r624b956],
4	genetic	JJ	O	genetic	amod	5	SENT_224	[p11l639t932r743b962],
5	polymorphisms	NNS	O	polymorphism	prep_between	2	SENT_224	[p11l756t931r974b962],
6	and	CC	O	and	_	0	SENT_224	[p11l988t931r1039b956],
7	grade	NN	O	grade	nn	9	SENT_224	[p11l1053t931r1134b962],
8	3-4	CD	NUMBER	3-4	num	9	SENT_224	[p11l1147t933r1196b956],
9	toxicity	NN	O	toxicity	prep_between	2	SENT_224	[p11l1208t932r1315b962],
10	.	.	O	.	_	0	SENT_224	[p11l1208t932r1315b962],

1	Associations	NNS	O	association	nsubj	6	SENT_225	[p11l1328t932r1502b956],
2	with	IN	O	with	_	0	SENT_225	[p11l1515t931r1575b956],
3	q	NN	O	q	prep_with	1	SENT_225	[p11l1589t933r1696b962],
4	<	JJR	O	<	dep	3	SENT_225	[p11l1589t933r1696b962],
5	0.10	CD	NUMBER	0.10	dep	4	SENT_225	[p11l1589t933r1696b962],
6	are	VBP	O	be	_	0	SENT_225	[p11l1709t938r1751b956],
7	in	IN	O	in	_	0	SENT_225	[p11l1765t932r1788b955],
8	bold	JJ	O	bold	prep_in	6	SENT_225	[p11l1803t931r1864b956],

1	SNP	NN	O	snp	nn	5	SENT_226	[p11l35t1009r89b1032],
2	Gene	NN	O	gene	nn	5	SENT_226	[p11l295t1009r362b1032],
3	Base	NN	O	base	nn	5	SENT_226	[p11l460t1009r520b1032],
4	change	NN	O	change	nn	5	SENT_226	[p11l532t1008r630b1039],
5	MAF	NN	O	maf	_	0	SENT_226	[p11l964t1009r1025b1032],
6	Most	JJS	O	most	dep	5	SENT_226	[p11l1522t1009r1588b1032],
7	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_226	[p11l1599t1008r1738b1039],
8	genetic	JJ	O	genetic	amod	9	SENT_226	[p11l1748t1009r1845b1039],
9	model	NN	O	model	dep	5	SENT_226	[p11l1856t1008r1940b1032],

1	Grade	NNP	O	Grade	dep	11	SENT_227	[p11l714t1101r794b1126],
2	23	CD	NUMBER	23	num	4	SENT_227	[p11l810t1103r852b1129],
3	toxicity	NN	O	toxicity	nn	4	SENT_227	[p11l866t1102r962b1132],
4	Grade	NNP	O	Grade	dep	1	SENT_227	[p11l1029t1101r1108b1126],
5	0-2	CD	NUMBER	0-2	num	7	SENT_227	[p11l1120t1103r1167b1126],
6	toxicity	NN	O	toxicity	nn	7	SENT_227	[p11l1181t1102r1277b1133],
7	Model	NNP	O	Model	dep	4	SENT_227	[p11l1372t1101r1455b1126],
8	OR	NN	O	or	dep	11	SENT_227	[p11l1591t1102r1628b1126],
9	(	CD	PERCENT	(	num	8	SENT_227	[p11l1642t1102r1706b1129],
10	95	CD	PERCENT	95	num	11	SENT_227	[p11l1642t1102r1706b1129],
11	%	NN	PERCENT	%	dep	15	SENT_227	[p11l1642t1102r1706b1129],
12	CI	NN	O	ci	nn	14	SENT_227	[p11l1719t1102r1752b1129],
13	)	CD	NUMBER	)	num	14	SENT_227	[p11l1719t1102r1752b1129],
14	Pa	NNP	O	Pa	dep	11	SENT_227	[p11l1891t1099r1918b1125],
15	q	VBD	O	q	_	0	SENT_227	[p11l2046t1102r2091b1132],
16	**	CD	NUMBER	**	dobj	15	SENT_227	[p11l2046t1102r2091b1132],

1	Neutropenia	NN	O	neutropenia	nn	3	SENT_228	[p11l36t1174r200b1203],
2	rs3136228	CD	NUMBER	rs3136228	num	3	SENT_228	[p11l70t1212r213b1235],
3	hM	NN	O	hm	dep	8	SENT_228	[p11l281t1210r376b1235],
4	$	$	MONEY	$	dep	3	SENT_228	[p11l281t1210r376b1235],
5	H6	CD	MONEY	h6	num	4	SENT_228	[p11l281t1210r376b1235],
6	T	NN	O	t	dep	8	SENT_228	[p11l508t1211r579b1234],
7	>	JJR	O	>	amod	8	SENT_228	[p11l508t1211r579b1234],
8	G	NN	O	g	dep	16	SENT_228	[p11l508t1211r579b1234],
9	0.509	CD	NUMBER	0.509	number	10	SENT_228	[p11l791t1212r865b1235],
10	0.410	CD	NUMBER	0.410	num	11	SENT_228	[p11l1106t1212r1180b1235],
11	Recessive	JJ	O	recessive	dep	8	SENT_228	[p11l1348t1211r1480b1235],
12	3.23	CD	NUMBER	3.23	num	13	SENT_228	[p11l1553t1212r1608b1235],
13	(	CD	NUMBER	(	dep	11	SENT_228	[p11l1623t1211r1772b1238],
14	1.38-7	CD	NUMBER	1.38-7	num	16	SENT_228	[p11l1623t1211r1772b1238],
15	.57	CD	NUMBER	.57	num	16	SENT_228	[p11l1623t1211r1772b1238],
16	)	NN	O	)	dep	23	SENT_228	[p11l1623t1211r1772b1238],
17	0.0071	CD	NUMBER	0.0071	number	18	SENT_228	[p11l1858t1212r1944b1235],
18	0.0937	CD	NUMBER	0.0937	dep	16	SENT_228	[p11l2018t1212r2118b1235],
19	rs35587	NN	O	rs35587	nn	21	SENT_228	[p11l70t1249r178b1272],
20	ABCC1	NN	O	abcc1	nn	21	SENT_228	[p11l283t1249r369b1272],
21	T	NN	O	t	dep	18	SENT_228	[p11l509t1249r578b1272],
22	>	JJR	O	>	amod	23	SENT_228	[p11l509t1249r578b1272],
23	C	NN	O	c	dep	25	SENT_228	[p11l509t1249r578b1272],
24	0.204	CD	NUMBER	0.204	num	25	SENT_228	[p11l791t1249r866b1272],
25	0.325	CD	NUMBER	0.325	dep	40	SENT_228	[p11l1106t1249r1179b1272],
26	Additive	JJ	O	additive	amod	27	SENT_228	[p11l1354t1248r1473b1272],
27	0.54	CD	NUMBER	0.54	dep	25	SENT_228	[p11l1552t1249r1610b1272],
28	(	CD	NUMBER	(	num	38	SENT_228	[p11l1623t1248r1772b1276],
29	O.	NNP	O	O.	nn	38	SENT_228	[p11l1623t1248r1772b1276],
30	31	CD	NUMBER	31	num	38	SENT_228	[p11l1623t1248r1772b1276],
31	—	CD	NUMBER	—	num	38	SENT_228	[p11l1623t1248r1772b1276],
32	0.96	CD	NUMBER	0.96	num	38	SENT_228	[p11l1623t1248r1772b1276],
33	)	NN	O	)	nn	38	SENT_228	[p11l1623t1248r1772b1276],
34	0.0368	CD	NUMBER	0.0368	num	38	SENT_228	[p11l1858t1249r1950b1272],
35	0.1273	CD	NUMBER	0.1273	num	38	SENT_228	[p11l2019t1249r2110b1272],
36	rs717620	NN	O	rs717620	nn	38	SENT_228	[p11l70t1287r196b1310],
37	ABCC2	NN	O	abcc2	nn	38	SENT_228	[p11l282t1286r372b1309],
38	C	NN	O	c	rcmod	27	SENT_228	[p11l510t1286r580b1310],
39	>	JJR	O	>	amod	40	SENT_228	[p11l510t1286r580b1310],
40	T	NN	O	t	dep	42	SENT_228	[p11l510t1286r580b1310],
41	0.269	CD	NUMBER	0.269	num	42	SENT_228	[p11l791t1287r865b1310],
42	0.165	CD	NUMBER	0.165	dep	51	SENT_228	[p11l1106t1287r1179b1310],
43	Additive	JJ	O	additive	amod	45	SENT_228	[p11l1354t1285r1473b1310],
44	1.81	CD	NUMBER	1.81	number	45	SENT_228	[p11l1555t1287r1604b1310],
45	(	CD	NUMBER	(	dep	42	SENT_228	[p11l1623t1286r1772b1313],
46	1.01	CD	NUMBER	1.01	num	47	SENT_228	[p11l1623t1286r1772b1313],
47	—	NN	O	—	dep	45	SENT_228	[p11l1623t1286r1772b1313],
48	3.26	CD	NUMBER	3.26	number	49	SENT_228	[p11l1623t1286r1772b1313],
49	)	CD	NUMBER	)	dep	47	SENT_228	[p11l1623t1286r1772b1313],
50	0.0466	CD	NUMBER	0.0466	num	51	SENT_228	[p11l1858t1287r1950b1310],
51	0.1273	CD	NUMBER	0.1273	_	0	SENT_228	[p11l2019t1287r2110b1310],

1	Any	DT	O	any	dep	101	SENT_229	[p11l34t1361r87b1391],
2	non-hematological	JJ	O	non-hematological	dep	101	SENT_229	[p11l98t1360r353b1391],
3	toxicity	NN	O	toxicity	dep	101	SENT_229	[p11l365t1361r461b1391],
4	rs1	NN	O	rs1	dep	101	SENT_229	[p11l70t1399r104b1421],
5	799794	CD	NUMBER	799794	dep	101	SENT_229	[p11l112t1399r213b1421],
6	XRCC3	NN	O	xrcc3	dep	101	SENT_229	[p11l283t1398r371b1421],
7	A	DT	O	a	dep	101	SENT_229	[p11l507t1398r527b1421],
8	>	JJR	O	>	dep	101	SENT_229	[p11l533t1404r555b1421],
9	G	NN	O	g	dep	101	SENT_229	[p11l561t1398r581b1421],
10	0.365	CD	NUMBER	0.365	dep	101	SENT_229	[p11l791t1399r864b1421],
11	0.225	CD	NUMBER	0.225	dep	101	SENT_229	[p11l1106t1399r1179b1421],
12	Recessive	JJ	O	recessive	dep	101	SENT_229	[p11l1348t1398r1480b1421],
13	8.90	CD	NUMBER	8.90	dep	101	SENT_229	[p11l1552t1399r1609b1421],
14	(	CD	NUMBER	(	dep	101	SENT_229	[p11l1623t1398r1734b1425],
15	2.48	CD	NUMBER	2.48	dep	101	SENT_229	[p11l1623t1398r1734b1425],
16	—	NN	O	—	dep	101	SENT_229	[p11l1623t1398r1734b1425],
17	31	CD	NUMBER	31	dep	101	SENT_229	[p11l1623t1398r1734b1425],
18	.97	CD	NUMBER	.97	dep	101	SENT_229	[p11l1742t1398r1789b1425],
19	)	NN	O	)	dep	101	SENT_229	[p11l1742t1398r1789b1425],
20	0.0008	CD	NUMBER	0.0008	dep	101	SENT_229	[p11l1858t1399r1950b1421],
21	0.0150	CD	NUMBER	0.0150	dep	101	SENT_229	[p11l2018t1399r2118b1421],
22	rs861539	NN	O	rs861539	dep	101	SENT_229	[p11l70t1436r196b1459],
23	XRCC3	NN	O	xrcc3	dep	101	SENT_229	[p11l284t1435r371b1459],
24	C	NN	O	c	dep	101	SENT_229	[p11l510t1435r528b1459],
25	>	JJR	O	>	dep	101	SENT_229	[p11l535t1436r580b1459],
26	T	NN	O	t	dep	101	SENT_229	[p11l535t1436r580b1459],
27	0.2917	CD	NUMBER	0.2917	dep	101	SENT_229	[p11l791t1436r882b1459],
28	0.4435	CD	NUMBER	0.4435	dep	101	SENT_229	[p11l1106t1436r1196b1459],
29	Additive	JJ	O	additive	dep	101	SENT_229	[p11l1354t1434r1473b1459],
30	0.49	CD	NUMBER	0.49	dep	101	SENT_229	[p11l1552t1436r1609b1459],
31	(	CD	NUMBER	(	dep	101	SENT_229	[p11l1623t1435r1772b1462],
32	0.24	CD	NUMBER	0.24	dep	101	SENT_229	[p11l1623t1435r1772b1462],
33	—	NN	O	—	dep	101	SENT_229	[p11l1623t1435r1772b1462],
34	1.00	CD	NUMBER	1.00	dep	101	SENT_229	[p11l1623t1435r1772b1462],
35	)	CD	NUMBER	)	dep	101	SENT_229	[p11l1623t1435r1772b1462],
36	0.0495	CD	NUMBER	0.0495	dep	101	SENT_229	[p11l1858t1436r1949b1459],
37	0.1326	CD	NUMBER	0.1326	dep	101	SENT_229	[p11l2019t1436r2111b1459],
38	rs3213239	NN	O	rs3213239	dep	101	SENT_229	[p11l70t1473r213b1496],
39	XRCC7	NN	O	xrcc7	dep	101	SENT_229	[p11l283t1473r368b1496],
40	|	CD	NUMBER	|	dep	101	SENT_229	[p11l509t1472r580b1496],
41	nDel	NN	O	ndel	dep	101	SENT_229	[p11l509t1472r580b1496],
42	0.212	CD	NUMBER	0.212	dep	101	SENT_229	[p11l791t1473r865b1496],
43	0.406	CD	NUMBER	0.406	dep	101	SENT_229	[p11l1106t1474r1180b1496],
44	Additive	JJ	O	additive	dep	101	SENT_229	[p11l1354t1472r1473b1496],
45	0.39	CD	NUMBER	0.39	dep	101	SENT_229	[p11l1552t1473r1609b1496],
46	(	CD	NUMBER	(	dep	101	SENT_229	[p11l1623t1472r1772b1500],
47	O.	NNP	O	O.	dep	101	SENT_229	[p11l1623t1472r1772b1500],
48	19	CD	NUMBER	19	dep	101	SENT_229	[p11l1623t1472r1772b1500],
49	—	CD	NUMBER	—	dep	101	SENT_229	[p11l1623t1472r1772b1500],
50	0.82	CD	NUMBER	0.82	dep	101	SENT_229	[p11l1623t1472r1772b1500],
51	)	NN	O	)	dep	101	SENT_229	[p11l1623t1472r1772b1500],
52	0.0130	CD	NUMBER	0.0130	dep	101	SENT_229	[p11l1858t1473r1950b1496],
53	0.1217	CD	NUMBER	0.1217	dep	101	SENT_229	[p11l2019t1473r2111b1496],
54	rs1130409	NN	O	rs1130409	dep	101	SENT_229	[p11l70t1511r213b1534],
55	APE	NN	O	ape	dep	101	SENT_229	[p11l288t1510r341b1533],
56	1	CD	NUMBER	1	dep	101	SENT_229	[p11l356t1511r364b1533],
57	T	NN	O	t	dep	101	SENT_229	[p11l508t1510r579b1533],
58	>	JJR	O	>	dep	101	SENT_229	[p11l508t1510r579b1533],
59	G	NN	O	g	dep	101	SENT_229	[p11l508t1510r579b1533],
60	0.6042	CD	NUMBER	0.6042	dep	101	SENT_229	[p11l791t1511r882b1534],
61	0.4396	CD	NUMBER	0.4396	dep	101	SENT_229	[p11l1106t1511r1197b1534],
62	Additive	JJ	O	additive	dep	101	SENT_229	[p11l1354t1509r1473b1534],
63	1.99	CD	NUMBER	1.99	dep	101	SENT_229	[p11l1555t1511r1609b1534],
64	(	CD	NUMBER	(	dep	101	SENT_229	[p11l1623t1510r1772b1537],
65	1.05	CD	NUMBER	1.05	dep	101	SENT_229	[p11l1623t1510r1772b1537],
66	—	NN	O	—	dep	101	SENT_229	[p11l1623t1510r1772b1537],
67	3.74	CD	NUMBER	3.74	dep	101	SENT_229	[p11l1623t1510r1772b1537],
68	)	CD	NUMBER	)	dep	101	SENT_229	[p11l1623t1510r1772b1537],
69	0.0339	CD	NUMBER	0.0339	dep	101	SENT_229	[p11l1858t1511r1950b1534],
70	0.1326	CD	NUMBER	0.1326	dep	101	SENT_229	[p11l2019t1511r2111b1534],
71	rs1136410	NN	O	rs1136410	dep	101	SENT_229	[p11l70t1548r213b1571],
72	PARP	NN	O	parp	dep	101	SENT_229	[p11l294t1548r363b1571],
73	T	NN	O	t	dep	101	SENT_229	[p11l509t1548r578b1571],
74	>	JJR	O	>	dep	101	SENT_229	[p11l509t1548r578b1571],
75	C	NN	O	c	dep	101	SENT_229	[p11l509t1548r578b1571],
76	0.2500	CD	NUMBER	0.2500	dep	101	SENT_229	[p11l791t1548r883b1571],
77	0.1710	CD	NUMBER	0.1710	dep	101	SENT_229	[p11l1106t1548r1197b1571],
78	Dominant	JJ	O	dominant	dep	101	SENT_229	[p11l1344t1547r1484b1571],
79	2.77	CD	NUMBER	2.77	dep	101	SENT_229	[p11l1553t1548r1609b1571],
80	(	CD	NUMBER	(	dep	101	SENT_229	[p11l1623t1547r1772b1575],
81	1.07	CD	NUMBER	1.07	dep	101	SENT_229	[p11l1623t1547r1772b1575],
82	—	NN	O	—	dep	101	SENT_229	[p11l1623t1547r1772b1575],
83	7.21	CD	NUMBER	7.21	dep	101	SENT_229	[p11l1623t1547r1772b1575],
84	)	CD	NUMBER	)	dep	101	SENT_229	[p11l1623t1547r1772b1575],
85	0.0366	CD	NUMBER	0.0366	dep	101	SENT_229	[p11l1858t1548r1950b1571],
86	0.1326	CD	NUMBER	0.1326	dep	101	SENT_229	[p11l2019t1548r2111b1571],
87	N/A	NN	O	n/a	dep	101	SENT_229	[p11l70t1585r122b1609],
88	G57T1	NN	O	g57t1	dep	101	SENT_229	[p11l287t1585r367b1608],
89	Gene	NN	O	gene	dep	101	SENT_229	[p11l443t1585r517b1608],
90	deletion	NN	O	deletion	dep	101	SENT_229	[p11l530t1584r644b1608],
91	0.500	CD	NUMBER	0.500	dep	101	SENT_229	[p11l791t1586r865b1608],
92	0.364	CD	NUMBER	0.364	dep	101	SENT_229	[p11l1106t1586r1180b1608],
93	Recessive	JJ	O	recessive	dep	101	SENT_229	[p11l1348t1585r1480b1608],
94	2.82	CD	NUMBER	2.82	dep	101	SENT_229	[p11l1553t1586r1609b1608],
95	(	CD	NUMBER	(	dep	101	SENT_229	[p11l1623t1585r1772b1612],
96	1.02	CD	NUMBER	1.02	dep	101	SENT_229	[p11l1623t1585r1772b1612],
97	—	NN	O	—	dep	101	SENT_229	[p11l1623t1585r1772b1612],
98	7.83	CD	NUMBER	7.83	dep	101	SENT_229	[p11l1623t1585r1772b1612],
99	)	CD	NUMBER	)	dep	101	SENT_229	[p11l1623t1585r1772b1612],
100	0.0467	CD	NUMBER	0.0467	dep	101	SENT_229	[p11l1858t1586r1949b1608],
101	0.1326	CD	NUMBER	0.1326	_	0	SENT_229	[p11l2019t1586r2111b1608],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_230	[p11l23t1648r215b1671],
2	:	:	O	:	_	0	SENT_230	[p11l23t1648r215b1671],
3	Cl	NN	O	cl	dep	1	SENT_230	[p11l227t1649r258b1674],
4	,	,	O	,	_	0	SENT_230	[p11l227t1649r258b1674],
5	conﬁdence	NN	O	conﬁdence	nn	6	SENT_230	[p11l270t1647r417b1671],
6	interval	NN	O	interval	appos	3	SENT_230	[p11l430t1648r535b1674],
7	;	:	O	;	_	0	SENT_230	[p11l430t1648r535b1674],
8	MAF	NN	O	maf	dep	1	SENT_230	[p11l547t1649r609b1674],
9	,	,	O	,	_	0	SENT_230	[p11l547t1649r609b1674],
10	minor	JJ	O	minor	amod	12	SENT_230	[p11l622t1649r700b1671],
11	allele	NN	O	allele	nn	12	SENT_230	[p11l711t1648r779b1671],
12	frequency	NN	O	frequency	appos	8	SENT_230	[p11l790t1647r931b1677],
13	;	:	O	;	_	0	SENT_230	[p11l790t1647r931b1677],
14	N/A	NNP	O	N/A	dep	1	SENT_230	[p11l944t1649r999b1674],
15	,	,	O	,	_	0	SENT_230	[p11l944t1649r999b1674],
16	not	RB	O	not	neg	17	SENT_230	[p11l1013t1651r1056b1671],
17	applicable	JJ	O	applicable	amod	14	SENT_230	[p11l1068t1648r1210b1676],
18	;	:	O	;	_	0	SENT_230	[p11l1068t1648r1210b1676],
19	OR	NN	O	or	dep	1	SENT_230	[p11l1222t1649r1267b1674],
20	,	,	O	,	_	0	SENT_230	[p11l1222t1649r1267b1674],
21	odds	NNS	O	odds	nn	22	SENT_230	[p11l1279t1648r1343b1671],
22	ratio	NN	O	ratio	appos	19	SENT_230	[p11l1357t1649r1421b1671],
23	.	.	O	.	_	0	SENT_230	[p11l1357t1649r1421b1671],

1	**	NN	O	**	nsubj	4	SENT_231	[p11l23t1685r226b1714],
2	FDR	NNP	O	FDR	dep	1	SENT_231	[p11l23t1685r226b1714],
3	—	CD	NUMBER	—	num	2	SENT_231	[p11l23t1685r226b1714],
4	adjusted	VBN	O	adjust	_	0	SENT_231	[p11l23t1685r226b1714],
5	P	NN	O	p	nn	8	SENT_231	[p11l239t1685r340b1708],
6	—	CD	NUMBER	—	num	8	SENT_231	[p11l239t1685r340b1708],
7	va	NN	O	va	nn	8	SENT_231	[p11l239t1685r340b1708],
8	|	NN	O	|	tmod	4	SENT_231	[p11l239t1685r340b1708],
9	ue	NN	O	ue	dep	8	SENT_231	[p11l239t1685r340b1708],
10	.	.	O	.	_	0	SENT_231	[p11l239t1685r340b1708],

1	“	NN	O	“	nsubj	2	SENT_232	[p11l23t1720r152b1752],
2	Adjusted	VBN	O	adjust	_	0	SENT_232	[p11l23t1720r152b1752],
3	for	IN	O	for	_	0	SENT_232	[p11l165t1722r202b1745],
4	sex	NN	O	sex	prep_for	2	SENT_232	[p11l213t1729r261b1749],
5	,	,	O	,	_	0	SENT_232	[p11l213t1729r261b1749],
6	age	NN	O	age	appos	4	SENT_232	[p11l273t1729r327b1751],
7	,	,	O	,	_	0	SENT_232	[p11l273t1729r327b1751],
8	neo-adjuvant	JJ	O	neo-adjuvant	amod	9	SENT_232	[p11l340t1722r515b1752],
9	therapy	NN	O	therapy	appos	6	SENT_232	[p11l527t1722r634b1752],
10	.	.	O	.	_	0	SENT_232	[p11l527t1722r634b1752],

1	Findings	NNS	O	finding	nsubjpass	12	SENT_233	[p11l90t1935r357b2007],
2	from	IN	O	from	_	0	SENT_233	[p11l390t1934r538b1991],
3	similar	JJ	O	similar	amod	5	SENT_233	[p11l577t1935r784b1991],
4	pharmacogenomic	JJ	O	pharmacogenomic	amod	5	SENT_233	[p11l819t1935r1421b2007],
5	studies	NNS	O	study	prep_from	1	SENT_233	[p11l1457t1935r1679b1991],
6	conducted	VBN	O	conduct	partmod	5	SENT_233	[p11l1715t1935r2054b1991],
7	in	IN	O	in	_	0	SENT_233	[p11l2094t1937r2145b1990],
8	different	JJ	O	different	amod	9	SENT_233	[p11l10t2020r282b2077],
9	settings	NNS	O	setting	prep_in	6	SENT_233	[p11l348t2023r595b2092],
10	should	MD	O	should	aux	12	SENT_233	[p11l663t2020r873b2077],
11	be	VB	O	be	auxpass	12	SENT_233	[p11l945t2020r1020b2077],
12	interpreted	VBN	O	interpret	_	0	SENT_233	[p11l1088t2020r1442b2092],
13	with	IN	O	with	_	0	SENT_233	[p11l1510t2020r1646b2077],
14	caution	NN	O	caution	prep_with	12	SENT_233	[p11l1715t2023r1967b2077],
15	.	.	O	.	_	0	SENT_233	[p11l1715t2023r1967b2077],

1	The	DT	O	the	det	3	SENT_234	[p11l2030t2020r2147b2077],
2	biological	JJ	O	biological	amod	3	SENT_234	[p11l12t2106r315b2178],
3	scenario	NN	O	scenario	nsubj	13	SENT_234	[p11l363t2109r627b2163],
4	of	IN	O	of	_	0	SENT_234	[p11l673t2106r738b2163],
5	patients	NNS	O	patient	prep_of	3	SENT_234	[p11l780t2109r1033b2178],
6	with	IN	O	with	_	0	SENT_234	[p11l1079t2106r1214b2163],
7	early	JJ	O	early	amod	8	SENT_234	[p11l1262t2106r1414b2179],
8	disease	NN	O	disease	prep_with	5	SENT_234	[p11l1458t2106r1690b2163],
9	treated	VBN	O	treat	partmod	8	SENT_234	[p11l1735t2106r1962b2163],
10	with	IN	O	with	_	0	SENT_234	[p11l2009t2106r2145b2163],
11	adjuvant	JJ	O	adjuvant	amod	12	SENT_234	[p11l9t2193r289b2265],
12	oxaliplatin	NN	O	oxaliplatin	prep_with	9	SENT_234	[p11l323t2193r649b2264],
13	differs	VBZ	O	differ	_	0	SENT_234	[p11l686t2192r881b2249],
14	from	IN	O	from	_	0	SENT_234	[p11l915t2192r1063b2249],
15	that	DT	O	that	prep_from	13	SENT_234	[p11l1099t2193r1227b2249],
16	of	IN	O	of	_	0	SENT_234	[p11l1260t2192r1326b2249],
17	patients	NNS	O	patient	prep_of	15	SENT_234	[p11l1357t2195r1609b2264],
18	with	IN	O	with	_	0	SENT_234	[p11l1644t2193r1779b2249],
19	metastatic	JJ	O	metastatic	amod	20	SENT_234	[p11l1819t2195r2147b2249],
20	disease	NN	O	disease	prep_with	17	SENT_234	[p11l10t2279r257b2335],
21	.	.	O	.	_	0	SENT_234	[p11l10t2279r257b2335],

1	The	DT	O	the	det	5	SENT_235	[p11l290t2279r407b2335],
2	molecular	JJ	O	molecular	amod	5	SENT_235	[p11l445t2279r759b2335],
3	and	CC	O	and	_	0	SENT_235	[p11l793t2279r909b2335],
4	metabolic	JJ	O	metabolic	conj_and	2	SENT_235	[p11l950t2279r1264b2335],
5	changes	NNS	O	change	nsubj	10	SENT_235	[p11l1299t2279r1563b2351],
6	related	VBN	O	relate	partmod	5	SENT_235	[p11l1602t2279r1817b2335],
7	to	TO	O	to	_	0	SENT_235	[p11l1854t2287r1918b2335],
8	tumor	NN	O	tumor	nn	9	SENT_235	[p11l1952t2287r2149b2335],
9	metastatization	NN	O	metastatization	prep_to	6	SENT_235	[p11l12t2367r500b2421],
10	involve	VBP	O	involve	_	0	SENT_235	[p11l532t2364r758b2421],
11	several	JJ	O	several	amod	12	SENT_235	[p11l785t2364r1002b2421],
12	pathways	NNS	O	pathway	dobj	10	SENT_235	[p11l1035t2364r1352b2437],
13	,	,	O	,	_	0	SENT_235	[p11l1035t2364r1352b2437],
14	including	VBG	O	include	_	0	SENT_235	[p11l1380t2364r1673b2436],
15	the	DT	O	the	det	16	SENT_235	[p11l1701t2364r1804b2421],
16	glycolysis	NN	O	glycolysis	prep_including	10	SENT_235	[p11l1831t2364r2148b2437],
17	,	,	O	,	_	0	SENT_235	[p11l1831t2364r2148b2437],
18	the	DT	O	the	det	21	SENT_235	[p11l8t2451r111b2507],
19	tricarboxylic	JJ	O	tricarboxylic	amod	21	SENT_235	[p11l137t2451r525b2523],
20	acid	NN	O	acid	nn	21	SENT_235	[p11l553t2451r679b2507],
21	cycle	NN	O	cycle	prep_including	10	SENT_235	[p11l709t2451r881b2523],
22	,	,	O	,	_	0	SENT_235	[p11l709t2451r881b2523],
23	the	DT	O	the	det	26	SENT_235	[p11l907t2451r1010b2507],
24	pentose	NN	O	pentose	nn	26	SENT_235	[p11l1040t2459r1294b2522],
25	phosphate	NN	O	phosphate	nn	26	SENT_235	[p11l1324t2451r1663b2522],
26	pathway	NN	O	pathway	prep_including	10	SENT_235	[p11l1693t2451r1980b2523],
27	,	,	O	,	_	0	SENT_235	[p11l1693t2451r1980b2523],
28	fatty	JJ	O	fatty	amod	29	SENT_235	[p11l2005t2450r2149b2523],
29	acid	NN	O	acid	conj_and	16	SENT_235	[p11l9t2537r135b2593],
30	and	CC	O	and	_	0	SENT_235	[p11l208t2537r324b2593],
31	nucleotide	NN	O	nucleotide	nn	32	SENT_235	[p11l401t2537r736b2593],
32	biosynthesis	NN	O	biosynthesis	conj_and	29	SENT_235	[p11l809t2537r1200b2609],
33	and	CC	O	and	_	0	SENT_235	[p11l1272t2537r1388b2593],
34	the	DT	O	the	det	37	SENT_235	[p11l1460t2537r1563b2593],
35	GSH-dependent	JJ	O	gsh-dependent	amod	37	SENT_235	[p11l1634t2537r2149b2608],
36	antioxidative	JJ	O	antioxidative	amod	37	SENT_235	[p11l9t2623r421b2679],
37	pathway	NN	O	pathway	prep_including	10	SENT_235	[p11l472t2610r818b2695],
38	.37	CD	NUMBER	.37	tmod	37	SENT_235	[p11l472t2610r818b2695],
39	Thus	RB	O	thus	advmod	38	SENT_235	[p11l864t2623r1031b2688],
40	,	,	O	,	_	0	SENT_235	[p11l864t2623r1031b2688],
41	because	IN	O	because	mark	60	SENT_235	[p11l1081t2623r1338b2679],
42	of	IN	O	of	_	0	SENT_235	[p11l1388t2622r1452b2679],
43	the	DT	O	the	det	44	SENT_235	[p11l1494t2623r1597b2679],
44	role	NN	O	role	prep_of	60	SENT_235	[p11l1648t2623r1763b2679],
45	played	VBN	O	play	partmod	44	SENT_235	[p11l1815t2623r2021b2695],
46	by	IN	O	by	_	0	SENT_235	[p11l2075t2623r2149b2695],
47	these	DT	O	these	det	48	SENT_235	[p11l8t2709r180b2765],
48	pathways	NNS	O	pathway	agent	45	SENT_235	[p11l279t2709r580b2781],
49	in	IN	O	in	_	0	SENT_235	[p11l680t2711r731b2764],
50	the	DT	O	the	det	51	SENT_235	[p11l828t2709r931b2765],
51	pathophysiology	NN	O	pathophysiology	prep_in	48	SENT_235	[p11l1031t2709r1567b2781],
52	of	IN	O	of	_	0	SENT_235	[p11l1662t2708r1727b2765],
53	oxaliplatin	NN	O	oxaliplatin	nn	54	SENT_235	[p11l1818t2709r2145b2780],
54	neurotoxicity	NN	O	neurotoxicity	prep_of	51	SENT_235	[p11l12t2781r574b2867],
55	,	,	O	,	_	0	SENT_235	[p11l12t2781r574b2867],
56	l2	NN	O	l2	appos	54	SENT_235	[p11l12t2781r574b2867],
57	'38	CD	NUMBER	'38	num	56	SENT_235	[p11l12t2781r574b2867],
58	it	PRP	O	it	nsubj	60	SENT_235	[p11l635t2797r672b2850],
59	is	VBZ	O	be	cop	60	SENT_235	[p11l732t2797r772b2850],
60	plausible	JJ	O	plausible	advcl	10	SENT_235	[p11l834t2794r1115b2865],
61	that	IN	O	that	complm	65	SENT_235	[p11l1172t2794r1300b2851],
62	genetic	JJ	O	genetic	amod	63	SENT_235	[p11l1358t2797r1593b2866],
63	polymorphisms	NNS	O	polymorphism	nsubj	65	SENT_235	[p11l1654t2794r2146b2866],
64	could	MD	O	could	aux	65	SENT_235	[p11l10t2880r182b2936],
65	have	VB	O	have	ccomp	60	SENT_235	[p11l212t2880r360b2936],
66	a	DT	O	a	det	68	SENT_235	[p11l385t2897r416b2936],
67	different	JJ	O	different	amod	68	SENT_235	[p11l443t2879r715b2936],
68	impact	NN	O	impact	dobj	65	SENT_235	[p11l742t2883r959b2951],
69	depending	VBG	O	depend	prep	65	SENT_235	[p11l983t2880r1330b2952],
70	upon	IN	O	upon	pcomp	69	SENT_235	[p11l1360t2897r1520b2951],
71	the	DT	O	the	det	73	SENT_235	[p11l1546t2880r1649b2936],
72	clinical	JJ	O	clinical	amod	73	SENT_235	[p11l1674t2880r1886b2936],
73	setting	NN	O	setting	pobj	70	SENT_235	[p11l1915t2882r2148b2952],
74	.	.	O	.	_	0	SENT_235	[p11l1915t2882r2148b2952],

1	The	DT	O	the	det	2	SENT_236	[p11l84t2966r201b3022],
2	panel	NN	O	panel	nsubjpass	11	SENT_236	[p11l240t2966r410b3037],
3	of	IN	O	of	_	0	SENT_236	[p11l450t2965r514b3022],
4	SNPs	NNS	O	snp	prep_of	2	SENT_236	[p11l546t2968r700b3022],
5	for	IN	O	for	_	0	SENT_236	[p11l736t2965r824b3022],
6	genotyping	VBG	O	genotype	prepc_for	4	SENT_236	[p11l858t2968r1225b3038],
7	in	IN	O	in	_	0	SENT_236	[p11l1266t2968r1317b3021],
8	this	DT	O	this	det	9	SENT_236	[p11l1355t2966r1467b3022],
9	study	NN	O	study	prep_in	6	SENT_236	[p11l1504t2966r1678b3038],
10	was	VBD	O	be	auxpass	11	SENT_236	[p11l1712t2982r1832b3022],
11	enriched	VBN	O	enrich	_	0	SENT_236	[p11l1869t2966r2145b3022],
12	with	IN	O	with	_	0	SENT_236	[p11l8t3052r144b3108],
13	SNPs	NNS	O	snp	prep_with	11	SENT_236	[p11l209t3054r364b3108],
14	of	IN	O	of	_	0	SENT_236	[p11l427t3051r491b3108],
15	oxaliplatin	NN	O	oxaliplatin	nn	16	SENT_236	[p11l548t3052r875b3123],
16	pharmacology	NN	O	pharmacology	prep_of	13	SENT_236	[p11l942t3052r1415b3124],
17	,	,	O	,	_	0	SENT_236	[p11l942t3052r1415b3124],
18	in	IN	O	in	_	0	SENT_236	[p11l1479t3054r1530b3107],
19	addition	NN	O	addition	_	0	SENT_236	[p11l1595t3052r1857b3108],
20	to	TO	O	to	_	0	SENT_236	[p11l1920t3060r1984b3108],
21	the	DT	O	the	det	22	SENT_236	[p11l2045t3052r2147b3108],
22	variants	NNS	O	variant	conj_in	13	SENT_236	[p11l8t3140r256b3194],
23	previously	RB	DATE	previously	advmod	24	SENT_236	[p11l287t3138r612b3210],
24	proposed	VBN	O	propose	partmod	22	SENT_236	[p11l641t3138r940b3209],
25	as	IN	O	as	_	0	SENT_236	[p11l971t3155r1033b3194],
26	markers	NNS	O	marker	prep_as	24	SENT_236	[p11l1064t3138r1314b3194],
27	in	IN	O	in	_	0	SENT_236	[p11l1344t3141r1395b3194],
28	the	DT	O	the	det	30	SENT_236	[p11l1424t3138r1527b3194],
29	metastatic	JJ	O	metastatic	amod	30	SENT_236	[p11l1558t3140r1887b3194],
30	setting	NN	O	setting	prep_in	26	SENT_236	[p11l1915t3140r2148b3210],
31	.	.	O	.	_	0	SENT_236	[p11l1915t3140r2148b3210],

1	The	DT	O	the	det	3	SENT_237	[p11l7t3224r124b3280],
2	main	JJ	O	main	amod	3	SENT_237	[p11l154t3227r307b3280],
3	ﬁnding	NN	O	ﬁnding	nsubj	9	SENT_237	[p11l336t3223r561b3296],
4	of	IN	O	of	_	0	SENT_237	[p11l592t3223r656b3280],
5	this	DT	O	this	det	6	SENT_237	[p11l678t3224r790b3280],
6	study	NN	O	study	prep_of	3	SENT_237	[p11l820t3224r993b3297],
7	is	VBZ	O	be	cop	9	SENT_237	[p11l1022t3227r1063b3280],
8	the	DT	O	the	det	9	SENT_237	[p11l1090t3224r1193b3280],
9	involvement	NN	O	involvement	_	0	SENT_237	[p11l1224t3224r1623b3280],
10	of	IN	O	of	_	0	SENT_237	[p11l1650t3223r1715b3280],
11	trans	JJ	O	trans	amod	13	SENT_237	[p11l1736t3224r2149b3280],
12	—	NN	O	—	nn	13	SENT_237	[p11l1736t3224r2149b3280],
13	ce	NN	O	ce	prep_of	9	SENT_237	[p11l1736t3224r2149b3280],
14	|	CD	NUMBER	|	num	18	SENT_237	[p11l1736t3224r2149b3280],
15	lu	NN	O	lu	nn	18	SENT_237	[p11l1736t3224r2149b3280],
16	|	NN	O	|	nn	18	SENT_237	[p11l1736t3224r2149b3280],
17	ar	NN	O	ar	nn	18	SENT_237	[p11l1736t3224r2149b3280],
18	transporters	NNS	O	transporter	dep	13	SENT_237	[p11l8t3316r410b3378],
19	,	,	O	,	_	0	SENT_237	[p11l8t3316r410b3378],
20	in	IN	O	in	_	0	SENT_237	[p11l451t3310r502b3363],
21	particular	JJ	O	particular	amod	22	SENT_237	[p11l546t3308r845b3378],
22	ABCC2	NN	O	abcc2	prep_in	13	SENT_237	[p11l883t3310r1094b3363],
23	and	CC	O	and	_	0	SENT_237	[p11l1135t3308r1250b3364],
24	ABCC1	NN	O	abcc1	prep_in	13	SENT_237	[p11l1291t3310r1520b3372],
25	,	,	O	,	_	0	SENT_237	[p11l1291t3310r1520b3372],
26	in	IN	O	in	_	0	SENT_237	[p11l1561t3310r1612b3363],
27	the	DT	O	the	det	28	SENT_237	[p11l1652t3308r1755b3363],
28	occurrence	NN	O	occurrence	prep_in	13	SENT_237	[p11l1794t3324r2147b3364],
29	of	IN	O	of	_	0	SENT_237	[p11l10t3393r75b3450],
30	FOLFOX4	NN	O	folfox4	nn	31	SENT_237	[p11l114t3396r407b3450],
31	toxicity	NN	O	toxicity	prep_of	28	SENT_237	[p11l446t3397r692b3466],
32	.	.	O	.	_	0	SENT_237	[p11l446t3397r692b3466],

1	We	PRP	O	we	nsubj	2	SENT_238	[p11l733t3396r833b3450],
2	identiﬁed	VBD	O	identiﬁed	_	0	SENT_238	[p11l878t3393r1176b3450],
3	ﬁve	JJ	O	ﬁve	amod	5	SENT_238	[p11l1219t3393r1332b3450],
4	genetic	JJ	O	genetic	amod	5	SENT_238	[p11l1374t3397r1610b3466],
5	polymorphisms	NNS	O	polymorphism	dobj	2	SENT_238	[p11l1654t3394r2146b3466],
6	in	IN	O	in	_	0	SENT_238	[p11l12t3482r62b3534],
7	ABCC2	NN	O	abcc2	nn	9	SENT_238	[p11l89t3481r296b3535],
8	(	CD	NUMBER	(	num	9	SENT_238	[p11l326t3480r689b3544],
9	rs3740066	NN	O	rs3740066	prep_in	2	SENT_238	[p11l326t3480r689b3544],
10	,	,	O	,	_	0	SENT_238	[p11l326t3480r689b3544],
11	rs1885301	NN	O	rs1885301	conj_and	9	SENT_238	[p11l720t3483r1060b3544],
12	,	,	O	,	_	0	SENT_238	[p11l720t3483r1060b3544],
13	rs4148396	NN	O	rs4148396	conj_and	9	SENT_238	[p11l1091t3483r1432b3544],
14	,	,	O	,	_	0	SENT_238	[p11l1091t3483r1432b3544],
15	rs717620	NN	O	rs717620	nn	16	SENT_238	[p11l1463t3480r1767b3543],
16	)	NN	O	)	conj_and	9	SENT_238	[p11l1463t3480r1767b3543],
17	and	CC	O	and	_	0	SENT_238	[p11l1799t3479r1915b3535],
18	ABCC1	NN	O	abcc1	nn	21	SENT_238	[p11l1942t3481r2142b3535],
19	(	CD	NUMBER	(	num	21	SENT_238	[p11l12t3566r378b3630],
20	rs2074087	NN	O	rs2074087	nn	21	SENT_238	[p11l12t3566r378b3630],
21	)	NN	O	)	prep_in	2	SENT_238	[p11l12t3566r378b3630],
22	as	IN	O	as	_	0	SENT_238	[p11l436t3581r498b3621],
23	predictors	NNS	O	predictor	prep_as	21	SENT_238	[p11l556t3565r874b3636],
24	of	IN	O	of	_	0	SENT_238	[p11l931t3564r996b3621],
25	grade	NN	O	grade	prep_of	23	SENT_238	[p11l1046t3565r1228b3637],
26	2-3	CD	NUMBER	2-3	num	25	SENT_238	[p11l1284t3568r1394b3621],
27	neurological	JJ	O	neurological	amod	28	SENT_238	[p11l1455t3565r1845b3637],
28	toxicity	NN	O	toxicity	dep	21	SENT_238	[p11l1902t3567r2148b3637],
29	,	,	O	,	_	0	SENT_238	[p11l1902t3567r2148b3637],
30	with	IN	O	with	dep	28	SENT_238	[p11l8t3651r144b3707],
31	an	DT	O	a	det	32	SENT_238	[p11l209t3668r282b3707],
32	FDR	NNP	O	FDR	dep	33	SENT_238	[p11l350t3653r472b3707],
33	<	JJR	O	<	pobj	30	SENT_238	[p11l545t3654r761b3716],
34	10	CD	PERCENT	10	number	35	SENT_238	[p11l545t3654r761b3716],
35	%	NN	PERCENT	%	amod	33	SENT_238	[p11l545t3654r761b3716],
36	,	,	O	,	_	0	SENT_238	[p11l545t3654r761b3716],
37	and	CC	O	and	_	0	SENT_238	[p11l824t3651r939b3707],
38	therefore	RB	O	therefore	advmod	39	SENT_238	[p11l1003t3650r1298b3707],
39	considered	VBN	O	consider	conj_and	28	SENT_238	[p11l1362t3651r1711b3707],
40	noteworthy	JJ	O	noteworthy	amod	42	SENT_238	[p11l1779t3651r2149b3723],
41	predictive	JJ	O	predictive	amod	42	SENT_238	[p11l12t3737r326b3808],
42	markers	NNS	O	marker	dobj	39	SENT_238	[p11l373t3737r638b3794],
43	.	.	O	.	_	0	SENT_238	[p11l373t3737r638b3794],

1	Similar	JJ	O	similar	amod	2	SENT_239	[p11l684t3737r898b3794],
2	associations	NNS	O	association	nsubjpass	5	SENT_239	[p11l940t3740r1323b3794],
3	were	VBD	O	be	auxpass	5	SENT_239	[p11l1366t3754r1522b3794],
4	also	RB	O	also	advmod	5	SENT_239	[p11l1566t3737r1689b3794],
5	obtained	VBN	O	obtain	_	0	SENT_239	[p11l1733t3737r2016b3794],
6	for	IN	O	for	_	0	SENT_239	[p11l2061t3736r2149b3794],
7	severe	JJ	O	severe	amod	8	SENT_239	[p12l10t32r213b71],
8	neutropenia	NN	O	neutropenia	prep_for	5	SENT_239	[p12l245t18r630b86],
9	though	IN	O	though	mark	13	SENT_239	[p12l659t15r890b87],
10	they	PRP	O	they	nsubj	13	SENT_239	[p12l920t15r1062b88],
11	did	VBD	O	do	aux	13	SENT_239	[p12l1089t15r1186b71],
12	not	RB	O	not	neg	13	SENT_239	[p12l1220t24r1323b72],
13	pass	VB	O	pass	advcl	5	SENT_239	[p12l1353t32r1487b86],
14	the	DT	O	the	det	18	SENT_239	[p12l1515t15r1618b71],
15	10	CD	PERCENT	10	number	16	SENT_239	[p12l1652t19r1782b72],
16	%	NN	PERCENT	%	amod	18	SENT_239	[p12l1652t19r1782b72],
17	FDR	NNP	O	FDR	nn	18	SENT_239	[p12l1814t17r1936b71],
18	cutoff	NN	O	cutoff	dobj	13	SENT_239	[p12l1964t14r2153b71],
19	(	CD	NUMBER	(	num	22	SENT_239	[p12l12t100r201b164],
20	Table	NNP	O	Table	nn	22	SENT_239	[p12l12t100r201b164],
21	5	CD	NUMBER	5	num	22	SENT_239	[p12l233t101r304b164],
22	)	NN	O	)	xcomp	13	SENT_239	[p12l233t101r304b164],
23	.	.	O	.	_	0	SENT_239	[p12l233t101r304b164],

1	ABCC1	NN	O	abcc1	nsubj	4	SENT_240	[p12l86t188r287b242],
2	and	CC	O	and	_	0	SENT_240	[p12l331t186r447b242],
3	ABCC2	NN	O	abcc2	nsubj	4	SENT_240	[p12l482t188r693b242],
4	belong	VBP	O	belong	_	0	SENT_240	[p12l729t186r947b258],
5	to	TO	O	to	_	0	SENT_240	[p12l981t194r1044b242],
6	ATP-binding	JJ	O	atp-binding	amod	9	SENT_240	[p12l1076t186r1470b258],
7	cassette	NN	O	cassette	nn	9	SENT_240	[p12l1505t194r1759b242],
8	transporter	NN	O	transporter	nn	9	SENT_240	[p12l1791t194r2149b257],
9	superfamily	NN	O	superfamily	prep_to	4	SENT_240	[p12l10t271r396b345],
10	,	,	O	,	_	0	SENT_240	[p12l10t271r396b345],
11	containing	VBG	O	contain	xcomp	4	SENT_240	[p12l448t275r786b344],
12	several	JJ	O	several	amod	14	SENT_240	[p12l841t272r1058b328],
13	family	NN	O	family	nn	14	SENT_240	[p12l1111t271r1306b345],
14	members	NNS	O	member	dobj	11	SENT_240	[p12l1359t272r1657b328],
15	that	WDT	O	that	nsubj	16	SENT_240	[p12l1708t272r1836b328],
16	mediate	VBP	O	mediate	rcmod	14	SENT_240	[p12l1889t272r2147b328],
17	the	DT	O	the	det	19	SENT_240	[p12l8t357r111b413],
18	cellular	JJ	O	cellular	amod	19	SENT_240	[p12l162t357r390b413],
19	trafﬁcking	NN	O	trafﬁcking	dobj	16	SENT_240	[p12l438t356r757b428],
20	of	IN	O	of	_	0	SENT_240	[p12l811t356r876b413],
21	drugs	NNS	O	drug	prep_of	19	SENT_240	[p12l923t357r1117b428],
22	,	,	O	,	_	0	SENT_240	[p12l923t357r1117b428],
23	their	PRP$	O	they	poss	24	SENT_240	[p12l1167t357r1314b413],
24	metabolites	NNS	O	metabolite	prep_of	19	SENT_240	[p12l1367t357r1739b413],
25	and	CC	O	and	_	0	SENT_240	[p12l1792t357r1908b413],
26	endogenous	JJ	O	endogenous	amod	27	SENT_240	[p12l1962t357r2148b413, p12l10t459r243b514],
27	factors	NNS	O	factor	prep_of	19	SENT_240	[p12l271t429r561b499],
28	.39	CD	NUMBER	.39	num	29	SENT_240	[p12l271t429r561b499],
29	ABCC1	NN	O	abcc1	nsubj	33	SENT_240	[p12l589t445r790b499],
30	and	CC	O	and	_	0	SENT_240	[p12l832t443r948b499],
31	ABCC2	NN	O	abcc2	nsubj	33	SENT_240	[p12l980t445r1191b499],
32	may	MD	O	may	aux	33	SENT_240	[p12l1225t459r1358b514],
33	act	VB	O	act	rcmod	19	SENT_240	[p12l1386t451r1479b499],
34	in	IN	O	in	_	0	SENT_240	[p12l1510t445r1561b498],
35	a	DT	O	a	det	37	SENT_240	[p12l1593t459r1624b499],
36	synergistic	JJ	O	synergistic	amod	37	SENT_240	[p12l1656t445r1993b514],
37	way	NN	O	way	prep_in	33	SENT_240	[p12l2021t459r2150b514],
38	modulating	VBG	O	modulate	partmod	37	SENT_240	[p12l12t528r377b600],
39	the	DT	O	the	det	40	SENT_240	[p12l428t528r531b584],
40	effect	NN	O	effect	dobj	38	SENT_240	[p12l581t527r760b584],
41	of	IN	O	of	_	0	SENT_240	[p12l808t527r873b584],
42	oxaliplatin	NN	O	oxaliplatin	prep_of	40	SENT_240	[p12l918t528r1244b599],
43	and	CC	O	and	_	0	SENT_240	[p12l1297t528r1413b584],
44	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	prep_of	40	SENT_240	[p12l1466t527r1886b584],
45	at	IN	O	at	_	0	SENT_240	[p12l1938t536r1997b584],
46	the	DT	O	the	det	48	SENT_240	[p12l2045t528r2147b584],
47	cellular	JJ	O	cellular	amod	48	SENT_240	[p12l10t614r237b670],
48	level	NN	O	level	prep_at	38	SENT_240	[p12l268t600r486b670],
49	.	.	O	.	_	0	SENT_240	[p12l268t600r486b670],

1	“	NN	O	“	_	0	SENT_241	[p12l268t600r486b670],

1	ABCC2-rs717620	NN	O	abcc2-rs717620	nsubjpass	23	SENT_242	[p12l82t698r608b761],
2	,	,	O	,	_	0	SENT_242	[p12l82t698r608b761],
3	located	JJ	O	located	amod	1	SENT_242	[p12l636t696r859b752],
4	on	IN	O	on	_	0	SENT_242	[p12l888t713r965b752],
5	the	DT	O	the	det	8	SENT_242	[p12l992t696r1094b752],
6	gene	NN	O	gene	nn	8	SENT_242	[p12l1119t713r1274b768],
7	promoter	NN	O	promoter	nn	8	SENT_242	[p12l1303t704r1597b767],
8	region	NN	O	region	prep_on	3	SENT_242	[p12l1624t698r1836b768],
9	,	,	O	,	_	0	SENT_242	[p12l1624t698r1836b768],
10	has	VBZ	O	have	aux	13	SENT_242	[p12l1864t696r1965b752],
11	been	VBN	O	be	auxpass	13	SENT_242	[p12l1994t696r2145b752],
12	previously	RB	DATE	previously	advmod	13	SENT_242	[p12l12t781r330b854],
13	associated	VBN	O	associate	_	0	SENT_242	[p12l350t781r672b838],
14	to	TO	O	to	_	0	SENT_242	[p12l696t790r759b838],
15	decreased	VBN	O	decrease	amod	17	SENT_242	[p12l782t781r1098b838],
16	protein	NN	O	protein	nn	17	SENT_242	[p12l1127t784r1346b852],
17	expression	NN	O	expression	prep_to	13	SENT_242	[p12l1372t784r1702b852],
18	in	IN	O	in	_	0	SENT_242	[p12l1727t784r1779b837],
19	vitrof	JJ	O	vitrof	amod	20	SENT_242	[p12l1804t769r2000b846],
20	”	NN	O	”	prep_in	17	SENT_242	[p12l1804t769r2000b846],
21	and	CC	O	and	_	0	SENT_242	[p12l2031t781r2145b838],
22	was	VBD	O	be	auxpass	23	SENT_242	[p12l8t884r127b924],
23	associated	VBN	O	associate	conj_and	13	SENT_242	[p12l190t867r511b924],
24	with	IN	O	with	_	0	SENT_242	[p12l575t867r708b924],
25	a	DT	O	a	det	33	SENT_242	[p12l774t884r804b924],
26	13-fold	RB	O	13-fold	amod	33	SENT_242	[p12l874t866r1084b924],
27	increased	VBN	O	increase	dep	26	SENT_242	[p12l1151t867r1443b924],
28	risk	NN	O	risk	dobj	27	SENT_242	[p12l1511t867r1613b924],
29	of	IN	O	of	_	0	SENT_242	[p12l1674t866r1737b924],
30	grade	NN	O	grade	prep_of	28	SENT_242	[p12l1795t867r1974b939],
31	2-3	CD	NUMBER	2-3	num	30	SENT_242	[p12l2038t871r2146b924],
32	neurological	JJ	O	neurological	amod	33	SENT_242	[p12l12t953r393b1025],
33	toxicity	NN	O	toxicity	prep_with	23	SENT_242	[p12l426t956r652b1026],
34	in	IN	O	in	_	0	SENT_242	[p12l686t956r737b1009],
35	our	PRP$	O	we	poss	36	SENT_242	[p12l772t970r876b1010],
36	study	NN	O	study	prep_in	33	SENT_242	[p12l908t953r1091b1026],
37	.	.	O	.	_	0	SENT_242	[p12l908t953r1091b1026],

1	It	PRP	O	it	nsubjpass	4	SENT_243	[p12l1127t956r1163b1010],
2	was	VBD	O	be	auxpass	4	SENT_243	[p12l1193t970r1312b1010],
3	also	RB	O	also	advmod	4	SENT_243	[p12l1345t953r1466b1010],
4	associated	VBN	O	associate	_	0	SENT_243	[p12l1499t953r1819b1010],
5	to	TO	O	to	_	0	SENT_243	[p12l1854t962r1917b1010],
6	a	DT	O	a	det	9	SENT_243	[p12l1950t970r1980b1010],
7	ﬁvefold	JJ	O	ﬁvefold	amod	9	SENT_243	[p12l2014t953r2148b1010, p12l8t1038r125b1096],
8	increased	VBN	O	increase	amod	9	SENT_243	[p12l165t1039r457b1096],
9	risk	NN	O	risk	prep_to	4	SENT_243	[p12l499t1039r602b1096],
10	of	IN	O	of	_	0	SENT_243	[p12l635t1038r698b1096],
11	severe	JJ	O	severe	amod	12	SENT_243	[p12l730t1056r928b1096],
12	neutropenia	NN	O	neutropenia	prep_of	9	SENT_243	[p12l967t1042r1361b1110],
13	,	,	O	,	_	0	SENT_243	[p12l967t1042r1361b1110],
14	though	IN	O	though	mark	17	SENT_243	[p12l1395t1039r1621b1111],
15	this	DT	O	this	det	16	SENT_243	[p12l1658t1039r1768b1096],
16	association	NN	O	association	nsubj	17	SENT_243	[p12l1805t1042r2146b1096],
17	had	VBD	O	have	advcl	4	SENT_243	[p12l12t1125r124b1182],
18	a	DT	O	a	det	19	SENT_243	[p12l158t1142r188b1182],
19	q-value	NN	O	q-value	npadvmod	20	SENT_243	[p12l222t1125r449b1196],
20	higher	JJR	O	higher	advmod	17	SENT_243	[p12l483t1125r682b1197],
21	than	IN	O	than	_	0	SENT_243	[p12l712t1125r851b1182],
22	0.10	CD	NUMBER	0.10	num	23	SENT_243	[p12l885t1129r1012b1182],
23	(	CD	NUMBER	(	prep_than	20	SENT_243	[p12l1045t1126r1286b1191],
24	0.1228	CD	NUMBER	0.1228	tmod	20	SENT_243	[p12l1045t1126r1286b1191],
25	)	NN	O	)	nn	27	SENT_243	[p12l1045t1126r1286b1191],
26	(	CD	NUMBER	(	num	27	SENT_243	[p12l1322t1125r1508b1191],
27	Table	NNP	O	Table	dobj	17	SENT_243	[p12l1322t1125r1508b1191],
28	5	CD	NUMBER	5	num	29	SENT_243	[p12l1540t1126r1610b1191],
29	)	NN	O	)	dep	27	SENT_243	[p12l1540t1126r1610b1191],
30	.	.	O	.	_	0	SENT_243	[p12l1540t1126r1610b1191],

1	ABCC2	NN	O	abcc2	nn	3	SENT_244	[p12l1638t1127r2149b1182],
2	—	CD	NUMBER	—	num	3	SENT_244	[p12l1638t1127r2149b1182],
3	rs71762O	NN	O	rs71762o	nsubj	6	SENT_244	[p12l1638t1127r2149b1182],
4	and	CC	O	and	_	0	SENT_244	[p12l10t1210r123b1267],
5	rs3740066	NN	O	rs3740066	conj_and	3	SENT_244	[p12l178t1214r495b1267],
6	had	VBD	O	have	_	0	SENT_244	[p12l547t1210r659b1267],
7	a	DT	O	a	det	9	SENT_244	[p12l709t1227r740b1267],
8	combined	JJ	O	combined	amod	9	SENT_244	[p12l791t1210r1104b1267],
9	effect	NN	O	effect	dobj	6	SENT_244	[p12l1155t1209r1330b1267],
10	in	IN	O	in	_	0	SENT_244	[p12l1379t1213r1429b1266],
11	increasing	VBG	O	increase	prepc_in	9	SENT_244	[p12l1482t1213r1796b1282],
12	platinumrelated	JJ	O	platinumrelated	amod	13	SENT_244	[p12l1849t1210r2149b1281, p12l12t1297r223b1353],
13	toxicity	NN	O	toxicity	dobj	11	SENT_244	[p12l258t1299r485b1369],
14	in	IN	O	in	_	0	SENT_244	[p12l519t1299r570b1352],
15	lung	NN	O	lung	nn	17	SENT_244	[p12l610t1297r742b1368],
16	cancer	NN	O	cancer	nn	17	SENT_244	[p12l780t1313r986b1353],
17	patients	NNS	O	patient	prep_in	11	SENT_244	[p12l1022t1283r1340b1368],
18	,	,	O	,	_	0	SENT_244	[p12l1022t1283r1340b1368],
19	“	NN	O	“	appos	17	SENT_244	[p12l1022t1283r1340b1368],
20	similar	JJ	O	similar	amod	19	SENT_244	[p12l1375t1297r1577b1353],
21	to	TO	O	to	_	0	SENT_244	[p12l1609t1306r1672b1353],
22	our	PRP$	O	we	poss	23	SENT_244	[p12l1707t1313r1811b1353],
23	results	NNS	O	result	prep_to	20	SENT_244	[p12l1847t1297r2059b1353],
24	.	.	O	.	_	0	SENT_244	[p12l1847t1297r2059b1353],

1	In	IN	O	in	_	0	SENT_245	[p12l2096t1299r2145b1352],
2	addition	NN	O	addition	nsubj	7	SENT_245	[p12l10t1382r265b1439],
3	to	TO	O	to	_	0	SENT_245	[p12l310t1391r373b1439],
4	the	DT	O	the	det	6	SENT_245	[p12l415t1382r517b1439],
5	ABCC2	NN	O	abcc2	nn	6	SENT_245	[p12l561t1384r768b1439],
6	variants	NNS	O	variant	prep_to	2	SENT_245	[p12l812t1385r1054b1439],
7	passing	VBG	O	pass	prepc_in	14	SENT_245	[p12l1102t1385r1332b1454],
8	the	DT	O	the	det	10	SENT_245	[p12l1377t1382r1479b1439],
9	FDR	NNP	O	FDR	nn	10	SENT_245	[p12l1525t1385r1646b1438],
10	cutoff	NN	O	cutoff	dobj	7	SENT_245	[p12l1689t1381r1884b1448],
11	,	,	O	,	_	0	SENT_245	[p12l1689t1381r1884b1448],
12	ABCC2rs2273697	NN	O	abcc2rs2273697	nsubjpass	14	SENT_245	[p12l1923t1384r2148b1439, p12l12t1472r329b1525],
13	was	VBD	O	be	auxpass	14	SENT_245	[p12l367t1485r486b1525],
14	associated	VBN	O	associate	_	0	SENT_245	[p12l525t1468r847b1525],
15	with	IN	O	with	_	0	SENT_245	[p12l886t1468r1020b1525],
16	a	DT	O	a	det	18	SENT_245	[p12l1061t1485r1091b1525],
17	protective	JJ	O	protective	amod	18	SENT_245	[p12l1135t1471r1447b1539],
18	effect	NN	O	effect	prep_with	14	SENT_245	[p12l1485t1467r1660b1525],
19	for	IN	O	for	_	0	SENT_245	[p12l1696t1467r1783b1525],
20	grade	NN	O	grade	prep_for	18	SENT_245	[p12l1819t1468r1998b1540],
21	2-3	CD	NUMBER	2-3	num	23	SENT_245	[p12l2037t1472r2146b1525],
22	neurological	JJ	O	neurological	amod	23	SENT_245	[p12l12t1554r393b1626],
23	toxicity	NN	O	toxicity	dep	20	SENT_245	[p12l415t1557r642b1627],
24	in	IN	O	in	_	0	SENT_245	[p12l665t1557r715b1610],
25	our	PRP$	O	we	poss	27	SENT_245	[p12l741t1571r844b1611],
26	study	NN	O	study	nn	27	SENT_245	[p12l865t1554r1036b1627],
27	CI	NN	O	ci	prep_in	23	SENT_245	[p12l1059t1556r1114b1620],
28	’	CD	NUMBER	’	num	31	SENT_245	[p12l1059t1556r1114b1620],
29	able	JJ	O	able	amod	31	SENT_245	[p12l1115t1554r1244b1611],
30	4	CD	NUMBER	4	tmod	29	SENT_245	[p12l1266t1556r1338b1620],
31	)	NN	O	)	dep	23	SENT_245	[p12l1266t1556r1338b1620],
32	.	.	O	.	_	0	SENT_245	[p12l1266t1556r1338b1620],

1	Although	IN	O	although	mark	6	SENT_246	[p12l1359t1554r1647b1626],
2	this	DT	O	this	det	3	SENT_246	[p12l1672t1554r1781b1611],
3	association	NN	O	association	nsubj	6	SENT_246	[p12l1805t1557r2146b1611],
4	did	VBD	O	do	aux	6	SENT_246	[p12l10t1641r105b1697],
5	not	RB	O	not	neg	6	SENT_246	[p12l162t1649r264b1697],
6	pass	VB	O	pass	advcl	23	SENT_246	[p12l317t1657r449b1712],
7	the	DT	O	the	det	15	SENT_246	[p12l500t1641r600b1697],
8	FDR	NNP	O	FDR	nn	15	SENT_246	[p12l656t1643r776b1697],
9	cutoff	NN	O	cutoff	nn	15	SENT_246	[p12l828t1640r1013b1697],
10	(	CD	NUMBER	(	num	15	SENT_246	[p12l1061t1641r1306b1712],
11	q	NN	O	q	nn	15	SENT_246	[p12l1061t1641r1306b1712],
12	—	CD	NUMBER	—	num	15	SENT_246	[p12l1061t1641r1306b1712],
13	va	NN	O	va	nn	15	SENT_246	[p12l1061t1641r1306b1712],
14	|	NN	O	|	nn	15	SENT_246	[p12l1061t1641r1306b1712],
15	ue	NN	O	ue	nsubj	17	SENT_246	[p12l1061t1641r1306b1712],
16	0.1109	CD	NUMBER	0.1109	num	17	SENT_246	[p12l1357t1642r1598b1706],
17	)	NN	O	)	xcomp	6	SENT_246	[p12l1357t1642r1598b1706],
18	,	,	O	,	_	0	SENT_246	[p12l1357t1642r1598b1706],
19	rs2273697	NN	O	rs2273697	nsubj	23	SENT_246	[p12l1651t1644r1968b1697],
20	is	VBZ	O	be	cop	23	SENT_246	[p12l2022t1643r2062b1697],
21	a	DT	O	a	det	23	SENT_246	[p12l2115t1657r2145b1697],
22	missense	NN	O	missense	nn	23	SENT_246	[p12l12t1729r292b1783],
23	polymorphism	NN	O	polymorphism	_	0	SENT_246	[p12l318t1726r769b1799],
24	causing	VBG	O	cause	partmod	23	SENT_246	[p12l793t1729r1029b1798],
25	a	DT	O	a	det	27	SENT_246	[p12l1053t1743r1083b1783],
26	Va	NNP	O	Va	nn	27	SENT_246	[p12l1105t1726r1386b1783],
27	|	NN	O	|	dobj	24	SENT_246	[p12l1105t1726r1386b1783],
28	417	CD	NUMBER	417	number	29	SENT_246	[p12l1105t1726r1386b1783],
29	|	CD	NUMBER	|	num	30	SENT_246	[p12l1105t1726r1386b1783],
30	|	NN	O	|	dep	27	SENT_246	[p12l1105t1726r1386b1783],
31	e	SYM	O	e	dep	33	SENT_246	[p12l1105t1726r1386b1783],
32	amino-acid	JJ	O	amino-acid	amod	33	SENT_246	[p12l1409t1726r1753b1783],
33	substitution	NN	O	substitution	dep	27	SENT_246	[p12l1779t1726r2146b1783],
34	increasing	VBG	O	increase	xcomp	24	SENT_246	[p12l12t1814r324b1883],
35	the	DT	O	the	det	37	SENT_246	[p12l351t1812r452b1868],
36	transporter	NN	O	transporter	nn	37	SENT_246	[p12l478t1821r827b1883],
37	efﬁciencyf	NN	O	efﬁciencyf	iobj	34	SENT_246	[p12l852t1799r1211b1884],
38	”	CD	NUMBER	”	dobj	34	SENT_246	[p12l852t1799r1211b1884],
39	Enhanced	VBN	O	enhance	partmod	38	SENT_246	[p12l1248t1812r1552b1868],
40	ABCC2	NN	O	abcc2	nn	41	SENT_246	[p12l1580t1814r1788b1868],
41	expression	NN	O	expression	nsubj	43	SENT_246	[p12l1816t1814r2146b1883],
42	can	MD	O	can	aux	43	SENT_246	[p12l10t1915r114b1954],
43	lead	VB	O	lead	ccomp	39	SENT_246	[p12l148t1898r273b1954],
44	to	TO	O	to	_	0	SENT_246	[p12l300t1907r363b1954],
45	decreased	VBN	O	decrease	amod	48	SENT_246	[p12l391t1898r706b1954],
46	cellular	JJ	O	cellular	amod	48	SENT_246	[p12l737t1898r958b1954],
47	glutathione	NN	O	glutathione	nn	48	SENT_246	[p12l984t1898r1344b1970],
48	content	NN	O	content	prep_to	43	SENT_246	[p12l1371t1884r1682b1954],
49	.43	CD	NUMBER	.43	num	50	SENT_246	[p12l1371t1884r1682b1954],
50	Glutathione	NN	O	glutathione	nsubj	51	SENT_246	[p12l1710t1898r2078b1954],
51	is	VBZ	O	be	rcmod	48	SENT_246	[p12l2107t1901r2148b1954],

1	©	RB	O	©	advmod	6	SENT_247	[p12l9t2131r54b2176],
2	2013	CD	DATE	2013	num	5	SENT_247	[p12l80t2129r214b2176],
3	Macmillan	NNP	ORGANIZATION	Macmillan	nn	5	SENT_247	[p12l244t2126r531b2176],
4	Publishers	NNPS	ORGANIZATION	Publishers	nn	5	SENT_247	[p12l562t2126r848b2176],
5	Limited	NNP	ORGANIZATION	Limited	nsubj	6	SENT_247	[p12l878t2126r1085b2176],
6	needed	VBD	O	need	ccomp	67	SENT_247	[p12l13t2206r244b2262],
7	for	IN	O	for	_	0	SENT_247	[p12l286t2205r373b2262],
8	oxaliplatin	NN	O	oxaliplatin	nn	9	SENT_247	[p12l412t2206r729b2277],
9	detoxiﬁcation	NN	O	detoxiﬁcation	prep_for	6	SENT_247	[p12l773t2205r1197b2262],
10	via	IN	O	via	_	0	SENT_247	[p12l1239t2208r1324b2262],
11	conjugation	NN	O	conjugation	prep_via	9	SENT_247	[p12l1367t2208r1754b2278],
12	,	,	O	,	_	0	SENT_247	[p12l1367t2208r1754b2278],
13	and	CC	O	and	_	0	SENT_247	[p12l1795t2206r1909b2262],
14	it	PRP	O	it	nsubjpass	16	SENT_247	[p12l1955t2208r1991b2262],
15	was	VBD	O	be	auxpass	16	SENT_247	[p12l2029t2222r2148b2262],
16	reported	VBN	O	report	conj_and	6	SENT_247	[p12l13t2291r278b2363],
17	that	IN	O	that	complm	30	SENT_247	[p12l341t2291r466b2348],
18	low	JJ	O	low	advmod	30	SENT_247	[p12l531t2291r640b2348],
19	glutathione	NN	O	glutathione	nsubj	30	SENT_247	[p12l700t2291r1059b2363],
20	intra	FW	O	intra	nn	19	SENT_247	[p12l1124t2291r1509b2348],
21	—	FW	O	—	nn	19	SENT_247	[p12l1124t2291r1509b2348],
22	ce	FW	O	ce	nn	19	SENT_247	[p12l1124t2291r1509b2348],
23	|	FW	O	|	nn	19	SENT_247	[p12l1124t2291r1509b2348],
24	|	FW	O	|	nn	19	SENT_247	[p12l1124t2291r1509b2348],
25	u	FW	O	u	nn	19	SENT_247	[p12l1124t2291r1509b2348],
26	|	FW	O	|	dep	19	SENT_247	[p12l1124t2291r1509b2348],
27	ar	NN	O	ar	nn	28	SENT_247	[p12l1124t2291r1509b2348],
28	levels	NNS	O	level	dep	19	SENT_247	[p12l1572t2291r1740b2348],
29	can	MD	O	can	aux	30	SENT_247	[p12l1803t2308r1908b2348],
30	cause	VB	O	cause	ccomp	16	SENT_247	[p12l1974t2308r2149b2348],
31	increased	VBN	O	increase	amod	33	SENT_247	[p12l12t2377r304b2433],
32	oxaliplatin	NN	O	oxaliplatin	nn	33	SENT_247	[p12l338t2377r655b2448],
33	cytotoxicity	NN	O	cytotoxicity	dobj	30	SENT_247	[p12l689t2364r1119b2449],
34	.4	CD	NUMBER	.4	number	35	SENT_247	[p12l689t2364r1119b2449],
35	°	CD	NUMBER	°	nsubj	58	SENT_247	[p12l689t2364r1119b2449],
36	Moreover	RB	O	moreover	advmod	39	SENT_247	[p12l1150t2379r1463b2442],
37	,	,	O	,	_	0	SENT_247	[p12l1150t2379r1463b2442],
38	ABCC2	NN	O	abcc2	nsubj	39	SENT_247	[p12l1493t2379r1701b2433],
39	mediates	VBZ	O	mediate	rcmod	35	SENT_247	[p12l1735t2377r2017b2433],
40	the	DT	O	the	det	41	SENT_247	[p12l2047t2377r2148b2433],
41	export	NN	O	export	dobj	39	SENT_247	[p12l10t2470r211b2533],
42	of	IN	O	of	_	0	SENT_247	[p12l244t2461r308b2518],
43	the	DT	O	the	det	44	SENT_247	[p12l334t2462r436b2518],
44	oxaliplatin-glutathione	JJ	O	oxaliplatin-glutathione	prep_of	41	SENT_247	[p12l469t2462r1174b2534],
45	conjugated	VBN	O	conjugate	partmod	44	SENT_247	[p12l1208t2462r1559b2534],
46	form	NN	O	form	dobj	45	SENT_247	[p12l1594t2461r1758b2527],
47	,	,	O	,	_	0	SENT_247	[p12l1594t2461r1758b2527],
48	and	CC	O	and	_	0	SENT_247	[p12l1790t2462r1904b2518],
49	ABCC2	NN	O	abcc2	nn	51	SENT_247	[p12l1939t2464r2148b2518],
50	overexpressing	NN	O	overexpressing	nn	51	SENT_247	[p12l10t2551r481b2620],
51	cells	NNS	O	cell	nsubj	53	SENT_247	[p12l510t2548r640b2605],
52	were	VBD	O	be	cop	53	SENT_247	[p12l667t2565r819b2605],
53	resistant	JJ	O	resistant	rcmod	35	SENT_247	[p12l849t2551r1109b2605],
54	to	TO	O	to	_	0	SENT_247	[p12l1133t2557r1196b2605],
55	platinum	NN	O	platinum	nn	56	SENT_247	[p12l1226t2548r1500b2619],
56	derivatives	NNS	O	derivative	prep_to	53	SENT_247	[p12l1530t2535r1939b2605],
57	.44	CD	NUMBER	.44	tmod	53	SENT_247	[p12l1530t2535r1939b2605],
58	Taken	VBN	O	take	rcmod	33	SENT_247	[p12l1961t2548r2146b2605],
59	together	RB	O	together	_	0	SENT_247	[p12l9t2633r280b2705],
60	with	IN	O	with	_	0	SENT_247	[p12l336t2633r468b2690],
61	our	PRP$	O	we	poss	62	SENT_247	[p12l530t2650r634b2690],
62	results	NNS	O	result	prep_together_with	58	SENT_247	[p12l693t2633r904b2699],
63	,	,	O	,	_	0	SENT_247	[p12l693t2633r904b2699],
64	ABCC2	NN	O	abcc2	nn	65	SENT_247	[p12l958t2635r1162b2690],
65	variants	NNS	O	variant	nsubj	67	SENT_247	[p12l1217t2636r1459b2690],
66	might	MD	O	might	aux	67	SENT_247	[p12l1521t2633r1704b2705],
67	change	VB	O	change	_	0	SENT_247	[p12l1761t2633r1990b2705],
68	the	DT	O	the	det	69	SENT_247	[p12l2047t2633r2148b2690],
69	susceptibility	NN	O	susceptibility	dobj	67	SENT_247	[p12l11t2720r417b2792],
70	of	IN	O	of	_	0	SENT_247	[p12l455t2719r520b2776],
71	patients	NNS	O	patient	prep_of	69	SENT_247	[p12l556t2722r802b2791],
72	to	TO	O	to	_	0	SENT_247	[p12l842t2728r905b2776],
73	oxaliplatin	NN	O	oxaliplatin	nn	74	SENT_247	[p12l945t2720r1262b2791],
74	toxicity	NN	O	toxicity	prep_to	67	SENT_247	[p12l1304t2722r1529b2792],
75	via	IN	O	via	_	0	SENT_247	[p12l1567t2722r1651b2776],
76	a	DT	O	a	det	78	SENT_247	[p12l1694t2736r1724b2776],
77	glutathionemediated	JJ	O	glutathionemediated	amod	78	SENT_247	[p12l1767t2720r2150b2792, p12l13t2805r305b2861],
78	mechanism	NN	O	mechanism	prep_via	74	SENT_247	[p12l340t2805r713b2861],
79	.	.	O	.	_	0	SENT_247	[p12l340t2805r713b2861],

1	For	IN	O	for	_	0	SENT_248	[p12l91t2893r189b2947],
2	ABCC1	NN	O	abcc1	prep_for	8	SENT_248	[p12l214t2892r436b2956],
3	,	,	O	,	_	0	SENT_248	[p12l214t2892r436b2956],
4	three	CD	NUMBER	three	num	6	SENT_248	[p12l466t2890r633b2947],
5	genetic	JJ	O	genetic	amod	6	SENT_248	[p12l665t2893r901b2962],
6	polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_248	[p12l935t2890r1428b2963],
7	were	VBD	O	be	auxpass	8	SENT_248	[p12l1460t2907r1615b2947],
8	associated	VBN	O	associate	_	0	SENT_248	[p12l1647t2890r1976b2947],
9	with	IN	O	with	_	0	SENT_248	[p12l2010t2890r2146b2947],
10	grade	NN	O	grade	prep_with	8	SENT_248	[p12l10t2977r192b3049],
11	2-3	CD	NUMBER	2-3	num	13	SENT_248	[p12l250t2980r360b3033],
12	neurological	JJ	O	neurological	amod	13	SENT_248	[p12l422t2977r812b3049],
13	toxicity	NN	O	toxicity	nsubjpass	20	SENT_248	[p12l870t2979r1102b3049],
14	and	CC	O	and	_	0	SENT_248	[p12l1158t2977r1274b3033],
15	one	CD	NUMBER	one	nsubjpass	20	SENT_248	[p12l1334t2993r1452b3033],
16	of	IN	O	of	_	0	SENT_248	[p12l1510t2976r1575b3033],
17	them	PRP	O	they	prep_of	15	SENT_248	[p12l1624t2977r1789b3033],
18	was	VBD	O	be	auxpass	20	SENT_248	[p12l1848t2993r1968b3033],
19	also	RB	O	also	advmod	20	SENT_248	[p12l2025t2977r2148b3033],
20	associated	VBN	O	associate	rcmod	10	SENT_248	[p12l10t3063r340b3119],
21	to	TO	O	to	_	0	SENT_248	[p12l378t3071r441b3119],
22	severe	JJ	O	severe	amod	23	SENT_248	[p12l478t3080r681b3119],
23	neutropenia	NN	O	neutropenia	prep_to	20	SENT_248	[p12l720t3066r1124b3134],
24	.	.	O	.	_	0	SENT_248	[p12l720t3066r1124b3134],

1	The	DT	O	the	det	3	SENT_249	[p12l1157t3063r1274b3119],
2	functional	JJ	O	functional	amod	3	SENT_249	[p12l1309t3062r1628b3119],
3	effect	NN	O	effect	nsubjpass	9	SENT_249	[p12l1667t3062r1845b3119],
4	of	IN	O	of	_	0	SENT_249	[p12l1881t3062r1946b3119],
5	these	DT	O	these	det	6	SENT_249	[p12l1976t3063r2148b3119],
6	variants	NNS	O	variant	prep_of	3	SENT_249	[p12l9t3151r257b3205],
7	is	VBZ	O	be	auxpass	9	SENT_249	[p12l297t3152r338b3205],
8	not	RB	O	not	neg	9	SENT_249	[p12l379t3157r483b3205],
9	known	VBN	O	know	_	0	SENT_249	[p12l522t3149r750b3214],
10	,	,	O	,	_	0	SENT_249	[p12l522t3149r750b3214],
11	and	CC	O	and	_	0	SENT_249	[p12l787t3149r903b3205],
12	they	PRP	O	they	nsubj	13	SENT_249	[p12l942t3149r1083b3222],
13	are	VBP	O	be	conj_and	9	SENT_249	[p12l1119t3166r1215b3205],
14	not	RB	O	not	neg	13	SENT_249	[p12l1256t3157r1359b3205],
15	in	IN	O	in	_	0	SENT_249	[p12l1398t3151r1449b3204],
16	LD	NN	O	ld	prep_in	13	SENT_249	[p12l1492t3151r1572b3205],
17	with	IN	O	with	_	0	SENT_249	[p12l1608t3149r1743b3205],
18	any	DT	O	any	det	20	SENT_249	[p12l1784t3166r1897b3221],
19	known	JJ	O	known	amod	20	SENT_249	[p12l1936t3149r2146b3205],
20	ABCC1	NN	O	abcc1	npadvmod	21	SENT_249	[p12l6t3236r206b3291],
21	functional	JJ	O	functional	amod	22	SENT_249	[p12l246t3234r565b3291],
22	variants	NNS	O	variant	prep_with	16	SENT_249	[p12l603t3237r868b3291],
23	.	.	O	.	_	0	SENT_249	[p12l603t3237r868b3291],

1	Overexpression	NN	O	overexpression	nsubjpass	7	SENT_250	[p12l904t3236r1396b3306],
2	of	IN	O	of	_	0	SENT_250	[p12l1435t3234r1500b3291],
3	the	DT	O	the	det	5	SENT_250	[p12l1530t3235r1633b3291],
4	ABCC1	NN	O	abcc1	nn	5	SENT_250	[p12l1669t3237r1869b3291],
5	protein	NN	O	protein	prep_of	1	SENT_250	[p12l1921t3237r2146b3306],
6	was	VBD	O	be	auxpass	7	SENT_250	[p12l9t3336r129b3375],
7	related	VBN	O	relate	_	0	SENT_250	[p12l161t3319r377b3375],
8	to	TO	O	to	_	0	SENT_250	[p12l408t3328r472b3375],
9	resistance	NN	O	resistance	prep_to	7	SENT_250	[p12l503t3322r816b3375],
10	to	TO	O	to	_	0	SENT_250	[p12l845t3328r908b3375],
11	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	prep_to	7	SENT_250	[p12l939t3318r1358b3375],
12	in	FW	O	in	nn	13	SENT_250	[p12l1390t3322r1442b3374],
13	vitro	FW	O	vitro	dep	19	SENT_250	[p12l1475t3306r1684b3375],
14	.4	FW	NUMBER	.4	nn	15	SENT_250	[p12l1475t3306r1684b3375],
15	°	FW	O	°	dep	13	SENT_250	[p12l1475t3306r1684b3375],
16	This	DT	O	this	nsubj	19	SENT_250	[p12l1710t3319r1836b3375],
17	could	MD	O	could	aux	19	SENT_250	[p12l1867t3319r2039b3375],
18	be	VB	O	be	cop	19	SENT_250	[p12l2073t3319r2148b3375],
19	due	JJ	O	due	rcmod	11	SENT_250	[p13l10t22r129b78],
20	to	TO	O	to	_	0	SENT_250	[p13l157t30r220b78],
21	the	DT	O	the	det	22	SENT_250	[p13l248t22r350b78],
22	ability	NN	O	ability	prep_to	19	SENT_250	[p13l380t22r572b94],
23	of	IN	O	of	_	0	SENT_250	[p13l600t21r665b78],
24	ABCC1	NN	O	abcc1	prep_of	22	SENT_250	[p13l687t24r888b78],
25	to	TO	O	to	aux	26	SENT_250	[p13l928t30r991b78],
26	extrude	VB	O	extrude	xcomp	19	SENT_250	[p13l1020t22r1264b78],
27	folates	NNS	O	folate	dobj	26	SENT_250	[p13l1290t21r1501b78],
28	and	CC	O	and	_	0	SENT_250	[p13l1530t22r1646b78],
29	thus	RB	O	thus	advmod	19	SENT_250	[p13l1676t22r1813b78],
30	depleting	VBG	O	deplete	conj_and	19	SENT_250	[p13l1843t22r2146b94],
31	their	PRP$	O	they	poss	37	SENT_250	[p13l9t108r156b164],
32	intra	JJ	O	intra	amod	37	SENT_250	[p13l185t108r581b164],
33	—	NN	O	—	nn	37	SENT_250	[p13l185t108r581b164],
34	ce	NN	O	ce	nn	37	SENT_250	[p13l185t108r581b164],
35	|	CD	NUMBER	|	num	37	SENT_250	[p13l185t108r581b164],
36	|	NN	O	|	nn	37	SENT_250	[p13l185t108r581b164],
37	u	NN	O	u	dobj	30	SENT_250	[p13l185t108r581b164],
38	|	CD	NUMBER	|	num	40	SENT_250	[p13l185t108r581b164],
39	ar	NN	O	ar	nn	40	SENT_250	[p13l185t108r581b164],
40	availability	NN	O	availability	nsubj	48	SENT_250	[p13l608t108r947b181],
41	for	IN	O	for	_	0	SENT_250	[p13l971t107r1059b164],
42	the	DT	O	the	det	43	SENT_250	[p13l1084t108r1187b164],
43	activity	NN	O	activity	prep_for	40	SENT_250	[p13l1216t111r1443b181],
44	of	IN	O	of	_	0	SENT_250	[p13l1470t107r1534b165],
45	5	CD	NUMBER	5	num	47	SENT_250	[p13l1558t107r1996b165],
46	—	NN	O	—	nn	47	SENT_250	[p13l1558t107r1996b165],
47	ﬂuorouraci	NNS	O	ﬂuorouraci	prep_of	43	SENT_250	[p13l1558t107r1996b165],
48	|	VBP	O	|	rcmod	37	SENT_250	[p13l1558t107r1996b165],
49	.	.	O	.	_	0	SENT_250	[p13l1558t107r1996b165],

1	This	DT	O	this	nsubj	2	SENT_251	[p13l2021t108r2148b164],
2	might	MD	O	might	dep	5	SENT_251	[p13l13t194r199b266],
3	in	IN	O	in	_	0	SENT_251	[p13l255t196r306b249],
4	part	NN	O	part	prep_in	2	SENT_251	[p13l367t202r491b265],
5	explain	VBP	O	explain	_	0	SENT_251	[p13l545t194r770b265],
6	the	DT	O	the	det	7	SENT_251	[p13l826t194r929b250],
7	effect	NN	O	effect	dobj	5	SENT_251	[p13l985t193r1163b250],
8	of	IN	O	of	_	0	SENT_251	[p13l1217t193r1282b250],
9	ABCC1	NN	O	abcc1	prep_of	7	SENT_251	[p13l1327t195r1809b250],
10	—	CD	NUMBER	—	num	11	SENT_251	[p13l1327t195r1809b250],
11	rs35587	NN	O	rs35587	nsubj	5	SENT_251	[p13l1327t195r1809b250],
12	on	IN	O	on	_	0	SENT_251	[p13l1865t210r1942b250],
13	both	DT	O	both	det	14	SENT_251	[p13l2002t194r2146b250],
14	neutropenia	NN	O	neutropenia	prep_on	11	SENT_251	[p13l13t283r399b351],
15	and	CC	O	and	_	0	SENT_251	[p13l449t280r564b336],
16	neurological	JJ	O	neurological	amod	17	SENT_251	[p13l617t280r1008b352],
17	toxicity	NN	O	toxicity	prep_on	11	SENT_251	[p13l1057t282r1303b352],
18	,	,	O	,	_	0	SENT_251	[p13l1057t282r1303b352],
19	suggesting	VBG	O	suggest	partmod	5	SENT_251	[p13l1352t282r1700b352],
20	that	IN	O	that	complm	23	SENT_251	[p13l1748t280r1876b336],
21	ABCC1rs35587	NN	O	abcc1rs35587	nsubj	23	SENT_251	[p13l1919t282r2150b336, p13l13t370r258b423],
22	might	MD	O	might	aux	23	SENT_251	[p13l294t366r481b438],
23	increase	VB	O	increase	ccomp	19	SENT_251	[p13l515t369r773b423],
24	the	DT	O	the	det	25	SENT_251	[p13l805t366r908b423],
25	function	NN	O	function	dobj	23	SENT_251	[p13l940t365r1204b423],
26	or	CC	O	or	_	0	SENT_251	[p13l1240t383r1303b423],
27	expression	NN	O	expression	dobj	23	SENT_251	[p13l1335t369r1672b437],
28	of	IN	O	of	_	0	SENT_251	[p13l1708t365r1774b423],
29	the	DT	O	the	det	31	SENT_251	[p13l1800t366r1903b423],
30	ABCC1	NN	O	abcc1	nn	31	SENT_251	[p13l1935t368r2136b423],
31	transporter	NN	O	transporter	prep_of	25	SENT_251	[p13l9t460r380b523],
32	.	.	O	.	_	0	SENT_251	[p13l9t460r380b523],

1	More	RBR	O	more	advmod	2	SENT_252	[p13l421t454r581b508],
2	conﬁrmatory	JJ	O	conﬁrmatory	amod	3	SENT_252	[p13l621t451r1032b524],
3	studies	NNS	O	study	nsubj	4	SENT_252	[p13l1069t452r1291b508],
4	(	VBP	O	(	_	0	SENT_252	[p13l1333t452r1498b517],
5	both	CC	O	both	dep	4	SENT_252	[p13l1333t452r1498b517],
6	at	IN	O	at	_	0	SENT_252	[p13l1540t460r1598b508],
7	the	DT	O	the	dep	8	SENT_252	[p13l1634t452r1736b508],
8	clinical	JJ	O	clinical	prep_at	4	SENT_252	[p13l1776t452r1988b508],
9	and	CC	O	and	_	0	SENT_252	[p13l2029t452r2145b508],
10	molecular	JJ	O	molecular	amod	12	SENT_252	[p13l13t537r326b593],
11	level	NN	O	level	nn	12	SENT_252	[p13l377t537r539b601],
12	)	NN	O	)	prep_at	4	SENT_252	[p13l377t537r539b601],
13	should	MD	O	should	aux	15	SENT_252	[p13l592t537r802b593],
14	be	VB	O	be	auxpass	15	SENT_252	[p13l858t537r933b593],
15	conducted	VBN	O	conduct	rcmod	8	SENT_252	[p13l983t537r1322b593],
16	to	TO	O	to	aux	17	SENT_252	[p13l1373t545r1437b593],
17	conﬁrm	VB	O	conﬁrm	xcomp	15	SENT_252	[p13l1487t536r1728b593],
18	the	DT	O	the	det	20	SENT_252	[p13l1780t537r1883b593],
19	clinical	JJ	O	clinical	amod	20	SENT_252	[p13l1933t537r2146b593],
20	associations	NNS	O	association	dobj	17	SENT_252	[p13l10t625r393b678],
21	and	CC	O	and	_	0	SENT_252	[p13l424t622r540b678],
22	their	PRP$	O	they	poss	24	SENT_252	[p13l572t622r719b678],
23	mechanistic	JJ	O	mechanistic	amod	24	SENT_252	[p13l751t622r1130b678],
24	basis	NN	O	basis	conj_and	20	SENT_252	[p13l1163t622r1331b678],
25	.	.	O	.	_	0	SENT_252	[p13l1163t622r1331b678],

1	XRCC3	NN	O	xrcc3	nsubjpass	5	SENT_253	[p13l83t710r643b765],
2	—	CD	NUMBER	—	num	3	SENT_253	[p13l83t710r643b765],
3	rs1799794	NN	O	rs1799794	dep	1	SENT_253	[p13l83t710r643b765],
4	was	VBD	O	be	auxpass	5	SENT_253	[p13l676t725r796b765],
5	associated	VBN	O	associate	_	0	SENT_253	[p13l831t708r1161b765],
6	with	IN	O	with	_	0	SENT_253	[p13l1197t708r1332b764],
7	severe	JJ	O	severe	amod	9	SENT_253	[p13l1370t725r1574b765],
8	non	JJ	O	non	amod	9	SENT_253	[p13l1611t708r2148b780],
9	—	NN	O	—	prep_with	5	SENT_253	[p13l1611t708r2148b780],
10	hemato	NN	O	hemato	nn	12	SENT_253	[p13l1611t708r2148b780],
11	|	NN	O	|	nn	12	SENT_253	[p13l1611t708r2148b780],
12	ogi	NN	O	ogus	dep	19	SENT_253	[p13l1611t708r2148b780],
13	—	CD	NUMBER	—	num	15	SENT_253	[p13l1611t708r2148b780],
14	cal	JJ	O	cal	amod	15	SENT_253	[p13l10t794r92b850],
15	toxicity	NN	O	toxicity	dep	12	SENT_253	[p13l123t796r356b866],
16	(	CD	NUMBER	(	num	17	SENT_253	[p13l386t794r637b865],
17	q	NN	O	q	dep	19	SENT_253	[p13l386t794r637b865],
18	—	CD	NUMBER	—	num	19	SENT_253	[p13l386t794r637b865],
19	va	NN	O	va	dep	9	SENT_253	[p13l386t794r637b865],
20	|	NN	O	|	nn	21	SENT_253	[p13l386t794r637b865],
21	ue	NN	O	ue	dep	19	SENT_253	[p13l386t794r637b865],
22	=	JJ	O	=	amod	24	SENT_253	[p13l657t795r973b859],
23	0.0235	CD	NUMBER	0.0235	tmod	22	SENT_253	[p13l657t795r973b859],
24	)	NN	O	)	dep	21	SENT_253	[p13l657t795r973b859],
25	.	.	O	.	_	0	SENT_253	[p13l657t795r973b859],

1	XRCC3	NN	O	xrcc3	nsubj	6	SENT_254	[p13l1002t796r1209b850],
2	is	VBZ	O	be	cop	6	SENT_254	[p13l1243t796r1284b850],
3	a	DT	O	a	det	6	SENT_254	[p13l1315t811r1345b850],
4	DNA	NN	MISC	dna	nn	6	SENT_254	[p13l1380t796r1522b850],
5	repair	NN	O	repair	nn	6	SENT_254	[p13l1554t796r1735b865],
6	protein	NN	O	protein	_	0	SENT_254	[p13l1765t796r1990b865],
7	that	WDT	O	that	nsubj	9	SENT_254	[p13l2022t794r2149b850],
8	is	VBZ	O	be	cop	9	SENT_254	[p13l12t883r53b936],
9	part	NN	O	part	rcmod	6	SENT_254	[p13l91t888r215b951],
10	of	IN	O	of	_	0	SENT_254	[p13l249t879r314b937],
11	the	DT	O	the	det	16	SENT_254	[p13l342t880r445b936],
12	double	JJ	O	double	amod	16	SENT_254	[p13l480t880r702b936],
13	strand	NN	O	strand	nn	16	SENT_254	[p13l738t880r934b936],
14	break	NN	O	break	nn	16	SENT_254	[p13l974t880r1150b936],
15	repair	NN	O	repair	nn	16	SENT_254	[p13l1184t883r1366b951],
16	machinery	NN	O	machinery	prep_of	9	SENT_254	[p13l1401t880r1749b953],
17	.	.	O	.	_	0	SENT_254	[p13l1401t880r1749b953],

1	Its	PRP$	O	its	poss	3	SENT_255	[p13l1787t883r1851b936],
2	reduced	VBN	O	reduce	amod	3	SENT_255	[p13l1890t880r2146b937],
3	activity	NN	O	activity	nsubjpass	5	SENT_255	[p13l10t968r238b1038],
4	is	VBZ	O	be	auxpass	5	SENT_255	[p13l267t968r308b1021],
5	associated	VBN	O	associate	_	0	SENT_255	[p13l338t965r667b1021],
6	with	IN	O	with	_	0	SENT_255	[p13l698t965r834b1021],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_255	[p13l866t964r1248b1038],
8	higher	JJR	O	higher	amod	9	SENT_255	[p13l1279t965r1483b1037],
9	levels	NNS	O	level	prep_with	5	SENT_255	[p13l1513t965r1686b1021],
10	of	IN	O	of	_	0	SENT_255	[p13l1716t964r1781b1021],
11	bulky	JJ	O	bulky	amod	13	SENT_255	[p13l1807t965r1977b1037],
12	DNA	NN	O	dna	nn	13	SENT_255	[p13l2008t967r2149b1021],
13	adducts	NNS	O	adduct	prep_of	9	SENT_255	[p13l10t1038r335b1108],
14	.45	CD	NUMBER	.45	dobj	5	SENT_255	[p13l10t1038r335b1108],
15	Our	PRP$	O	we	poss	16	SENT_255	[p13l362t1053r479b1108],
16	study	NN	O	study	nsubj	17	SENT_255	[p13l504t1051r678b1124],
17	suggests	VBZ	O	suggest	rcmod	14	SENT_255	[p13l703t1060r980b1123],
18	that	IN	O	that	complm	22	SENT_255	[p13l1005t1051r1133b1108],
19	this	DT	O	this	det	20	SENT_255	[p13l1156t1051r1269b1108],
20	SNP	NN	O	snp	nsubj	22	SENT_255	[p13l1295t1053r1419b1108],
21	might	MD	O	might	aux	22	SENT_255	[p13l1449t1051r1635b1123],
22	confer	VB	O	confer	ccomp	17	SENT_255	[p13l1660t1050r1863b1108],
23	reduced	VBN	O	reduce	amod	25	SENT_255	[p13l1890t1051r2146b1108],
24	DNA	NN	O	dna	nn	25	SENT_255	[p13l13t1139r155b1193],
25	repair	NN	O	repair	dobj	22	SENT_255	[p13l190t1139r372b1208],
26	of	IN	O	of	_	0	SENT_255	[p13l404t1136r469b1193],
27	oxaliplatin	NN	O	oxaliplatin	nn	29	SENT_255	[p13l498t1137r824b1208],
28	DNA	NN	O	dna	nn	29	SENT_255	[p13l863t1139r1005b1193],
29	adducts	NNS	O	adduct	prep_of	25	SENT_255	[p13l1038t1137r1305b1202],
30	,	,	O	,	_	0	SENT_255	[p13l1038t1137r1305b1202],
31	leading	VBG	O	lead	partmod	5	SENT_255	[p13l1342t1137r1573b1209],
32	to	TO	O	to	_	0	SENT_255	[p13l1607t1145r1670b1193],
33	more	JJR	O	more	amod	34	SENT_255	[p13l1707t1154r1869b1193],
34	toxicity	NN	O	toxicity	prep_to	31	SENT_255	[p13l1902t1139r2148b1209],
35	.	.	O	.	_	0	SENT_255	[p13l1902t1139r2148b1209],

1	However	RB	O	however	advmod	11	SENT_256	[p13l13t1226r309b1288],
2	,	,	O	,	_	0	SENT_256	[p13l13t1226r309b1288],
3	the	DT	O	the	det	5	SENT_256	[p13l330t1223r433b1279],
4	molecular	JJ	O	molecular	amod	5	SENT_256	[p13l459t1223r773b1279],
5	function	NN	O	function	nsubj	11	SENT_256	[p13l793t1222r1056b1279],
6	of	IN	O	of	_	0	SENT_256	[p13l1083t1222r1148b1279],
7	this	DT	O	this	det	8	SENT_256	[p13l1165t1223r1277b1279],
8	SNP	NN	O	snp	prep_of	5	SENT_256	[p13l1301t1225r1425b1279],
9	is	VBZ	O	be	cop	11	SENT_256	[p13l1451t1226r1492b1279],
10	presently	RB	O	presently	advmod	11	SENT_256	[p13l1518t1223r1811b1296],
11	unknown	JJ	O	unknown	_	0	SENT_256	[p13l1835t1223r2149b1288],
12	,	,	O	,	_	0	SENT_256	[p13l1835t1223r2149b1288],
13	and	CC	O	and	_	0	SENT_256	[p13l10t1307r126b1363],
14	controversial	JJ	O	controversial	amod	15	SENT_256	[p13l154t1307r561b1363],
15	data	NNS	O	datum	nsubjpass	18	SENT_256	[p13l590t1307r726b1363],
16	have	VBP	O	have	aux	18	SENT_256	[p13l756t1307r904b1363],
17	been	VBN	O	be	auxpass	18	SENT_256	[p13l932t1307r1086b1363],
18	reported	VBN	O	report	conj_and	11	SENT_256	[p13l1116t1307r1387b1377],
19	on	IN	O	on	_	0	SENT_256	[p13l1416t1324r1493b1363],
20	the	DT	O	the	det	23	SENT_256	[p13l1519t1307r1622b1363],
21	possible	JJ	O	possible	amod	23	SENT_256	[p13l1650t1307r1907b1377],
22	clinical	JJ	O	clinical	amod	23	SENT_256	[p13l1933t1307r2146b1363],
23	role	NN	O	role	prep_on	18	SENT_256	[p13l13t1392r128b1448],
24	of	IN	O	of	_	0	SENT_256	[p13l163t1391r228b1448],
25	this	DT	O	this	det	26	SENT_256	[p13l256t1392r368b1448],
26	SNP	NN	O	snp	prep_of	23	SENT_256	[p13l403t1394r527b1448],
27	on	IN	O	on	_	0	SENT_256	[p13l562t1409r640b1448],
28	the	DT	O	the	det	29	SENT_256	[p13l675t1392r778b1448],
29	response	NN	O	response	prep_on	26	SENT_256	[p13l815t1408r1099b1463],
30	and	CC	O	and	_	0	SENT_256	[p13l1134t1392r1250b1448],
31	toxicity	NN	O	toxicity	prep_on	26	SENT_256	[p13l1285t1394r1518b1464],
32	to	TO	O	to	_	0	SENT_256	[p13l1549t1400r1613b1448],
33	DNA	NN	O	dna	nn	35	SENT_256	[p13l1650t1394r1792b1448],
34	damaging	NN	O	damaging	nn	35	SENT_256	[p13l1825t1392r2146b1464],
35	agents	NNS	O	agent	prep_to	18	SENT_256	[p13l10t1465r368b1550],
36	.46	CD	NUMBER	.46	number	37	SENT_256	[p13l10t1465r368b1550],
37	'47	CD	NUMBER	'47	num	35	SENT_256	[p13l10t1465r368b1550],

1	hMSH6	NN	O	hmsh6	nsubjpass	5	SENT_257	[p13l87t1577r660b1633],
2	—	CD	NUMBER	—	num	3	SENT_257	[p13l87t1577r660b1633],
3	rs3136228	NN	O	rs3136228	dep	1	SENT_257	[p13l87t1577r660b1633],
4	was	VBD	O	be	auxpass	5	SENT_257	[p13l692t1594r812b1633],
5	associated	VBN	O	associate	_	0	SENT_257	[p13l845t1577r1174b1633],
6	with	IN	O	with	_	0	SENT_257	[p13l1208t1577r1344b1633],
7	increased	VBN	O	increase	amod	8	SENT_257	[p13l1381t1577r1680b1633],
8	risk	NN	O	risk	prep_with	5	SENT_257	[p13l1718t1577r1823b1633],
9	of	IN	O	of	_	0	SENT_257	[p13l1852t1576r1917b1633],
10	severe	JJ	O	severe	amod	11	SENT_257	[p13l1945t1594r2148b1633],
11	neutropenia	NN	O	neutropenia	prep_of	8	SENT_257	[p13l13t1666r398b1735],
12	(	CD	NUMBER	(	num	13	SENT_257	[p13l466t1663r1053b1735],
13	q	NN	O	q	dep	11	SENT_257	[p13l466t1663r1053b1735],
14	—	CD	NUMBER	—	num	17	SENT_257	[p13l466t1663r1053b1735],
15	va	NN	O	va	nn	17	SENT_257	[p13l466t1663r1053b1735],
16	|	NN	O	|	nn	17	SENT_257	[p13l466t1663r1053b1735],
17	ue	NN	O	ue	dep	13	SENT_257	[p13l466t1663r1053b1735],
18	=	JJ	O	=	amod	20	SENT_257	[p13l466t1663r1053b1735],
19	0.0937	CD	NUMBER	0.0937	tmod	18	SENT_257	[p13l466t1663r1053b1735],
20	)	NN	O	)	dep	17	SENT_257	[p13l466t1663r1053b1735],
21	.	.	O	.	_	0	SENT_257	[p13l466t1663r1053b1735],

1	hMSH6	NN	O	hmsh6	_	0	SENT_258	[p13l1118t1663r1359b1729],
2	,	,	O	,	_	0	SENT_258	[p13l1118t1663r1359b1729],
3	expressed	VBN	O	express	partmod	1	SENT_258	[p13l1422t1663r1739b1735],
4	in	IN	O	in	_	0	SENT_258	[p13l1808t1666r1858b1719],
5	normal	JJ	O	normal	amod	10	SENT_258	[p13l1926t1663r2145b1720],
6	marrow	NN	O	marrow	nn	10	SENT_258	[p13l13t1766r257b1806],
7	ce	NN	O	ce	nn	10	SENT_258	[p13l324t1736r534b1814],
8	|	CD	NUMBER	|	num	10	SENT_258	[p13l324t1736r534b1814],
9	|	NN	O	|	nn	10	SENT_258	[p13l324t1736r534b1814],
10	s	NNS	O	s	prep_in	3	SENT_258	[p13l324t1736r534b1814],
11	,48	CD	NUMBER	,48	num	12	SENT_258	[p13l324t1736r534b1814],
12	deals	NNS	O	deal	dobj	3	SENT_258	[p13l602t1749r764b1806],
13	with	IN	O	with	_	0	SENT_258	[p13l832t1749r968b1806],
14	the	DT	O	the	det	15	SENT_258	[p13l1038t1749r1141b1806],
15	DNA	NN	MISC	dna	prep_with	12	SENT_258	[p13l1213t1752r1354b1805],
16	mis	FW	O	mis	nn	19	SENT_258	[p13l1425t1749r1755b1806],
17	—	FW	O	—	nn	19	SENT_258	[p13l1425t1749r1755b1806],
18	match	NN	O	match	nn	19	SENT_258	[p13l1425t1749r1755b1806],
19	repair	NN	O	repair	dep	15	SENT_258	[p13l1829t1752r2024b1820],
20	.	.	O	.	_	0	SENT_258	[p13l1829t1752r2024b1820],

1	In	IN	O	in	_	0	SENT_259	[p13l2096t1752r2146b1805],
2	particular	JJ	O	particular	prep_in	5	SENT_259	[p13l13t1835r326b1906],
3	,	,	O	,	_	0	SENT_259	[p13l13t1835r326b1906],
4	it	PRP	O	it	nsubj	5	SENT_259	[p13l360t1838r397b1892],
5	forms	VBZ	O	form	_	0	SENT_259	[p13l427t1834r608b1892],
6	an	DT	O	a	det	8	SENT_259	[p13l640t1852r713b1892],
7	heterodimeric	JJ	O	heterodimeric	amod	8	SENT_259	[p13l751t1835r1198b1892],
8	complex	NN	O	complex	nsubj	11	SENT_259	[p13l1230t1835r1503b1906],
9	with	IN	O	with	_	0	SENT_259	[p13l1533t1835r1669b1892],
10	MSH2	NN	O	msh2	prep_with	8	SENT_259	[p13l1706t1837r1888b1892],
11	able	JJ	O	able	xcomp	5	SENT_259	[p13l1921t1835r2054b1892],
12	to	TO	O	to	aux	13	SENT_259	[p13l2085t1844r2149b1892],
13	recognize	VB	O	recognize	xcomp	11	SENT_259	[p13l13t1924r320b1993],
14	mispaired	JJ	O	mispaired	amod	15	SENT_259	[p13l354t1921r662b1992],
15	bases	NNS	O	basis	dobj	13	SENT_259	[p13l698t1921r871b1978],
16	in	IN	O	in	_	0	SENT_259	[p13l904t1924r955b1977],
17	DNA	NN	O	dna	prep_in	13	SENT_259	[p13l991t1924r1147b1978],
18	.	.	O	.	_	0	SENT_259	[p13l991t1924r1147b1978],

1	A	DT	O	a	det	4	SENT_260	[p13l1177t1924r1220b1977],
2	functional	JJ	O	functional	amod	4	SENT_260	[p13l1248t1920r1566b1978],
3	mis	FW	O	mis	nn	4	SENT_260	[p13l1603t1921r1933b1978],
4	—	FW	O	—	nsubjpass	9	SENT_260	[p13l1603t1921r1933b1978],
5	match	NN	O	match	nn	7	SENT_260	[p13l1603t1921r1933b1978],
6	repair	NN	O	repair	nn	7	SENT_260	[p13l1968t1924r2150b1992],
7	system	NN	O	system	dep	4	SENT_260	[p13l11t2015r228b2079],
8	is	VBZ	O	be	auxpass	9	SENT_260	[p13l263t2009r304b2063],
9	required	VBN	O	require	ccomp	25	SENT_260	[p13l337t2006r600b2078],
10	for	IN	O	for	_	0	SENT_260	[p13l631t2006r719b2063],
11	the	DT	O	the	det	12	SENT_260	[p13l745t2006r848b2063],
12	detection	NN	O	detection	prep_for	9	SENT_260	[p13l878t2006r1179b2063],
13	of	IN	O	of	_	0	SENT_260	[p13l1211t2006r1276b2063],
14	damaged	JJ	O	damaged	amod	15	SENT_260	[p13l1301t2006r1600b2078],
15	DNA	NN	O	dna	prep_of	12	SENT_260	[p13l1635t2009r1777b2062],
16	created	VBN	O	create	partmod	15	SENT_260	[p13l1806t2006r2041b2063],
17	by	IN	O	by	_	0	SENT_260	[p13l2076t2006r2150b2079],
18	platinum	NN	O	platinum	nn	19	SENT_260	[p13l13t2092r293b2163],
19	derivatives	NNS	O	derivative	agent	16	SENT_260	[p13l338t2079r756b2149],
20	.49	CD	NUMBER	.49	tmod	16	SENT_260	[p13l338t2079r756b2149],
21	The	DT	O	the	det	23	SENT_260	[p13l795t2092r912b2149],
22	rs3136228	NN	O	rs3136228	nn	23	SENT_260	[p13l957t2096r1281b2149],
23	polymorphism	NN	O	polymorphism	dep	20	SENT_260	[p13l1326t2092r1805b2165],
24	,	,	O	,	_	0	SENT_260	[p13l1326t2092r1805b2165],
25	seems	VBZ	O	seem	_	0	SENT_260	[p13l1846t2109r2044b2149],
26	to	TO	O	to	aux	27	SENT_260	[p13l2085t2101r2149b2149],
27	modulate	VB	O	modulate	xcomp	25	SENT_260	[p13l13t2177r315b2233],
28	gene	NN	O	gene	nn	29	SENT_260	[p13l356t2194r514b2249],
29	transcription	NN	O	transcription	dobj	27	SENT_260	[p13l554t2180r957b2248],
30	causing	VBG	O	cause	partmod	29	SENT_260	[p13l1001t2180r1241b2249],
31	the	DT	O	the	det	32	SENT_260	[p13l1283t2177r1386b2233],
32	loss	NN	O	loss	dobj	30	SENT_260	[p13l1430t2177r1543b2233],
33	of	IN	O	of	_	0	SENT_260	[p13l1584t2176r1649b2233],
34	a	DT	O	a	det	38	SENT_260	[p13l1685t2194r1715b2233],
35	Sp1	NN	O	sp1	nn	38	SENT_260	[p13l1758t2177r2146b2249],
36	—	NN	O	—	nn	38	SENT_260	[p13l1758t2177r2146b2249],
37	binding	VBG	O	bind	amod	38	SENT_260	[p13l1758t2177r2146b2249],
38	site	NN	O	site	prep_of	32	SENT_260	[p13l11t2250r193b2320],
39	.5	CD	NUMBER	.5	number	40	SENT_260	[p13l11t2250r193b2320],
40	°	CD	NUMBER	°	nsubj	25	SENT_260	[p13l11t2250r193b2320],
41	It	PRP	O	it	nsubj	43	SENT_260	[p13l227t2266r263b2320],
42	is	VBZ	O	be	cop	43	SENT_260	[p13l296t2266r337b2320],
43	likely	JJ	O	likely	rcmod	40	SENT_260	[p13l373t2263r532b2336],
44	that	IN	O	that	complm	49	SENT_260	[p13l561t2263r688b2320],
45	the	DT	O	the	det	47	SENT_260	[p13l718t2263r821b2320],
46	rs3136228	NN	O	rs3136228	nn	47	SENT_260	[p13l856t2267r1181b2320],
47	variant	NN	O	variant	nsubj	49	SENT_260	[p13l1212t2266r1431b2320],
48	can	MD	O	can	aux	49	SENT_260	[p13l1463t2280r1569b2320],
49	affect	VB	O	affect	ccomp	43	SENT_260	[p13l1604t2263r1781b2320],
50	mis	FW	O	mis	nn	53	SENT_260	[p13l1815t2263r2145b2320],
51	—	FW	O	—	nn	53	SENT_260	[p13l1815t2263r2145b2320],
52	match	NN	O	match	nn	53	SENT_260	[p13l1815t2263r2145b2320],
53	repair	NN	O	repair	nn	54	SENT_260	[p13l13t2352r194b2421],
54	activity	NN	O	activity	dobj	49	SENT_260	[p13l224t2352r452b2422],
55	in	IN	O	in	_	0	SENT_260	[p13l484t2352r535b2405],
56	non	JJ	O	non	amod	58	SENT_260	[p13l572t2366r689b2406],
57	cancer	NN	O	cancer	nn	58	SENT_260	[p13l724t2366r934b2406],
58	cells	NNS	O	cell	prep_in	54	SENT_260	[p13l965t2350r1099b2406],
59	modulating	VBG	O	modulate	partmod	58	SENT_260	[p13l1134t2350r1499b2422],
60	the	DT	O	the	det	62	SENT_260	[p13l1532t2350r1635b2406],
61	toxic	JJ	O	toxic	amod	62	SENT_260	[p13l1665t2352r1817b2406],
62	effects	NNS	O	effect	dobj	59	SENT_260	[p13l1848t2349r2056b2406],
63	of	IN	O	of	_	0	SENT_260	[p13l2089t2349r2153b2406],
64	FOLFOX	NNP	O	FOLFOX	prep_of	62	SENT_260	[p13l13t2436r282b2490],
65	.	.	O	.	_	0	SENT_260	[p13l13t2436r282b2490],

1	For	IN	O	for	_	0	SENT_261	[p13l91t2523r189b2577],
2	the	DT	O	the	det	4	SENT_261	[p13l211t2520r314b2577],
3	novel	JJ	O	novel	amod	4	SENT_261	[p13l342t2520r510b2577],
4	SNPs	NNS	O	snp	pobj	1	SENT_261	[p13l539t2522r694b2577],
5	indentiﬁed	VBN	O	indentiﬁed	partmod	4	SENT_261	[p13l722t2520r1063b2577],
6	in	IN	O	in	_	0	SENT_261	[p13l1094t2523r1144b2576],
7	this	DT	O	this	det	8	SENT_261	[p13l1171t2520r1283b2577],
8	study	NN	O	study	prep_in	5	SENT_261	[p13l1310t2520r1498b2593],
9	,	,	O	,	_	0	SENT_261	[p13l1310t2520r1498b2593],
10	the	DT	O	the	det	12	SENT_261	[p13l1522t2520r1625b2577],
11	limited	JJ	O	limited	amod	12	SENT_261	[p13l1654t2520r1868b2577],
12	number	NN	O	number	prep_in	5	SENT_261	[p13l1899t2520r2150b2577],
13	of	IN	O	of	_	0	SENT_261	[p13l10t2606r75b2663],
14	patients	NNS	O	patient	prep_of	12	SENT_261	[p13l96t2609r349b2678],
15	and	CC	O	and	_	0	SENT_261	[p13l374t2607r489b2663],
16	lack	NN	O	lack	prep_in	5	SENT_261	[p13l519t2607r640b2663],
17	of	IN	O	of	_	0	SENT_261	[p13l661t2606r727b2663],
18	an	DT	O	a	det	21	SENT_261	[p13l745t2623r817b2663],
19	independent	JJ	O	independent	amod	21	SENT_261	[p13l846t2607r1258b2678],
20	validation	NN	O	validation	nn	21	SENT_261	[p13l1279t2607r1591b2663],
21	cohort	NN	O	cohort	prep_of	16	SENT_261	[p13l1618t2607r1825b2663],
22	make	VB	O	make	ccomp	5	SENT_261	[p13l1851t2607r2020b2663],
23	our	PRP$	O	we	dobj	22	SENT_261	[p13l2044t2623r2150b2663],

1	The	DT	O	the	det	3	SENT_262	[p13l708t2834r812b2884],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_262	[p13l842t2834r1400b2897],
3	Journal	NNP	O	Journal	_	0	SENT_262	[p13l1426t2834r1630b2884],
4	(	CD	NUMBER	(	num	6	SENT_262	[p13l1660t2835r1847b2891],
5	2013	CD	DATE	2013	num	6	SENT_262	[p13l1660t2835r1847b2891],
6	)	NN	O	)	dep	3	SENT_262	[p13l1660t2835r1847b2891],
7	,	,	O	,	_	0	SENT_262	[p13l1660t2835r1847b2891],
8	403-409	CD	NUMBER	403-409	appos	6	SENT_262	[p13l1884t2837r2149b2884],

1	_	NN	O	_	_	0	SENT_263	[p13l95t3082r110b3101],
2	Pharmacogenomic	JJ	O	pharmacogenomic	amod	3	SENT_263	[p13l555t3027r1044b3086],
3	markers	NNS	O	marker	dep	1	SENT_263	[p13l1071t3027r1275b3073],
4	of	IN	O	of	_	0	SENT_263	[p13l1300t3026r1353b3073],
5	toxicity	NN	O	toxicity	prep_of	3	SENT_263	[p13l1372t3029r1562b3086],
6	in	IN	O	in	_	0	SENT_263	[p13l1587t3029r1628b3072],
7	adjuvant	JJ	O	adjuvant	amod	8	SENT_263	[p13l1656t3027r1884b3086],
8	FOLFOX4	NN	O	folfox4	prep_in	5	SENT_263	[p13l1910t3028r2150b3073],
9	@	IN	O	@	_	0	SENT_263	[p13l7t3042r126b3158],
10	E	NN	O	e	nn	11	SENT_263	[p13l1757t3108r1782b3152],
11	Cecchin	NN	O	cecchin	prep_@	8	SENT_263	[p13l1807t3106r2010b3152],
12	et	FW	O	et	nn	13	SENT_263	[p13l2036t3113r2084b3152],
13	al	FW	O	al	dep	1	SENT_263	[p13l2105t3106r2152b3152],

1	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_264	[p14l182t24r418b90],
2	preliminary	JJ	O	preliminary	dep	1	SENT_264	[p14l446t24r791b91],
3	,	,	O	,	_	0	SENT_264	[p14l446t24r791b91],
4	requiring	VBG	O	require	_	0	SENT_264	[p14l818t27r1080b90],
5	further	JJ	O	further	amod	6	SENT_264	[p14l1106t24r1308b76],
6	conﬁrmation	NN	O	conﬁrmation	dobj	4	SENT_264	[p14l1332t24r1722b76],
7	.	.	O	.	_	0	SENT_264	[p14l1332t24r1722b76],

1	The	DT	O	the	det	2	SENT_265	[p14l1744t24r1852b76],
2	use	NN	O	use	nsubj	14	SENT_265	[p14l1880t40r1975b76],
3	of	IN	O	of	_	0	SENT_265	[p14l2001t24r2060b76],
4	an	DT	O	a	det	12	SENT_265	[p14l2081t40r2147b76],
5	oxalip	JJ	O	oxalip	amod	12	SENT_265	[p14l184t103r729b169],
6	|	NN	O	|	nn	12	SENT_265	[p14l184t103r729b169],
7	atin	NN	O	atin	nn	12	SENT_265	[p14l184t103r729b169],
8	—	NN	O	—	nn	12	SENT_265	[p14l184t103r729b169],
9	speciﬁc	NN	O	speciﬁc	nn	12	SENT_265	[p14l184t103r729b169],
10	sca	NN	O	sca	nn	12	SENT_265	[p14l755t91r950b155],
11	|	CD	NUMBER	|	num	12	SENT_265	[p14l755t91r950b155],
12	e23	NN	O	e23	prep_of	2	SENT_265	[p14l755t91r950b155],
13	could	MD	O	could	aux	14	SENT_265	[p14l977t104r1135b156],
14	impair	VB	O	impair	_	0	SENT_265	[p14l1165t106r1350b169],
15	the	DT	O	the	det	16	SENT_265	[p14l1373t104r1467b155],
16	ability	NN	O	ability	dobj	14	SENT_265	[p14l1493t104r1670b170],
17	to	TO	O	to	aux	18	SENT_265	[p14l1692t112r1751b155],
18	replicate	VB	O	replicate	infmod	16	SENT_265	[p14l1779t104r2028b169],
19	our	PRP$	O	we	poss	20	SENT_265	[p14l2054t119r2151b155],
20	ﬁndings	NNS	O	ﬁndings	dobj	18	SENT_265	[p14l182t182r418b248],
21	in	IN	O	in	_	0	SENT_265	[p14l453t185r500b234],
22	studies	NNS	O	study	prep_in	18	SENT_265	[p14l534t182r739b234],
23	using	VBG	O	use	xcomp	18	SENT_265	[p14l774t185r926b248],
24	the	DT	O	the	det	25	SENT_265	[p14l960t182r1054b234],
25	deﬁnitions	NNS	O	deﬁnitions	dobj	23	SENT_265	[p14l1086t182r1395b234],
26	of	IN	O	of	_	0	SENT_265	[p14l1428t182r1488b234],
27	the	DT	O	the	det	28	SENT_265	[p14l1513t182r1608b234],
28	NCl	NNP	O	NCl	prep_of	25	SENT_265	[p14l1643t170r2011b234],
29	.	.	O	.	_	0	SENT_265	[p14l1643t170r2011b234],

1	—	NN	O	—	_	0	SENT_266	[p14l1643t170r2011b234],
2	.	.	O	.	_	0	SENT_266	[p14l1643t170r2011b234],

1	CTC	NNP	O	CTC	nn	3	SENT_267	[p14l1643t170r2011b234],
2	.5	CD	NUMBER	.5	num	3	SENT_267	[p14l1643t170r2011b234],
3	l'52	NN	O	l'52	nsubj	8	SENT_267	[p14l1643t170r2011b234],
4	Our	PRP$	O	we	poss	5	SENT_267	[p14l2044t184r2151b234],
5	study	NN	O	study	dep	3	SENT_267	[p14l184t261r344b328],
6	did	VBD	O	do	aux	8	SENT_267	[p14l380t261r470b313],
7	not	RB	O	not	neg	8	SENT_267	[p14l512t269r607b313],
8	validate	VB	O	validate	_	0	SENT_267	[p14l643t261r873b313],
9	existing	VBG	O	exist	amod	10	SENT_267	[p14l911t264r1135b327],
10	markers	NNS	O	marker	dobj	8	SENT_267	[p14l1177t261r1406b313],
11	previously	RB	DATE	previously	advmod	12	SENT_267	[p14l1447t261r1746b328],
12	identiﬁed	VBN	O	identiﬁed	partmod	10	SENT_267	[p14l1784t261r2059b313],
13	in	IN	O	in	_	0	SENT_267	[p14l2101t264r2147b313],
14	metastatic	JJ	O	metastatic	amod	15	SENT_267	[p14l186t342r488b392],
15	patients	NNS	O	patient	prep_in	12	SENT_267	[p14l516t342r763b405],
16	,	,	O	,	_	0	SENT_267	[p14l516t342r763b405],
17	and	CC	O	and	_	0	SENT_267	[p14l789t340r896b392],
18	provides	VBZ	O	provide	conj_and	8	SENT_267	[p14l927t339r1175b405],
19	the	DT	O	the	det	20	SENT_267	[p14l1201t339r1295b392],
20	basis	NN	O	basis	dobj	18	SENT_267	[p14l1324t340r1464b392],
21	for	IN	O	for	_	0	SENT_267	[p14l1489t339r1570b392],
22	testing	VBG	O	test	prepc_for	18	SENT_267	[p14l1593t342r1792b406],
23	the	DT	O	the	det	24	SENT_267	[p14l1819t340r1914b392],
24	validity	NN	O	validity	dobj	22	SENT_267	[p14l1939t340r2151b406],
25	of	IN	O	of	_	0	SENT_267	[p14l184t417r244b470],
26	new	JJ	O	new	amod	27	SENT_267	[p14l280t433r402b470],
27	markers	NNS	O	marker	prep_of	24	SENT_267	[p14l442t418r671b470],
28	in	IN	O	in	_	0	SENT_267	[p14l712t420r759b469],
29	future	JJ	DATE	future	amod	30	SENT_267	[p14l800t417r976b470],
30	studies	NNS	O	study	prep_in	22	SENT_267	[p14l1016t418r1220b470],
31	in	IN	O	in	_	0	SENT_267	[p14l1262t420r1309b469],
32	adjuvant	JJ	O	adjuvant	amod	33	SENT_267	[p14l1351t418r1608b484],
33	FOLFOX	NN	O	folfox	prep_in	30	SENT_267	[p14l1649t420r1896b470],
34	.	.	O	.	_	0	SENT_267	[p14l1649t420r1896b470],

1	Among	IN	O	among	_	0	SENT_268	[p14l1934t420r2148b484],
2	those	DT	O	those	prep_among	8	SENT_268	[p14l182t496r358b556],
3	,	,	O	,	_	0	SENT_268	[p14l182t496r358b556],
4	the	DT	O	the	det	5	SENT_268	[p14l379t496r474b548],
5	variants	NNS	O	variant	nsubjpass	23	SENT_268	[p14l495t499r724b548],
6	in	IN	O	in	_	0	SENT_268	[p14l749t499r796b547],
7	ABCC2	NN	O	abcc2	prep_in	5	SENT_268	[p14l817t498r1008b548],
8	have	VBP	O	have	_	0	SENT_268	[p14l1032t496r1168b548],
9	a	DT	O	a	det	11	SENT_268	[p14l1191t512r1219b548],
10	clinical	JJ	O	clinical	amod	11	SENT_268	[p14l1244t496r1439b548],
11	effect	NN	O	effect	dobj	8	SENT_268	[p14l1464t496r1628b548],
12	that	WDT	O	that	nsubj	14	SENT_268	[p14l1649t496r1766b548],
13	is	VBZ	O	be	cop	14	SENT_268	[p14l1790t499r1828b548],
14	consistent	JJ	O	consistent	rcmod	11	SENT_268	[p14l1851t499r2151b548],
15	with	IN	O	with	_	0	SENT_268	[p14l182t574r307b626],
16	their	PRP$	O	they	poss	18	SENT_268	[p14l331t574r467b626],
17	molecular	JJ	O	molecular	amod	18	SENT_268	[p14l491t574r779b626],
18	function	NN	O	function	prep_with	14	SENT_268	[p14l799t573r1058b633],
19	,	,	O	,	_	0	SENT_268	[p14l799t573r1058b633],
20	and	CC	O	and	_	0	SENT_268	[p14l1081t574r1188b626],
21	should	MD	O	should	aux	23	SENT_268	[p14l1214t574r1407b626],
22	be	VB	O	be	auxpass	23	SENT_268	[p14l1435t574r1504b626],
23	prioritized	VBN	O	prioritize	conj_and	8	SENT_268	[p14l1529t574r1822b639],
24	for	IN	O	for	_	0	SENT_268	[p14l1847t573r1928b626],
25	testing	NN	O	testing	prep_for	23	SENT_268	[p14l1948t576r2148b640],
26	of	IN	O	of	_	0	SENT_268	[p14l184t651r244b704],
27	their	PRP$	O	they	poss	29	SENT_268	[p14l265t652r401b704],
28	clinical	JJ	O	clinical	amod	29	SENT_268	[p14l427t652r623b704],
29	validity	NN	O	validity	prep_of	25	SENT_268	[p14l652t652r865b718],
30	in	IN	O	in	_	0	SENT_268	[p14l893t654r940b703],
31	future	JJ	DATE	future	amod	32	SENT_268	[p14l969t651r1145b704],
32	studies	NNS	O	study	prep_in	29	SENT_268	[p14l1174t652r1393b704],
33	.	.	O	.	_	0	SENT_268	[p14l1174t652r1393b704],

1	CONFLICT	NN	O	conflict	_	0	SENT_269	[p14l183t861r497b911],
2	OF	IN	O	of	_	0	SENT_269	[p14l523t861r606b911],
3	INTEREST	NN	O	interest	prep_of	1	SENT_269	[p14l637t861r933b911],

1	The	DT	O	the	det	2	SENT_270	[p14l181t958r265b998],
2	authors	NNS	O	author	nsubj	3	SENT_270	[p14l287t958r458b998],
3	declare	VBP	O	declare	_	0	SENT_270	[p14l481t958r646b998],
4	no	DT	O	no	det	5	SENT_270	[p14l669t969r725b998],
5	conﬂict	NN	O	conﬂict	dobj	3	SENT_270	[p14l747t957r914b998],
6	of	IN	O	of	_	0	SENT_270	[p14l935t957r982b998],
7	interest	NN	O	interest	prep_of	5	SENT_270	[p14l1001t960r1182b998],
8	.	.	O	.	_	0	SENT_270	[p14l1001t960r1182b998],

1	REFERENCES	NNS	O	reference	_	0	SENT_271	[p14l186t1141r580b1192],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_272	[p14l269t1240r345b1278],
2	SY	NNP	PERSON	SY	_	0	SENT_272	[p14l383t1240r447b1284],
3	,	,	O	,	_	0	SENT_272	[p14l383t1240r447b1284],
4	McLeod	NNP	PERSON	McLeod	nn	5	SENT_272	[p14l486t1238r663b1278],
5	HL	NNS	O	hl	appos	2	SENT_272	[p14l705t1240r773b1278],
6	.	.	O	.	_	0	SENT_272	[p14l705t1240r773b1278],

1	Pharmacogenetic	JJ	MISC	pharmacogenetic	amod	2	SENT_273	[p14l812t1238r1211b1289],
2	tests	NNS	O	test	_	0	SENT_273	[p14l1248t1245r1352b1278],
3	in	IN	O	in	_	0	SENT_273	[p14l1392t1240r1429b1278],
4	cancer	NN	O	cancer	nn	5	SENT_273	[p14l1469t1250r1618b1278],
5	chemotherapy	NN	O	chemotherapy	prep_in	2	SENT_273	[p14l1655t1238r2000b1289],
6	:	:	O	:	_	0	SENT_273	[p14l1655t1238r2000b1289],
7	what	WP	O	what	dobj	10	SENT_273	[p14l2038t1238r2151b1278],
8	physicians	NNS	O	physician	nsubj	10	SENT_273	[p14l269t1309r502b1361],
9	should	MD	O	should	aux	10	SENT_273	[p14l525t1309r675b1349],
10	know	VB	O	know	rcmod	2	SENT_273	[p14l702t1309r824b1349],
11	for	IN	O	for	_	0	SENT_273	[p14l844t1309r907b1349],
12	clinical	JJ	O	clinical	amod	13	SENT_273	[p14l928t1309r1080b1349],
13	application	NN	O	application	prep_for	10	SENT_273	[p14l1104t1309r1369b1360],
14	.	.	O	.	_	0	SENT_273	[p14l1104t1309r1369b1360],

1	J	NNP	O	J	nn	2	SENT_274	[p14l1387t1311r1410b1349],
2	Pathol	NNP	O	Pathol	_	0	SENT_274	[p14l1429t1309r1573b1349],
3	2011	CD	DATE	2011	num	2	SENT_274	[p14l1592t1312r1713b1355],
4	;	:	O	;	_	0	SENT_274	[p14l1592t1312r1713b1355],
5	223	CD	NUMBER	223	num	7	SENT_274	[p14l1735t1312r1835b1349],
6	:	:	O	:	_	0	SENT_274	[p14l1735t1312r1835b1349],
7	15-27	CD	DATE	15-27	dep	2	SENT_274	[p14l1860t1312r2005b1349],
8	.	.	O	.	_	0	SENT_274	[p14l1860t1312r2005b1349],

1	Sim	NNP	PERSON	Sim	nn	2	SENT_275	[p14l267t1381r347b1420],
2	SC	NNP	O	SC	_	0	SENT_275	[p14l385t1381r452b1426],
3	,	,	O	,	_	0	SENT_275	[p14l385t1381r452b1426],
4	|	CD	NUMBER	|	num	5	SENT_275	[p14l489t1380r942b1431],
5	ngelman	NN	O	ngelman	appos	2	SENT_275	[p14l489t1380r942b1431],
6	.	.	O	.	_	0	SENT_275	[p14l489t1380r942b1431],

1	—	NN	O	—	_	0	SENT_276	[p14l489t1380r942b1431],
2	.	.	O	.	_	0	SENT_276	[p14l489t1380r942b1431],

1	Sundberg	NNP	PERSON	Sundberg	nn	4	SENT_277	[p14l489t1380r942b1431],
2	M.	NNP	PERSON	M.	nn	4	SENT_277	[p14l980t1382r1032b1420],
3	Pharmacogenomic	NNP	PERSON	Pharmacogenomic	nn	4	SENT_277	[p14l1069t1380r1499b1431],
4	biomarkers	NNS	O	biomarker	_	0	SENT_277	[p14l1536t1380r1800b1420],
5	:	:	O	:	_	0	SENT_277	[p14l1536t1380r1800b1420],
6	new	JJ	O	new	amod	7	SENT_277	[p14l1837t1392r1932b1420],
7	tools	NNS	O	tool	dep	4	SENT_277	[p14l1964t1380r2074b1420],
8	in	IN	O	in	_	0	SENT_277	[p14l2112t1382r2148b1419],
9	current	JJ	DATE	current	prep_in	7	SENT_277	[p14l267t1457r431b1491],
10	and	CC	O	and	_	0	SENT_277	[p14l452t1451r535b1491],
11	future	JJ	DATE	future	amod	13	SENT_277	[p14l558t1451r695b1491],
12	drug	NN	O	drug	nn	13	SENT_277	[p14l717t1451r822b1502],
13	therapy	NN	O	therapy	conj_and	9	SENT_277	[p14l845t1451r1032b1502],
14	.	.	O	.	_	0	SENT_277	[p14l845t1451r1032b1502],

1	Trends	NNS	O	trend	_	0	SENT_278	[p14l1055t1451r1197b1491],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_278	[p14l1219t1451r1459b1491],
3	Sci	NNP	O	Sci	dep	1	SENT_278	[p14l1477t1453r1538b1491],
4	2011	CD	DATE	2011	num	3	SENT_278	[p14l1558t1454r1678b1497],
5	;	:	O	;	_	0	SENT_278	[p14l1558t1454r1678b1497],
6	32	CD	NUMBER	32	num	8	SENT_278	[p14l1700t1454r1769b1491],
7	:	:	O	:	_	0	SENT_278	[p14l1700t1454r1769b1491],
8	72-81	CD	NUMBER	72-81	dep	1	SENT_278	[p14l1792t1454r1939b1491],
9	.	.	O	.	_	0	SENT_278	[p14l1792t1454r1939b1491],

1	Cecchin	NNP	MISC	Cecchin	nn	2	SENT_279	[p14l267t1524r445b1564],
2	E	NNP	O	E	_	0	SENT_279	[p14l481t1526r513b1570],
3	,	,	O	,	_	0	SENT_279	[p14l481t1526r513b1570],
4	Innocenti	NNP	PERSON	Innocenti	nn	5	SENT_279	[p14l547t1526r758b1564],
5	F	NN	O	f	appos	2	SENT_279	[p14l794t1526r826b1570],
6	,	,	O	,	_	0	SENT_279	[p14l794t1526r826b1570],
7	D’Andrea	NN	O	d’andrea	nn	8	SENT_279	[p14l860t1524r1068b1564],
8	M	NN	O	m	appos	2	SENT_279	[p14l1103t1526r1154b1570],
9	,	,	O	,	_	0	SENT_279	[p14l1103t1526r1154b1570],
10	Corona	NNP	PERSON	Corona	nn	11	SENT_279	[p14l1186t1525r1348b1564],
11	G	NNP	PERSON	G	appos	2	SENT_279	[p14l1382t1525r1425b1570],
12	,	,	O	,	_	0	SENT_279	[p14l1382t1525r1425b1570],
13	De	NNP	PERSON	De	nn	15	SENT_279	[p14l1459t1526r1517b1564],
14	Mattia	NNP	PERSON	Mattia	nn	15	SENT_279	[p14l1551t1526r1691b1564],
15	E	NNP	PERSON	E	appos	2	SENT_279	[p14l1727t1526r1760b1570],
16	,	,	O	,	_	0	SENT_279	[p14l1727t1526r1760b1570],
17	Biason	NNP	O	Biason	nn	18	SENT_279	[p14l1794t1526r1938b1564],
18	P	NN	O	p	appos	2	SENT_279	[p14l1975t1526r1998b1564],
19	et	FW	O	et	nn	20	SENT_279	[p14l2030t1530r2072b1564],
20	al.	FW	O	al.	dep	18	SENT_279	[p14l2101t1524r2148b1564],
21	.	.	O	.	_	0	SENT_279	[p14l2101t1524r2148b1564],

1	Predictive	JJ	O	predictive	amod	2	SENT_280	[p14l269t1595r492b1635],
2	role	NN	O	role	nsubj	24	SENT_280	[p14l544t1595r627b1635],
3	of	IN	O	of	_	0	SENT_280	[p14l677t1594r723b1635],
4	the	DT	O	the	det	5	SENT_280	[p14l768t1595r841b1635],
5	UGT1A1	NN	O	ugt1a1	prep_of	2	SENT_280	[p14l894t1596r1089b1641],
6	,	,	O	,	_	0	SENT_280	[p14l894t1596r1089b1641],
7	UGT1A7	NN	O	ugt1a7	prep_of	2	SENT_280	[p14l1140t1596r1334b1641],
8	,	,	O	,	_	0	SENT_280	[p14l1140t1596r1334b1641],
9	and	CC	O	and	_	0	SENT_280	[p14l1384t1595r1467b1635],
10	UGT1A9	NN	O	ugt1a9	conj_and	5	SENT_280	[p14l1521t1596r1704b1635],
11	genetic	JJ	O	genetic	amod	12	SENT_280	[p14l1754t1597r1923b1646],
12	variants	NNS	O	variant	dep	5	SENT_280	[p14l1972t1597r2150b1635],
13	and	CC	O	and	_	0	SENT_280	[p14l267t1665r350b1705],
14	their	PRP$	O	they	poss	15	SENT_280	[p14l378t1665r484b1705],
15	haplotypes	NNS	O	haplotype	conj_and	5	SENT_280	[p14l512t1665r762b1716],
16	on	IN	O	on	_	0	SENT_280	[p14l790t1677r846b1705],
17	the	DT	O	the	det	18	SENT_280	[p14l874t1665r947b1705],
18	outcome	NN	O	outcome	prep_on	15	SENT_280	[p14l975t1671r1178b1705],
19	of	IN	O	of	_	0	SENT_280	[p14l1206t1664r1253b1705],
20	metastatic	JJ	O	metastatic	amod	23	SENT_280	[p14l1278t1667r1513b1705],
21	colorectal	JJ	O	colorectal	amod	23	SENT_280	[p14l1541t1665r1760b1705],
22	cancer	NN	O	cancer	nn	23	SENT_280	[p14l1791t1677r1941b1705],
23	patients	NNS	O	patient	prep_of	18	SENT_280	[p14l1969t1667r2149b1715],
24	treated	VBN	O	treat	_	0	SENT_280	[p14l266t1737r428b1778],
25	with	IN	O	with	_	0	SENT_280	[p14l466t1737r563b1778],
26	ﬂuorouracil	NN	O	ﬂuorouracil	prep_with	24	SENT_280	[p14l600t1737r871b1784],
27	,	,	O	,	_	0	SENT_280	[p14l600t1737r871b1784],
28	leucovorin	NN	O	leucovorin	conj_and	26	SENT_280	[p14l909t1737r1158b1784],
29	,	,	O	,	_	0	SENT_280	[p14l909t1737r1158b1784],
30	and	CC	O	and	_	0	SENT_280	[p14l1194t1737r1277b1778],
31	irinotecan	NN	O	irinotecan	conj_and	26	SENT_280	[p14l1317t1739r1555b1778],
32	.	.	O	.	_	0	SENT_280	[p14l1317t1739r1555b1778],

1	J	NNP	O	J	nn	3	SENT_281	[p14l1588t1739r1611b1778],
2	Clin	NNP	O	Clin	nn	3	SENT_281	[p14l1645t1737r1724b1778],
3	Oncol	NNP	O	Oncol	_	0	SENT_281	[p14l1761t1737r1891b1778],
4	2009	CD	DATE	2009	num	3	SENT_281	[p14l1925t1740r2046b1784],
5	;	:	O	;	_	0	SENT_281	[p14l1925t1740r2046b1784],
6	27	CD	NUMBER	27	num	8	SENT_281	[p14l2082t1740r2151b1778],
7	:	:	O	:	_	0	SENT_281	[p14l2082t1740r2151b1778],
8	2457-2465	CD	DATE	2457-2465	dep	3	SENT_281	[p14l267t1811r529b1849],
9	.	.	O	.	_	0	SENT_281	[p14l267t1811r529b1849],

1	Innocenti	NNP	PERSON	Innocenti	nn	2	SENT_282	[p14l269t1881r479b1919],
2	F	NN	O	f	_	0	SENT_282	[p14l508t1881r541b1925],
3	,	,	O	,	_	0	SENT_282	[p14l508t1881r541b1925],
4	Undevia	NNP	O	Undevia	nn	5	SENT_282	[p14l568t1879r752b1919],
5	SD	NN	O	sd	appos	2	SENT_282	[p14l779t1881r850b1925],
6	,	,	O	,	_	0	SENT_282	[p14l779t1881r850b1925],
7	Iyer	NNP	PERSON	Iyer	nn	8	SENT_282	[p14l876t1881r957b1930],
8	L	NNP	PERSON	L	appos	2	SENT_282	[p14l983t1881r1015b1925],
9	,	,	O	,	_	0	SENT_282	[p14l983t1881r1015b1925],
10	Chen	NNP	LOCATION	Chen	nn	11	SENT_282	[p14l1039t1879r1154b1919],
11	PX	NNP	LOCATION	PX	appos	2	SENT_282	[p14l1184t1881r1250b1925],
12	,	,	O	,	_	0	SENT_282	[p14l1184t1881r1250b1925],
13	Das	NNP	O	Das	nn	14	SENT_282	[p14l1277t1881r1356b1919],
14	S	NNP	O	S	appos	2	SENT_282	[p14l1382t1881r1417b1925],
15	,	,	O	,	_	0	SENT_282	[p14l1382t1881r1417b1925],
16	Kocherginsky	NNP	O	Kocherginsky	nn	17	SENT_282	[p14l1443t1879r1748b1930],
17	M	NNP	O	M	appos	2	SENT_282	[p14l1773t1881r1812b1919],
18	et	FW	O	et	nn	19	SENT_282	[p14l1838t1885r1880b1919],
19	al.	FW	O	al.	dep	17	SENT_282	[p14l1901t1879r1949b1919],
20	.	.	O	.	_	0	SENT_282	[p14l1901t1879r1949b1919],

1	Genetic	JJ	O	genetic	amod	2	SENT_283	[p14l1976t1881r2150b1919],
2	variants	NNS	O	variant	nsubj	8	SENT_283	[p14l266t1952r444b1990],
3	in	IN	O	in	_	0	SENT_283	[p14l469t1952r505b1990],
4	the	DT	O	the	det	7	SENT_283	[p14l529t1950r603b1990],
5	UDP-glucuronosyltransferase	NN	O	udp-glucuronosyltransferase	nn	7	SENT_283	[p14l628t1950r1291b2001],
6	1A1	NN	O	1a1	nn	7	SENT_283	[p14l1319t1952r1393b1990],
7	gene	NN	O	gene	prep_in	2	SENT_283	[p14l1425t1962r1538b2001],
8	predict	VBP	O	predict	_	0	SENT_283	[p14l1563t1950r1722b2000],
9	the	DT	O	the	det	10	SENT_283	[p14l1743t1950r1817b1990],
10	risk	NN	O	risk	dobj	8	SENT_283	[p14l1842t1950r1917b1990],
11	of	IN	O	of	_	0	SENT_283	[p14l1938t1950r1985b1990],
12	severe	JJ	O	severe	amod	13	SENT_283	[p14l2004t1962r2150b1990],
13	neutropenia	NN	O	neutropenia	prep_of	10	SENT_283	[p14l269t2024r545b2073],
14	of	IN	O	of	_	0	SENT_283	[p14l568t2022r615b2063],
15	irinotecan	NN	O	irinotecan	prep_of	13	SENT_283	[p14l634t2024r873b2063],
16	.	.	O	.	_	0	SENT_283	[p14l634t2024r873b2063],

1	J	NNP	O	J	nn	3	SENT_284	[p14l891t2024r914b2063],
2	Clin	NNP	O	Clin	nn	3	SENT_284	[p14l933t2022r1012b2063],
3	Oncol	NNP	O	Oncol	_	0	SENT_284	[p14l1036t2022r1166b2063],
4	2004	CD	DATE	2004	num	3	SENT_284	[p14l1185t2025r1306b2069],
5	;	:	O	;	_	0	SENT_284	[p14l1185t2025r1306b2069],
6	22	CD	NUMBER	22	num	8	SENT_284	[p14l1327t2025r1396b2063],
7	:	:	O	:	_	0	SENT_284	[p14l1327t2025r1396b2063],
8	1382-1388	CD	DATE	1382-1388	dep	3	SENT_284	[p14l1422t2025r1680b2063],
9	.	.	O	.	_	0	SENT_284	[p14l1422t2025r1680b2063],

1	Ruzzo	NNP	MISC	Ruzzo	nn	2	SENT_285	[p14l269t2096r400b2135],
2	A	NNP	MISC	A	_	0	SENT_285	[p14l424t2096r466b2141],
3	,	,	O	,	_	0	SENT_285	[p14l424t2096r466b2141],
4	Graziano	NNP	PERSON	Graziano	nn	5	SENT_285	[p14l489t2096r689b2135],
5	F	NN	O	f	appos	2	SENT_285	[p14l715t2096r748b2141],
6	,	,	O	,	_	0	SENT_285	[p14l715t2096r748b2141],
7	Loupakis	NNP	O	Loupakis	nn	8	SENT_285	[p14l773t2094r972b2145],
8	F	NN	O	f	appos	2	SENT_285	[p14l998t2096r1030b2141],
9	,	,	O	,	_	0	SENT_285	[p14l998t2096r1030b2141],
10	Santini	NNP	PERSON	Santini	nn	11	SENT_285	[p14l1054t2095r1207b2135],
11	D	NNP	O	D	appos	2	SENT_285	[p14l1235t2096r1277b2141],
12	,	,	O	,	_	0	SENT_285	[p14l1235t2096r1277b2141],
13	Catalano	NNP	PERSON	Catalano	nn	14	SENT_285	[p14l1300t2094r1499b2135],
14	V	NNP	PERSON	V	appos	2	SENT_285	[p14l1522t2096r1562b2141],
15	,	,	O	,	_	0	SENT_285	[p14l1522t2096r1562b2141],
16	Bisonni	NNP	PERSON	Bisonni	nn	17	SENT_285	[p14l1587t2096r1749b2135],
17	R	NNP	O	R	appos	2	SENT_285	[p14l1776t2096r1801b2134],
18	et	FW	O	et	nn	19	SENT_285	[p14l1824t2100r1866b2135],
19	al.	FW	O	al.	dep	17	SENT_285	[p14l1886t2094r1934b2135],
20	.	.	O	.	_	0	SENT_285	[p14l1886t2094r1934b2135],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_286	[p14l1962t2094r2150b2135, p14l267t2167r490b2216],
2	proﬁling	NN	O	proﬁling	nsubj	9	SENT_286	[p14l511t2164r699b2216],
3	in	IN	O	in	_	0	SENT_286	[p14l722t2167r758b2204],
4	patients	NNS	O	patient	prep_in	2	SENT_286	[p14l781t2167r962b2215],
5	with	IN	O	with	_	0	SENT_286	[p14l981t2165r1078b2205],
6	advanced	JJ	O	advanced	amod	8	SENT_286	[p14l1099t2165r1319b2205],
7	colorectal	JJ	O	colorectal	amod	8	SENT_286	[p14l1341t2165r1560b2205],
8	cancer	NN	O	cancer	prep_with	4	SENT_286	[p14l1582t2177r1732b2205],
9	treated	VBN	O	treat	_	0	SENT_286	[p14l1749t2165r1911b2205],
10	with	IN	O	with	_	0	SENT_286	[p14l1932t2165r2029b2205],
11	ﬁrst	NN	O	ﬁrst	nn	15	SENT_286	[p14l2049t2164r2150b2205],
12	—	CD	NUMBER	—	num	15	SENT_286	[p14l2049t2164r2150b2205],
13	line	NN	O	line	nn	15	SENT_286	[p14l269t2236r347b2276],
14	FOLFIRI	NN	O	folfirus	nn	15	SENT_286	[p14l371t2237r536b2276],
15	chemotherapy	NN	O	chemotherapy	prep_with	9	SENT_286	[p14l560t2236r905b2287],
16	.	.	O	.	_	0	SENT_286	[p14l560t2236r905b2287],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_287	[p14l927t2236r1365b2287],
2	J	NNP	O	J	dep	1	SENT_287	[p14l1383t2238r1406b2276],
3	2008	CD	DATE	2008	num	2	SENT_287	[p14l1425t2239r1546b2282],
4	;	:	O	;	_	0	SENT_287	[p14l1425t2239r1546b2282],
5	8	CD	NUMBER	8	num	7	SENT_287	[p14l1567t2239r1606b2276],
6	:	:	O	:	_	0	SENT_287	[p14l1567t2239r1606b2276],
7	278-288	CD	NUMBER	278-288	dep	1	SENT_287	[p14l1628t2239r1832b2276],
8	.	.	O	.	_	0	SENT_287	[p14l1628t2239r1832b2276],

1	Toffoli	NNP	MISC	Toffoli	nn	2	SENT_288	[p14l265t2307r407b2348],
2	G	NNP	O	G	_	0	SENT_288	[p14l432t2309r476b2353],
3	,	,	O	,	_	0	SENT_288	[p14l432t2309r476b2353],
4	Cecchin	NNP	O	Cecchin	nn	5	SENT_288	[p14l499t2308r676b2348],
5	E	NNP	O	E	appos	2	SENT_288	[p14l705t2309r737b2354],
6	,	,	O	,	_	0	SENT_288	[p14l705t2309r737b2354],
7	Gasparini	NNP	PERSON	Gasparini	nn	8	SENT_288	[p14l760t2309r972b2358],
8	G	NNP	O	G	appos	2	SENT_288	[p14l997t2309r1041b2354],
9	,	,	O	,	_	0	SENT_288	[p14l997t2309r1041b2354],
10	D’Andrea	NNP	O	D’Andrea	nn	11	SENT_288	[p14l1066t2307r1274b2348],
11	M	NNP	O	M	appos	2	SENT_288	[p14l1300t2309r1351b2354],
12	,	,	O	,	_	0	SENT_288	[p14l1300t2309r1351b2354],
13	Azzarello	NNP	PERSON	Azzarello	nn	14	SENT_288	[p14l1374t2307r1580b2348],
14	G	NNP	PERSON	G	appos	2	SENT_288	[p14l1604t2309r1647b2354],
15	,	,	O	,	_	0	SENT_288	[p14l1604t2309r1647b2354],
16	Basso	NNP	PERSON	Basso	nn	18	SENT_288	[p14l1673t2309r1798b2348],
17	U	NNP	O	U	nn	18	SENT_288	[p14l1824t2309r1852b2348],
18	et	NNP	O	et	appos	2	SENT_288	[p14l1877t2314r1919b2348],
19	al.	FW	O	al.	dep	18	SENT_288	[p14l1940t2308r1987b2348],
20	.	.	O	.	_	0	SENT_288	[p14l1940t2308r1987b2348],

1	Genotype	NN	O	genotype	nn	2	SENT_289	[p14l2013t2309r2150b2348, p14l266t2378r528b2429],
2	—	NN	O	—	nsubj	9	SENT_289	[p14l2013t2309r2150b2348, p14l266t2378r528b2429],
3	driven	VBN	O	drive	partmod	2	SENT_289	[p14l2013t2309r2150b2348, p14l266t2378r528b2429],
4	phase	NN	O	phase	iobj	3	SENT_289	[p14l555t2378r687b2428],
5	I	PRP	O	I	dobj	3	SENT_289	[p14l713t2380r718b2418],
6	study	NN	O	study	dobj	3	SENT_289	[p14l744t2378r868b2429],
7	of	IN	O	of	_	0	SENT_289	[p14l890t2378r937b2418],
8	irinotecan	NN	O	irinotecan	prep_of	3	SENT_289	[p14l957t2380r1183b2418],
9	administered	VBN	O	administer	_	0	SENT_289	[p14l1208t2378r1507b2418],
10	in	IN	O	in	_	0	SENT_289	[p14l1533t2380r1570b2418],
11	combination	NN	O	combination	prep_in	9	SENT_289	[p14l1595t2378r1883b2418],
12	with	IN	O	with	_	0	SENT_289	[p14l1908t2378r2005b2418],
13	ﬂuorouracil	NN	O	ﬂuorouracil	prep_with	11	SENT_289	[p14l2029t2378r2150b2418, p14l267t2450r678b2493],
14	/	:	O	/	punct	15	SENT_289	[p14l2029t2378r2150b2418, p14l267t2450r678b2493],
15	leucovorin	NN	O	leucovorin	dep	9	SENT_289	[p14l2029t2378r2150b2418, p14l267t2450r678b2493],
16	in	IN	O	in	_	0	SENT_289	[p14l700t2452r736b2490],
17	patients	NNS	O	patient	prep_in	15	SENT_289	[p14l759t2452r939b2501],
18	with	IN	O	with	_	0	SENT_289	[p14l958t2450r1055b2491],
19	metastatic	JJ	O	metastatic	amod	21	SENT_289	[p14l1077t2452r1312b2491],
20	colorectal	JJ	O	colorectal	amod	21	SENT_289	[p14l1331t2450r1551b2491],
21	cancer	NN	O	cancer	prep_with	17	SENT_289	[p14l1571t2462r1731b2491],
22	.	.	O	.	_	0	SENT_289	[p14l1571t2462r1731b2491],

1	J	NNP	O	J	nn	3	SENT_290	[p14l1746t2452r1769b2491],
2	Clin	NNP	O	Clin	nn	3	SENT_290	[p14l1785t2450r1864b2491],
3	Oncol	NNP	O	Oncol	_	0	SENT_290	[p14l1884t2450r2014b2491],
4	2010	CD	DATE	2010	num	3	SENT_290	[p14l2030t2453r2151b2497],
5	;	:	O	;	_	0	SENT_290	[p14l2030t2453r2151b2497],
6	28	CD	NUMBER	28	num	8	SENT_290	[p14l267t2524r336b2562],
7	:	:	O	:	_	0	SENT_290	[p14l267t2524r336b2562],
8	866-871	CD	NUMBER	866-871	dep	3	SENT_290	[p14l357t2524r563b2562],
9	.	.	O	.	_	0	SENT_290	[p14l357t2524r563b2562],

1	Andre	NNP	PERSON	Andre	nn	2	SENT_291	[p14l267t2592r404b2632],
2	T	NN	PERSON	t	_	0	SENT_291	[p14l430t2594r467b2638],
3	,	,	O	,	_	0	SENT_291	[p14l430t2594r467b2638],
4	Boni	NNP	PERSON	Boni	nn	5	SENT_291	[p14l497t2594r593b2632],
5	C	NNP	O	C	appos	2	SENT_291	[p14l623t2593r662b2638],
6	,	,	O	,	_	0	SENT_291	[p14l623t2593r662b2638],
7	Mounedji	NNP	LOCATION	Mounedji	appos	5	SENT_291	[p14l691t2591r1105b2643],
8	.	.	O	.	_	0	SENT_291	[p14l691t2591r1105b2643],

1	—	NN	O	—	_	0	SENT_292	[p14l691t2591r1105b2643],
2	.	.	O	.	_	0	SENT_292	[p14l691t2591r1105b2643],

1	Boudiaf	NNP	PERSON	Boudiaf	nn	2	SENT_293	[p14l691t2591r1105b2643],
2	L	NNP	PERSON	L	_	0	SENT_293	[p14l1131t2594r1162b2638],
3	,	,	O	,	_	0	SENT_293	[p14l1131t2594r1162b2638],
4	Navarro	NNP	PERSON	Navarro	nn	5	SENT_293	[p14l1192t2594r1369b2632],
5	M	NNP	O	M	appos	2	SENT_293	[p14l1398t2594r1449b2638],
6	,	,	O	,	_	0	SENT_293	[p14l1398t2594r1449b2638],
7	Tabernero	NNP	PERSON	Tabernero	nn	8	SENT_293	[p14l1474t2592r1710b2632],
8	J	NNP	PERSON	J	appos	2	SENT_293	[p14l1736t2594r1766b2638],
9	,	,	O	,	_	0	SENT_293	[p14l1736t2594r1766b2638],
10	Hickish	JJ	O	hickish	amod	11	SENT_293	[p14l1796t2592r1953b2632],
11	T	NN	O	t	appos	2	SENT_293	[p14l1981t2594r2009b2631],
12	et	FW	O	et	nn	13	SENT_293	[p14l2034t2598r2076b2632],
13	al.	FW	O	al.	dep	11	SENT_293	[p14l2101t2592r2148b2632],
14	.	.	O	.	_	0	SENT_293	[p14l2101t2592r2148b2632],

1	Oxaliplatin	NNP	O	Oxaliplatin	_	0	SENT_294	[p14l267t2663r522b2713],
2	,	,	O	,	_	0	SENT_294	[p14l267t2663r522b2713],
3	ﬂuorouracil	NN	O	ﬂuorouracil	conj_and	1	SENT_294	[p14l544t2662r816b2709],
4	,	,	O	,	_	0	SENT_294	[p14l544t2662r816b2709],
5	and	CC	O	and	_	0	SENT_294	[p14l839t2663r922b2703],
6	leucovorin	NN	O	leucovorin	conj_and	1	SENT_294	[p14l950t2663r1186b2703],
7	as	IN	O	as	_	0	SENT_294	[p14l1212t2675r1257b2703],
8	adjuvant	JJ	O	adjuvant	amod	9	SENT_294	[p14l1281t2663r1481b2714],
9	treatment	NN	O	treatment	prep_as	6	SENT_294	[p14l1504t2669r1733b2703],
10	for	IN	O	for	_	0	SENT_294	[p14l1755t2662r1818b2703],
11	colon	NN	O	colon	nn	12	SENT_294	[p14l1841t2663r1964b2703],
12	cancer	NN	O	cancer	prep_for	9	SENT_294	[p14l1990t2675r2150b2703],
13	.	.	O	.	_	0	SENT_294	[p14l1990t2675r2150b2703],

1	N	NN	O	n	nn	3	SENT_295	[p14l267t2736r301b2774],
2	Engl	NNP	O	Engl	nn	3	SENT_295	[p14l320t2734r416b2785],
3	J	NNP	O	J	nsubj	4	SENT_295	[p14l431t2736r454b2774],
4	Med	VBD	O	med	_	0	SENT_295	[p14l472t2734r569b2774],
5	2004	CD	DATE	2004	dobj	4	SENT_295	[p14l588t2737r709b2780],
6	;	:	O	;	_	0	SENT_295	[p14l588t2737r709b2780],
7	350	CD	NUMBER	350	num	9	SENT_295	[p14l731t2737r831b2774],
8	:	:	O	:	_	0	SENT_295	[p14l731t2737r831b2774],
9	2343-2351	CD	DATE	2343-2351	dep	5	SENT_295	[p14l852t2737r1114b2774],
10	.	.	O	.	_	0	SENT_295	[p14l852t2737r1114b2774],

1	Ibrahim	NNP	PERSON	Ibrahim	nn	2	SENT_296	[p14l269t2806r439b2846],
2	A	NNP	O	A	_	0	SENT_296	[p14l463t2808r505b2852],
3	,	,	O	,	_	0	SENT_296	[p14l463t2808r505b2852],
4	Hirschfeld	NNP	PERSON	Hirschfeld	nn	5	SENT_296	[p14l528t2805r752b2846],
5	S	NNP	O	S	appos	2	SENT_296	[p14l777t2807r812b2852],
6	,	,	O	,	_	0	SENT_296	[p14l777t2807r812b2852],
7	Cohen	NNP	PERSON	Cohen	nn	8	SENT_296	[p14l833t2806r979b2846],
8	MH	NNP	O	MH	appos	2	SENT_296	[p14l1004t2808r1090b2852],
9	,	,	O	,	_	0	SENT_296	[p14l1004t2808r1090b2852],
10	Griebel	NNP	PERSON	Griebel	nn	11	SENT_296	[p14l1112t2806r1272b2846],
11	DJ	NNP	O	DJ	appos	2	SENT_296	[p14l1299t2807r1361b2852],
12	,	,	O	,	_	0	SENT_296	[p14l1299t2807r1361b2852],
13	Williams	NNP	ORGANIZATION	Williams	nn	14	SENT_296	[p14l1382t2806r1572b2846],
14	GA	NNP	ORGANIZATION	GA	appos	2	SENT_296	[p14l1594t2807r1671b2852],
15	,	,	O	,	_	0	SENT_296	[p14l1594t2807r1671b2852],
16	Pazdur	NNP	ORGANIZATION	Pazdur	nn	18	SENT_296	[p14l1695t2806r1849b2846],
17	R.	NNP	ORGANIZATION	R.	nn	18	SENT_296	[p14l1872t2807r1907b2846],
18	FDA	NNP	ORGANIZATION	FDA	appos	2	SENT_296	[p14l1931t2807r2023b2846],
19	drug	NN	O	drug	nn	21	SENT_296	[p14l2044t2806r2148b2857],
20	approval	NN	O	approval	nn	21	SENT_296	[p14l267t2877r464b2927],
21	summaries	NNS	O	summary	dep	18	SENT_296	[p14l488t2879r748b2917],
22	:	:	O	:	_	0	SENT_296	[p14l488t2879r748b2917],
23	oxaliplatin	NN	O	oxaliplatin	dep	2	SENT_296	[p14l769t2877r1016b2927],
24	.	.	O	.	_	0	SENT_296	[p14l769t2877r1016b2927],

1	Oncologist	NN	O	oncologist	_	0	SENT_297	[p14l1038t2877r1275b2928],
2	2004	CD	DATE	2004	num	1	SENT_297	[p14l1295t2880r1416b2923],
3	;	:	O	;	_	0	SENT_297	[p14l1295t2880r1416b2923],
4	9	CD	NUMBER	9	num	6	SENT_297	[p14l1437t2880r1475b2917],
5	:	:	O	:	_	0	SENT_297	[p14l1437t2880r1475b2917],
6	8-12	CD	NUMBER	8-12	dep	1	SENT_297	[p14l1497t2880r1618b2917],
7	.	.	O	.	_	0	SENT_297	[p14l1497t2880r1618b2917],

1	Kuebler	NNP	PERSON	Kuebler	nn	2	SENT_298	[p14l269t2947r442b2987],
2	JP	NNP	O	JP	_	0	SENT_298	[p14l464t2949r523b2993],
3	,	,	O	,	_	0	SENT_298	[p14l464t2949r523b2993],
4	Wieand	NNP	O	Wieand	nn	5	SENT_298	[p14l547t2947r718b2987],
5	HS	NN	O	h	appos	2	SENT_298	[p14l748t2949r817b2993],
6	,	,	O	,	_	0	SENT_298	[p14l748t2949r817b2993],
7	O'Connell	NNP	PERSON	O'Connell	nn	8	SENT_298	[p14l842t2947r1062b2987],
8	MJ	NNP	PERSON	MJ	appos	2	SENT_298	[p14l1090t2949r1161b2993],
9	,	,	O	,	_	0	SENT_298	[p14l1090t2949r1161b2993],
10	Smith	NNP	PERSON	Smith	nn	11	SENT_298	[p14l1187t2947r1316b2987],
11	RE	NNP	O	RE	appos	2	SENT_298	[p14l1345t2949r1407b2993],
12	,	,	O	,	_	0	SENT_298	[p14l1345t2949r1407b2993],
13	Colangelo	NNP	ORGANIZATION	Colangelo	nn	14	SENT_298	[p14l1432t2947r1661b2998],
14	LH	NNP	ORGANIZATION	LH	appos	2	SENT_298	[p14l1690t2949r1757b2993],
15	,	,	O	,	_	0	SENT_298	[p14l1690t2949r1757b2993],
16	Yothers	NNP	PERSON	Yothers	nn	17	SENT_298	[p14l1781t2947r1954b2987],
17	G	NNP	O	G	appos	2	SENT_298	[p14l1979t2949r2010b2987],
18	et	FW	O	et	nn	19	SENT_298	[p14l2037t2953r2079b2987],
19	al.	FW	O	al.	dep	17	SENT_298	[p14l2101t2947r2148b2987],
20	.	.	O	.	_	0	SENT_298	[p14l2101t2947r2148b2987],

1	Oxaliplatin	NN	O	oxaliplatin	_	0	SENT_299	[p14l267t3018r509b3068],
2	combined	VBN	O	combine	partmod	1	SENT_299	[p14l536t3018r765b3058],
3	with	IN	O	with	_	0	SENT_299	[p14l792t3018r889b3058],
4	weekly	JJ	SET	weekly	amod	6	SENT_299	[p14l916t3018r1075b3069],
5	bolus	NN	O	bolus	nn	6	SENT_299	[p14l1100t3018r1221b3058],
6	ﬂuorouracil	NN	O	ﬂuorouracil	prep_with	2	SENT_299	[p14l1245t3017r1503b3058],
7	and	CC	O	and	_	0	SENT_299	[p14l1530t3018r1613b3058],
8	leucovorin	NN	O	leucovorin	prep_with	2	SENT_299	[p14l1643t3018r1879b3058],
9	as	IN	O	as	_	0	SENT_299	[p14l1906t3030r1950b3058],
10	surgical	JJ	O	surgical	amod	12	SENT_299	[p14l1976t3018r2148b3069],
11	adjuvant	JJ	O	adjuvant	amod	12	SENT_299	[p14l267t3089r467b3140],
12	chemotherapy	NN	O	chemotherapy	prep_as	2	SENT_299	[p14l485t3089r820b3140],
13	for	IN	O	for	_	0	SENT_299	[p14l836t3088r899b3129],
14	stage	NN	O	stage	prep_for	12	SENT_299	[p14l917t3095r1038b3140],
15	II	CD	NUMBER	ii	num	14	SENT_299	[p14l1058t3091r1077b3128],
16	and	CC	O	and	_	0	SENT_299	[p14l1097t3089r1180b3129],
17	Ill	NNP	O	Ill	nn	19	SENT_299	[p14l1202t3091r1233b3128],
18	colon	NN	O	colon	nn	19	SENT_299	[p14l1253t3089r1376b3129],
19	cancer	NN	O	cancer	prep_for	12	SENT_299	[p14l1397t3101r1557b3129],
20	:	:	O	:	_	0	SENT_299	[p14l1397t3101r1557b3129],
21	results	NNS	O	result	dep	1	SENT_299	[p14l1577t3089r1721b3129],
22	from	IN	O	from	_	0	SENT_299	[p14l1739t3088r1845b3129],
23	NSABP	NNP	ORGANIZATION	NSABP	nn	24	SENT_299	[p14l1868t3090r2019b3129],
24	C-07	NNP	O	C-07	prep_from	21	SENT_299	[p14l2037t3090r2150b3129],
25	.	.	O	.	_	0	SENT_299	[p14l2037t3090r2150b3129],

1	J	NNP	O	J	nn	3	SENT_300	[p14l263t3163r286b3202],
2	Clin	NNP	O	Clin	nn	3	SENT_300	[p14l305t3161r385b3202],
3	Oncol	NNP	O	Oncol	_	0	SENT_300	[p14l408t3161r538b3202],
4	2007	CD	DATE	2007	num	3	SENT_300	[p14l557t3164r678b3208],
5	;	:	O	;	_	0	SENT_300	[p14l557t3164r678b3208],
6	25	CD	NUMBER	25	num	8	SENT_300	[p14l700t3164r769b3202],
7	:	:	O	:	_	0	SENT_300	[p14l700t3164r769b3202],
8	2198-2204	CD	DATE	2198-2204	dep	3	SENT_300	[p14l791t3164r1053b3202],
9	.	.	O	.	_	0	SENT_300	[p14l791t3164r1053b3202],

1	10	CD	NUMBER	10	num	3	SENT_301	[p14l187t3236r236b3273],
2	Pachman	NNP	ORGANIZATION	Pachman	nn	3	SENT_301	[p14l269t3233r477b3273],
3	DR	NN	ORGANIZATION	dr	_	0	SENT_301	[p14l525t3234r597b3279],
4	,	,	O	,	_	0	SENT_301	[p14l525t3234r597b3279],
5	Barton	NNP	ORGANIZATION	Barton	nn	6	SENT_301	[p14l643t3235r789b3273],
6	DL	NNP	ORGANIZATION	DL	appos	3	SENT_301	[p14l837t3234r906b3279],
7	,	,	O	,	_	0	SENT_301	[p14l837t3234r906b3279],
8	Watson	NNP	PERSON	Watson	nn	9	SENT_301	[p14l949t3235r1118b3273],
9	JC	NNP	O	JC	appos	3	SENT_301	[p14l1163t3234r1225b3279],
10	,	,	O	,	_	0	SENT_301	[p14l1163t3234r1225b3279],
11	Loprinzi	NNP	PERSON	Loprinzi	nn	12	SENT_301	[p14l1271t3235r1448b3283],
12	CL	NN	O	cl	appos	3	SENT_301	[p14l1494t3234r1560b3273],
13	.	.	O	.	_	0	SENT_301	[p14l1494t3234r1560b3273],

1	Chemotherapy	NN	O	chemotherapy	nn	2	SENT_302	[p14l1604t3233r2148b3284],
2	—	NN	O	—	nsubj	3	SENT_302	[p14l1604t3233r2148b3284],
3	induced	VBD	O	induce	_	0	SENT_302	[p14l1604t3233r2148b3284],
4	peripheral	JJ	O	peripheral	amod	5	SENT_302	[p14l269t3304r499b3354],
5	neuropathy	NN	O	neuropathy	dobj	3	SENT_302	[p14l524t3304r799b3355],
6	:	:	O	:	_	0	SENT_302	[p14l524t3304r799b3355],
7	prevention	NN	O	prevention	dep	5	SENT_302	[p14l823t3306r1068b3354],
8	and	CC	O	and	_	0	SENT_302	[p14l1092t3304r1175b3344],
9	treatment	NN	O	treatment	dep	5	SENT_302	[p14l1198t3310r1437b3344],
10	.	.	O	.	_	0	SENT_302	[p14l1198t3310r1437b3344],

1	Clin	NNP	O	Clin	nn	3	SENT_303	[p14l1460t3304r1539b3344],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_303	[p14l1563t3304r1803b3344],
3	Ther	NNP	O	Ther	_	0	SENT_303	[p14l1824t3304r1920b3344],
4	2011	CD	DATE	2011	num	3	SENT_303	[p14l1939t3307r2060b3350],
5	;	:	O	;	_	0	SENT_303	[p14l1939t3307r2060b3350],
6	90	CD	NUMBER	90	num	8	SENT_303	[p14l2081t3307r2151b3344],
7	:	:	O	:	_	0	SENT_303	[p14l2081t3307r2151b3344],
8	377-387	CD	NUMBER	377-387	dep	3	SENT_303	[p14l268t3378r472b3415],
9	.	.	O	.	_	0	SENT_303	[p14l268t3378r472b3415],

1	11	CD	NUMBER	11	num	3	SENT_304	[p14l187t3449r228b3485],
2	Reilly	NNP	ORGANIZATION	Reilly	nn	3	SENT_304	[p14l269t3446r386b3497],
3	MM	NN	ORGANIZATION	mm	_	0	SENT_304	[p14l405t3448r501b3492],
4	,	,	O	,	_	0	SENT_304	[p14l405t3448r501b3492],
5	Murphy	NNP	PERSON	Murphy	nn	6	SENT_304	[p14l521t3446r697b3497],
6	SM	NNP	O	SM	appos	3	SENT_304	[p14l715t3447r794b3492],
7	,	,	O	,	_	0	SENT_304	[p14l715t3447r794b3492],
8	Laura	NNP	PERSON	Laura	nn	10	SENT_304	[p14l815t3448r936b3486],
9	M.	NNP	PERSON	M.	nn	10	SENT_304	[p14l957t3448r1008b3486],
10	Charcot	NNP	PERSON	Charcot	appos	6	SENT_304	[p14l1026t3446r1499b3486],
11	.	.	O	.	_	0	SENT_304	[p14l1026t3446r1499b3486],

1	—	NN	O	—	_	0	SENT_305	[p14l1026t3446r1499b3486],
2	.	.	O	.	_	0	SENT_305	[p14l1026t3446r1499b3486],

1	Marie	NNP	PERSON	Marie	_	0	SENT_306	[p14l1026t3446r1499b3486],
2	.	.	O	.	_	0	SENT_306	[p14l1026t3446r1499b3486],

1	—	NN	O	—	_	0	SENT_307	[p14l1026t3446r1499b3486],
2	.	.	O	.	_	0	SENT_307	[p14l1026t3446r1499b3486],

1	Tooth	NN	O	tooth	_	0	SENT_308	[p14l1026t3446r1499b3486],
2	disease	NN	O	disease	dep	1	SENT_308	[p14l1520t3446r1697b3486],
3	.	.	O	.	_	0	SENT_308	[p14l1520t3446r1697b3486],

1	J	NNP	O	J	nn	4	SENT_309	[p14l1713t3448r1736b3486],
2	Peripher	NNP	O	Peripher	nn	4	SENT_309	[p14l1751t3446r1934b3496],
3	Nerv	NNP	O	Nerv	nn	4	SENT_309	[p14l1949t3448r2051b3486],
4	Syst	NNP	O	Syst	_	0	SENT_309	[p14l2065t3447r2153b3497],

1	12	CD	NUMBER	12	num	3	SENT_310	[p15l187t22r235b59],
2	Park	NNP	O	Park	nn	3	SENT_310	[p15l269t19r366b59],
3	SB	NN	O	sb	_	0	SENT_310	[p15l383t21r448b65],
4	,	,	O	,	_	0	SENT_310	[p15l383t21r448b65],
5	Lin	NNP	O	Lin	nn	6	SENT_310	[p15l468t21r530b59],
6	CS	NNP	O	CS	appos	3	SENT_310	[p15l551t21r617b65],
7	,	,	O	,	_	0	SENT_310	[p15l551t21r617b65],
8	Krishnan	NNP	PERSON	Krishnan	nn	9	SENT_310	[p15l638t19r831b59],
9	AV	NNP	O	AV	appos	6	SENT_310	[p15l852t21r924b65],
10	,	,	O	,	_	0	SENT_310	[p15l852t21r924b65],
11	Goldstein	NNP	PERSON	Goldstein	nn	12	SENT_310	[p15l942t19r1157b59],
12	D	NNP	O	D	appos	6	SENT_310	[p15l1181t21r1223b65],
13	,	,	O	,	_	0	SENT_310	[p15l1181t21r1223b65],
14	Friedlander	NNP	PERSON	Friedlander	nn	15	SENT_310	[p15l1243t19r1501b59],
15	ML	NNP	O	ML	appos	6	SENT_310	[p15l1520t21r1597b65],
16	,	,	O	,	_	0	SENT_310	[p15l1520t21r1597b65],
17	Kiernan	NNP	PERSON	Kiernan	nn	18	SENT_310	[p15l1618t21r1786b59],
18	MC	NNP	O	MC	appos	6	SENT_310	[p15l1809t21r1891b59],
19	.	.	O	.	_	0	SENT_310	[p15l1809t21r1891b59],

1	Long	JJ	O	long	amod	4	SENT_311	[p15l1912t21r2148b70],
2	—	NN	O	—	nn	4	SENT_311	[p15l1912t21r2148b70],
3	term	NN	O	term	nn	4	SENT_311	[p15l1912t21r2148b70],
4	neuropathy	NN	O	neuropathy	dep	5	SENT_311	[p15l269t91r533b142],
5	after	IN	O	after	dep	9	SENT_311	[p15l561t90r665b131],
6	oxaliplatin	NN	O	oxaliplatin	nn	7	SENT_311	[p15l692t91r926b141],
7	treatment	NN	O	treatment	pobj	5	SENT_311	[p15l955t97r1194b131],
8	:	:	O	:	_	0	SENT_311	[p15l955t97r1194b131],
9	challenging	VBG	O	challenge	_	0	SENT_311	[p15l1222t91r1487b142],
10	the	DT	O	the	det	11	SENT_311	[p15l1516t91r1590b131],
11	dictum	NN	O	dictum	dobj	9	SENT_311	[p15l1618t91r1776b131],
12	of	IN	O	of	_	0	SENT_311	[p15l1806t90r1853b131],
13	reversibility	NN	O	reversibility	prep_of	11	SENT_311	[p15l1878t91r2150b142],
14	.	.	O	.	_	0	SENT_311	[p15l1878t91r2150b142],

1	Oncologist	NN	O	oncologist	_	0	SENT_312	[p15l268t162r505b213],
2	2011	CD	DATE	2011	num	1	SENT_312	[p15l525t165r645b208],
3	;	:	O	;	_	0	SENT_312	[p15l525t165r645b208],
4	16	CD	NUMBER	16	num	6	SENT_312	[p15l670t165r736b202],
5	:	:	O	:	_	0	SENT_312	[p15l670t165r736b202],
6	708-716	CD	NUMBER	708-716	dep	1	SENT_312	[p15l758t165r962b202],
7	.	.	O	.	_	0	SENT_312	[p15l758t165r962b202],

1	Cassidy	NNP	PERSON	Cassidy	nn	2	SENT_313	[p15l267t232r437b284],
2	J	NNP	PERSON	J	_	0	SENT_313	[p15l466t234r495b278],
3	,	,	O	,	_	0	SENT_313	[p15l466t234r495b278],
4	Tabernero	NNP	PERSON	Tabernero	nn	5	SENT_313	[p15l524t232r760b272],
5	J	NNP	PERSON	J	appos	2	SENT_313	[p15l790t234r819b279],
6	,	,	O	,	_	0	SENT_313	[p15l790t234r819b279],
7	Twelves	NNP	O	Twelves	nn	8	SENT_313	[p15l848t232r1031b272],
8	C	NNP	O	C	appos	2	SENT_313	[p15l1063t234r1102b278],
9	,	,	O	,	_	0	SENT_313	[p15l1063t234r1102b278],
10	Brunet	NNP	PERSON	Brunet	nn	11	SENT_313	[p15l1136t234r1285b272],
11	R	NNP	O	R	appos	2	SENT_313	[p15l1318t234r1353b278],
12	,	,	O	,	_	0	SENT_313	[p15l1318t234r1353b278],
13	Butts	NNP	O	Butts	nn	14	SENT_313	[p15l1386t234r1497b272],
14	C	NNP	O	C	appos	2	SENT_313	[p15l1529t234r1569b278],
15	,	,	O	,	_	0	SENT_313	[p15l1529t234r1569b278],
16	Conroy	NNP	PERSON	Conroy	nn	17	SENT_313	[p15l1600t234r1764b284],
17	T	NN	O	t	appos	2	SENT_313	[p15l1792t234r1821b272],
18	et	FW	O	et	nn	19	SENT_313	[p15l1849t238r1891b272],
19	al.	FW	O	al.	dep	17	SENT_313	[p15l1919t232r1966b272],
20	.	.	O	.	_	0	SENT_313	[p15l1919t232r1966b272],

1	XELOX	NNP	O	XELOX	nn	3	SENT_314	[p15l2000t234r2151b272],
2	(	CD	NUMBER	(	num	3	SENT_314	[p15l269t304r574b354],
3	capecitabine	NN	O	capecitabine	_	0	SENT_314	[p15l269t304r574b354],
4	plus	CC	O	plus	prep	3	SENT_314	[p15l593t303r683b354],
5	oxaliplatin	NN	O	oxaliplatin	dep	4	SENT_314	[p15l700t304r962b354],
6	)	CD	NUMBER	)	num	5	SENT_314	[p15l700t304r962b354],
7	:	:	O	:	_	0	SENT_314	[p15l700t304r962b354],
8	active	JJ	O	active	amod	13	SENT_314	[p15l979t306r1112b344],
9	ﬁrst	JJ	O	ﬁrst	amod	13	SENT_314	[p15l1128t303r1312b344],
10	—	NN	O	—	nn	13	SENT_314	[p15l1128t303r1312b344],
11	|	NN	O	|	nn	13	SENT_314	[p15l1128t303r1312b344],
12	ine	NN	O	ine	nn	13	SENT_314	[p15l1128t303r1312b344],
13	therapy	NN	O	therapy	dep	3	SENT_314	[p15l1328t303r1506b355],
14	for	IN	O	for	_	0	SENT_314	[p15l1520t303r1583b344],
15	patients	NNS	O	patient	prep_for	13	SENT_314	[p15l1600t306r1781b354],
16	with	IN	O	with	_	0	SENT_314	[p15l1797t303r1895b344],
17	metastatic	JJ	O	metastatic	amod	19	SENT_314	[p15l1915t306r2150b344],
18	colorectal	JJ	O	colorectal	amod	19	SENT_314	[p15l267t376r487b416],
19	cancer	NN	O	cancer	prep_with	15	SENT_314	[p15l511t387r672b416],
20	.	.	O	.	_	0	SENT_314	[p15l511t387r672b416],

1	J	NNP	O	J	nn	3	SENT_315	[p15l690t378r713b416],
2	Clin	NNP	O	Clin	nn	3	SENT_315	[p15l732t376r811b416],
3	Oncol	NNP	O	Oncol	_	0	SENT_315	[p15l835t376r965b416],
4	2004	CD	DATE	2004	num	3	SENT_315	[p15l984t378r1105b422],
5	;	:	O	;	_	0	SENT_315	[p15l984t378r1105b422],
6	22	CD	NUMBER	22	num	8	SENT_315	[p15l1127t378r1195b416],
7	:	:	O	:	_	0	SENT_315	[p15l1127t378r1195b416],
8	2084-2091	CD	DATE	2084-2091	dep	3	SENT_315	[p15l1217t378r1479b416],
9	.	.	O	.	_	0	SENT_315	[p15l1217t378r1479b416],

1	Kiernan	NNP	PERSON	Kiernan	nn	2	SENT_316	[p15l269t448r438b486],
2	MC	NNP	O	MC	_	0	SENT_316	[p15l474t448r556b492],
3	,	,	O	,	_	0	SENT_316	[p15l474t448r556b492],
4	Krishnan	NNP	PERSON	Krishnan	nn	5	SENT_316	[p15l590t446r784b486],
5	AV	NNP	O	AV	appos	2	SENT_316	[p15l817t448r890b486],
6	.	.	O	.	_	0	SENT_316	[p15l817t448r890b486],

1	The	DT	O	the	det	2	SENT_317	[p15l919t446r1003b486],
2	pathophysiology	NN	O	pathophysiology	nsubj	10	SENT_317	[p15l1037t446r1422b497],
3	of	IN	O	of	_	0	SENT_317	[p15l1453t446r1499b486],
4	oxa	NN	O	oxa	nn	7	SENT_317	[p15l1528t446r1967b496],
5	|	CD	NUMBER	|	num	7	SENT_317	[p15l1528t446r1967b496],
6	ip	NN	O	ip	nn	7	SENT_317	[p15l1528t446r1967b496],
7	|	NN	O	|	prep_of	2	SENT_317	[p15l1528t446r1967b496],
8	atin	NN	O	atin	nn	9	SENT_317	[p15l1528t446r1967b496],
9	—	NN	O	—	dep	2	SENT_317	[p15l1528t446r1967b496],
10	induced	VBD	O	induce	_	0	SENT_317	[p15l1528t446r1967b496],
11	neurotoxicity	NN	O	neurotoxicity	dobj	10	SENT_317	[p15l2002t458r2150b486, p15l266t519r442b568],
12	.	.	O	.	_	0	SENT_317	[p15l2002t458r2150b486, p15l266t519r442b568],

1	Curr	NNP	O	Curr	nn	3	SENT_318	[p15l465t519r559b557],
2	Med	NNP	O	Med	nn	3	SENT_318	[p15l576t517r673b557],
3	Chem	NNP	O	Chem	_	0	SENT_318	[p15l693t517r817b557],
4	2006	CD	DATE	2006	num	3	SENT_318	[p15l840t520r961b563],
5	;	:	O	;	_	0	SENT_318	[p15l840t520r961b563],
6	13	CD	NUMBER	13	num	8	SENT_318	[p15l985t520r1052b557],
7	:	:	O	:	_	0	SENT_318	[p15l985t520r1052b557],
8	2901-2907	CD	DATE	2901-2907	dep	3	SENT_318	[p15l1074t520r1335b557],
9	.	.	O	.	_	0	SENT_318	[p15l1074t520r1335b557],

1	Adelsberger	NN	O	adelsberger	nn	2	SENT_319	[p15l267t588r546b639],
2	H	NN	O	h	nsubj	21	SENT_319	[p15l570t590r612b634],
3	,	,	O	,	_	0	SENT_319	[p15l570t590r612b634],
4	Quasthoff	NNP	PERSON	Quasthoff	nn	5	SENT_319	[p15l636t587r864b632],
5	S	NNP	O	S	appos	2	SENT_319	[p15l885t589r919b634],
6	,	,	O	,	_	0	SENT_319	[p15l885t589r919b634],
7	Grosskreutz	NNP	PERSON	Grosskreutz	nn	8	SENT_319	[p15l943t588r1211b628],
8	J	NNP	PERSON	J	appos	2	SENT_319	[p15l1234t590r1264b634],
9	,	,	O	,	_	0	SENT_319	[p15l1234t590r1264b634],
10	Lepier	NNP	O	Lepier	nn	11	SENT_319	[p15l1289t590r1428b638],
11	A	NNP	O	A	appos	2	SENT_319	[p15l1451t590r1493b634],
12	,	,	O	,	_	0	SENT_319	[p15l1451t590r1493b634],
13	Eckel	NNP	PERSON	Eckel	nn	14	SENT_319	[p15l1518t588r1630b628],
14	F	NN	O	f	appos	2	SENT_319	[p15l1658t590r1690b634],
15	,	,	O	,	_	0	SENT_319	[p15l1658t590r1690b634],
16	Lersch	NNP	O	Lersch	nn	20	SENT_319	[p15l1716t588r1857b628],
17	C.	NNP	O	C.	nn	20	SENT_319	[p15l1884t589r1923b628],
18	The	NNP	O	The	nn	20	SENT_319	[p15l1945t588r2029b628],
19	chemotherapeutic	JJ	O	chemotherapeutic	amod	20	SENT_319	[p15l2054t588r2150b628, p15l269t659r605b709],
20	oxaliplatin	NN	O	oxaliplatin	appos	2	SENT_319	[p15l637t659r870b709],
21	alters	VBZ	O	alter	_	0	SENT_319	[p15l903t659r1024b699],
22	vo	FW	O	vo	nn	25	SENT_319	[p15l1055t659r1373b710],
23	|	FW	O	|	nn	25	SENT_319	[p15l1055t659r1373b710],
24	tage	FW	O	tage	nn	25	SENT_319	[p15l1055t659r1373b710],
25	—	FW	O	—	dobj	21	SENT_319	[p15l1055t659r1373b710],
26	gated	VBN	O	gate	partmod	25	SENT_319	[p15l1055t659r1373b710],
27	Na	NN	O	na	nn	28	SENT_319	[p15l1408t660r1557b705],
28	(	NN	O	(	dobj	26	SENT_319	[p15l1408t660r1557b705],
29	+	CC	O	+	_	0	SENT_319	[p15l1408t660r1557b705],
30	)	NN	O	)	nn	32	SENT_319	[p15l1408t660r1557b705],
31	channel	NN	O	channel	nn	32	SENT_319	[p15l1590t659r1768b699],
32	kinetics	NNS	O	kinetics	conj_+	28	SENT_319	[p15l1803t659r1971b699],
33	on	IN	O	on	_	0	SENT_319	[p15l2003t671r2059b699],
34	rat	NN	O	rat	nn	36	SENT_319	[p15l2093t665r2151b699],
35	sensory	JJ	O	sensory	amod	36	SENT_319	[p15l268t742r441b781],
36	neurons	NNS	O	neuron	prep_on	32	SENT_319	[p15l464t742r658b770],
37	.	.	O	.	_	0	SENT_319	[p15l464t742r658b770],

1	Eur	NNP	MISC	Eur	nn	3	SENT_320	[p15l680t732r753b770],
2	J	NNP	O	J	nn	3	SENT_320	[p15l768t732r791b770],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_320	[p15l809t730r1050b770],
4	2000	CD	DATE	2000	num	3	SENT_320	[p15l1070t733r1190b776],
5	;	:	O	;	_	0	SENT_320	[p15l1070t733r1190b776],
6	406	CD	NUMBER	406	num	8	SENT_320	[p15l1211t733r1311b770],
7	:	:	O	:	_	0	SENT_320	[p15l1211t733r1311b770],
8	25-32	CD	NUMBER	25-32	dep	3	SENT_320	[p15l1333t733r1482b770],
9	.	.	O	.	_	0	SENT_320	[p15l1333t733r1482b770],

1	Ta	NNP	O	Ta	nn	2	SENT_321	[p15l265t803r316b841],
2	LE	NNP	O	LE	_	0	SENT_321	[p15l354t803r412b847],
3	,	,	O	,	_	0	SENT_321	[p15l354t803r412b847],
4	Espeset	NNP	ORGANIZATION	Espeset	nn	5	SENT_321	[p15l448t803r620b851],
5	L	NNP	ORGANIZATION	L	appos	2	SENT_321	[p15l655t803r686b847],
6	,	,	O	,	_	0	SENT_321	[p15l655t803r686b847],
7	Podratz	NNP	PERSON	Podratz	nn	8	SENT_321	[p15l722t801r894b841],
8	J	NNP	PERSON	J	appos	2	SENT_321	[p15l925t803r955b847],
9	,	,	O	,	_	0	SENT_321	[p15l925t803r955b847],
10	Windebank	NNP	O	Windebank	nn	11	SENT_321	[p15l988t801r1251b841],
11	AJ	NNP	O	AJ	appos	2	SENT_321	[p15l1282t803r1345b841],
12	.	.	O	.	_	0	SENT_321	[p15l1282t803r1345b841],

1	Neurotoxicity	NN	O	neurotoxicity	nsubj	11	SENT_322	[p15l1381t803r1686b852],
2	of	IN	O	of	_	0	SENT_322	[p15l1719t801r1765b841],
3	oxaliplatin	NN	O	oxaliplatin	prep_of	1	SENT_322	[p15l1796t801r2029b851],
4	and	CC	O	and	_	0	SENT_322	[p15l2065t801r2148b841],
5	cisplatin	NN	O	cisplatin	prep_of	1	SENT_322	[p15l267t872r453b923],
6	for	IN	O	for	_	0	SENT_322	[p15l474t872r537b912],
7	dorsal	NN	O	dorsal	nn	10	SENT_322	[p15l557t872r691b912],
8	root	NN	O	root	nn	10	SENT_322	[p15l715t878r807b912],
9	ganglion	NN	O	ganglion	nn	10	SENT_322	[p15l827t872r1026b923],
10	neurons	NNS	O	neuron	prep_for	3	SENT_322	[p15l1050t884r1233b912],
11	correlates	VBZ	O	correlate	_	0	SENT_322	[p15l1254t872r1475b912],
12	with	IN	O	with	_	0	SENT_322	[p15l1496t872r1593b912],
13	p	NN	O	p	nn	15	SENT_322	[p15l1617t872r1943b923],
14	|	NN	O	|	nn	15	SENT_322	[p15l1617t872r1943b923],
15	atinum	NN	O	atinum	prep_with	11	SENT_322	[p15l1617t872r1943b923],
16	.	.	O	.	_	0	SENT_322	[p15l1617t872r1943b923],

1	—	NN	O	—	_	0	SENT_323	[p15l1617t872r1943b923],
2	.	.	O	.	_	0	SENT_323	[p15l1617t872r1943b923],

1	DNA	NN	O	dna	nsubj	2	SENT_324	[p15l1617t872r1943b923],
2	binding	NN	O	binding	_	0	SENT_324	[p15l1965t872r2150b923],
3	.	.	O	.	_	0	SENT_324	[p15l1965t872r2150b923],

1	Neurotoxicology	NNP	O	Neurotoxicology	_	0	SENT_325	[p15l267t943r631b995],
2	2006	CD	DATE	2006	num	1	SENT_325	[p15l650t946r771b989],
3	;	:	O	;	_	0	SENT_325	[p15l650t946r771b989],
4	27	CD	NUMBER	27	num	6	SENT_325	[p15l792t946r861b983],
5	:	:	O	:	_	0	SENT_325	[p15l792t946r861b983],
6	992-1002	CD	NUMBER	992-1002	dep	1	SENT_325	[p15l883t946r1117b983],
7	.	.	O	.	_	0	SENT_325	[p15l883t946r1117b983],

1	Martin	NNP	ORGANIZATION	Martin	nn	2	SENT_326	[p15l269t1016r412b1054],
2	LP	NN	ORGANIZATION	lp	_	0	SENT_326	[p15l440t1016r501b1060],
3	,	,	O	,	_	0	SENT_326	[p15l440t1016r501b1060],
4	Hamilton	NNP	ORGANIZATION	Hamilton	nn	5	SENT_326	[p15l527t1014r732b1054],
5	TC	NNP	ORGANIZATION	TC	appos	2	SENT_326	[p15l755t1015r824b1060],
6	,	,	O	,	_	0	SENT_326	[p15l755t1015r824b1060],
7	Schilder	NNP	PERSON	Schilder	nn	8	SENT_326	[p15l848t1014r1030b1054],
8	RJ	NN	PERSON	rj	appos	5	SENT_326	[p15l1055t1016r1110b1054],
9	.	.	O	.	_	0	SENT_326	[p15l1055t1016r1110b1054],

1	Platinum	NN	O	platinum	nn	2	SENT_327	[p15l1136t1014r1334b1054],
2	resistance	NN	O	resistance	_	0	SENT_327	[p15l1362t1016r1598b1054],
3	:	:	O	:	_	0	SENT_327	[p15l1362t1016r1598b1054],
4	the	DT	O	the	det	5	SENT_327	[p15l1620t1014r1694b1054],
5	role	NN	O	role	dep	2	SENT_327	[p15l1720t1014r1802b1054],
6	of	IN	O	of	_	0	SENT_327	[p15l1827t1013r1873b1054],
7	DNA	NN	O	dna	nn	9	SENT_327	[p15l1895t1016r1996b1054],
8	repair	NN	O	repair	nn	9	SENT_327	[p15l2021t1016r2151b1064],
9	pathways	NNS	O	pathway	prep_of	5	SENT_327	[p15l269t1085r496b1136],
10	.	.	O	.	_	0	SENT_327	[p15l269t1085r496b1136],

1	Clin	NNP	O	Clin	nn	3	SENT_328	[p15l519t1085r598b1125],
2	Cancer	NNP	O	Cancer	nn	3	SENT_328	[p15l622t1086r775b1125],
3	Res	NNP	O	Res	_	0	SENT_328	[p15l794t1087r865b1125],
4	2008	CD	DATE	2008	num	3	SENT_328	[p15l887t1088r1007b1131],
5	;	:	O	;	_	0	SENT_328	[p15l887t1088r1007b1131],
6	14	CD	NUMBER	14	num	8	SENT_328	[p15l1032t1088r1098b1125],
7	:	:	O	:	_	0	SENT_328	[p15l1032t1088r1098b1125],
8	1291-1295	CD	DATE	1291-1295	dep	3	SENT_328	[p15l1123t1088r1382b1125],
9	.	.	O	.	_	0	SENT_328	[p15l1123t1088r1382b1125],

1	Lecomte	NNP	ORGANIZATION	Lecomte	nn	2	SENT_329	[p15l269t1159r464b1197],
2	T	NN	ORGANIZATION	t	_	0	SENT_329	[p15l489t1159r526b1203],
3	,	,	O	,	_	0	SENT_329	[p15l489t1159r526b1203],
4	Landi	NN	PERSON	landus	nn	5	SENT_329	[p15l555t1157r675b1197],
5	B	NN	PERSON	b	appos	2	SENT_329	[p15l705t1159r741b1203],
6	,	,	O	,	_	0	SENT_329	[p15l705t1159r741b1203],
7	Beaune	NNP	LOCATION	Beaune	nn	8	SENT_329	[p15l770t1159r937b1197],
8	P	NN	O	p	appos	2	SENT_329	[p15l966t1158r1001b1203],
9	,	,	O	,	_	0	SENT_329	[p15l966t1158r1001b1203],
10	Laurent	NNP	PERSON	Laurent	appos	2	SENT_329	[p15l1030t1159r1319b1208],
11	.	.	O	.	_	0	SENT_329	[p15l1030t1159r1319b1208],

1	—	NN	O	—	_	0	SENT_330	[p15l1030t1159r1319b1208],
2	.	.	O	.	_	0	SENT_330	[p15l1030t1159r1319b1208],

1	Puig	NNP	PERSON	Puig	nn	2	SENT_331	[p15l1030t1159r1319b1208],
2	P	NN	O	p	_	0	SENT_331	[p15l1349t1159r1385b1203],
3	,	,	O	,	_	0	SENT_331	[p15l1349t1159r1385b1203],
4	Loriot	NNP	O	Loriot	nn	5	SENT_331	[p15l1413t1159r1543b1197],
5	MA	NNP	O	MA	appos	2	SENT_331	[p15l1571t1159r1655b1197],
6	.	.	O	.	_	0	SENT_331	[p15l1571t1159r1655b1197],

1	Glutathione	NN	O	glutathione	nn	2	SENT_332	[p15l1682t1157r1951b1197],
2	S	NN	O	s	nsubj	13	SENT_332	[p15l1978t1158r2150b1197],
3	—	CD	NUMBER	—	num	5	SENT_332	[p15l1978t1158r2150b1197],
4	trans	JJ	O	trans	amod	5	SENT_332	[p15l1978t1158r2150b1197],
5	—	NN	O	—	dep	2	SENT_332	[p15l1978t1158r2150b1197],
6	ferase	NN	O	ferase	nn	11	SENT_332	[p15l266t1227r402b1268],
7	P1	NN	O	p1	nn	11	SENT_332	[p15l429t1229r473b1267],
8	polymorphism	NN	O	polymorphism	nn	11	SENT_332	[p15l509t1228r838b1279],
9	(	CD	NUMBER	(	num	11	SENT_332	[p15l867t1228r1100b1274],
10	|	NN	O	|	nn	11	SENT_332	[p15l867t1228r1100b1274],
11	le105Val	NN	O	le105val	dep	2	SENT_332	[p15l867t1228r1100b1274],
12	)	CD	NUMBER	)	dep	11	SENT_332	[p15l867t1228r1100b1274],
13	predicts	VBZ	O	predict	_	0	SENT_332	[p15l1129t1228r1308b1278],
14	cumulative	JJ	O	cumulative	amod	15	SENT_332	[p15l1334t1228r1586b1268],
15	neuropathy	NN	O	neuropathy	dobj	13	SENT_332	[p15l1613t1228r1877b1279],
16	in	IN	O	in	_	0	SENT_332	[p15l1903t1230r1940b1267],
17	patients	NNS	O	patient	prep_in	13	SENT_332	[p15l1969t1230r2149b1278],
18	receiving	VBG	O	receive	partmod	17	SENT_332	[p15l269t1301r473b1350],
19	oxa	NN	O	oxa	dobj	18	SENT_332	[p15l498t1299r887b1349],
20	|	CD	NUMBER	|	num	19	SENT_332	[p15l498t1299r887b1349],
21	ip	NN	O	ip	nn	24	SENT_332	[p15l498t1299r887b1349],
22	|	NN	O	|	nn	24	SENT_332	[p15l498t1299r887b1349],
23	atin	NN	O	atin	nn	24	SENT_332	[p15l498t1299r887b1349],
24	—	NN	O	—	dep	19	SENT_332	[p15l498t1299r887b1349],
25	based	VBN	O	base	dep	24	SENT_332	[p15l498t1299r887b1349],
26	chemotherapy	NN	O	chemotherapy	dep	25	SENT_332	[p15l911t1299r1256b1350],
27	.	.	O	.	_	0	SENT_332	[p15l911t1299r1256b1350],

1	Clin	NNP	O	Clin	nn	3	SENT_333	[p15l1278t1299r1357b1339],
2	Cancer	NNP	O	Cancer	nn	3	SENT_333	[p15l1381t1300r1535b1339],
3	Res	NNP	O	Res	_	0	SENT_333	[p15l1553t1301r1624b1339],
4	2006	CD	DATE	2006	num	3	SENT_333	[p15l1646t1302r1767b1345],
5	;	:	O	;	_	0	SENT_333	[p15l1646t1302r1767b1345],
6	12	CD	NUMBER	12	num	8	SENT_333	[p15l1791t1302r1858b1339],
7	:	:	O	:	_	0	SENT_333	[p15l1791t1302r1858b1339],
8	3050-3056	CD	DURATION	3050-3056	dep	3	SENT_333	[p15l1880t1302r2141b1339],
9	.	.	O	.	_	0	SENT_333	[p15l1880t1302r2141b1339],

1	19	CD	NUMBER	19	num	3	SENT_334	[p15l187t1373r236b1411],
2	Ruzzo	NN	MISC	ruzzo	nn	3	SENT_334	[p15l269t1372r401b1411],
3	A	NN	MISC	a	_	0	SENT_334	[p15l424t1372r465b1417],
4	,	,	O	,	_	0	SENT_334	[p15l424t1372r465b1417],
5	Graziano	NNP	PERSON	Graziano	nn	6	SENT_334	[p15l488t1372r689b1411],
6	F	NN	O	f	appos	3	SENT_334	[p15l714t1372r747b1417],
7	,	,	O	,	_	0	SENT_334	[p15l714t1372r747b1417],
8	Loupakis	NNP	O	Loupakis	nn	9	SENT_334	[p15l772t1370r970b1421],
9	F	NN	O	f	appos	3	SENT_334	[p15l996t1372r1028b1417],
10	,	,	O	,	_	0	SENT_334	[p15l996t1372r1028b1417],
11	Rulli	NNP	PERSON	Rulli	nn	12	SENT_334	[p15l1053t1370r1144b1411],
12	E	NNP	O	E	appos	3	SENT_334	[p15l1171t1372r1203b1417],
13	,	,	O	,	_	0	SENT_334	[p15l1171t1372r1203b1417],
14	Canestrari	NNP	PERSON	Canestrari	nn	15	SENT_334	[p15l1226t1371r1453b1411],
15	E	NNP	O	E	appos	3	SENT_334	[p15l1480t1372r1513b1417],
16	,	,	O	,	_	0	SENT_334	[p15l1480t1372r1513b1417],
17	Santini	NNP	PERSON	Santini	nn	18	SENT_334	[p15l1537t1371r1689b1411],
18	D	NNP	O	D	appos	3	SENT_334	[p15l1716t1372r1747b1410],
19	et	FW	O	et	nn	20	SENT_334	[p15l1770t1376r1812b1411],
20	al.	FW	O	al.	dep	18	SENT_334	[p15l1832t1370r1880b1411],
21	.	.	O	.	_	0	SENT_334	[p15l1832t1370r1880b1411],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_335	[p15l1907t1370r2150b1411, p15l267t1443r436b1492],
2	proﬁling	NN	O	proﬁling	nsubj	9	SENT_335	[p15l462t1440r651b1492],
3	in	IN	O	in	_	0	SENT_335	[p15l678t1443r715b1480],
4	patients	NNS	O	patient	prep_in	2	SENT_335	[p15l743t1443r924b1491],
5	with	IN	O	with	_	0	SENT_335	[p15l948t1441r1045b1481],
6	advanced	JJ	O	advanced	amod	8	SENT_335	[p15l1072t1441r1292b1481],
7	colorectal	JJ	O	colorectal	amod	8	SENT_335	[p15l1319t1441r1539b1481],
8	cancer	NN	O	cancer	prep_with	4	SENT_335	[p15l1565t1453r1716b1481],
9	treated	VBN	O	treat	_	0	SENT_335	[p15l1738t1441r1900b1481],
10	with	IN	O	with	_	0	SENT_335	[p15l1927t1441r2024b1481],
11	ﬁrst	NN	O	ﬁrst	nn	14	SENT_335	[p15l2049t1440r2150b1481],
12	—	CD	NUMBER	—	num	14	SENT_335	[p15l2049t1440r2150b1481],
13	line	NN	O	line	nn	14	SENT_335	[p15l269t1512r347b1552],
14	FOLFOX	NN	O	folfox	prep_with	9	SENT_335	[p15l372t1513r599b1552],
15	—	CD	NUMBER	—	number	16	SENT_335	[p15l372t1513r599b1552],
16	4	CD	NUMBER	4	num	17	SENT_335	[p15l372t1513r599b1552],
17	chemotherapy	NN	O	chemotherapy	dobj	9	SENT_335	[p15l620t1512r965b1563],
18	.	.	O	.	_	0	SENT_335	[p15l620t1512r965b1563],

1	J	NNP	O	J	nn	3	SENT_336	[p15l983t1514r1006b1552],
2	Clin	NNP	O	Clin	nn	3	SENT_336	[p15l1026t1512r1105b1552],
3	Oncol	NNP	O	Oncol	_	0	SENT_336	[p15l1128t1512r1259b1552],
4	2007	CD	DATE	2007	num	3	SENT_336	[p15l1278t1515r1398b1558],
5	;	:	O	;	_	0	SENT_336	[p15l1278t1515r1398b1558],
6	25	CD	NUMBER	25	num	8	SENT_336	[p15l1420t1515r1489b1552],
7	:	:	O	:	_	0	SENT_336	[p15l1420t1515r1489b1552],
8	1247-1254	CD	DATE	1247-1254	dep	3	SENT_336	[p15l1514t1515r1773b1552],
9	.	.	O	.	_	0	SENT_336	[p15l1514t1515r1773b1552],

1	20	CD	NUMBER	20	num	2	SENT_337	[p15l183t1586r236b1624],
2	Knupfer	NN	O	knupfer	_	0	SENT_337	[p15l269t1583r449b1634],
3	H	NN	O	h	dep	2	SENT_337	[p15l477t1586r519b1630],
4	,	,	O	,	_	0	SENT_337	[p15l477t1586r519b1630],
5	Preiss	NNP	PERSON	Preiss	nn	6	SENT_337	[p15l549t1585r675b1624],
6	R.	NNP	PERSON	R.	appos	3	SENT_337	[p15l705t1585r741b1624],
7	Serum	NN	PERSON	serum	nn	9	SENT_337	[p15l769t1585r912b1624],
8	inter	NN	O	inter	nn	9	SENT_337	[p15l943t1584r1230b1624],
9	|	NN	O	|	dep	2	SENT_337	[p15l943t1584r1230b1624],
10	eukin	FW	O	eukin	nn	11	SENT_337	[p15l943t1584r1230b1624],
11	—	FW	O	—	dep	9	SENT_337	[p15l943t1584r1230b1624],
12	6	CD	NUMBER	6	num	13	SENT_337	[p15l943t1584r1230b1624],
13	levels	NNS	O	level	dep	2	SENT_337	[p15l1260t1584r1384b1624],
14	in	IN	O	in	_	0	SENT_337	[p15l1414t1586r1450b1623],
15	colorectal	JJ	O	colorectal	amod	17	SENT_337	[p15l1480t1584r1700b1624],
16	cancer	NN	O	cancer	nn	17	SENT_337	[p15l1730t1595r1880b1624],
17	patients	NNS	O	patient	prep_in	13	SENT_337	[p15l1909t1586r2149b1634],
18	.	.	O	.	_	0	SENT_337	[p15l1909t1586r2149b1634],

1	—	NN	O	—	_	0	SENT_338	[p15l1909t1586r2149b1634],
2	.	.	O	.	_	0	SENT_338	[p15l1909t1586r2149b1634],

1	.	.	O	.	_	0	SENT_339	[p15l1909t1586r2149b1634],

1	—	NN	O	—	_	0	SENT_340	[p15l1909t1586r2149b1634],
2	.	.	O	.	_	0	SENT_340	[p15l1909t1586r2149b1634],

1	a	DT	O	a	det	2	SENT_341	[p15l1909t1586r2149b1634],
2	summary	NN	O	summary	_	0	SENT_341	[p15l268t1666r480b1706],
3	of	IN	O	of	_	0	SENT_341	[p15l501t1654r547b1695],
4	published	VBN	O	publish	amod	5	SENT_341	[p15l567t1655r790b1705],
5	results	NNS	O	result	prep_of	2	SENT_341	[p15l815t1655r972b1695],
6	.	.	O	.	_	0	SENT_341	[p15l815t1655r972b1695],

1	Int	NN	O	int	nn	2	SENT_342	[p15l993t1657r1053b1695],
2	J	NN	O	j	_	0	SENT_342	[p15l1068t1657r1091b1695],
3	Colorectal	JJ	O	colorectal	amod	4	SENT_342	[p15l1110t1655r1333b1695],
4	Dis	NN	O	di	dep	2	SENT_342	[p15l1352t1656r1417b1695],
5	2010	CD	DATE	2010	num	4	SENT_342	[p15l1439t1657r1560b1701],
6	;	:	O	;	_	0	SENT_342	[p15l1439t1657r1560b1701],
7	25	CD	NUMBER	25	num	9	SENT_342	[p15l1582t1657r1651b1695],
8	:	:	O	:	_	0	SENT_342	[p15l1582t1657r1651b1695],
9	135-140	CD	NUMBER	135-140	dep	2	SENT_342	[p15l1676t1657r1877b1695],
10	.	.	O	.	_	0	SENT_342	[p15l1676t1657r1877b1695],

1	The	DT	O	the	det	3	SENT_343	[p15l181t1849r277b1895],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_343	[p15l304t1849r818b1907],
3	Journal	NNP	O	Journal	_	0	SENT_343	[p15l841t1849r1028b1895],
4	(	CD	NUMBER	(	num	6	SENT_343	[p15l1057t1850r1229b1902],
5	2013	CD	DATE	2013	num	6	SENT_343	[p15l1057t1850r1229b1902],
6	)	NN	O	)	dep	3	SENT_343	[p15l1057t1850r1229b1902],
7	,	,	O	,	_	0	SENT_343	[p15l1057t1850r1229b1902],
8	403-409	CD	NUMBER	403-409	appos	6	SENT_343	[p15l1262t1852r1507b1895],

1	Sparmann	NNP	MISC	Sparmann	nn	2	SENT_344	[p15l100t1929r351b1982],
2	A	NNP	MISC	A	_	0	SENT_344	[p15l375t1929r420b1978],
3	,	,	O	,	_	0	SENT_344	[p15l375t1929r420b1978],
4	Bar	NNP	O	Bar	appos	2	SENT_344	[p15l444t1929r641b1983],
5	.	.	O	.	_	0	SENT_344	[p15l444t1929r641b1983],

1	—	NN	O	—	_	0	SENT_345	[p15l444t1929r641b1983],
2	.	.	O	.	_	0	SENT_345	[p15l444t1929r641b1983],

1	Sagi	NNP	PERSON	Sagi	nn	2	SENT_346	[p15l444t1929r641b1983],
2	D.	NNP	PERSON	D.	nsubj	5	SENT_346	[p15l667t1929r712b1971],
3	Ras	NN	PERSON	ra	nn	4	SENT_346	[p15l736t1927r1036b1971],
4	—	NN	O	—	dep	2	SENT_346	[p15l736t1927r1036b1971],
5	induced	VBD	O	induce	_	0	SENT_346	[p15l736t1927r1036b1971],
6	inter	NN	O	inter	nn	7	SENT_346	[p15l1060t1927r1372b1971],
7	|	NN	O	|	iobj	5	SENT_346	[p15l1060t1927r1372b1971],
8	eukin	FW	O	eukin	nn	9	SENT_346	[p15l1060t1927r1372b1971],
9	—	FW	O	—	dobj	5	SENT_346	[p15l1060t1927r1372b1971],
10	8	CD	NUMBER	8	num	11	SENT_346	[p15l1060t1927r1372b1971],
11	expression	NN	O	expression	nsubj	12	SENT_346	[p15l1394t1929r1657b1982],
12	plays	VBZ	O	play	rcmod	9	SENT_346	[p15l1683t1927r1806b1983],
13	a	DT	O	a	det	15	SENT_346	[p15l1827t1940r1851b1971],
14	critical	JJ	O	critical	amod	15	SENT_346	[p15l1874t1927r2032b1971],
15	role	NN	O	role	dobj	12	SENT_346	[p15l2057t1927r2147b1971],
16	in	IN	O	in	_	0	SENT_346	[p15l101t2008r141b2049],
17	tumor	NN	O	tumor	nn	18	SENT_346	[p15l166t2012r319b2050],
18	growth	NN	O	growth	prep_in	15	SENT_346	[p15l342t2006r518b2061],
19	and	CC	O	and	_	0	SENT_346	[p15l544t2006r634b2050],
20	angiogenesis	NN	O	angiogenesis	conj_and	18	SENT_346	[p15l660t2008r999b2061],
21	.	.	O	.	_	0	SENT_346	[p15l660t2008r999b2061],

1	Cancer	NN	O	cancer	nn	2	SENT_347	[p15l1024t2007r1191b2050],
2	Cell	NN	O	cell	_	0	SENT_347	[p15l1212t2006r1298b2050],
3	2004	CD	DATE	2004	dep	2	SENT_347	[p15l1318t2009r1450b2056],
4	;	:	O	;	_	0	SENT_347	[p15l1318t2009r1450b2056],
5	6	CD	NUMBER	6	num	7	SENT_347	[p15l1473t2009r1515b2050],
6	:	:	O	:	_	0	SENT_347	[p15l1473t2009r1515b2050],
7	447-458	CD	NUMBER	447-458	dep	2	SENT_347	[p15l1537t2009r1762b2050],
8	.	.	O	.	_	0	SENT_347	[p15l1537t2009r1762b2050],

1	Erreni	NNP	MISC	Erreni	nn	2	SENT_348	[p15l102t2083r240b2125],
2	M	NNP	O	M	_	0	SENT_348	[p15l274t2083r329b2132],
3	,	,	O	,	_	0	SENT_348	[p15l274t2083r329b2132],
4	Mantovani	NNP	PERSON	Mantovani	nn	5	SENT_348	[p15l361t2083r622b2125],
5	A	NNP	O	A	appos	2	SENT_348	[p15l654t2083r699b2132],
6	,	,	O	,	_	0	SENT_348	[p15l654t2083r699b2132],
7	Allavena	NNP	PERSON	Allavena	nn	10	SENT_348	[p15l729t2081r938b2125],
8	P.	NNP	O	P.	nn	10	SENT_348	[p15l973t2083r1011b2125],
9	Tumor	NN	O	tumor	nn	10	SENT_348	[p15l1038t2081r1480b2125],
10	—	NN	O	—	appos	2	SENT_348	[p15l1038t2081r1480b2125],
11	associated	VBN	O	associate	partmod	10	SENT_348	[p15l1038t2081r1480b2125],
12	Macrophages	NNS	O	macrophage	dobj	11	SENT_348	[p15l1515t2081r1849b2137],
13	(	CD	NUMBER	(	num	15	SENT_348	[p15l1881t2082r2023b2132],
14	TAM	NN	O	tam	nn	15	SENT_348	[p15l1881t2082r2023b2132],
15	)	NN	O	)	dep	12	SENT_348	[p15l1881t2082r2023b2132],
16	and	CC	O	and	_	0	SENT_348	[p15l2055t2081r2145b2125],
17	Inﬂammation	NN	O	inﬂammation	conj_and	12	SENT_348	[p15l102t2158r431b2203],
18	in	IN	O	in	_	0	SENT_348	[p15l458t2161r498b2202],
19	Colorectal	JJ	O	colorectal	amod	20	SENT_348	[p15l524t2159r770b2203],
20	Cancer	NN	O	cancer	prep_in	17	SENT_348	[p15l797t2160r978b2203],
21	.	.	O	.	_	0	SENT_348	[p15l797t2160r978b2203],

1	Cancer	NNP	O	Cancer	nn	2	SENT_349	[p15l1002t2160r1169b2203],
2	Microenviron	NNP	O	Microenviron	_	0	SENT_349	[p15l1189t2161r1502b2203],
3	2011	CD	DATE	2011	num	2	SENT_349	[p15l1528t2161r1659b2209],
4	;	:	O	;	_	0	SENT_349	[p15l1528t2161r1659b2209],
5	4	CD	NUMBER	4	num	7	SENT_349	[p15l1681t2162r1724b2203],
6	:	:	O	:	_	0	SENT_349	[p15l1681t2162r1724b2203],
7	141-154	CD	NUMBER	141-154	dep	2	SENT_349	[p15l1752t2162r1970b2203],
8	.	.	O	.	_	0	SENT_349	[p15l1752t2162r1970b2203],

1	Caussanel	NNP	O	Caussanel	nn	2	SENT_350	[p15l100t2236r344b2280],
2	JP	NNP	O	JP	_	0	SENT_350	[p15l364t2238r428b2287],
3	,	,	O	,	_	0	SENT_350	[p15l364t2238r428b2287],
4	Levi	NNP	PERSON	Levi	nn	5	SENT_350	[p15l450t2238r543b2280],
5	F	NN	PERSON	f	appos	2	SENT_350	[p15l566t2238r601b2287],
6	,	,	O	,	_	0	SENT_350	[p15l566t2238r601b2287],
7	Brienza	NNP	LOCATION	Brienza	nn	8	SENT_350	[p15l623t2238r799b2280],
8	S	NNP	LOCATION	S	appos	2	SENT_350	[p15l821t2237r858b2287],
9	,	,	O	,	_	0	SENT_350	[p15l821t2237r858b2287],
10	Misset	NNP	O	Misset	nn	11	SENT_350	[p15l879t2238r1034b2280],
11	JL	NNP	O	JL	appos	2	SENT_350	[p15l1051t2238r1111b2287],
12	,	,	O	,	_	0	SENT_350	[p15l1051t2238r1111b2287],
13	ltzhaki	NN	O	ltzhakus	nn	14	SENT_350	[p15l1132t2236r1289b2280],
14	M	NN	O	m	appos	2	SENT_350	[p15l1311t2238r1366b2287],
15	,	,	O	,	_	0	SENT_350	[p15l1311t2238r1366b2287],
16	Adam	NNP	PERSON	Adam	nn	17	SENT_350	[p15l1385t2236r1529b2280],
17	R	NNP	PERSON	R	appos	2	SENT_350	[p15l1553t2238r1579b2279],
18	et	FW	O	et	nn	19	SENT_350	[p15l1598t2243r1643b2280],
19	al.	FW	O	al.	dep	17	SENT_350	[p15l1659t2236r1711b2280],
20	.	.	O	.	_	0	SENT_350	[p15l1659t2236r1711b2280],

1	Phase	NN	O	phase	nn	3	SENT_351	[p15l1734t2236r1876b2280],
2	I	CD	NUMBER	i	num	3	SENT_351	[p15l1899t2238r1904b2279],
3	trial	NN	O	trial	_	0	SENT_351	[p15l1924t2236r2015b2280],
4	of	IN	O	of	_	0	SENT_351	[p15l2037t2235r2088b2280],
5	5day	JJ	O	5day	amod	8	SENT_351	[p15l2103t2239r2148b2280, p15l100t2314r189b2370],
6	continuous	JJ	O	continuous	amod	8	SENT_351	[p15l206t2316r483b2358],
7	venous	JJ	O	venous	amod	8	SENT_351	[p15l501t2327r680b2358],
8	infusion	NN	O	infusion	prep_of	3	SENT_351	[p15l700t2313r894b2358],
9	of	IN	O	of	_	0	SENT_351	[p15l915t2313r966b2358],
10	oxaliplatin	NN	O	oxaliplatin	prep_of	3	SENT_351	[p15l980t2314r1235b2369],
11	at	IN	O	at	_	0	SENT_351	[p15l1255t2321r1301b2358],
12	circadian	JJ	O	circadian	amod	14	SENT_351	[p15l1319t2314r1539b2358],
13	rhythm	NN	O	rhythm	nn	14	SENT_351	[p15l1562t2314r2032b2370],
14	—	NN	O	—	prep_at	3	SENT_351	[p15l1562t2314r2032b2370],
15	modu	FW	O	modu	nn	16	SENT_351	[p15l1562t2314r2032b2370],
16	|	FW	O	|	dep	14	SENT_351	[p15l1562t2314r2032b2370],
17	ated	VBN	O	ate	partmod	3	SENT_351	[p15l1562t2314r2032b2370],
18	rate	NN	O	rate	dobj	17	SENT_351	[p15l2055t2321r2147b2358],
19	compared	VBN	O	compare	_	0	SENT_351	[p15l100t2389r350b2444],
20	with	IN	O	with	prepc_compared_with	17	SENT_351	[p15l376t2389r481b2433],
21	constant	JJ	O	constant	amod	22	SENT_351	[p15l507t2396r722b2433],
22	rate	NN	O	rate	pobj	17	SENT_351	[p15l748t2396r852b2433],
23	.	.	O	.	_	0	SENT_351	[p15l748t2396r852b2433],

1	J	NNP	O	J	nn	4	SENT_352	[p15l872t2391r897b2433],
2	Natl	NNP	O	Natl	nn	4	SENT_352	[p15l917t2389r1018b2433],
3	Cancer	NNP	O	Cancer	nn	4	SENT_352	[p15l1039t2391r1206b2433],
4	Inst	NNP	O	Inst	_	0	SENT_352	[p15l1226t2391r1312b2433],
5	1990	CD	DATE	1990	num	4	SENT_352	[p15l1337t2392r1465b2440],
6	;	:	O	;	_	0	SENT_352	[p15l1337t2392r1465b2440],
7	82	CD	NUMBER	82	num	9	SENT_352	[p15l1488t2392r1563b2433],
8	:	:	O	:	_	0	SENT_352	[p15l1488t2392r1563b2433],
9	1046-1050	CD	DATE	1046-1050	dep	4	SENT_352	[p15l1591t2392r1871b2433],
10	.	.	O	.	_	0	SENT_352	[p15l1591t2392r1871b2433],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_353	[p15l100t2466r223b2510],
2	YC	NNP	PERSON	YC	_	0	SENT_353	[p15l241t2468r315b2517],
3	,	,	O	,	_	0	SENT_353	[p15l241t2468r315b2517],
4	Tzeng	NNP	ORGANIZATION	Tzeng	nn	5	SENT_353	[p15l330t2468r476b2522],
5	CH	NN	ORGANIZATION	ch	appos	2	SENT_353	[p15l495t2468r576b2517],
6	,	,	O	,	_	0	SENT_353	[p15l495t2468r576b2517],
7	Chen	NNP	O	Chen	nn	8	SENT_353	[p15l593t2466r715b2510],
8	PM	NNP	O	PM	appos	2	SENT_353	[p15l737t2468r822b2517],
9	,	,	O	,	_	0	SENT_353	[p15l737t2468r822b2517],
10	Lin	NNP	PERSON	Lin	nn	11	SENT_353	[p15l841t2468r906b2509],
11	JK	NNP	PERSON	JK	appos	2	SENT_353	[p15l924t2468r987b2517],
12	,	,	O	,	_	0	SENT_353	[p15l924t2468r987b2517],
13	Lin	NNP	PERSON	Lin	nn	14	SENT_353	[p15l1007t2468r1072b2509],
14	TC	NNP	O	TC	appos	2	SENT_353	[p15l1090t2468r1163b2517],
15	,	,	O	,	_	0	SENT_353	[p15l1090t2468r1163b2517],
16	Chen	NNP	PERSON	Chen	nn	17	SENT_353	[p15l1179t2466r1302b2510],
17	WS	NNP	O	WS	appos	2	SENT_353	[p15l1321t2468r1398b2510],
18	et	FW	O	et	nn	19	SENT_353	[p15l1416t2473r1460b2510],
19	al.	FW	O	al.	dep	17	SENT_353	[p15l1474t2466r1525b2510],
20	.	.	O	.	_	0	SENT_353	[p15l1474t2466r1525b2510],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_354	[p15l1546t2465r1764b2510],
2	of	IN	O	of	_	0	SENT_354	[p15l1782t2465r1833b2510],
3	GSTP1	NN	O	gstp1	nn	6	SENT_354	[p15l1845t2468r1989b2510],
4	|	CD	NUMBER	|	num	6	SENT_354	[p15l2018t2468r2151b2510],
5	105V	NN	O	105v	nn	6	SENT_354	[p15l2018t2468r2151b2510],
6	polymorphism	NN	O	polymorphism	prep_of	1	SENT_354	[p15l102t2543r449b2599],
7	on	IN	O	on	_	0	SENT_354	[p15l476t2556r535b2587],
8	cumulative	JJ	O	cumulative	amod	9	SENT_354	[p15l561t2543r827b2587],
9	neuropathy	NN	O	neuropathy	prep_on	6	SENT_354	[p15l852t2543r1132b2599],
10	and	CC	O	and	_	0	SENT_354	[p15l1154t2543r1242b2587],
11	outcome	NN	O	outcome	prep_on	6	SENT_354	[p15l1268t2550r1484b2587],
12	of	IN	O	of	_	0	SENT_354	[p15l1507t2543r1558b2587],
13	FOLFOX	NNP	O	FOLFOX	prep_of	1	SENT_354	[p15l1579t2545r1820b2587],
14	—	CD	NUMBER	—	num	13	SENT_354	[p15l1579t2545r1820b2587],
15	4	CD	NUMBER	4	num	16	SENT_354	[p15l1579t2545r1820b2587],
16	treatment	NN	O	treatment	dep	1	SENT_354	[p15l1841t2550r2082b2587],
17	in	IN	O	in	_	0	SENT_354	[p15l2107t2545r2146b2587],
18	Asian	JJ	LOCATION	asian	amod	19	SENT_354	[p15l100t2623r228b2665],
19	patients	NNS	O	patient	prep_in	16	SENT_354	[p15l253t2623r443b2676],
20	with	IN	O	with	_	0	SENT_354	[p15l465t2621r568b2665],
21	colorectal	JJ	O	colorectal	amod	22	SENT_354	[p15l593t2621r823b2665],
22	carcinoma	NN	O	carcinoma	prep_with	19	SENT_354	[p15l848t2623r1109b2665],
23	.	.	O	.	_	0	SENT_354	[p15l848t2623r1109b2665],

1	Cancer	NN	O	cancer	_	0	SENT_355	[p15l1132t2622r1294b2665],
2	Sci	NNP	O	Sci	dep	1	SENT_355	[p15l1312t2622r1377b2665],
3	2010	CD	DATE	2010	num	2	SENT_355	[p15l1397t2624r1524b2671],
4	;	:	O	;	_	0	SENT_355	[p15l1397t2624r1524b2671],
5	101	CD	NUMBER	101	num	7	SENT_355	[p15l1549t2624r1651b2665],
6	:	:	O	:	_	0	SENT_355	[p15l1549t2624r1651b2665],
7	530-535	CD	NUMBER	530-535	dep	1	SENT_355	[p15l1674t2624r1891b2665],
8	.	.	O	.	_	0	SENT_355	[p15l1674t2624r1891b2665],

1	Gamelin	NNP	MISC	Gamelin	nn	2	SENT_356	[p15l100t2697r303b2741],
2	L	NNP	O	L	_	0	SENT_356	[p15l337t2699r372b2748],
3	,	,	O	,	_	0	SENT_356	[p15l337t2699r372b2748],
4	Capitain	NNP	O	Capitain	nn	5	SENT_356	[p15l401t2699r601b2752],
5	O	NNP	O	O	appos	2	SENT_356	[p15l633t2699r683b2748],
6	,	,	O	,	_	0	SENT_356	[p15l633t2699r683b2748],
7	Morel	NNP	O	Morel	nn	8	SENT_356	[p15l714t2697r851b2741],
8	A	NNP	O	A	appos	2	SENT_356	[p15l882t2699r927b2748],
9	,	,	O	,	_	0	SENT_356	[p15l882t2699r927b2748],
10	Dumont	NNP	O	Dumont	nn	11	SENT_356	[p15l959t2699r1162b2741],
11	A	NNP	O	A	appos	2	SENT_356	[p15l1190t2699r1235b2748],
12	,	,	O	,	_	0	SENT_356	[p15l1190t2699r1235b2748],
13	Traore	NNP	PERSON	Traore	appos	2	SENT_356	[p15l1262t2699r1420b2741],
14	5	CD	NUMBER	5	num	13	SENT_356	[p15l1451t2699r1488b2748],
15	,	,	O	,	_	0	SENT_356	[p15l1451t2699r1488b2748],
16	Anne	NNP	PERSON	Anne	nn	17	SENT_356	[p15l1517t2699r1646b2741],
17	IB	NNP	O	IB	appos	2	SENT_356	[p15l1679t2697r1719b2741],
18	et	FW	O	et	nn	19	SENT_356	[p15l1748t2704r1793b2741],
19	al.	FW	O	al.	dep	17	SENT_356	[p15l1819t2697r1871b2741],
20	.	.	O	.	_	0	SENT_356	[p15l1819t2697r1871b2741],

1	Predictive	JJ	O	predictive	amod	2	SENT_357	[p15l1905t2697r2148b2741],
2	factors	NNS	O	factor	_	0	SENT_357	[p15l99t2773r264b2818],
3	of	IN	O	of	_	0	SENT_357	[p15l301t2773r352b2818],
4	oxaliplatin	NN	O	oxaliplatin	nn	5	SENT_357	[p15l384t2774r638b2829],
5	neurotoxicity	NN	O	neurotoxicity	prep_of	2	SENT_357	[p15l679t2776r1016b2830],
6	:	:	O	:	_	0	SENT_357	[p15l679t2776r1016b2830],
7	the	DT	O	the	det	8	SENT_357	[p15l1051t2774r1131b2818],
8	involvement	NN	O	involvement	dep	2	SENT_357	[p15l1168t2774r1479b2818],
9	of	IN	O	of	_	0	SENT_357	[p15l1514t2773r1565b2818],
10	the	DT	O	the	det	13	SENT_357	[p15l1596t2774r1676b2818],
11	oxalate	NN	O	oxalate	nn	13	SENT_357	[p15l1712t2774r1890b2818],
12	outcome	NN	O	outcome	nn	13	SENT_357	[p15l1926t2781r2147b2818],
13	pathway	NN	O	pathway	prep_of	8	SENT_357	[p15l102t2851r325b2907],
14	.	.	O	.	_	0	SENT_357	[p15l102t2851r325b2907],

1	Clin	NNP	O	Clin	nn	3	SENT_358	[p15l350t2851r435b2895],
2	Cancer	NNP	O	Cancer	nn	3	SENT_358	[p15l461t2853r628b2895],
3	Res	NNP	O	Res	_	0	SENT_358	[p15l649t2853r726b2895],
4	2007	CD	DATE	2007	num	3	SENT_358	[p15l749t2854r881b2902],
5	;	:	O	;	_	0	SENT_358	[p15l749t2854r881b2902],
6	13	CD	NUMBER	13	num	8	SENT_358	[p15l907t2854r979b2895],
7	:	:	O	:	_	0	SENT_358	[p15l907t2854r979b2895],
8	6359-6368	CD	DURATION	6359-6368	dep	3	SENT_358	[p15l1003t2854r1288b2895],
9	.	.	O	.	_	0	SENT_358	[p15l1003t2854r1288b2895],

1	McLeod	NNP	PERSON	McLeod	nn	2	SENT_359	[p15l101t2928r294b2972],
2	HL	NNS	O	hl	_	0	SENT_359	[p15l324t2930r397b2979],
3	,	,	O	,	_	0	SENT_359	[p15l324t2930r397b2979],
4	Sargent	NNP	O	Sargent	nn	5	SENT_359	[p15l422t2930r613b2984],
5	DJ	NNP	O	DJ	appos	2	SENT_359	[p15l639t2930r706b2979],
6	,	,	O	,	_	0	SENT_359	[p15l639t2930r706b2979],
7	Marsh	NNP	PERSON	Marsh	nn	8	SENT_359	[p15l732t2928r878b2972],
8	S	NNP	O	S	appos	2	SENT_359	[p15l906t2930r943b2979],
9	,	,	O	,	_	0	SENT_359	[p15l906t2930r943b2979],
10	Green	NNP	ORGANIZATION	Green	nn	11	SENT_359	[p15l968t2930r1113b2972],
11	EM	NNP	ORGANIZATION	EM	appos	2	SENT_359	[p15l1142t2930r1226b2979],
12	,	,	O	,	_	0	SENT_359	[p15l1142t2930r1226b2979],
13	King	NNP	O	King	nn	14	SENT_359	[p15l1253t2930r1358b2984],
14	CR	NN	O	cr	appos	2	SENT_359	[p15l1385t2930r1460b2979],
15	,	,	O	,	_	0	SENT_359	[p15l1385t2930r1460b2979],
16	Fuchs	NNP	PERSON	Fuchs	nn	17	SENT_359	[p15l1486t2928r1625b2972],
17	CS	NNP	O	CS	appos	2	SENT_359	[p15l1651t2930r1711b2972],
18	et	FW	O	et	nn	19	SENT_359	[p15l1736t2935r1781b2972],
19	al.	FW	O	al.	dep	17	SENT_359	[p15l1802t2928r1854b2972],
20	.	.	O	.	_	0	SENT_359	[p15l1802t2928r1854b2972],

1	Pharmacogenetic	JJ	MISC	pharmacogenetic	amod	2	SENT_360	[p15l1883t2928r2148b2972, p15l100t3008r283b3062],
2	predictors	NNS	O	predictor	_	0	SENT_360	[p15l304t3006r551b3061],
3	of	IN	O	of	_	0	SENT_360	[p15l571t3006r622b3050],
4	adverse	JJ	O	adverse	amod	5	SENT_360	[p15l635t3006r827b3050],
5	events	NNS	O	event	prep_of	2	SENT_360	[p15l846t3013r1008b3050],
6	and	CC	O	and	_	0	SENT_360	[p15l1026t3006r1116b3050],
7	response	NN	O	response	conj_and	2	SENT_360	[p15l1139t3019r1361b3061],
8	to	TO	O	to	_	0	SENT_360	[p15l1378t3013r1428b3050],
9	chemotherapy	NN	O	chemotherapy	prep_to	7	SENT_360	[p15l1447t3006r1810b3063],
10	in	IN	O	in	_	0	SENT_360	[p15l1830t3009r1869b3050],
11	metastatic	JJ	O	metastatic	amod	13	SENT_360	[p15l1892t3008r2148b3050],
12	colorectal	JJ	O	colorectal	amod	13	SENT_360	[p15l100t3082r339b3126],
13	cancer	NN	O	cancer	prep_in	9	SENT_360	[p15l370t3095r543b3126],
14	:	:	O	:	_	0	SENT_360	[p15l370t3095r543b3126],
15	results	NNS	O	result	dep	2	SENT_360	[p15l573t3082r730b3126],
16	from	IN	O	from	_	0	SENT_360	[p15l757t3081r873b3126],
17	North	JJ	MISC	north	amod	22	SENT_360	[p15l906t3082r1042b3126],
18	American	JJ	MISC	american	amod	22	SENT_360	[p15l1072t3084r1305b3126],
19	Gastrointestinal	JJ	MISC	gastrointestinal	amod	22	SENT_360	[p15l1336t3082r1723b3126],
20	lntergroup	NN	O	lntergroup	nn	22	SENT_360	[p15l1755t3084r2018b3138],
21	Trial	NN	O	trial	nn	22	SENT_360	[p15l2044t3082r2145b3126],
22	N9741	NN	O	n9741	prep_from	15	SENT_360	[p15l102t3161r271b3203],
23	.	.	O	.	_	0	SENT_360	[p15l102t3161r271b3203],

1	J	NNP	O	J	nn	3	SENT_361	[p15l291t3161r316b3203],
2	Clin	NNP	O	Clin	nn	3	SENT_361	[p15l337t3159r423b3203],
3	Oncol	NNP	O	Oncol	_	0	SENT_361	[p15l449t3159r590b3203],
4	2010	CD	DATE	2010	num	3	SENT_361	[p15l611t3162r742b3210],
5	;	:	O	;	_	0	SENT_361	[p15l611t3162r742b3210],
6	28	CD	NUMBER	28	num	8	SENT_361	[p15l766t3162r841b3203],
7	:	:	O	:	_	0	SENT_361	[p15l766t3162r841b3203],
8	3227-3233	CD	DURATION	3227-3233	dep	3	SENT_361	[p15l865t3162r1150b3203],
9	.	.	O	.	_	0	SENT_361	[p15l865t3162r1150b3203],

1	Pare	VB	O	pare	_	0	SENT_362	[p15l102t3238r206b3280],
2	L	NN	O	l	dobj	1	SENT_362	[p15l231t3238r265b3287],
3	,	,	O	,	_	0	SENT_362	[p15l231t3238r265b3287],
4	Marcuello	NNP	O	Marcuello	nn	5	SENT_362	[p15l289t3236r531b3280],
5	E	NNP	O	E	appos	2	SENT_362	[p15l555t3238r591b3287],
6	,	,	O	,	_	0	SENT_362	[p15l555t3238r591b3287],
7	Altes	NNP	O	Altes	nn	8	SENT_362	[p15l611t3236r731b3280],
8	A	NNP	O	A	appos	2	SENT_362	[p15l753t3238r799b3287],
9	,	,	O	,	_	0	SENT_362	[p15l753t3238r799b3287],
10	del	FW	O	del	dep	2	SENT_362	[p15l821t3236r893b3280],
11	Rio	NNP	O	Rio	nn	12	SENT_362	[p15l919t3238r991b3280],
12	E	NNP	O	E	dep	2	SENT_362	[p15l1016t3238r1051b3287],
13	,	,	O	,	_	0	SENT_362	[p15l1016t3238r1051b3287],
14	Sedano	NNP	PERSON	Sedano	nn	19	SENT_362	[p15l1074t3236r1258b3280],
15	L	NNP	O	L	nn	19	SENT_362	[p15l1282t3238r1317b3287],
16	,	,	O	,	_	0	SENT_362	[p15l1282t3238r1317b3287],
17	Sa	NNP	O	Sa	appos	19	SENT_362	[p15l1339t3236r1548b3280],
18	|	CD	NUMBER	|	num	19	SENT_362	[p15l1339t3236r1548b3280],
19	azarJ	NNP	O	azarJ	appos	2	SENT_362	[p15l1339t3236r1548b3280],
20	et	FW	O	et	nn	21	SENT_362	[p15l1572t3243r1617b3280],
21	al.	FW	O	al.	dep	19	SENT_362	[p15l1636t3236r1687b3280],
22	.	.	O	.	_	0	SENT_362	[p15l1636t3236r1687b3280],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_363	[p15l1714t3236r2148b3292],
2	prediction	NN	O	prediction	_	0	SENT_363	[p15l102t3313r351b3368],
3	of	IN	O	of	_	0	SENT_363	[p15l381t3313r432b3357],
4	clinical	JJ	O	clinical	amod	5	SENT_363	[p15l455t3313r620b3357],
5	outcome	NN	O	outcome	prep_of	2	SENT_363	[p15l650t3320r871b3357],
6	in	IN	O	in	_	0	SENT_363	[p15l899t3316r939b3357],
7	advanced	JJ	O	advanced	amod	10	SENT_363	[p15l968t3313r1208b3357],
8	colorectal	JJ	O	colorectal	amod	10	SENT_363	[p15l1237t3313r1476b3357],
9	cancer	NN	O	cancer	nn	10	SENT_363	[p15l1506t3326r1669b3357],
10	patients	NNS	O	patient	prep_in	5	SENT_363	[p15l1697t3316r1893b3369],
11	receiving	VBG	O	receive	partmod	2	SENT_363	[p15l1924t3315r2146b3369],
12	oxaliplatin/5	NN	O	oxaliplatin/5	nn	14	SENT_363	[p15l100t3389r708b3445],
13	—	NN	O	—	nn	14	SENT_363	[p15l100t3389r708b3445],
14	ﬂuorouracil	NN	O	ﬂuorouracil	dobj	11	SENT_363	[p15l100t3389r708b3445],
15	as	IN	O	as	_	0	SENT_363	[p15l758t3403r806b3434],
16	ﬁrst	NN	O	ﬁrst	nn	20	SENT_363	[p15l853t3389r1053b3434],
17	—	CD	NUMBER	—	num	20	SENT_363	[p15l853t3389r1053b3434],
18	|	NN	O	|	nn	20	SENT_363	[p15l853t3389r1053b3434],
19	ine	NN	O	ine	nn	20	SENT_363	[p15l853t3389r1053b3434],
20	chemotherapy	NN	O	chemotherapy	prep_as	14	SENT_363	[p15l1102t3390r1476b3446],
21	.	.	O	.	_	0	SENT_363	[p15l1102t3390r1476b3446],

1	Br	NN	O	br	nn	3	SENT_364	[p15l1524t3392r1574b3434],
2	J	NN	O	j	nn	3	SENT_364	[p15l1614t3392r1638b3434],
3	Cancer	NN	O	cancer	_	0	SENT_364	[p15l1683t3391r1850b3434],
4	2008	CD	DATE	2008	dep	3	SENT_364	[p15l1895t3393r2026b3441],
5	;	:	O	;	_	0	SENT_364	[p15l1895t3393r2026b3441],
6	99	CD	NUMBER	99	num	8	SENT_364	[p15l2072t3393r2148b3434],
7	:	:	O	:	_	0	SENT_364	[p15l2072t3393r2148b3434],
8	1050-1055	CD	DATE	1050-1055	dep	3	SENT_364	[p15l104t3470r385b3510],
9	.	.	O	.	_	0	SENT_364	[p15l104t3470r385b3510],

1	Benjamini	NNP	ORGANIZATION	Benjamini	nn	2	SENT_365	[p15l102t3546r346b3600],
2	YA	NNP	ORGANIZATION	YA	_	0	SENT_365	[p15l374t3547r452b3595],
3	,	,	O	,	_	0	SENT_365	[p15l374t3547r452b3595],
4	Hochberg	NNP	PERSON	Hochberg	nn	5	SENT_365	[p15l482t3545r723b3600],
5	Y.	NNP	O	Y.	appos	2	SENT_365	[p15l751t3547r793b3588],
6	Controlling	VBG	O	control	partmod	5	SENT_365	[p15l820t3545r1094b3600],
7	the	DT	O	the	det	10	SENT_365	[p15l1123t3545r1203b3589],
8	false	JJ	O	false	amod	10	SENT_365	[p15l1230t3544r1342b3589],
9	discovery	NN	O	discovery	nn	10	SENT_365	[p15l1370t3545r1606b3601],
10	rate	NN	O	rate	dobj	6	SENT_365	[p15l1634t3551r1738b3589],
11	:	:	O	:	_	0	SENT_365	[p15l1634t3551r1738b3589],
12	a	DT	O	a	det	16	SENT_365	[p15l1766t3557r1789b3589],
13	practical	JJ	O	practical	amod	16	SENT_365	[p15l1821t3545r2026b3600],
14	and	CC	O	and	_	0	SENT_365	[p15l2055t3545r2145b3589],
15	powerful	JJ	O	powerful	conj_and	13	SENT_365	[p15l102t3621r318b3676],
16	approach	NN	O	approach	dep	2	SENT_365	[p15l344t3621r576b3676],
17	to	TO	O	to	_	0	SENT_365	[p15l601t3628r651b3665],
18	multiple	JJ	O	multiple	amod	19	SENT_365	[p15l677t3621r879b3676],
19	testing	NN	O	testing	prep_to	16	SENT_365	[p15l902t3623r1085b3677],
20	.	.	O	.	_	0	SENT_365	[p15l902t3623r1085b3677],

1	J	NNP	O	J	nn	6	SENT_366	[p15l1105t3623r1130b3665],
2	Royal	NNP	O	Royal	nn	6	SENT_366	[p15l1150t3621r1283b3677],
3	Stat	NN	O	stat	nn	6	SENT_366	[p15l1303t3623r1400b3665],
4	Soc	NNP	O	Soc	nn	6	SENT_366	[p15l1420t3623r1504b3665],
5	Ser	NNP	O	Ser	nn	6	SENT_366	[p15l1524t3623r1599b3665],
6	B	NNP	O	B	_	0	SENT_366	[p15l1619t3623r1647b3665],
7	1995	CD	DATE	1995	num	6	SENT_366	[p15l1674t3624r1802b3672],
8	;	:	O	;	_	0	SENT_366	[p15l1674t3624r1802b3672],
9	57	CD	NUMBER	57	num	11	SENT_366	[p15l1826t3625r1900b3665],
10	:	:	O	:	_	0	SENT_366	[p15l1826t3625r1900b3665],
11	289-300	CD	NUMBER	289-300	dep	6	SENT_366	[p15l1924t3624r2147b3665],
12	.	.	O	.	_	0	SENT_366	[p15l1924t3624r2147b3665],

1	Purcell	NNP	PERSON	Purcell	nn	2	SENT_367	[p15l102t3697r263b3741],
2	S	NNP	O	S	_	0	SENT_367	[p15l291t3699r328b3748],
3	,	,	O	,	_	0	SENT_367	[p15l291t3699r328b3748],
4	Cherny	NNP	PERSON	Cherny	nn	5	SENT_367	[p15l354t3697r530b3753],
5	SS	NNP	O	SS	appos	2	SENT_367	[p15l555t3699r622b3748],
6	,	,	O	,	_	0	SENT_367	[p15l555t3699r622b3748],
7	Sham	NNP	O	Sham	nn	8	SENT_367	[p15l648t3697r783b3741],
8	PC	NNP	O	PC	appos	5	SENT_367	[p15l813t3699r886b3741],
9	.	.	O	.	_	0	SENT_367	[p15l813t3699r886b3741],

1	Genetic	JJ	O	genetic	amod	3	SENT_368	[p15l911t3699r1100b3741],
2	Power	NN	O	power	nn	3	SENT_368	[p15l1128t3699r1281b3741],
3	Calculator	NN	O	calculator	_	0	SENT_368	[p15l1305t3697r1565b3741],
4	:	:	O	:	_	0	SENT_368	[p15l1305t3697r1565b3741],
5	design	NN	O	design	dep	3	SENT_368	[p15l1590t3697r1752b3753],
6	of	IN	O	of	_	0	SENT_368	[p15l1780t3696r1831b3741],
7	linkage	NN	O	linkage	nn	12	SENT_368	[p15l1854t3697r2030b3753],
8	and	CC	O	and	_	0	SENT_368	[p15l2055t3697r2145b3741],
9	association	NN	O	association	nn	12	SENT_368	[p16l100t20r372b62],
10	genetic	JJ	O	genetic	amod	12	SENT_368	[p16l403t20r586b73],
11	mapping	NN	O	mapping	nn	12	SENT_368	[p16l616t20r836b73],
12	studies	NNS	O	study	prep_of	5	SENT_368	[p16l866t18r1039b62],
13	of	IN	O	of	_	0	SENT_368	[p16l1067t17r1118b62],
14	complex	JJ	O	complex	amod	15	SENT_368	[p16l1142t18r1354b73],
15	traits	NNS	O	trait	prep_of	5	SENT_368	[p16l1380t20r1515b62],
16	.	.	O	.	_	0	SENT_368	[p16l1380t20r1515b62],

1	Bioinformatics	NNS	O	bioinformatic	_	0	SENT_369	[p16l1542t17r1887b62],
2	2003	CD	DATE	2003	num	1	SENT_369	[p16l1914t20r2046b68],
3	;	:	O	;	_	0	SENT_369	[p16l1914t20r2046b68],
4	19	CD	NUMBER	19	num	6	SENT_369	[p16l2076t20r2148b62],
5	:	:	O	:	_	0	SENT_369	[p16l2076t20r2148b62],
6	149-150	CD	NUMBER	149-150	dep	1	SENT_369	[p16l104t97r323b138],
7	.	.	O	.	_	0	SENT_369	[p16l104t97r323b138],

1	Barrett	NNP	PERSON	Barrett	nn	2	SENT_370	[p16l102t174r266b216],
2	JC	NNP	O	JC	_	0	SENT_370	[p16l283t173r350b222],
3	,	,	O	,	_	0	SENT_370	[p16l283t173r350b222],
4	Fry	NNP	O	Fry	nn	5	SENT_370	[p16l372t174r444b228],
5	B	NNP	O	B	appos	2	SENT_370	[p16l464t174r503b222],
6	,	,	O	,	_	0	SENT_370	[p16l464t174r503b222],
7	Maller	NNP	PERSON	Maller	nn	8	SENT_370	[p16l523t172r674b216],
8	J	NNP	PERSON	J	appos	2	SENT_370	[p16l690t174r723b222],
9	,	,	O	,	_	0	SENT_370	[p16l690t174r723b222],
10	Daly	NNP	PERSON	Daly	nn	11	SENT_370	[p16l744t172r850b228],
11	MJ	NNP	O	MJ	appos	2	SENT_370	[p16l869t174r946b216],
12	.	.	O	.	_	0	SENT_370	[p16l869t174r946b216],

1	Haploviewz	NN	PERSON	haploviewz	nn	2	SENT_371	[p16l968t172r1240b227],
2	analysis	NN	O	analysis	_	0	SENT_371	[p16l1258t172r1448b228],
3	and	CC	O	and	_	0	SENT_371	[p16l1469t172r1559b216],
4	visualization	NN	O	visualization	conj_and	2	SENT_371	[p16l1580t172r1884b216],
5	of	IN	O	of	_	0	SENT_371	[p16l1906t171r1957b216],
6	LD	NN	O	ld	nn	9	SENT_371	[p16l1974t174r2036b215],
7	and	CC	O	and	_	0	SENT_371	[p16l2055t172r2145b216],
8	haplotype	NN	O	haplotype	nn	9	SENT_371	[p16l102t249r350b305],
9	maps	NNS	O	map	prep_of	2	SENT_371	[p16l377t262r520b304],
10	.	.	O	.	_	0	SENT_371	[p16l377t262r520b304],

1	Bioinformatics	NNS	O	bioinformatic	_	0	SENT_372	[p16l544t248r888b293],
2	2005	CD	DATE	2005	num	1	SENT_372	[p16l911t252r1043b299],
3	;	:	O	;	_	0	SENT_372	[p16l911t252r1043b299],
4	21	CD	NUMBER	21	num	6	SENT_372	[p16l1066t252r1141b293],
5	:	:	O	:	_	0	SENT_372	[p16l1066t252r1141b293],
6	263-265	CD	NUMBER	263-265	dep	1	SENT_372	[p16l1165t252r1388b293],
7	.	.	O	.	_	0	SENT_372	[p16l1165t252r1388b293],

1	Stephens	NNP	PERSON	Stephens	nn	2	SENT_373	[p16l100t326r330b381],
2	M	NNP	O	M	_	0	SENT_373	[p16l369t328r424b376],
3	,	,	O	,	_	0	SENT_373	[p16l369t328r424b376],
4	Smith	NNP	ORGANIZATION	Smith	nn	5	SENT_373	[p16l462t326r601b369],
5	NJ	NNP	ORGANIZATION	NJ	appos	2	SENT_373	[p16l643t328r711b376],
6	,	,	O	,	_	0	SENT_373	[p16l643t328r711b376],
7	Donnelly	NNP	PERSON	Donnelly	nn	9	SENT_373	[p16l750t326r970b382],
8	P.	NNP	O	P.	nn	9	SENT_373	[p16l1008t327r1047b369],
9	A	NNP	O	A	appos	2	SENT_373	[p16l1083t328r1117b369],
10	new	JJ	O	new	amod	12	SENT_373	[p16l1156t338r1259b369],
11	statistical	JJ	O	statistical	amod	12	SENT_373	[p16l1295t326r1521b370],
12	method	NN	O	method	dep	9	SENT_373	[p16l1562t326r1755b370],
13	for	IN	O	for	_	0	SENT_373	[p16l1792t325r1861b370],
14	haplotype	NN	O	haplotype	nn	15	SENT_373	[p16l1899t326r2148b382],
15	reconstruction	NN	O	reconstruction	prep_for	12	SENT_373	[p16l102t403r459b445],
16	from	IN	O	from	_	0	SENT_373	[p16l483t401r598b445],
17	population	NN	O	population	nn	18	SENT_373	[p16l627t401r894b456],
18	data	NNS	O	datum	prep_from	15	SENT_373	[p16l920t401r1040b445],
19	.	.	O	.	_	0	SENT_373	[p16l920t401r1040b445],

1	Am	VBP	O	be	dep	4	SENT_374	[p16l1060t403r1141b445],
2	J	NN	O	j	nn	4	SENT_374	[p16l1162t403r1187b445],
3	Hum	NNP	O	Hum	nn	4	SENT_374	[p16l1207t403r1320b445],
4	Genet	NNP	O	Genet	_	0	SENT_374	[p16l1346t403r1486b445],
5	2001	CD	DATE	2001	num	4	SENT_374	[p16l1508t404r1639b452],
6	;	:	O	;	_	0	SENT_374	[p16l1508t404r1639b452],
7	68	CD	NUMBER	68	dep	4	SENT_374	[p16l1662t404r1738b445],
8	:	:	O	:	_	0	SENT_374	[p16l1662t404r1738b445],
9	978-989	CD	NUMBER	978-989	dep	7	SENT_374	[p16l1761t404r1984b445],
10	.	.	O	.	_	0	SENT_374	[p16l1761t404r1984b445],

1	Stephens	NNP	PERSON	Stephens	nn	2	SENT_375	[p16l101t480r330b535],
2	M	NNP	O	M	_	0	SENT_375	[p16l369t482r424b530],
3	,	,	O	,	_	0	SENT_375	[p16l369t482r424b530],
4	Donnelly	NNP	PERSON	Donnelly	nn	7	SENT_375	[p16l464t480r684b536],
5	P.	NNP	O	P.	nn	7	SENT_375	[p16l722t482r761b524],
6	A	NNP	O	A	nn	7	SENT_375	[p16l797t482r831b523],
7	comparison	NN	O	comparison	appos	2	SENT_375	[p16l868t482r1158b535],
8	of	IN	O	of	_	0	SENT_375	[p16l1197t479r1248b524],
9	bayesian	JJ	O	bayesian	amod	10	SENT_375	[p16l1283t480r1496b536],
10	methods	NNS	O	method	prep_of	7	SENT_375	[p16l1538t480r1755b524],
11	for	IN	O	for	_	0	SENT_375	[p16l1792t479r1861b524],
12	haplotype	NN	O	haplotype	nn	13	SENT_375	[p16l1899t480r2147b536],
13	reconstruction	NN	O	reconstruction	prep_for	10	SENT_375	[p16l102t559r459b600],
14	from	IN	O	from	_	0	SENT_375	[p16l498t556r614b600],
15	population	NN	O	population	nn	17	SENT_375	[p16l656t556r924b611],
16	genotype	NN	O	genotype	nn	17	SENT_375	[p16l965t563r1202b613],
17	data	NNS	O	datum	prep_from	13	SENT_375	[p16l1241t556r1361b600],
18	.	.	O	.	_	0	SENT_375	[p16l1241t556r1361b600],

1	Am	VBP	O	be	dep	4	SENT_376	[p16l1396t558r1477b600],
2	J	NN	O	j	nn	4	SENT_376	[p16l1513t558r1538b600],
3	Hum	NNP	O	Hum	nn	4	SENT_376	[p16l1573t558r1686b600],
4	Genet	NNP	O	Genet	_	0	SENT_376	[p16l1727t558r1867b600],
5	2003	CD	DATE	2003	num	4	SENT_376	[p16l1903t559r2034b607],
6	;	:	O	;	_	0	SENT_376	[p16l1903t559r2034b607],
7	73	CD	NUMBER	73	dep	4	SENT_376	[p16l2074t559r2148b600],
8	:	:	O	:	_	0	SENT_376	[p16l2074t559r2148b600],
9	1162-1169	CD	DATE	1162-1169	dep	7	SENT_376	[p16l104t635r385b676],
10	.	.	O	.	_	0	SENT_376	[p16l104t635r385b676],

1	Boige	NNP	MISC	Boige	nn	2	SENT_377	[p16l102t710r239b764],
2	V	NNP	O	V	_	0	SENT_377	[p16l262t710r306b759],
3	,	,	O	,	_	0	SENT_377	[p16l262t710r306b759],
4	Mendiboure	NNP	PERSON	Mendiboure	nn	5	SENT_377	[p16l332t708r635b752],
5	J	NNP	PERSON	J	appos	2	SENT_377	[p16l660t710r692b759],
6	,	,	O	,	_	0	SENT_377	[p16l660t710r692b759],
7	Pignon	NNP	PERSON	Pignon	nn	8	SENT_377	[p16l719t710r890b764],
8	JP	NNP	O	JP	appos	2	SENT_377	[p16l915t710r980b759],
9	,	,	O	,	_	0	SENT_377	[p16l915t710r980b759],
10	Loriot	NNP	LOCATION	Loriot	nn	11	SENT_377	[p16l1007t710r1148b752],
11	MA	NNP	LOCATION	MA	appos	2	SENT_377	[p16l1174t710r1266b759],
12	,	,	O	,	_	0	SENT_377	[p16l1174t710r1266b759],
13	Castaing	NNP	O	Castaing	nn	14	SENT_377	[p16l1291t710r1502b764],
14	M	NNP	O	M	appos	2	SENT_377	[p16l1530t710r1586b759],
15	,	,	O	,	_	0	SENT_377	[p16l1530t710r1586b759],
16	Barrois	NNP	O	Barrois	nn	17	SENT_377	[p16l1613t710r1777b752],
17	M	NNP	O	M	appos	2	SENT_377	[p16l1805t710r1846b752],
18	et	FW	O	et	nn	19	SENT_377	[p16l1873t715r1918b752],
19	al.	FW	O	al.	dep	17	SENT_377	[p16l1940t708r1992b752],
20	.	.	O	.	_	0	SENT_377	[p16l1940t708r1992b752],

1	Pharmacogenetic	JJ	MISC	pharmacogenetic	amod	2	SENT_378	[p16l2022t708r2148b752, p16l102t789r423b842],
2	assessment	NN	O	assessment	_	0	SENT_378	[p16l455t794r740b831],
3	of	IN	O	of	_	0	SENT_378	[p16l772t786r823b831],
4	toxicity	NN	O	toxicity	prep_of	2	SENT_378	[p16l850t789r1032b843],
5	and	CC	O	and	_	0	SENT_378	[p16l1063t787r1153b831],
6	outcome	NN	O	outcome	prep_of	2	SENT_378	[p16l1188t794r1409b831],
7	in	IN	O	in	_	0	SENT_378	[p16l1444t789r1483b830],
8	patients	NNS	O	patient	prep_in	2	SENT_378	[p16l1520t789r1717b842],
9	with	IN	O	with	_	0	SENT_378	[p16l1749t787r1855b831],
10	metastatic	JJ	O	metastatic	amod	12	SENT_378	[p16l1892t789r2148b831],
11	colorectal	JJ	O	colorectal	amod	12	SENT_378	[p16l100t862r339b907],
12	cancer	NN	O	cancer	prep_with	8	SENT_378	[p16l361t875r524b906],
13	treated	VBN	O	treat	partmod	12	SENT_378	[p16l542t862r718b906],
14	with	IN	O	with	_	0	SENT_378	[p16l740t862r845b906],
15	LV5FU2	NN	O	lv5fu2	prep_with	13	SENT_378	[p16l869t864r1066b913],
16	,	,	O	,	_	0	SENT_378	[p16l869t864r1066b913],
17	FOLFOX	NN	LOCATION	folfox	prep_with	13	SENT_378	[p16l1088t864r1297b913],
18	,	,	O	,	_	0	SENT_378	[p16l1088t864r1297b913],
19	and	CC	O	and	_	0	SENT_378	[p16l1316t862r1407b906],
20	FOLFIRI	NNP	O	FOLFIRI	prep_with	13	SENT_378	[p16l1430t864r1624b906],
21	:	:	O	:	_	0	SENT_378	[p16l1430t864r1624b906],
22	FFCD	NN	O	ffcd	dep	2	SENT_378	[p16l1646t864r1772b906],
23	2000-05	CD	DATE	2000-05	dep	22	SENT_378	[p16l1792t865r2003b906],
24	.	.	O	.	_	0	SENT_378	[p16l1792t865r2003b906],

1	J	NNP	O	J	nn	3	SENT_379	[p16l2019t864r2043b906],
2	Clin	NNP	O	Clin	nn	3	SENT_379	[p16l2061t862r2147b906],
3	Oncol	NNP	O	Oncol	_	0	SENT_379	[p16l101t939r241b983],
4	2010	CD	DATE	2010	num	3	SENT_379	[p16l263t942r394b990],
5	;	:	O	;	_	0	SENT_379	[p16l263t942r394b990],
6	28	CD	NUMBER	28	num	8	SENT_379	[p16l418t942r492b983],
7	:	:	O	:	_	0	SENT_379	[p16l418t942r492b983],
8	2556-2564	CD	DATE	2556-2564	dep	3	SENT_379	[p16l516t942r801b983],
9	.	.	O	.	_	0	SENT_379	[p16l516t942r801b983],

1	Walther	NNP	PERSON	Walther	nn	2	SENT_380	[p16l99t1016r293b1060],
2	A	NNP	O	A	dep	22	SENT_380	[p16l325t1018r371b1067],
3	,	,	O	,	_	0	SENT_380	[p16l325t1018r371b1067],
4	Johnstone	NNP	PERSON	Johnstone	nn	5	SENT_380	[p16l402t1016r661b1060],
5	E	NNP	O	E	appos	2	SENT_380	[p16l696t1018r732b1067],
6	,	,	O	,	_	0	SENT_380	[p16l696t1018r732b1067],
7	Swanton	NNP	LOCATION	Swanton	nn	8	SENT_380	[p16l766t1018r981b1060],
8	C	NNP	O	C	appos	2	SENT_380	[p16l1017t1018r1059b1067],
9	,	,	O	,	_	0	SENT_380	[p16l1017t1018r1059b1067],
10	Midgley	NNP	PERSON	Midgley	nn	11	SENT_380	[p16l1094t1016r1292b1072],
11	R	NNP	PERSON	R	appos	2	SENT_380	[p16l1326t1018r1364b1067],
12	,	,	O	,	_	0	SENT_380	[p16l1326t1018r1364b1067],
13	Tomlinson	NNP	PERSON	Tomlinson	appos	2	SENT_380	[p16l1395t1016r1656b1060],
14	I	PRP	O	I	dep	13	SENT_380	[p16l1693t1018r1713b1067],
15	,	,	O	,	_	0	SENT_380	[p16l1693t1018r1713b1067],
16	Kerr	NNP	PERSON	Kerr	nn	18	SENT_380	[p16l1748t1018r1845b1060],
17	D.	NNP	O	D.	nn	18	SENT_380	[p16l1880t1018r1926b1060],
18	Genetic	NNP	O	Genetic	appos	2	SENT_380	[p16l1958t1018r2147b1060],
19	prognostic	JJ	O	prognostic	amod	22	SENT_380	[p16l102t1096r366b1149],
20	and	CC	O	and	_	0	SENT_380	[p16l391t1094r482b1138],
21	predictive	JJ	O	predictive	conj_and	19	SENT_380	[p16l512t1094r757b1149],
22	markers	NNS	O	marker	_	0	SENT_380	[p16l785t1094r979b1138],
23	in	IN	O	in	_	0	SENT_380	[p16l1007t1096r1047b1137],
24	colorectal	JJ	O	colorectal	amod	25	SENT_380	[p16l1075t1094r1314b1138],
25	cancer	NN	O	cancer	prep_in	22	SENT_380	[p16l1342t1106r1516b1138],
26	.	.	O	.	_	0	SENT_380	[p16l1342t1106r1516b1138],

1	Nat	NNP	O	Nat	nn	3	SENT_381	[p16l1541t1096r1629b1138],
2	Rev	NN	O	rev	nn	3	SENT_381	[p16l1651t1095r1737b1138],
3	Cancer	NN	O	cancer	_	0	SENT_381	[p16l1760t1095r1926b1138],
4	2009	CD	DATE	2009	dep	3	SENT_381	[p16l1950t1096r2081b1144],
5	;	:	O	;	_	0	SENT_381	[p16l1950t1096r2081b1144],
6	9	CD	NUMBER	9	num	8	SENT_381	[p16l2106t1096r2148b1138],
7	:	:	O	:	_	0	SENT_381	[p16l2106t1096r2148b1138],
8	489-499	CD	NUMBER	489-499	dep	3	SENT_381	[p16l99t1175r323b1215],
9	.	.	O	.	_	0	SENT_381	[p16l99t1175r323b1215],

1	de	IN	O	de	dep	6	SENT_382	[p16l100t1248r160b1292],
2	Gramont	NNP	O	Gramont	nn	3	SENT_382	[p16l187t1249r407b1292],
3	A	NNP	O	A	pobj	1	SENT_382	[p16l433t1250r478b1298],
4	,	,	O	,	_	0	SENT_382	[p16l433t1250r478b1298],
5	Figer	NNP	PERSON	Figer	nn	6	SENT_382	[p16l507t1250r628b1303],
6	A	NNP	O	A	_	0	SENT_382	[p16l653t1250r698b1298],
7	,	,	O	,	_	0	SENT_382	[p16l653t1250r698b1298],
8	Seymour	NNP	PERSON	Seymour	nn	9	SENT_382	[p16l725t1249r945b1304],
9	M	NNP	PERSON	M	appos	6	SENT_382	[p16l972t1250r1027b1298],
10	,	,	O	,	_	0	SENT_382	[p16l972t1250r1027b1298],
11	Homerin	NNP	O	Homerin	nn	12	SENT_382	[p16l1056t1250r1267b1292],
12	M	NNP	O	M	appos	6	SENT_382	[p16l1297t1250r1353b1298],
13	,	,	O	,	_	0	SENT_382	[p16l1297t1250r1353b1298],
14	Hmissi	NNP	O	Hmissi	nn	15	SENT_382	[p16l1381t1250r1538b1292],
15	A	NNP	O	A	appos	6	SENT_382	[p16l1566t1250r1612b1298],
16	,	,	O	,	_	0	SENT_382	[p16l1566t1250r1612b1298],
17	Cassidy	NNP	PERSON	Cassidy	nn	18	SENT_382	[p16l1638t1248r1823b1304],
18	J	NNP	O	J	appos	6	SENT_382	[p16l1846t1250r1865b1292],
19	et	FW	O	et	nn	20	SENT_382	[p16l1893t1255r1939b1292],
20	al.	FW	O	al.	dep	18	SENT_382	[p16l1961t1248r2013b1292],
21	.	.	O	.	_	0	SENT_382	[p16l1961t1248r2013b1292],

1	Leucovorin	NNP	O	Leucovorin	_	0	SENT_383	[p16l2044t1250r2148b1292, p16l100t1325r282b1367],
2	and	CC	O	and	_	0	SENT_383	[p16l319t1323r409b1367],
3	ﬂuorouracil	NN	O	ﬂuorouracil	conj_or	3	SENT_383	[p16l444t1322r725b1367],
4	with	IN	O	with	_	0	SENT_383	[p16l761t1323r866b1367],
5	or	CC	O	or	_	0	SENT_383	[p16l903t1336r953b1367],
6	without	IN	O	without	_	0	SENT_383	[p16l986t1323r1179b1367],
7	oxaliplatin	NN	O	oxaliplatin	prep_with	3	SENT_383	[p16l1213t1323r1467b1378],
8	as	IN	O	as	_	0	SENT_383	[p16l1504t1336r1553b1367],
9	ﬁrst	NN	O	ﬁrst	nn	12	SENT_383	[p16l1587t1322r1787b1367],
10	—	CD	NUMBER	—	num	12	SENT_383	[p16l1587t1322r1787b1367],
11	|	NN	O	|	nn	12	SENT_383	[p16l1587t1322r1787b1367],
12	ine	NN	O	ine	prep_as	7	SENT_383	[p16l1587t1322r1787b1367],
13	treatment	NN	O	treatment	dep	1	SENT_383	[p16l1821t1330r2070b1367],
14	in	IN	O	in	_	0	SENT_383	[p16l2106t1325r2145b1366],
15	advanced	JJ	O	advanced	amod	17	SENT_383	[p16l100t1401r339b1445],
16	colorectal	JJ	O	colorectal	amod	17	SENT_383	[p16l365t1401r604b1445],
17	cancer	NN	O	cancer	prep_in	13	SENT_383	[p16l630t1413r804b1445],
18	.	.	O	.	_	0	SENT_383	[p16l630t1413r804b1445],

1	J	NNP	O	J	nn	3	SENT_384	[p16l825t1403r849b1445],
2	Clin	NNP	O	Clin	nn	3	SENT_384	[p16l871t1401r957b1445],
3	Oncol	NNP	O	Oncol	_	0	SENT_384	[p16l982t1401r1123b1445],
4	2000	CD	DATE	2000	num	3	SENT_384	[p16l1144t1403r1276b1451],
5	;	:	O	;	_	0	SENT_384	[p16l1144t1403r1276b1451],
6	18	CD	NUMBER	18	num	8	SENT_384	[p16l1302t1403r1374b1445],
7	:	:	O	:	_	0	SENT_384	[p16l1302t1403r1374b1445],
8	2938-2947	CD	DATE	2938-2947	dep	3	SENT_384	[p16l1398t1403r1683b1445],
9	.	.	O	.	_	0	SENT_384	[p16l1398t1403r1683b1445],

1	Cavaletti	NNP	O	Cavaletti	nn	2	SENT_385	[p16l100t1477r312b1521],
2	G	NNP	O	G	nsubj	11	SENT_385	[p16l340t1479r387b1528],
3	,	,	O	,	_	0	SENT_385	[p16l340t1479r387b1528],
4	Alberti	NNP	PERSON	Alberti	nn	5	SENT_385	[p16l412t1477r573b1521],
5	P	NN	O	p	appos	2	SENT_385	[p16l603t1479r641b1528],
6	,	,	O	,	_	0	SENT_385	[p16l603t1479r641b1528],
7	Marmiroli	NNP	O	Marmiroli	nn	10	SENT_385	[p16l667t1477r901b1521],
8	P.	NNP	O	P.	nn	10	SENT_385	[p16l931t1479r969b1521],
9	Chemotherapy	NNP	O	Chemotherapy	nn	10	SENT_385	[p16l994t1477r1585b1533],
10	—	NN	O	—	appos	5	SENT_385	[p16l994t1477r1585b1533],
11	induced	VBD	O	induce	_	0	SENT_385	[p16l994t1477r1585b1533],
12	peripheral	JJ	O	peripheral	amod	13	SENT_385	[p16l1614t1477r1864b1532],
13	neurotoxi	NN	O	neurotoxus	iobj	11	SENT_385	[p16l1893t1479r2147b1521],
14	—	CD	NUMBER	—	num	15	SENT_385	[p16l1893t1479r2147b1521],
15	city	NN	O	city	dobj	11	SENT_385	[p16l100t1558r186b1612],
16	in	IN	O	in	_	0	SENT_385	[p16l210t1558r250b1599],
17	the	DT	O	the	det	18	SENT_385	[p16l275t1556r355b1600],
18	era	NN	O	era	prep_in	15	SENT_385	[p16l379t1569r452b1600],
19	of	IN	O	of	_	0	SENT_385	[p16l478t1555r529b1600],
20	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	18	SENT_385	[p16l550t1556r1055b1611],
21	.	.	O	.	_	0	SENT_385	[p16l550t1556r1055b1611],

1	Lancet	NNP	O	Lancet	nn	2	SENT_386	[p16l1079t1558r1239b1600],
2	Oncol	NNP	O	Oncol	_	0	SENT_386	[p16l1260t1556r1403b1600],
3	2011	CD	DATE	2011	num	2	SENT_386	[p16l1423t1559r1554b1606],
4	;	:	O	;	_	0	SENT_386	[p16l1423t1559r1554b1606],
5	12	CD	NUMBER	12	num	7	SENT_386	[p16l1581t1559r1652b1600],
6	:	:	O	:	_	0	SENT_386	[p16l1581t1559r1652b1600],
7	1151-1161	CD	DATE	1151-1161	dep	2	SENT_386	[p16l1680t1559r1961b1600],
8	.	.	O	.	_	0	SENT_386	[p16l1680t1559r1961b1600],

1	Denkert	NN	O	denkert	nn	2	SENT_387	[p16l102t1631r297b1675],
2	C	NN	O	c	nsubj	17	SENT_387	[p16l332t1633r375b1682],
3	,	,	O	,	_	0	SENT_387	[p16l332t1633r375b1682],
4	Budczies	NNPS	O	Budczies	nn	5	SENT_387	[p16l413t1631r627b1675],
5	J	NNP	O	J	appos	2	SENT_387	[p16l660t1633r693b1682],
6	,	,	O	,	_	0	SENT_387	[p16l660t1633r693b1682],
7	Weichert	NNP	O	Weichert	nn	8	SENT_387	[p16l727t1631r950b1675],
8	W	NNP	O	W	appos	5	SENT_387	[p16l983t1633r1043b1682],
9	,	,	O	,	_	0	SENT_387	[p16l983t1633r1043b1682],
10	Wohlgemuth	NNP	PERSON	Wohlgemuth	nn	11	SENT_387	[p16l1078t1631r1403b1687],
11	G	NNP	PERSON	G	appos	8	SENT_387	[p16l1441t1633r1488b1682],
12	,	,	O	,	_	0	SENT_387	[p16l1441t1633r1488b1682],
13	Scholz	NNP	ORGANIZATION	Scholz	nn	14	SENT_387	[p16l1524t1631r1683b1675],
14	M	NNP	ORGANIZATION	M	appos	5	SENT_387	[p16l1719t1633r1774b1682],
15	,	,	O	,	_	0	SENT_387	[p16l1719t1633r1774b1682],
16	Kind	NNP	O	Kind	dep	17	SENT_387	[p16l1812t1631r1917b1675],
17	T	NN	O	t	_	0	SENT_387	[p16l1953t1633r1984b1675],
18	et	FW	O	et	nn	17	SENT_387	[p16l2016t1638r2062b1675],
19	al.	FW	O	al.	dep	17	SENT_387	[p16l2094t1631r2146b1675],
20	.	.	O	.	_	0	SENT_387	[p16l2094t1631r2146b1675],

1	Metabolite	NN	O	metabolite	nn	2	SENT_388	[p16l101t1710r367b1754],
2	proﬁling	NN	O	proﬁling	_	0	SENT_388	[p16l396t1709r600b1765],
3	of	IN	O	of	_	0	SENT_388	[p16l629t1709r680b1754],
4	human	JJ	O	human	amod	6	SENT_388	[p16l704t1710r875b1754],
5	colon	NN	O	colon	nn	6	SENT_388	[p16l904t1710r1037b1754],
6	carcinoma	NN	O	carcinoma	prep_of	2	SENT_388	[p16l1066t1710r1680b1765],
7	.	.	O	.	_	0	SENT_388	[p16l1066t1710r1680b1765],

1	—	NN	O	—	_	0	SENT_389	[p16l1066t1710r1680b1765],
2	.	.	O	.	_	0	SENT_389	[p16l1066t1710r1680b1765],

1	.	.	O	.	_	0	SENT_390	[p16l1066t1710r1680b1765],

1	—	NN	O	—	_	0	SENT_391	[p16l1066t1710r1680b1765],
2	.	.	O	.	_	0	SENT_391	[p16l1066t1710r1680b1765],

1	deregu	NN	O	deregu	nn	3	SENT_392	[p16l1066t1710r1680b1765],
2	|	NN	O	|	nn	3	SENT_392	[p16l1066t1710r1680b1765],
3	ation	NN	O	ation	_	0	SENT_392	[p16l1066t1710r1680b1765],
4	of	IN	O	of	_	0	SENT_392	[p16l1709t1709r1760b1754],
5	TCA	NNP	ORGANIZATION	TCA	nn	6	SENT_392	[p16l1780t1711r1880b1753],
6	cycle	NN	O	cycle	prep_of	3	SENT_392	[p16l1906t1710r2028b1766],
7	and	CC	O	and	_	0	SENT_392	[p16l2055t1710r2145b1754],
8	amino	NN	O	amino	nn	10	SENT_392	[p16l100t1787r255b1829],
9	acid	NN	O	acid	nn	10	SENT_392	[p16l279t1785r377b1829],
10	turnover	NN	O	turnover	prep_of	3	SENT_392	[p16l402t1792r627b1829],
11	.	.	O	.	_	0	SENT_392	[p16l402t1792r627b1829],

1	Mol	NNP	O	Mol	nn	2	SENT_393	[p16l650t1785r742b1829],
2	Cancer	NNP	O	Cancer	_	0	SENT_393	[p16l763t1787r930b1829],
3	2008	CD	DATE	2008	num	2	SENT_393	[p16l951t1788r1082b1836],
4	;	:	O	;	_	0	SENT_393	[p16l951t1788r1082b1836],
5	7	CD	NUMBER	7	num	7	SENT_393	[p16l1106t1789r1148b1829],
6	:	:	O	:	_	0	SENT_393	[p16l1106t1789r1148b1829],
7	72	CD	NUMBER	72	dep	2	SENT_393	[p16l1172t1788r1241b1829],
8	.	.	O	.	_	0	SENT_393	[p16l1172t1788r1241b1829],

1	Rabik	NNP	O	Rabik	nn	2	SENT_394	[p16l102t1864r235b1908],
2	CA	NNP	O	CA	_	0	SENT_394	[p16l256t1865r335b1914],
3	,	,	O	,	_	0	SENT_394	[p16l256t1865r335b1914],
4	Dolan	NNP	PERSON	Dolan	nn	5	SENT_394	[p16l360t1864r501b1908],
5	ME	NNP	O	ME	appos	2	SENT_394	[p16l526t1866r612b1908],
6	.	.	O	.	_	0	SENT_394	[p16l526t1866r612b1908],

1	Molecular	JJ	O	molecular	amod	2	SENT_395	[p16l635t1864r878b1908],
2	mechanisms	NNS	O	mechanism	nsubj	7	SENT_395	[p16l902t1864r1211b1908],
3	of	IN	O	of	_	0	SENT_395	[p16l1234t1863r1285b1908],
4	resistance	NN	O	resistance	prep_of	2	SENT_395	[p16l1305t1866r1549b1908],
5	and	CC	O	and	_	0	SENT_395	[p16l1572t1864r1663b1908],
6	toxicity	NN	O	toxicity	conj_and	4	SENT_395	[p16l1686t1866r1867b1920],
7	associated	VBN	O	associate	_	0	SENT_395	[p16l1889t1864r2145b1908],
8	with	IN	O	with	_	0	SENT_395	[p16l99t1939r205b1983],
9	platinating	JJ	O	platinating	amod	10	SENT_395	[p16l233t1939r497b1995],
10	agents	NNS	O	agent	prep_with	7	SENT_395	[p16l523t1946r701b1995],
11	.	.	O	.	_	0	SENT_395	[p16l523t1946r701b1995],

1	Cancer	NNP	O	Cancer	nn	3	SENT_396	[p16l725t1941r891b1983],
2	Treat	NNP	O	Treat	nn	3	SENT_396	[p16l914t1941r1036b1983],
3	Rev	NN	O	rev	_	0	SENT_396	[p16l1056t1941r1142b1983],
4	2007	CD	DATE	2007	num	3	SENT_396	[p16l1163t1942r1294b1990],
5	;	:	O	;	_	0	SENT_396	[p16l1163t1942r1294b1990],
6	33	CD	NUMBER	33	num	8	SENT_396	[p16l1317t1942r1392b1983],
7	:	:	O	:	_	0	SENT_396	[p16l1317t1942r1392b1983],
8	9-23	CD	NUMBER	9-23	dep	3	SENT_396	[p16l1417t1942r1547b1983],
9	.	.	O	.	_	0	SENT_396	[p16l1417t1942r1547b1983],

1	Gottesman	NNP	PERSON	Gottesman	nn	2	SENT_397	[p16l100t2018r371b2060],
2	MM	NN	O	mm	_	0	SENT_397	[p16l406t2018r509b2067],
3	,	,	O	,	_	0	SENT_397	[p16l406t2018r509b2067],
4	Fojo	NN	O	fojo	nn	5	SENT_397	[p16l542t2018r645b2072],
5	T	NN	O	t	appos	2	SENT_397	[p16l673t2018r713b2067],
6	,	,	O	,	_	0	SENT_397	[p16l673t2018r713b2067],
7	Bates	NNP	PERSON	Bates	nn	8	SENT_397	[p16l746t2018r875b2060],
8	SE	NN	O	se	appos	5	SENT_397	[p16l907t2018r973b2060],
9	.	.	O	.	_	0	SENT_397	[p16l907t2018r973b2060],

1	Multidrug	JJ	O	multidrug	amod	2	SENT_398	[p16l1005t2016r1246b2072],
2	resistance	NN	O	resistance	_	0	SENT_398	[p16l1280t2018r1525b2060],
3	in	IN	O	in	_	0	SENT_398	[p16l1557t2018r1597b2059],
4	cancer	NN	O	cancer	prep_in	2	SENT_398	[p16l1629t2029r1804b2060],
5	:	:	O	:	_	0	SENT_398	[p16l1629t2029r1804b2060],
6	role	NN	O	role	dep	2	SENT_398	[p16l1837t2016r1927b2060],
7	of	IN	O	of	_	0	SENT_398	[p16l1958t2015r2008b2060],
8	ATPdependent	NN	O	atpdependent	nn	9	SENT_398	[p16l2035t2018r2148b2059, p16l100t2093r376b2148],
9	transporters	NNS	O	transporter	prep_of	6	SENT_398	[p16l397t2100r711b2148],
10	.	.	O	.	_	0	SENT_398	[p16l397t2100r711b2148],

1	Nat	NNP	O	Nat	nn	3	SENT_399	[p16l735t2095r822b2137],
2	Rev	NN	O	rev	nn	3	SENT_399	[p16l843t2095r929b2137],
3	Cancer	NN	O	cancer	_	0	SENT_399	[p16l949t2095r1116b2137],
4	2002	CD	DATE	2002	dep	3	SENT_399	[p16l1137t2096r1269b2144],
5	;	:	O	;	_	0	SENT_399	[p16l1137t2096r1269b2144],
6	2	CD	NUMBER	2	num	8	SENT_399	[p16l1292t2096r1333b2137],
7	:	:	O	:	_	0	SENT_399	[p16l1292t2096r1333b2137],
8	48-58	CD	NUMBER	48-58	dep	3	SENT_399	[p16l1356t2096r1519b2137],
9	.	.	O	.	_	0	SENT_399	[p16l1356t2096r1519b2137],

1	Theile	NN	O	theile	nn	2	SENT_400	[p16l98t2170r247b2214],
2	D	NN	O	d	_	0	SENT_400	[p16l268t2172r314b2221],
3	,	,	O	,	_	0	SENT_400	[p16l268t2172r314b2221],
4	Grebhardt	NNP	PERSON	Grebhardt	nn	5	SENT_400	[p16l331t2170r586b2214],
5	S	NNP	PERSON	S	appos	2	SENT_400	[p16l604t2172r642b2221],
6	,	,	O	,	_	0	SENT_400	[p16l604t2172r642b2221],
7	Haefeli	NNP	PERSON	Haefeli	nn	8	SENT_400	[p16l662t2170r828b2214],
8	WE	NNP	O	WE	appos	2	SENT_400	[p16l846t2172r936b2221],
9	,	,	O	,	_	0	SENT_400	[p16l846t2172r936b2221],
10	Weiss	NNP	PERSON	Weiss	nn	12	SENT_400	[p16l953t2172r1092b2214],
11	J.	NNP	O	J.	nn	12	SENT_400	[p16l1110t2172r1142b2214],
12	Involvement	NN	O	involvement	appos	2	SENT_400	[p16l1162t2170r1472b2214],
13	of	IN	O	of	_	0	SENT_400	[p16l1489t2170r1540b2214],
14	drug	NN	O	drug	nn	15	SENT_400	[p16l1554t2170r1668b2226],
15	transporters	NNS	O	transporter	prep_of	12	SENT_400	[p16l1687t2177r1988b2225],
16	in	IN	O	in	_	0	SENT_400	[p16l2008t2172r2048b2214],
17	the	DT	O	the	det	19	SENT_400	[p16l2067t2170r2147b2214],
18	synergistic	JJ	O	synergistic	amod	19	SENT_400	[p16l100t2251r362b2305],
19	action	NN	O	action	prep_in	15	SENT_400	[p16l396t2251r545b2292],
20	of	IN	O	of	_	0	SENT_400	[p16l581t2248r632b2292],
21	FOLFOX	NNP	O	FOLFOX	nn	23	SENT_400	[p16l663t2250r861b2292],
22	combination	NN	O	combination	nn	23	SENT_400	[p16l894t2248r1207b2292],
23	chemotherapy	NN	O	chemotherapy	prep_of	19	SENT_400	[p16l1243t2248r1618b2305],
24	.	.	O	.	_	0	SENT_400	[p16l1243t2248r1618b2305],

1	Biochem	NNP	O	Biochem	nn	2	SENT_401	[p16l1652t2248r1855b2292],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_401	[p16l1889t2248r2151b2292],
3	2009	CD	DATE	2009	num	2	SENT_401	[p16l100t2327r232b2375],
4	;	:	O	;	_	0	SENT_401	[p16l100t2327r232b2375],
5	78	CD	NUMBER	78	num	7	SENT_401	[p16l256t2327r330b2368],
6	:	:	O	:	_	0	SENT_401	[p16l256t2327r330b2368],
7	1366-1373	CD	DATE	1366-1373	dep	2	SENT_401	[p16l358t2327r639b2368],
8	.	.	O	.	_	0	SENT_401	[p16l358t2327r639b2368],

1	Haenisch	NNP	O	Haenisch	nn	2	SENT_402	[p16l102t2403r323b2447],
2	S	NNP	O	S	_	0	SENT_402	[p16l353t2404r391b2453],
3	,	,	O	,	_	0	SENT_402	[p16l353t2404r391b2453],
4	May	NNP	DATE	May	nn	5	SENT_402	[p16l419t2405r521b2459],
5	K	NNP	O	K	appos	2	SENT_402	[p16l549t2405r588b2453],
6	,	,	O	,	_	0	SENT_402	[p16l549t2405r588b2453],
7	Wegner	NNP	PERSON	Wegner	nn	8	SENT_402	[p16l614t2405r810b2458],
8	D	NNP	O	D	appos	2	SENT_402	[p16l838t2404r884b2453],
9	,	,	O	,	_	0	SENT_402	[p16l838t2404r884b2453],
10	Caliebe	NNP	O	Caliebe	nn	11	SENT_402	[p16l911t2403r1092b2447],
11	A	NNP	O	A	appos	2	SENT_402	[p16l1119t2405r1165b2453],
12	,	,	O	,	_	0	SENT_402	[p16l1119t2405r1165b2453],
13	Cascorbi	NNP	PERSON	Cascorbi	nn	14	SENT_402	[p16l1192t2403r1400b2447],
14	l	NN	O	l	appos	2	SENT_402	[p16l1431t2405r1452b2453],
15	,	,	O	,	_	0	SENT_402	[p16l1431t2405r1452b2453],
16	Siegmund	NNP	PERSON	Siegmund	nn	18	SENT_402	[p16l1479t2403r1730b2458],
17	W.	NNP	PERSON	W.	nn	18	SENT_402	[p16l1758t2405r1819b2447],
18	Inﬂuence	NNP	PERSON	Inﬂuence	appos	2	SENT_402	[p16l1848t2402r2073b2447],
19	of	IN	O	of	_	0	SENT_402	[p16l2101t2402r2152b2447],
20	genetic	JJ	O	genetic	amod	21	SENT_402	[p16l100t2480r283b2534],
21	polymorphisms	NNS	O	polymorphism	prep_of	18	SENT_402	[p16l317t2478r701b2534],
22	on	IN	O	on	_	0	SENT_402	[p16l732t2491r792b2522],
23	intestinal	JJ	O	intestinal	amod	24	SENT_402	[p16l827t2478r1049b2522],
24	expression	NN	O	expression	prep_on	21	SENT_402	[p16l1083t2480r1345b2533],
25	and	CC	O	and	_	0	SENT_402	[p16l1378t2478r1469b2522],
26	rifampicin	NN	O	rifampicin	nn	29	SENT_402	[p16l1504t2478r1880b2534],
27	—	CD	NUMBER	—	num	29	SENT_402	[p16l1504t2478r1880b2534],
28	type	NN	O	type	nn	29	SENT_402	[p16l1504t2478r1880b2534],
29	induction	NN	O	induction	prep_on	21	SENT_402	[p16l1913t2478r2145b2522],
30	of	IN	O	of	_	0	SENT_402	[p16l100t2555r151b2599],
31	ABCC2	NN	O	abcc2	prep_of	29	SENT_402	[p16l172t2557r337b2599],
32	and	CC	O	and	_	0	SENT_402	[p16l364t2555r454b2599],
33	on	IN	O	on	_	0	SENT_402	[p16l483t2568r543b2599],
34	bioavailability	NN	O	bioavailability	prep_on	21	SENT_402	[p16l573t2555r915b2611],
35	of	IN	O	of	_	0	SENT_402	[p16l940t2555r991b2599],
36	talinolol	NN	O	talinolol	prep_of	34	SENT_402	[p16l1011t2555r1223b2599],
37	.	.	O	.	_	0	SENT_402	[p16l1011t2555r1223b2599],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_403	[p16l1249t2555r1634b2611],
2	Genomics	NNP	O	Genomics	_	0	SENT_403	[p16l1657t2557r1890b2599],
3	2008	CD	DATE	2008	num	2	SENT_403	[p16l1916t2558r2047b2606],
4	;	:	O	;	_	0	SENT_403	[p16l1916t2558r2047b2606],
5	18	CD	NUMBER	18	num	7	SENT_403	[p16l2076t2558r2148b2599],
6	:	:	O	:	_	0	SENT_403	[p16l2076t2558r2148b2599],
7	357-365	CD	NUMBER	357-365	dep	2	SENT_403	[p16l100t2635r323b2675],
8	.	.	O	.	_	0	SENT_403	[p16l100t2635r323b2675],

1	Han	NN	O	han	nn	2	SENT_404	[p16l102t2712r195b2754],
2	B	NN	O	b	_	0	SENT_404	[p16l232t2711r270b2760],
3	,	,	O	,	_	0	SENT_404	[p16l232t2711r270b2760],
4	Gao	NNP	O	Gao	nn	5	SENT_404	[p16l302t2711r399b2754],
5	G	NNP	O	G	appos	2	SENT_404	[p16l432t2711r479b2760],
6	,	,	O	,	_	0	SENT_404	[p16l432t2711r479b2760],
7	Wu	NNP	O	Wu	nn	8	SENT_404	[p16l509t2712r589b2754],
8	W	NNP	O	W	appos	2	SENT_404	[p16l622t2712r682b2760],
9	,	,	O	,	_	0	SENT_404	[p16l622t2712r682b2760],
10	Gao	NNP	O	Gao	nn	11	SENT_404	[p16l714t2711r811b2754],
11	Z	NNP	O	Z	appos	2	SENT_404	[p16l842t2712r884b2760],
12	,	,	O	,	_	0	SENT_404	[p16l842t2712r884b2760],
13	Zhao	NNP	PERSON	Zhao	nn	14	SENT_404	[p16l916t2710r1041b2754],
14	X	NNP	PERSON	X	appos	2	SENT_404	[p16l1073t2712r1115b2760],
15	,	,	O	,	_	0	SENT_404	[p16l1073t2712r1115b2760],
16	Li	NNP	PERSON	Li	nn	17	SENT_404	[p16l1149t2712r1184b2753],
17	L	NNP	O	L	appos	2	SENT_404	[p16l1220t2712r1243b2753],
18	et	FW	O	et	nn	19	SENT_404	[p16l1274t2716r1319b2754],
19	al.	FW	O	al.	dep	17	SENT_404	[p16l1348t2710r1400b2754],
20	.	.	O	.	_	0	SENT_404	[p16l1348t2710r1400b2754],

1	Association	NN	O	association	_	0	SENT_405	[p16l1434t2712r1714b2754],
2	of	IN	O	of	_	0	SENT_405	[p16l1748t2709r1799b2754],
3	ABCC2	NN	O	abcc2	nn	4	SENT_405	[p16l1827t2711r1991b2753],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_405	[p16l2026t2710r2148b2766, p16l102t2787r377b2842],
5	with	IN	O	with	_	0	SENT_405	[p16l403t2787r509b2831],
6	platinum-based	JJ	O	platinum-based	amod	8	SENT_405	[p16l540t2787r927b2842],
7	chemotherapy	NN	O	chemotherapy	nn	8	SENT_405	[p16l955t2787r1320b2843],
8	response	NN	O	response	prep_with	1	SENT_405	[p16l1347t2800r1568b2842],
9	and	CC	O	and	_	0	SENT_405	[p16l1595t2787r1686b2831],
10	severe	JJ	O	severe	amod	11	SENT_405	[p16l1714t2799r1872b2831],
11	toxicity	NN	O	toxicity	conj_and	8	SENT_405	[p16l1898t2789r2079b2843],
12	in	IN	O	in	_	0	SENT_405	[p16l2106t2789r2145b2830],
13	non	JJ	O	non	amod	19	SENT_405	[p16l102t2862r343b2906],
14	—	JJ	O	—	amod	19	SENT_405	[p16l102t2862r343b2906],
15	small	JJ	O	small	amod	19	SENT_405	[p16l102t2862r343b2906],
16	cell	NN	O	cell	nn	19	SENT_405	[p16l369t2862r447b2906],
17	lung	NN	O	lung	nn	19	SENT_405	[p16l475t2862r581b2918],
18	cancer	NN	O	cancer	nn	19	SENT_405	[p16l607t2875r769b2906],
19	patients	NNS	O	patient	prep_in	1	SENT_405	[p16l795t2864r1004b2918],
20	.	.	O	.	_	0	SENT_405	[p16l795t2864r1004b2918],

1	Lung	NN	O	lung	nn	2	SENT_406	[p16l1027t2864r1145b2918],
2	Cancer	NN	O	cancer	_	0	SENT_406	[p16l1170t2864r1337b2906],
3	2011	CD	DATE	2011	dep	2	SENT_406	[p16l1358t2865r1489b2913],
4	;	:	O	;	_	0	SENT_406	[p16l1358t2865r1489b2913],
5	72	CD	NUMBER	72	num	7	SENT_406	[p16l1513t2865r1587b2906],
6	:	:	O	:	_	0	SENT_406	[p16l1513t2865r1587b2906],
7	238-243	CD	NUMBER	238-243	dep	2	SENT_406	[p16l1611t2865r1834b2906],
8	.	.	O	.	_	0	SENT_406	[p16l1611t2865r1834b2906],

1	Ballatori	NNP	PERSON	Ballatori	nn	2	SENT_407	[p16l102t2939r299b2983],
2	N	NNP	PERSON	N	nn	16	SENT_407	[p16l335t2941r380b2990],
3	,	,	O	,	_	0	SENT_407	[p16l335t2941r380b2990],
4	Hammond	NNP	ORGANIZATION	Hammond	nn	5	SENT_407	[p16l415t2939r675b2983],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_407	[p16l710t2940r781b2990],
6	,	,	O	,	_	0	SENT_407	[p16l710t2940r781b2990],
7	Cunningham	NNP	PERSON	Cunningham	nn	8	SENT_407	[p16l814t2939r1134b2995],
8	JB	NNP	O	JB	appos	2	SENT_407	[p16l1167t2941r1232b2990],
9	,	,	O	,	_	0	SENT_407	[p16l1167t2941r1232b2990],
10	Krance	NNP	ORGANIZATION	Krance	nn	11	SENT_407	[p16l1267t2941r1432b2983],
11	SM	NNP	ORGANIZATION	SM	appos	2	SENT_407	[p16l1465t2940r1552b2990],
12	,	,	O	,	_	0	SENT_407	[p16l1465t2940r1552b2990],
13	Marchan	NNP	PERSON	Marchan	nn	14	SENT_407	[p16l1585t2939r1797b2983],
14	R.	NNP	PERSON	R.	appos	2	SENT_407	[p16l1834t2941r1872b2983],
15	Molecular	JJ	PERSON	molecular	amod	16	SENT_407	[p16l1906t2939r2149b2983],
16	mechanisms	NNS	O	mechanism	_	0	SENT_407	[p16l102t3017r410b3061],
17	of	IN	O	of	_	0	SENT_407	[p16l438t3016r488b3061],
18	reduced	VBN	O	reduce	amod	20	SENT_407	[p16l513t3017r712b3061],
19	glutathione	NN	O	glutathione	nn	20	SENT_407	[p16l740t3017r1027b3072],
20	transport	NN	O	transport	prep_of	16	SENT_407	[p16l1053t3023r1293b3072],
21	:	:	O	:	_	0	SENT_407	[p16l1053t3023r1293b3072],
22	role	NN	O	role	dep	16	SENT_407	[p16l1321t3017r1411b3061],
23	of	IN	O	of	_	0	SENT_407	[p16l1438t3016r1489b3061],
24	the	DT	O	the	det	28	SENT_407	[p16l1510t3017r1590b3061],
25	MRP/CFTR/ABCC	NN	O	mrp/cftr/abcc	nn	28	SENT_407	[p16l1618t3018r2029b3062],
26	and	CC	O	and	_	0	SENT_407	[p16l2055t3017r2145b3061],
27	OATP/SLC21A	NN	O	oatp/slc21a	nn	28	SENT_407	[p16l100t3095r447b3139],
28	families	NNS	O	family	prep_of	22	SENT_407	[p16l468t3093r658b3138],
29	of	IN	O	of	_	0	SENT_407	[p16l682t3093r732b3138],
30	membrane	NN	O	membrane	nn	31	SENT_407	[p16l753t3094r1024b3138],
31	proteins	NNS	O	protein	prep_of	28	SENT_407	[p16l1049t3096r1262b3149],
32	.	.	O	.	_	0	SENT_407	[p16l1049t3096r1262b3149],

1	Toxicol	NNP	O	Toxicol	nn	3	SENT_408	[p16l1287t3094r1454b3138],
2	Appl	NNP	O	Appl	nn	3	SENT_408	[p16l1471t3094r1584b3149],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_408	[p16l1603t3094r1865b3138],
4	2005	CD	DATE	2005	num	3	SENT_408	[p16l1885t3096r2017b3144],
5	;	:	O	;	_	0	SENT_408	[p16l1885t3096r2017b3144],
6	204	CD	NUMBER	204	num	8	SENT_408	[p16l2040t3096r2148b3138],
7	:	:	O	:	_	0	SENT_408	[p16l2040t3096r2148b3138],
8	238-255	CD	NUMBER	238-255	dep	3	SENT_408	[p16l100t3173r323b3213],
9	.	.	O	.	_	0	SENT_408	[p16l100t3173r323b3213],

1	Taniguchi	NNP	PERSON	Taniguchi	nn	2	SENT_409	[p16l98t3246r340b3302],
2	K	NNP	PERSON	K	_	0	SENT_409	[p16l374t3248r413b3297],
3	,	,	O	,	_	0	SENT_409	[p16l374t3248r413b3297],
4	Wada	NNP	PERSON	Wada	nn	5	SENT_409	[p16l442t3246r580b3290],
5	M	NNP	O	M	appos	2	SENT_409	[p16l613t3248r668b3297],
6	,	,	O	,	_	0	SENT_409	[p16l613t3248r668b3297],
7	Kohno	NNP	PERSON	Kohno	nn	8	SENT_409	[p16l700t3246r859b3290],
8	K	NNP	PERSON	K	appos	2	SENT_409	[p16l891t3248r930b3297],
9	,	,	O	,	_	0	SENT_409	[p16l891t3248r930b3297],
10	Nakamura	NNP	ORGANIZATION	Nakamura	nn	11	SENT_409	[p16l962t3246r1211b3290],
11	T	NN	ORGANIZATION	t	appos	2	SENT_409	[p16l1241t3248r1281b3297],
12	,	,	O	,	_	0	SENT_409	[p16l1241t3248r1281b3297],
13	Kawabe	NN	ORGANIZATION	kawabe	nn	14	SENT_409	[p16l1313t3246r1505b3290],
14	T	NN	ORGANIZATION	t	appos	2	SENT_409	[p16l1533t3248r1573b3297],
15	,	,	O	,	_	0	SENT_409	[p16l1533t3248r1573b3297],
16	Kawakami	NNP	PERSON	Kawakami	nn	17	SENT_409	[p16l1606t3246r1853b3290],
17	M	NNP	O	M	appos	2	SENT_409	[p16l1886t3248r1928b3289],
18	et	FW	O	et	nn	19	SENT_409	[p16l1959t3253r2005b3290],
19	al.	FW	O	al.	dep	17	SENT_409	[p16l2032t3246r2083b3290],
20	.	.	O	.	_	0	SENT_409	[p16l2032t3246r2083b3290],

1	A	DT	O	a	det	11	SENT_410	[p16l2115t3248r2149b3289],
2	human	JJ	O	human	amod	11	SENT_410	[p16l102t3324r273b3368],
3	canalicular	JJ	O	canalicular	amod	11	SENT_410	[p16l316t3324r580b3368],
4	multispeciﬁc	JJ	O	multispeciﬁc	amod	11	SENT_410	[p16l622t3323r934b3379],
5	organic	JJ	O	organic	amod	11	SENT_410	[p16l974t3326r1159b3379],
6	anion	NN	O	anion	nn	11	SENT_410	[p16l1200t3326r1336b3368],
7	transporter	NN	O	transporter	nn	11	SENT_410	[p16l1378t3330r1656b3379],
8	(	CD	NUMBER	(	num	11	SENT_410	[p16l1698t3324r1907b3374],
9	cMOAT	NN	O	cmoat	nn	11	SENT_410	[p16l1698t3324r1907b3374],
10	)	NN	O	)	nn	11	SENT_410	[p16l1698t3324r1907b3374],
11	gene	NN	O	gene	nsubjpass	13	SENT_410	[p16l1950t3336r2073b3379],
12	is	VBZ	O	be	auxpass	13	SENT_410	[p16l2115t3326r2147b3368],
13	overexpressed	VBN	O	overexpress	_	0	SENT_410	[p16l100t3401r459b3456],
14	in	IN	O	in	_	0	SENT_410	[p16l485t3403r525b3444],
15	cisp	JJ	O	cisp	amod	17	SENT_410	[p16l549t3401r985b3456],
16	|	NN	O	|	nn	17	SENT_410	[p16l549t3401r985b3456],
17	atin	NN	O	atin	prep_in	13	SENT_410	[p16l549t3401r985b3456],
18	—	CD	NUMBER	—	num	23	SENT_410	[p16l549t3401r985b3456],
19	resistant	JJ	O	resistant	amod	23	SENT_410	[p16l549t3401r985b3456],
20	human	JJ	O	human	amod	23	SENT_410	[p16l1009t3401r1180b3445],
21	cancer	NN	O	cancer	nn	23	SENT_410	[p16l1204t3413r1367b3445],
22	cell	NN	O	cell	nn	23	SENT_410	[p16l1389t3401r1468b3445],
23	lines	NNS	O	line	dobj	13	SENT_410	[p16l1495t3401r1603b3445],
24	with	IN	O	with	_	0	SENT_410	[p16l1625t3401r1731b3445],
25	decreased	VBN	O	decrease	amod	27	SENT_410	[p16l1756t3401r2007b3445],
26	drug	NN	O	drug	nn	27	SENT_410	[p16l2032t3401r2145b3456],
27	accumulation	NN	O	accumulation	prep_with	23	SENT_410	[p16l100t3477r449b3521],
28	.	.	O	.	_	0	SENT_410	[p16l100t3477r449b3521],

1	Cancer	NNP	O	Cancer	nn	2	SENT_411	[p16l473t3479r641b3521],
2	Res	NNP	O	Res	_	0	SENT_411	[p16l661t3479r738b3521],
3	1996	CD	DATE	1996	num	2	SENT_411	[p16l766t3480r893b3528],
4	;	:	O	;	_	0	SENT_411	[p16l766t3480r893b3528],
5	56	CD	NUMBER	56	num	7	SENT_411	[p16l917t3480r992b3521],
6	:	:	O	:	_	0	SENT_411	[p16l917t3480r992b3521],
7	4124-4129	CD	DURATION	4124-4129	dep	2	SENT_411	[p16l1014t3480r1300b3521],
8	.	.	O	.	_	0	SENT_411	[p16l1014t3480r1300b3521],

1	Matullo	NNP	O	Matullo	nn	2	SENT_412	[p16l101t3555r286b3599],
2	G	NNP	O	G	_	0	SENT_412	[p16l315t3556r362b3605],
3	,	,	O	,	_	0	SENT_412	[p16l315t3556r362b3605],
4	Palli	NNP	PERSON	Palli	nn	5	SENT_412	[p16l392t3555r487b3599],
5	D	NNP	O	D	appos	2	SENT_412	[p16l520t3557r566b3605],
6	,	,	O	,	_	0	SENT_412	[p16l520t3557r566b3605],
7	Peluso	NNP	PERSON	Peluso	nn	8	SENT_412	[p16l596t3555r755b3599],
8	M	NNP	O	M	appos	2	SENT_412	[p16l785t3557r841b3606],
9	,	,	O	,	_	0	SENT_412	[p16l785t3557r841b3606],
10	Guarrera	NNP	PERSON	Guarrera	nn	11	SENT_412	[p16l868t3556r1081b3599],
11	S	NNP	PERSON	S	appos	2	SENT_412	[p16l1112t3556r1149b3606],
12	,	,	O	,	_	0	SENT_412	[p16l1112t3556r1149b3606],
13	Carturan	NNP	O	Carturan	nn	14	SENT_412	[p16l1177t3556r1389b3599],
14	S	NNP	O	S	appos	2	SENT_412	[p16l1420t3556r1457b3606],
15	,	,	O	,	_	0	SENT_412	[p16l1420t3556r1457b3606],
16	Celentano	NNP	PERSON	Celentano	nn	17	SENT_412	[p16l1486t3555r1738b3599],
17	E	NNP	O	E	appos	2	SENT_412	[p16l1769t3557r1792b3598],
18	et	FW	O	et	nn	19	SENT_412	[p16l1821t3561r1867b3599],
19	al.	FW	O	al.	dep	17	SENT_412	[p16l1891t3555r1943b3599],
20	.	.	O	.	_	0	SENT_412	[p16l1891t3555r1943b3599],

1	XRCC1	NN	O	xrcc1	_	0	SENT_413	[p16l1973t3556r2148b3605],
2	,	,	O	,	_	0	SENT_413	[p16l1973t3556r2148b3605],
3	XRCC3	NN	O	xrcc3	appos	1	SENT_413	[p16l100t3634r274b3683],
4	,	,	O	,	_	0	SENT_413	[p16l100t3634r274b3683],
5	XPD	NN	O	xpd	nn	7	SENT_413	[p16l292t3634r394b3676],
6	gene	NN	O	gene	nn	7	SENT_413	[p16l412t3645r535b3688],
7	polymorphisms	NNS	O	polymorphism	appos	1	SENT_413	[p16l555t3632r952b3689],
8	,	,	O	,	_	0	SENT_413	[p16l555t3632r952b3689],
9	smoking	NN	O	smoking	appos	1	SENT_413	[p16l971t3632r1180b3688],
10	and	CC	O	and	_	0	SENT_413	[p16l1200t3632r1291b3676],
11	(	NN	O	(	appos	1	SENT_413	[p16l1312t3633r1570b3683],
12	32	CD	NUMBER	32	number	13	SENT_413	[p16l1312t3633r1570b3683],
13	)	CD	NUMBER	)	num	14	SENT_413	[p16l1312t3633r1570b3683],
14	P	NN	O	p	dep	9	SENT_413	[p16l1312t3633r1570b3683],
15	.	.	O	.	_	0	SENT_413	[p16l1312t3633r1570b3683],

1	—	NN	O	—	_	0	SENT_414	[p16l1312t3633r1570b3683],
2	.	.	O	.	_	0	SENT_414	[p16l1312t3633r1570b3683],

1	DNA	NN	O	dna	nn	2	SENT_415	[p16l1312t3633r1570b3683],
2	adducts	NNS	O	adduct	_	0	SENT_415	[p16l1587t3632r1783b3676],
3	in	IN	O	in	_	0	SENT_415	[p16l1803t3635r1843b3676],
4	a	DT	O	a	det	5	SENT_415	[p16l1862t3645r1886b3676],
5	sample	NN	O	sample	prep_in	2	SENT_415	[p16l1907t3632r2083b3687],
6	of	IN	O	of	_	0	SENT_415	[p16l2102t3632r2152b3676],
7	healthy	JJ	O	healthy	amod	8	SENT_415	[p17l102t17r285b73],
8	subjects	NNS	O	subject	prep_of	2	SENT_415	[p17l308t17r521b72],
9	.	.	O	.	_	0	SENT_415	[p17l308t17r521b72],

1	Carcinogenesis	NN	O	carcinogenesis	_	0	SENT_416	[p17l546t18r902b72],
2	2001	CD	DATE	2001	num	1	SENT_416	[p17l926t19r1057b67],
3	;	:	O	;	_	0	SENT_416	[p17l926t19r1057b67],
4	22	CD	NUMBER	22	num	6	SENT_416	[p17l1081t19r1156b60],
5	:	:	O	:	_	0	SENT_416	[p17l1081t19r1156b60],
6	1437-1445	CD	DATE	1437-1445	dep	1	SENT_416	[p17l1183t19r1464b61],
7	.	.	O	.	_	0	SENT_416	[p17l1183t19r1464b61],

1	46	CD	NUMBER	46	num	3	SENT_417	[p17l7t95r66b136],
2	Ott	NN	O	ott	nn	3	SENT_417	[p17l100t94r176b136],
3	K	NN	O	k	_	0	SENT_417	[p17l204t94r242b143],
4	,	,	O	,	_	0	SENT_417	[p17l204t94r242b143],
5	Rachakonda	NNP	ORGANIZATION	Rachakonda	nn	6	SENT_417	[p17l270t92r564b136],
6	PS	NNP	ORGANIZATION	PS	appos	3	SENT_417	[p17l594t94r661b143],
7	,	,	O	,	_	0	SENT_417	[p17l594t94r661b143],
8	Panzram	NNP	PERSON	Panzram	nn	9	SENT_417	[p17l688t94r896b136],
9	B	NNP	O	B	appos	3	SENT_417	[p17l925t94r964b143],
10	,	,	O	,	_	0	SENT_417	[p17l925t94r964b143],
11	Keller	NNP	PERSON	Keller	nn	12	SENT_417	[p17l992t92r1125b136],
12	G	NNP	O	G	appos	3	SENT_417	[p17l1148t94r1195b143],
13	,	,	O	,	_	0	SENT_417	[p17l1148t94r1195b143],
14	Lordick	NNP	O	Lordick	nn	15	SENT_417	[p17l1223t92r1400b136],
15	F	NN	O	f	appos	3	SENT_417	[p17l1425t94r1460b143],
16	,	,	O	,	_	0	SENT_417	[p17l1425t94r1460b143],
17	Becker	NNP	PERSON	Becker	nn	18	SENT_417	[p17l1487t92r1648b136],
18	K	NNP	O	K	appos	3	SENT_417	[p17l1674t94r1703b136],
19	et	FW	O	et	nn	20	SENT_417	[p17l1727t99r1772b136],
20	al.	FW	O	al.	dep	18	SENT_417	[p17l1794t92r1844b136],
21	.	.	O	.	_	0	SENT_417	[p17l1794t92r1844b136],

1	DNA	NN	O	dna	nn	3	SENT_418	[p17l1874t94r1984b136],
2	repair	NN	O	repair	nn	3	SENT_418	[p17l2011t94r2149b147],
3	gene	NN	O	gene	_	0	SENT_418	[p17l100t184r222b226],
4	and	CC	O	and	_	0	SENT_418	[p17l244t171r334b215],
5	MTHFR	NN	O	mthfr	nn	7	SENT_418	[p17l360t173r532b214],
6	gene	NN	O	gene	nn	7	SENT_418	[p17l553t183r675b226],
7	polymorphisms	NNS	O	polymorphism	conj_and	3	SENT_418	[p17l700t171r1076b227],
8	as	IN	O	as	dep	3	SENT_418	[p17l1100t184r1148b215],
9	prognostic	JJ	O	prognostic	amod	10	SENT_418	[p17l1173t173r1432b226],
10	markers	NNS	O	marker	pobj	8	SENT_418	[p17l1457t171r1647b215],
11	in	IN	O	in	prep	10	SENT_418	[p17l1673t173r1712b214],
12	locally	RB	O	locally	advmod	13	SENT_418	[p17l1739t171r1889b227],
13	advanced	VBN	O	advance	dep	11	SENT_418	[p17l1910t171r2146b215],

1	©	RB	O	©	dep	2	SENT_419	[p17l1069t388r1114b433],
2	2013	CD	DATE	2013	dep	4	SENT_419	[p17l1141t386r1274b433],
3	Macmillan	NNP	ORGANIZATION	Macmillan	nn	4	SENT_419	[p17l1305t383r1591b433],
4	Publishers	NNPS	ORGANIZATION	Publishers	_	0	SENT_419	[p17l1623t383r1909b433],
5	Limited	NNP	ORGANIZATION	Limited	dep	4	SENT_419	[p17l1938t383r2146b433],

1	Pharmacogenomic	JJ	O	pharmacogenomic	amod	2	SENT_420	[p17l1032t508r1289b539],
2	markers	NNS	O	marker	_	0	SENT_420	[p17l1303t508r1410b533],
3	of	IN	O	of	_	0	SENT_420	[p17l1423t508r1451b533],
4	toxicity	NN	O	toxicity	prep_of	2	SENT_420	[p17l1461t510r1561b539],
5	in	IN	O	in	_	0	SENT_420	[p17l1573t510r1595b532],
6	adjuvant	JJ	O	adjuvant	amod	9	SENT_420	[p17l1610t508r1730b539],
7	FOLFOX4	NN	O	folfox4	nn	9	SENT_420	[p17l1743t509r1869b533],
8	E	NN	O	e	nn	9	SENT_420	[p17l1032t551r1045b574],
9	Cecchin	NNP	O	Cecchin	prep_in	4	SENT_420	[p17l1058t550r1165b574],
10	et	FW	O	et	nn	11	SENT_420	[p17l1179t554r1204b574],
11	al	FW	O	al	dep	2	SENT_420	[p17l1215t550r1239b574],
12	@	SYM	O	@	dep	13	SENT_420	[p17l2091t516r2154b577],
13	409	CD	NUMBER	409	rcmod	11	SENT_420	[p17l2095t614r2154b642],

1	adenocarcinoma	NN	O	adenocarcinoma	nsubj	15	SENT_421	[p17l51t665r247b686],
2	of	IN	O	of	_	0	SENT_421	[p17l260t665r284b686],
3	the	DT	O	the	det	4	SENT_421	[p17l293t665r332b686],
4	esophagus	NN	O	esophagus	prep_of	1	SENT_421	[p17l344t665r471b692],
5	or	CC	O	or	_	0	SENT_421	[p17l483t671r507b686],
6	stomach	NN	O	stomach	conj_or	4	SENT_421	[p17l518t665r618b686],
7	treated	VBN	O	treat	partmod	4	SENT_421	[p17l630t665r714b686],
8	with	IN	O	with	_	0	SENT_421	[p17l726t665r776b686],
9	cisplatin	NN	O	cisplatin	prep_with	7	SENT_421	[p17l789t665r885b692],
10	and	CC	O	and	_	0	SENT_421	[p17l897t665r941b686],
11	5	CD	NUMBER	5	number	12	SENT_421	[p17l954t665r1039b686],
12	—	CD	NUMBER	—	num	14	SENT_421	[p17l954t665r1039b686],
13	ﬂuor	NN	O	ﬂuor	nn	14	SENT_421	[p17l954t665r1039b686],
14	—	NN	O	—	conj_and	9	SENT_421	[p17l954t665r1039b686],
15	advanced	VBD	O	advance	_	0	SENT_421	[p17l1159t665r1274b686],
16	colorectal	JJ	O	colorectal	amod	17	SENT_421	[p17l1288t665r1403b686],
17	cancer	NN	O	cancer	dobj	15	SENT_421	[p17l1416t671r1495b686],
18	treated	VBN	O	treat	partmod	17	SENT_421	[p17l1505t665r1590b686],
19	with	IN	O	with	_	0	SENT_421	[p17l1603t665r1654b686],
20	a	DT	O	a	det	24	SENT_421	[p17l1667t671r1678b686],
21	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	nn	24	SENT_421	[p17l1690t665r1891b692],
22	and	CC	O	and	_	0	SENT_421	[p17l1903t665r1947b686],
23	oxaliplatin	NN	O	oxaliplatin	nn	24	SENT_421	[p17l1960t665r2082b692],
24	con	NN	O	con	prep_with	18	SENT_421	[p17l6t709r58b724],
25	~	CD	NUMBER	~	num	28	SENT_421	[p17l6t709r58b724],
26	ouracil-based	JJ	O	ouracil-based	amod	28	SENT_421	[p17l51t739r207b761],
27	neoadjuvant	JJ	O	neoadjuvant	amod	28	SENT_421	[p17l220t739r368b767],
28	chemotherapy	NN	O	chemotherapy	dep	24	SENT_421	[p17l379t739r557b767],
29	.	.	O	.	_	0	SENT_421	[p17l379t739r557b767],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_422	[p17l566t740r612b761],
2	Surg	NNP	O	Surg	nn	3	SENT_422	[p17l623t740r674b767],
3	Oncol	NNP	O	Oncol	_	0	SENT_422	[p17l685t739r752b761],
4	2011	CD	DATE	2011	num	3	SENT_422	[p17l762t741r825b764],
5	;	:	O	;	_	0	SENT_422	[p17l762t741r825b764],
6	18	CD	NUMBER	18	num	8	SENT_422	[p17l837t741r871b761],
7	:	:	O	:	_	0	SENT_422	[p17l837t741r871b761],
8	2688-2698	CD	DATE	2688-2698	dep	3	SENT_422	[p17l882t741r1017b761],
9	.	.	O	.	_	0	SENT_422	[p17l882t741r1017b761],

1	talning	VBG	O	taln	_	0	SENT_423	[p17l1159t740r1241b767],
2	ﬁrst-line	JJ	O	ﬁrst-line	amod	3	SENT_423	[p17l1252t739r1350b761],
3	chemotherapy	NN	O	chemotherapy	dobj	1	SENT_423	[p17l1360t739r1541b767],
4	.	.	O	.	_	0	SENT_423	[p17l1360t739r1541b767],

1	A	DT	O	a	det	2	SENT_424	[p17l1552t740r1568b761],
2	report	NN	O	report	_	0	SENT_424	[p17l1580t743r1652b767],
3	of	IN	O	of	_	0	SENT_424	[p17l1663t739r1687b761],
4	the	DT	O	the	det	8	SENT_424	[p17l1695t739r1734b761],
5	A10	NN	O	a10	nn	8	SENT_424	[p17l1745t740r1787b761],
6	Colorectal	JJ	O	colorectal	amod	8	SENT_424	[p17l1798t739r1917b761],
7	Study	NNP	O	Study	nn	8	SENT_424	[p17l1929t739r1997b767],
8	Group	NNP	O	Group	prep_of	2	SENT_424	[p17l2007t740r2087b767],
9	.	.	O	.	_	0	SENT_424	[p17l2007t740r2087b767],

1	Int	NN	O	int	nn	2	SENT_425	[p17l2098t740r2129b761],
2	J	NN	O	j	_	0	SENT_425	[p17l6t778r18b799],
3	47	CD	NUMBER	47	num	5	SENT_425	[p17l30t779r58b799],
4	Damaraju	NNP	O	Damaraju	nn	5	SENT_425	[p17l76t778r189b805],
5	S	NN	O	s	dep	2	SENT_425	[p17l207t778r224b802],
6	,	,	O	,	_	0	SENT_425	[p17l207t778r224b802],
7	Murray	NNP	ORGANIZATION	Murray	nn	8	SENT_425	[p17l241t778r325b805],
8	D	NNP	ORGANIZATION	D	appos	5	SENT_425	[p17l341t778r363b802],
9	,	,	O	,	_	0	SENT_425	[p17l341t778r363b802],
10	Dufour	NNP	PERSON	Dufour	nn	11	SENT_425	[p17l380t777r462b799],
11	J	NNP	PERSON	J	appos	5	SENT_425	[p17l477t778r492b802],
12	,	,	O	,	_	0	SENT_425	[p17l477t778r492b802],
13	Carandang	NNP	PERSON	Carandang	nn	14	SENT_425	[p17l508t777r638b805],
14	D	NNP	PERSON	D	appos	5	SENT_425	[p17l656t778r678b802],
15	,	,	O	,	_	0	SENT_425	[p17l656t778r678b802],
16	Myrehaug	NNP	O	Myrehaug	nn	17	SENT_425	[p17l695t777r814b805],
17	S	NNP	O	S	appos	5	SENT_425	[p17l832t778r849b802],
18	,	,	O	,	_	0	SENT_425	[p17l832t778r849b802],
19	Fallone	NNP	PERSON	Fallone	nn	20	SENT_425	[p17l866t777r951b799],
20	G	NNP	O	G	appos	5	SENT_425	[p17l967t778r984b799],
21	et	FW	O	et	nn	22	SENT_425	[p17l1000t781r1022b799],
22	al.	FW	O	al.	dep	20	SENT_425	[p17l1036t777r1062b799],
23	.	.	O	.	_	0	SENT_425	[p17l1036t777r1062b799],

1	Colorectal	JJ	O	colorectal	amod	2	SENT_426	[p17l1184t777r1301b799],
2	Dis	NN	O	di	_	0	SENT_426	[p17l1311t778r1345b799],
3	2008	CD	DATE	2008	num	2	SENT_426	[p17l1356t779r1420b802],
4	;	:	O	;	_	0	SENT_426	[p17l1356t779r1420b802],
5	23	CD	NUMBER	23	num	7	SENT_426	[p17l1431t779r1467b799],
6	:	:	O	:	_	0	SENT_426	[p17l1431t779r1467b799],
7	1033-1039	CD	DATE	1033-1039	dep	2	SENT_426	[p17l1481t779r1616b799],
8	.	.	O	.	_	0	SENT_426	[p17l1481t779r1616b799],

1	Association	NN	O	association	_	0	SENT_427	[p17l50t815r186b835],
2	of	IN	O	of	_	0	SENT_427	[p17l202t814r227b835],
3	DNA	NN	O	dna	nn	4	SENT_427	[p17l242t815r295b835],
4	repair	NN	O	repair	prep_of	1	SENT_427	[p17l311t815r379b841],
5	and	CC	O	and	_	0	SENT_427	[p17l394t814r438b835],
6	steroid	NN	O	steroid	nn	9	SENT_427	[p17l455t814r535b835],
7	metabolism	NN	O	metabolism	nn	9	SENT_427	[p17l553t814r693b835],
8	gene	NN	O	gene	nn	9	SENT_427	[p17l710t820r769b841],
9	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_427	[p17l785t814r971b841],
10	with	IN	O	with	_	0	SENT_427	[p17l986t814r1038b835],
11	50	CD	NUMBER	50	num	12	SENT_427	[p17l1115t815r1143b835],
12	Gazzoli	NNS	O	gazzolus	prep_with	1	SENT_427	[p17l1159t814r1243b835],
13	I	PRP	O	I	dep	1	SENT_427	[p17l1259t815r1269b839],
14	,	,	O	,	_	0	SENT_427	[p17l1259t815r1269b839],
15	Kolodner	NNP	PERSON	Kolodner	nn	16	SENT_427	[p17l1283t814r1391b835],
16	RD.	NNP	O	RD.	appos	13	SENT_427	[p17l1405t815r1443b835],
17	.	.	O	.	_	0	SENT_427	[p17l1405t815r1443b835],

1	Regulation	NN	O	regulation	nsubj	15	SENT_428	[p17l1457t814r1584b841],
2	of	IN	O	of	_	0	SENT_428	[p17l1599t814r1623b835],
3	the	DT	O	the	det	6	SENT_428	[p17l1634t814r1673b835],
4	human	JJ	O	human	amod	6	SENT_428	[p17l1687t814r1770b835],
5	MSH6	NN	O	msh6	nn	6	SENT_428	[p17l1785t815r1854b835],
6	gene	NN	O	gene	prep_of	1	SENT_428	[p17l1867t820r1927b841],
7	by	IN	O	by	_	0	SENT_428	[p17l1941t814r1969b841],
8	the	DT	O	the	det	12	SENT_428	[p17l1982t814r2020b835],
9	Sp1	NN	O	sp1	nn	12	SENT_428	[p17l2034t815r2073b841],
10	tranclinical	NN	O	tranclinical	nn	12	SENT_428	[p17l6t855r63b873, p17l51t889r130b911],
11	late	JJ	O	late	amod	12	SENT_428	[p17l144t889r186b911],
12	toxicity	NN	O	toxicity	prep_by	6	SENT_428	[p17l197t890r285b917],
13	in	IN	O	in	_	0	SENT_428	[p17l296t890r316b911],
14	patients	NNS	O	patient	prep_in	12	SENT_428	[p17l329t890r424b916],
15	treated	VBN	O	treat	_	0	SENT_428	[p17l436t889r521b911],
16	with	IN	O	with	_	0	SENT_428	[p17l533t889r584b911],
17	conformal	JJ	O	conformal	amod	18	SENT_428	[p17l597t889r717b911],
18	radiotherapy	NN	O	radiotherapy	prep_with	15	SENT_428	[p17l731t889r885b917],
19	for	IN	O	for	_	0	SENT_428	[p17l895t889r928b911],
20	prostate	NN	O	prostate	nn	22	SENT_428	[p17l941t892r1038b916],
21	scription	NN	O	scription	nn	22	SENT_428	[p17l1159t890r1261b916],
22	factor	NN	O	factor	prep_for	15	SENT_428	[p17l1279t889r1349b911],
23	and	CC	O	and	_	0	SENT_428	[p17l1366t889r1409b911],
24	alteration	NN	O	alteration	prep_for	15	SENT_428	[p17l1428t889r1541b911],
25	of	IN	O	of	_	0	SENT_428	[p17l1560t889r1584b911],
26	promoter	NN	O	promoter	nn	27	SENT_428	[p17l1601t892r1714b916],
27	activity	NN	O	activity	prep_of	24	SENT_428	[p17l1730t890r1816b917],
28	and	CC	O	and	_	0	SENT_428	[p17l1833t889r1877b911],
29	expression	NN	O	expression	conj_and	27	SENT_428	[p17l1895t890r2022b916],
30	by	IN	O	by	_	0	SENT_428	[p17l2042t889r2070b917],
31	polycancer	NN	O	polycancer	prep_by	15	SENT_428	[p17l6t926r65b954, p17l51t969r135b985],
32	.	.	O	.	_	0	SENT_428	[p17l6t926r65b954, p17l51t969r135b985],

1	Clin	NNP	O	Clin	nn	3	SENT_429	[p17l146t963r188b985],
2	Cancer	NNP	O	Cancer	nn	3	SENT_429	[p17l200t964r281b985],
3	Res	NNP	O	Res	_	0	SENT_429	[p17l290t964r328b985],
4	2006	CD	DATE	2006	num	3	SENT_429	[p17l339t964r403b988],
5	;	:	O	;	_	0	SENT_429	[p17l339t964r403b988],
6	12	CD	NUMBER	12	num	8	SENT_429	[p17l415t964r450b985],
7	:	:	O	:	_	0	SENT_429	[p17l415t964r450b985],
8	2545-2554	CD	DATE	2545-2554	dep	3	SENT_429	[p17l462t964r599b985],
9	.	.	O	.	_	0	SENT_429	[p17l462t964r599b985],

1	morphisms	NNS	O	morphism	_	0	SENT_430	[p17l1160t963r1299b990],
2	.	.	O	.	_	0	SENT_430	[p17l1160t963r1299b990],

1	Mol	NNP	O	Mol	nn	3	SENT_431	[p17l1310t963r1354b985],
2	Cell	NNP	O	Cell	nn	3	SENT_431	[p17l1364t963r1406b985],
3	Biol	NNP	O	Biol	_	0	SENT_431	[p17l1415t963r1458b985],
4	2003	CD	DATE	2003	num	3	SENT_431	[p17l1468t964r1531b988],
5	;	:	O	;	_	0	SENT_431	[p17l1468t964r1531b988],
6	23	CD	NUMBER	23	num	8	SENT_431	[p17l1543t964r1579b985],
7	:	:	O	:	_	0	SENT_431	[p17l1543t964r1579b985],
8	7992-8007	CD	DURATION	7992-8007	dep	3	SENT_431	[p17l1591t964r1728b985],
9	.	.	O	.	_	0	SENT_431	[p17l1591t964r1728b985],

1	48	CD	NUMBER	48	num	3	SENT_432	[p17l1741t965r1769b985],
2	Matheson	NNP	ORGANIZATION	Matheson	nn	3	SENT_432	[p17l1786t963r1903b985],
3	EC	NNP	ORGANIZATION	EC	_	0	SENT_432	[p17l1921t964r1955b988],
4	,	,	O	,	_	0	SENT_432	[p17l1921t964r1955b988],
5	Hall	NNP	ORGANIZATION	Hall	nn	6	SENT_432	[p17l1972t963r2014b985],
6	AG	NNP	ORGANIZATION	AG	appos	3	SENT_432	[p17l2031t964r2072b985],
7	.	.	O	.	_	0	SENT_432	[p17l2031t964r2072b985],

1	Expression	NN	O	expression	_	0	SENT_433	[p17l6t1001r131b1027],
2	of	IN	O	of	_	0	SENT_433	[p17l148t1000r173b1022],
3	DNA	NN	O	dna	nn	6	SENT_433	[p17l188t1001r241b1022],
4	mismatch	NN	O	mismatch	nn	6	SENT_433	[p17l258t1000r373b1022],
5	repair	NN	O	repair	nn	6	SENT_433	[p17l391t1001r459b1027],
6	proteins	NNS	O	protein	prep_of	1	SENT_433	[p17l476t1001r572b1027],
7	in	IN	O	in	_	0	SENT_433	[p17l589t1001r609b1022],
8	acute	JJ	O	acute	amod	11	SENT_433	[p17l625t1004r690b1022],
9	51	CD	NUMBER	51	tmod	8	SENT_433	[p17l767t1002r790b1022],
10	lnoue	NN	O	lnoue	nn	11	SENT_433	[p17l812t1001r877b1022],
11	N	NN	O	n	prep_in	6	SENT_433	[p17l892t1001r914b1025],
12	,	,	O	,	_	0	SENT_433	[p17l892t1001r914b1025],
13	lshida	NN	O	lshida	nn	14	SENT_433	[p17l928t1000r994b1022],
14	H	NN	O	h	appos	1	SENT_433	[p17l1010t1001r1032b1025],
15	,	,	O	,	_	0	SENT_433	[p17l1010t1001r1032b1025],
16	Sano	NNP	PERSON	Sano	nn	17	SENT_433	[p17l1045t1001r1103b1022],
17	M	NNP	O	M	appos	1	SENT_433	[p17l1116t1001r1143b1025],
18	,	,	O	,	_	0	SENT_433	[p17l1116t1001r1143b1025],
19	Kishino	NNP	PERSON	Kishino	nn	20	SENT_433	[p17l1157t1000r1242b1022],
20	T	NN	O	t	appos	1	SENT_433	[p17l1254t1001r1273b1025],
21	,	,	O	,	_	0	SENT_433	[p17l1254t1001r1273b1025],
22	Okada	NNP	ORGANIZATION	Okada	nn	23	SENT_433	[p17l1287t1000r1361b1022],
23	N	NNP	ORGANIZATION	N	appos	1	SENT_433	[p17l1376t1001r1398b1025],
24	,	,	O	,	_	0	SENT_433	[p17l1376t1001r1398b1025],
25	Kumamoto	NNP	LOCATION	Kumamoto	nn	26	SENT_433	[p17l1413t1001r1543b1022],
26	K	NNP	O	K	appos	1	SENT_433	[p17l1557t1001r1571b1022],
27	et	FW	O	et	nn	28	SENT_433	[p17l1584t1004r1606b1022],
28	al.	FW	O	al.	dep	26	SENT_433	[p17l1617t1000r1642b1022],
29	.	.	O	.	_	0	SENT_433	[p17l1617t1000r1642b1022],

1	Discrepancy	NN	O	discrepancy	_	0	SENT_434	[p17l1657t1001r1800b1028],
2	lymphoblastic	JJ	O	lymphoblastic	amod	3	SENT_434	[p17l52t1037r219b1064],
3	leukaemia	NN	O	leukaemia	dep	1	SENT_434	[p17l231t1037r352b1058],
4	and	CC	O	and	_	0	SENT_434	[p17l363t1037r407b1058],
5	normal	JJ	O	normal	amod	7	SENT_434	[p17l420t1037r502b1058],
6	bone	NN	O	bone	nn	7	SENT_434	[p17l515t1037r575b1058],
7	marrow	NN	O	marrow	conj_and	3	SENT_434	[p17l587t1043r684b1058],
8	.	.	O	.	_	0	SENT_434	[p17l587t1043r684b1058],

1	Adv	NNP	O	Adv	nn	4	SENT_435	[p17l694t1037r740b1058],
2	Exp	NNP	O	Exp	nn	4	SENT_435	[p17l749t1038r789b1064],
3	Med	NNP	O	Med	nn	4	SENT_435	[p17l799t1037r850b1058],
4	Biol	NNP	O	Biol	_	0	SENT_435	[p17l860t1037r903b1058],
5	1999	CD	DATE	1999	num	4	SENT_435	[p17l914t1038r976b1062],
6	;	:	O	;	_	0	SENT_435	[p17l914t1038r976b1062],
7	457	CD	NUMBER	457	dep	4	SENT_435	[p17l986t1039r1039b1058],
8	:	:	O	:	_	0	SENT_435	[p17l986t1039r1039b1058],
9	between	IN	O	between	_	0	SENT_435	[p17l1160t1037r1262b1058],
10	the	DT	O	the	det	12	SENT_435	[p17l1271t1037r1309b1058],
11	NC	NN	O	nc	nn	12	SENT_435	[p17l1319t1038r1445b1058],
12	|	NN	O	|	prep_between	7	SENT_435	[p17l1319t1038r1445b1058],
13	.	.	O	.	_	0	SENT_435	[p17l1319t1038r1445b1058],

1	—	NN	O	—	_	0	SENT_436	[p17l1319t1038r1445b1058],
2	.	.	O	.	_	0	SENT_436	[p17l1319t1038r1445b1058],

1	CTCAE	NNP	O	CTCAE	_	0	SENT_437	[p17l1319t1038r1445b1058],
2	and	CC	O	and	_	0	SENT_437	[p17l1453t1037r1496b1058],
3	DEB	NNP	O	DEB	conj_and	1	SENT_437	[p17l1507t1038r1611b1058],
4	.	.	O	.	_	0	SENT_437	[p17l1507t1038r1611b1058],

1	—	NN	O	—	_	0	SENT_438	[p17l1507t1038r1611b1058],
2	.	.	O	.	_	0	SENT_438	[p17l1507t1038r1611b1058],

1	NTC	NNP	ORGANIZATION	NTC	nn	2	SENT_439	[p17l1507t1038r1611b1058],
2	scales	NNS	O	scale	nsubj	15	SENT_439	[p17l1620t1037r1688b1058],
3	in	IN	O	in	_	0	SENT_439	[p17l1697t1038r1717b1058],
4	the	DT	O	the	det	5	SENT_439	[p17l1725t1037r1764b1058],
5	evaluation	NN	O	evaluation	prep_in	15	SENT_439	[p17l1773t1037r1894b1058],
6	of	IN	O	of	_	0	SENT_439	[p17l1904t1037r1928b1058],
7	oxa	NN	O	oxa	nn	11	SENT_439	[p17l6t1074r217b1101],
8	|	CD	NUMBER	|	num	11	SENT_439	[p17l6t1074r217b1101],
9	ip	NN	O	ip	nn	11	SENT_439	[p17l6t1074r217b1101],
10	|	NN	O	|	nn	11	SENT_439	[p17l6t1074r217b1101],
11	atin	NN	O	atin	prep_of	5	SENT_439	[p17l6t1074r217b1101],
12	—	CD	NUMBER	—	num	14	SENT_439	[p17l6t1074r217b1101],
13	re	NN	O	re	nn	14	SENT_439	[p17l6t1074r217b1101],
14	|	NN	O	|	nsubj	15	SENT_439	[p17l6t1074r217b1101],
15	ated	VBD	O	ate	_	0	SENT_439	[p17l6t1074r217b1101],
16	579-583	CD	NUMBER	579-583	dobj	15	SENT_439	[p17l51t1112r158b1132],
17	.	.	O	.	_	0	SENT_439	[p17l51t1112r158b1132],

1	neurotoxicity	NN	O	neurotoxicity	_	0	SENT_440	[p17l1160t1112r1314b1138],
2	in	IN	O	in	_	0	SENT_440	[p17l1325t1112r1345b1132],
3	patients	NNS	O	patient	prep_in	1	SENT_440	[p17l1357t1112r1451b1138],
4	with	IN	O	with	_	0	SENT_440	[p17l1461t1111r1512b1132],
5	metastatic	JJ	O	metastatic	amod	7	SENT_440	[p17l1524t1112r1646b1132],
6	colorectal	JJ	O	colorectal	amod	7	SENT_440	[p17l1657t1111r1769b1132],
7	cancer	NN	O	cancer	prep_with	1	SENT_440	[p17l1782t1117r1864b1132],
8	.	.	O	.	_	0	SENT_440	[p17l1782t1117r1864b1132],

1	Int	NN	O	int	nn	4	SENT_441	[p17l1875t1112r1905b1132],
2	J	NN	O	j	nn	4	SENT_441	[p17l1913t1112r1925b1132],
3	Clin	NN	O	clin	nn	4	SENT_441	[p17l1935t1111r1976b1132],
4	Oncol	NN	O	oncol	_	0	SENT_441	[p17l1988t1111r2055b1132],
5	2011	CD	DATE	2011	dep	4	SENT_441	[p17l2065t1112r2127b1132],
6	.	.	O	.	_	0	SENT_441	[p17l2065t1112r2127b1132],

1	49	CD	NUMBER	49	_	0	SENT_442	[p17l6t1150r34b1170],
2	Muller	NNP	ORGANIZATION	Muller	nn	3	SENT_442	[p17l51t1148r126b1170],
3	Cl	NNP	ORGANIZATION	Cl	dep	1	SENT_442	[p17l135t1149r162b1173],
4	,	,	O	,	_	0	SENT_442	[p17l135t1149r162b1173],
5	Schulmann	NNP	PERSON	Schulmann	nn	6	SENT_442	[p17l173t1148r305b1170],
6	K	NNP	PERSON	K	appos	3	SENT_442	[p17l317t1149r336b1173],
7	,	,	O	,	_	0	SENT_442	[p17l317t1149r336b1173],
8	Reinacher-Schick	NNP	O	Reinacher-Schick	nn	9	SENT_442	[p17l347t1148r550b1170],
9	A	NNP	O	A	appos	3	SENT_442	[p17l559t1149r581b1173],
10	,	,	O	,	_	0	SENT_442	[p17l559t1149r581b1173],
11	Andre	NNP	PERSON	Andre	nn	12	SENT_442	[p17l591t1148r663b1170],
12	N	NNP	PERSON	N	appos	3	SENT_442	[p17l674t1149r696b1173],
13	,	,	O	,	_	0	SENT_442	[p17l674t1149r696b1173],
14	Arnold	NNP	ORGANIZATION	Arnold	nn	15	SENT_442	[p17l705t1148r784b1170],
15	D	NNP	ORGANIZATION	D	appos	3	SENT_442	[p17l797t1149r819b1173],
16	,	,	O	,	_	0	SENT_442	[p17l797t1149r819b1173],
17	Tannapfel	NNP	O	Tannapfel	nn	18	SENT_442	[p17l827t1148r946b1175],
18	A	NNP	O	A	appos	3	SENT_442	[p17l957t1149r973b1170],
19	et	FW	O	et	nn	20	SENT_442	[p17l982t1152r1004b1170],
20	al.	FW	O	al.	dep	1	SENT_442	[p17l1013t1148r1037b1170],
21	52	CD	NUMBER	52	num	23	SENT_442	[p17l1115t1150r1142b1170],
22	Postma	NNP	ORGANIZATION	Postma	nn	23	SENT_442	[p17l1160t1149r1247b1170],
23	TJ	NNP	ORGANIZATION	TJ	dep	20	SENT_442	[p17l1256t1149r1286b1173],
24	,	,	O	,	_	0	SENT_442	[p17l1256t1149r1286b1173],
25	Heimans	NNP	O	Heimans	nn	26	SENT_442	[p17l1296t1149r1399b1170],
26	JJ	NN	O	jj	appos	1	SENT_442	[p17l1407t1149r1433b1170],
27	.	.	O	.	_	0	SENT_442	[p17l1407t1149r1433b1170],

1	Grading	NN	O	grading	_	0	SENT_443	[p17l1442t1148r1537b1176],
2	of	IN	O	of	_	0	SENT_443	[p17l1547t1148r1571b1170],
3	chemotherapy-induced	JJ	O	chemotherapy-induced	amod	5	SENT_443	[p17l1579t1148r1860b1176],
4	peripheral	JJ	O	peripheral	amod	5	SENT_443	[p17l1872t1148r1992b1175],
5	neuropathy	NN	O	neuropathy	prep_of	1	SENT_443	[p17l6t1186r150b1213],
6	.	.	O	.	_	0	SENT_443	[p17l6t1186r150b1213],

1	Predictive	JJ	O	predictive	amod	4	SENT_444	[p17l52t1222r169b1244],
2	and	CC	O	and	_	0	SENT_444	[p17l187t1222r231b1244],
3	prognostic	JJ	O	prognostic	conj_and	1	SENT_444	[p17l251t1223r378b1250],
4	value	NN	O	value	_	0	SENT_444	[p17l397t1222r460b1244],
5	of	IN	O	of	_	0	SENT_444	[p17l479t1222r503b1244],
6	microsatellite	NN	O	microsatellite	nn	7	SENT_444	[p17l521t1222r680b1244],
7	instability	NN	O	instability	prep_of	4	SENT_444	[p17l700t1222r815b1250],
8	in	IN	O	in	_	0	SENT_444	[p17l833t1223r852b1244],
9	patients	NNS	O	patient	prep_in	7	SENT_444	[p17l873t1223r968b1249],
10	with	IN	O	with	_	0	SENT_444	[p17l986t1222r1037b1244],
11	Ann	NNP	PERSON	Ann	nn	12	SENT_444	[p17l1157t1223r1204b1244],
12	Oncol2000	NNP	O	Oncol2000	prep_with	9	SENT_444	[p17l1216t1222r1358b1247],
13	;	:	O	;	_	0	SENT_444	[p17l1216t1222r1358b1247],
14	11	CD	NUMBER	11	num	16	SENT_444	[p17l1370t1224r1405b1244],
15	:	:	O	:	_	0	SENT_444	[p17l1370t1224r1405b1244],
16	509-513	CD	NUMBER	509-513	dep	4	SENT_444	[p17l1417t1224r1524b1244],
17	.	.	O	.	_	0	SENT_444	[p17l1417t1224r1524b1244],

1	Supplementary	NNP	O	Supplementary	nn	2	SENT_445	[p17l6t1299r242b1334],
2	Information	NNP	O	Information	dep	3	SENT_445	[p17l257t1299r435b1327],
3	accompanies	VBZ	O	accompany	_	0	SENT_445	[p17l451t1301r653b1334],
4	the	DT	O	the	det	5	SENT_445	[p17l667t1299r717b1327],
5	paper	NN	O	paper	dobj	3	SENT_445	[p17l733t1307r821b1334],
6	on	IN	O	on	_	0	SENT_445	[p17l835t1307r872b1327],
7	the	DT	O	the	det	11	SENT_445	[p17l887t1299r937b1327],
8	The	NNP	O	The	nn	11	SENT_445	[p17l950t1299r1007b1327],
9	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	11	SENT_445	[p17l1023t1299r1327b1334],
10	Journal	NNP	O	Journal	nn	11	SENT_445	[p17l1341t1299r1452b1327],
11	website	NN	O	website	prep_on	3	SENT_445	[p17l1467t1299r1586b1327],
12	(	CD	NUMBER	(	num	14	SENT_445	[p17l1602t1299r2037b1334],
13	http://www.nature.com/tpj	NN	O	http://www.nature.com/tpj	nn	14	SENT_445	[p17l1602t1299r2037b1334],
14	)	NN	O	)	nsubj	3	SENT_445	[p17l1602t1299r2037b1334],

1	©	RB	O	©	amod	5	SENT_446	[p17l6t1411r28b1434],
2	2013	CD	DATE	2013	tmod	1	SENT_446	[p17l40t1410r105b1434],
3	Macmillan	NNP	ORGANIZATION	Macmillan	nn	5	SENT_446	[p17l119t1409r258b1434],
4	Publishers	NNPS	ORGANIZATION	Publishers	nn	5	SENT_446	[p17l273t1409r411b1434],
5	Limited	NNP	ORGANIZATION	Limited	_	0	SENT_446	[p17l425t1409r525b1434],
6	The	DT	ORGANIZATION	the	det	8	SENT_446	[p17l1451t1409r1501b1433],
7	Pharmacogenomics	NNP	ORGANIZATION	Pharmacogenomics	nn	8	SENT_446	[p17l1516t1409r1785b1440],
8	Journal	NNP	ORGANIZATION	Journal	dep	5	SENT_446	[p17l1797t1409r1896b1434],
9	(	CD	NUMBER	(	num	11	SENT_446	[p17l1910t1409r2001b1437],
10	2013	CD	DATE	2013	num	11	SENT_446	[p17l1910t1409r2001b1437],
11	)	NN	O	)	dep	5	SENT_446	[p17l1910t1409r2001b1437],
12	,	,	O	,	_	0	SENT_446	[p17l1910t1409r2001b1437],
13	403-409	CD	NUMBER	403-409	appos	11	SENT_446	[p17l2018t1410r2146b1434],

